data_1leb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1leb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 CA--C 1.568 1.664 0 CA-C-O 121.866 0.841 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -71.75 147.99 46.78 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.765 -0.585 . . . . 0.0 111.841 167.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.99 -39.77 56.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -66.97 -46.71 73.8 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -54.61 -45.96 73.75 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 164.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -58.99 -41.93 88.79 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.72 -40.0 95.67 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 165.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.93 -44.39 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 120.259 1.391 . . . . 0.0 113.7 167.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -54.2 -47.91 71.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.33 -39.28 86.51 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.63 -29.84 64.87 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm -58.89 -50.8 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.267 0 CA-C-N 120.036 1.289 . . . . 0.0 113.027 164.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -65.05 -46.06 82.83 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.36 -42.25 96.29 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -36.03 81.73 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.187 1.812 . . . . 0.0 115.301 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.91 -53.45 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 164.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -72.68 -37.24 67.96 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -92.38 1.13 57.41 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.2 m -150.07 -57.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.024 1.284 . . . . 0.0 111.218 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.57 -29.83 2.55 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -105.19 145.3 30.5 Favored Pre-proline 0 CA--C 1.569 1.707 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.39 146.89 22.37 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-N 122.421 1.9 . . . . 0.0 114.26 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 146.64 13.95 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.211 1.825 . . . . 0.0 116.535 -161.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.8 p -73.7 161.81 29.86 Favored 'General case' 0 CA--C 1.577 2.014 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.321 165.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -34.41 67.79 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.17 83.13 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 163.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 49.0 mt-10 -68.68 -40.77 79.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 169.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.13 -47.2 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.309 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 162.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.6 -35.7 72.85 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.72 -42.89 81.24 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.64 -55.34 5.43 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.275 1.398 . . . . 0.0 113.893 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.0 -20.67 60.26 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.24 58.97 2.49 Favored Glycine 0 N--CA 1.48 1.628 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -95.78 126.88 41.35 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -54.08 -28.24 37.83 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.071 2.989 . . . . 0.0 119.071 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.9 m -155.97 158.15 31.57 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 123.852 0.861 . . . . 0.0 111.335 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -46.36 -31.54 9.61 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 N-CA-C 120.375 3.183 . . . . 0.0 120.375 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -54.33 -34.42 61.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.732 2.864 . . . . 0.0 118.732 166.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.44 -40.79 42.13 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.44 84.61 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' HE2' ' NZ ' ' A' ' 48' ' ' LYS . 11.4 pt-20 -58.87 -34.8 72.02 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 169.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.44 -43.58 88.81 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -70.34 -41.96 72.51 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 169.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.24 -50.67 58.72 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' NZ ' ' HE2' ' A' ' 44' ' ' GLU . 15.5 ptpt -67.73 -37.73 82.61 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 169.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.15 89.57 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -57.09 -44.22 82.94 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 163.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.91 96.24 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.64 -40.03 82.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.72 -22.34 65.28 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.71 17.69 37.67 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.34 -21.45 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.2 pt -139.48 143.94 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.165 0 CA-C-N 120.511 1.505 . . . . 0.0 111.9 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 17.7 tt0 -110.82 111.01 21.87 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 124.811 1.245 . . . . 0.0 109.269 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.36 128.88 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.68 133.45 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -85.18 86.51 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.862 . . . . 0.0 112.146 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.23 -72.61 0.24 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.62 120.83 25.57 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.7 t -59.52 -35.7 74.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.639 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 74.0 mtt85 -97.89 84.28 3.3 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.163 0.892 . . . . 0.0 110.337 167.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.19 85.03 0.13 Allowed Glycine 0 N--CA 1.482 1.738 0 O-C-N 121.919 -0.488 . . . . 0.0 112.908 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.06 109.77 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 24.2 ttm180 -95.21 126.36 40.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.217 0.607 . . . . 0.0 109.751 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.46 125.49 29.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.808 -1.182 . . . . 0.0 113.565 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.574 1.886 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.3 2.1 pt? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.1 p -138.14 143.05 40.15 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 154.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 119.402 3.112 . . . . 0.0 119.402 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -78.31 -25.71 46.68 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.28 6.7 pt20 -70.07 -34.91 73.78 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 121.607 2.003 . . . . 0.0 115.807 160.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -57.4 -41.77 80.97 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 162.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -54.84 -45.96 74.57 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.58 -48.2 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.39 -48.4 81.79 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.58 -37.7 73.63 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.33 -42.28 96.36 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 164.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.2 mt -57.76 -46.03 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.938 1.699 . . . . 0.0 113.483 170.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -62.36 -49.24 76.35 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.64 -56.87 12.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -58.88 -40.29 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -44.07 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 167.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -70.67 -24.03 62.61 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 118.691 2.849 . . . . 0.0 118.691 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.53 -47.33 3.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.573 1.149 . . . . 0.0 113.481 -167.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -85.59 -43.52 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.95 -39.87 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -96.22 151.13 37.97 Favored Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.96 124.04 9.79 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 122.185 1.816 . . . . 0.0 113.427 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.9 114.48 3.84 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.182 1.921 . . . . 0.0 115.607 -167.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 t -83.59 -172.73 4.31 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -33.2 -58.19 0.39 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.76 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.52 -40.32 89.1 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 172.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.8 mm -60.59 -52.11 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 119.922 1.237 . . . . 0.0 113.349 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.42 -48.68 66.59 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -72.74 -44.33 61.79 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.1 mt -86.67 -9.64 55.55 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.541 2.422 . . . . 0.0 117.541 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.39 61.04 3.08 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.63 103.37 16.08 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.862 0.839 . . . . 0.0 111.435 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' NE ' ' HG ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -70.56 -9.75 57.55 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 161.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.451 ' HG ' ' NE ' ' A' ' 38' ' ' ARG . 68.7 m -107.25 109.5 62.85 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 117.496 -1.24 . . . . 0.0 110.725 -169.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.73 -44.55 40.28 Favored 'Trans proline' 0 N--CA 1.509 2.422 0 N-CA-C 120.159 3.1 . . . . 0.0 120.159 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.01 -42.99 83.99 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.71 -47.45 73.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.5 -37.98 20.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.55 -35.54 80.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -60.13 -38.42 83.02 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 163.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.58 -45.81 92.57 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.06 -41.4 83.26 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.09 94.76 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 mt -57.68 -41.95 82.63 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 167.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.67 91.01 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 166.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -58.6 -40.97 84.72 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -71.89 -15.96 62.12 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.58 3.86 55.02 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.13 -17.8 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -130.79 129.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.052 1.297 . . . . 0.0 110.813 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -90.68 115.94 28.16 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.247 -0.908 . . . . 0.0 109.916 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.02 132.23 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.68 118.9 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.677 -0.639 . . . . 0.0 109.376 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.4 t -77.53 69.96 3.85 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.86 39.63 0.07 OUTLIER Glycine 0 CA--C 1.548 2.096 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.99 125.28 5.63 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.675 1.238 . . . . 0.0 110.231 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 m -59.53 -47.02 87.14 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -109.61 89.11 2.91 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.62 85.49 0.19 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 116.394 -0.366 . . . . 0.0 113.779 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.24 114.56 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.946 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -96.09 117.28 30.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.213 0.605 . . . . 0.0 110.757 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -74.99 105.17 5.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.571 1.753 0 CA-C-O 122.621 1.201 . . . . 0.0 109.135 171.763 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 98.5 mt . . . . . 0 CA--C 1.568 1.64 0 CA-C-O 121.418 0.628 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -68.45 159.68 31.2 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.05 -45.96 52.69 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -71.08 -39.91 71.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -67.44 -33.98 76.26 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -56.8 -42.92 80.35 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 165.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -53.19 -43.77 67.43 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 164.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.29 -48.5 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -56.64 -47.03 80.62 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.1 -43.24 66.7 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 168.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -39.06 79.89 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.61 -48.49 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 CA-C-N 120.216 1.371 . . . . 0.0 113.457 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.45 -49.44 77.8 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 166.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.37 -49.48 73.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -62.07 -35.68 79.37 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.449 1.931 . . . . 0.0 115.978 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.52 -43.3 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 119.51 1.05 . . . . 0.0 113.029 165.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -64.82 -33.82 76.89 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.55 -47.18 12.44 Favored 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -102.56 -23.97 13.83 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.31 -34.37 4.62 Favored Glycine 0 CA--C 1.552 2.36 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 -159.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.13 154.6 40.55 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.82 152.3 63.73 Favored 'Trans proline' 0 CA--C 1.567 2.129 0 C-N-CA 122.056 1.837 . . . . 0.0 114.929 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.49 144.65 10.29 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.294 1.855 . . . . 0.0 115.094 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 58.6 p -76.47 161.33 28.73 Favored 'General case' 0 CA--C 1.577 2.011 0 O-C-N 121.877 -0.514 . . . . 0.0 112.285 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -50.69 -28.54 9.21 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.84 -36.53 80.51 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 163.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -62.02 -45.84 91.81 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 120.586 1.539 . . . . 0.0 114.518 163.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.04 -53.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 CA-C-N 119.799 1.181 . . . . 0.0 112.603 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.5 99.01 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -78.01 -48.21 16.68 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -70.26 -41.87 72.91 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.12 -17.6 27.37 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.74 62.32 1.95 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -90.82 148.2 22.68 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.426 1.108 . . . . 0.0 113.136 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -35.48 73.75 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -144.94 149.76 43.64 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.843 167.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.36 -33.06 21.58 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 N-CA-C 119.393 2.805 . . . . 0.0 119.393 163.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -65.78 -37.1 85.39 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 167.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.6 96.01 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.49 63.88 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 164.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.98 -34.4 76.48 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 171.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.81 -46.62 84.4 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -63.48 -39.32 94.15 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -53.89 -47.34 71.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 166.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -59.45 -35.75 74.64 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.37 -18.79 65.28 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 169.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.71 -46.0 84.18 Favored 'General case' 0 CA--C 1.592 2.594 0 CA-C-N 119.913 1.233 . . . . 0.0 113.668 159.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.05 175.38 4.52 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.296 1.6 mpt_? 75.74 -54.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.245 -0.909 . . . . 0.0 113.157 -173.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -61.6 -56.58 18.33 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 156.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.22 52.28 0.18 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 117.982 1.953 . . . . 0.0 117.982 169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.298 10.2 p -116.04 -20.64 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 168.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.24 155.61 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 122.218 2.281 . . . . 0.0 113.287 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.21 128.08 34.18 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.914 -0.491 . . . . 0.0 111.577 161.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.83 134.23 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.11 116.79 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.738 0.78 . . . . 0.0 111.917 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -85.53 100.85 12.2 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.738 -0.601 . . . . 0.0 112.267 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.42 -64.74 0.58 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.81 30.85 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.8 m -75.84 -38.84 57.64 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -134.33 100.12 4.58 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.612 1.096 . . . . 0.0 112.306 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.98 64.79 0.45 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.809 167.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.7 96.21 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -86.89 133.24 33.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 122.928 0.491 . . . . 0.0 112.103 169.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.47 125.19 28.94 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-O 121.737 0.78 . . . . 0.0 112.56 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.564 1.518 0 C-N-CA 123.957 0.903 . . . . 0.0 112.679 -171.199 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 CA--C 1.567 1.609 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -66.09 154.89 38.38 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.59 -47.96 28.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -71.11 -41.71 70.23 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.49 -37.19 86.09 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.06 -49.2 77.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 170.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.23 -36.3 79.58 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.47 -50.6 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.465 1.03 . . . . 0.0 113.333 165.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -50.21 -51.68 42.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.55 -39.16 92.74 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.76 -46.27 86.02 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 121.263 1.847 . . . . 0.0 115.043 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.282 36.6 pt -59.06 -46.18 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -54.78 -51.05 66.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 165.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.28 -38.2 90.22 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -72.16 -30.18 64.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.59 -42.3 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.746 1.157 . . . . 0.0 112.908 160.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -64.89 -31.05 72.09 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.3 -43.24 57.59 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 p -125.96 -18.18 5.15 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.29 -43.14 1.95 Allowed Glycine 0 CA--C 1.546 1.978 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 -165.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.05 147.0 32.89 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.15 146.3 88.88 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 N-CA-C 118.886 2.61 . . . . 0.0 118.886 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.45 120.32 3.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.528 2.152 . . . . 0.0 112.58 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -89.21 82.02 6.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 111.624 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.323 23.5 tpt180 66.66 -52.59 0.44 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.07 50.48 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 -167.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.6 -31.17 71.03 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.8 mt -61.21 -53.97 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 CA-C-N 118.941 0.791 . . . . 0.0 112.129 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.88 85.21 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -72.02 -52.11 18.55 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.54 -40.91 28.45 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.63 -24.73 26.98 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.53 81.2 1.33 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 119.411 1.005 . . . . 0.0 114.718 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.72 102.9 8.71 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 117.678 0.739 . . . . 0.0 109.658 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -25.97 61.19 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -98.2 127.13 37.53 Favored Pre-proline 0 CA--C 1.566 1.56 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.327 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.31 -49.27 14.67 Favored 'Trans proline' 0 N--CA 1.508 2.37 0 N-CA-C 119.332 2.782 . . . . 0.0 119.332 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -94.27 75.63 3.97 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.156 0.979 . . . . 0.0 111.444 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.77 -48.61 0.96 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.034 168.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.11 -35.57 80.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.22 -45.87 92.78 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -61.89 -29.21 70.05 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -62.47 -47.42 84.11 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 120.317 1.417 . . . . 0.0 114.301 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.46 -43.31 79.42 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -60.29 -46.14 90.89 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.84 88.73 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 167.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.78 -43.19 94.52 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.13 -46.39 71.01 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -59.72 -40.22 87.28 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -65.11 -30.34 71.27 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 166.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.7 17.21 7.6 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.49 -13.95 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.79 134.55 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 119.863 1.211 . . . . 0.0 111.885 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.19 108.72 19.42 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.164 0.585 . . . . 0.0 110.563 168.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.4 mt -93.38 119.35 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.3 t -83.25 98.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -68.84 98.49 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.92 -55.68 0.68 Allowed Glycine 0 N--CA 1.486 2.009 0 CA-C-N 115.454 -0.794 . . . . 0.0 114.34 -163.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 116.96 23.63 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.6 p -53.68 -41.26 66.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -104.49 41.73 1.29 Allowed 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.62 72.8 0.3 Allowed Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.467 -0.771 . . . . 0.0 112.746 165.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.26 93.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -121.58 133.02 55.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.798 -0.564 . . . . 0.0 111.81 -155.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.92 114.78 11.45 Favored 'General case' 0 CA--C 1.578 2.038 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -165.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 CA--C 1.572 1.798 0 CA-C-O 121.839 0.828 . . . . 0.0 109.171 173.352 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.559 1.322 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 p -75.88 157.26 33.49 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.54 72.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.508 ' NE ' ' HE2' ' A' ' 10' ' ' GLU . 13.5 mmt180 -71.8 -31.39 66.53 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -69.89 -31.25 68.95 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 161.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -60.62 -43.47 97.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 165.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HE2' ' NE ' ' A' ' 7' ' ' ARG . 45.6 mt-10 -55.06 -45.15 75.28 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 165.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.63 -50.23 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.13 -47.74 68.44 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.56 -44.22 89.62 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.48 -37.03 86.12 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.23 -48.62 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 118.05 -0.976 . . . . 0.0 113.208 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -51.23 -46.37 62.26 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -49.24 78.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -71.34 -27.68 63.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mm -51.48 -43.24 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.265 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 158.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -77.09 -35.44 56.52 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.32 -29.47 65.06 Favored 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -146.75 -49.7 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.129 0.971 . . . . 0.0 112.006 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.28 18.37 0.93 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 118.038 1.975 . . . . 0.0 118.038 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptp -155.96 159.18 31.73 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-N 119.652 1.726 . . . . 0.0 113.43 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.83 128.67 31.25 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 122.623 2.216 . . . . 0.0 115.015 160.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 175.18 11.71 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 123.831 2.404 . . . . 0.0 115.55 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.0 p -66.79 154.74 40.06 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -61.2 -22.61 64.92 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 169.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.43 -46.64 69.31 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 160.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 42.4 mt-10 -57.6 -53.21 60.77 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.58 -43.11 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.17 -48.75 78.67 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -79.79 -35.06 39.09 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.68 -39.28 73.61 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 -20.19 21.75 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.95 49.16 2.52 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -105.27 111.36 24.07 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -83.05 56.91 3.66 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 m 171.59 114.17 0.05 OUTLIER Pre-proline 0 CA--C 1.582 2.197 0 C-N-CA 126.148 1.779 . . . . 0.0 107.685 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.7 -33.72 60.95 Favored 'Trans proline' 0 N--CA 1.511 2.523 0 N-CA-C 119.136 2.706 . . . . 0.0 119.136 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -65.95 -33.8 76.64 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.98 96.19 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -52.38 65.05 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 162.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 7.7 tp10 -53.2 -44.84 68.3 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.73 -38.05 66.65 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -72.61 -31.54 65.24 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 167.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.91 -40.17 87.93 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 121.272 1.851 . . . . 0.0 114.747 159.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -60.32 -51.51 69.22 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-N 120.032 1.287 . . . . 0.0 114.248 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.88 73.26 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 169.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.61 -39.03 81.01 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.76 88.72 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 164.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -65.49 -32.78 74.58 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -60.31 -12.62 9.58 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 157.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.69 13.71 66.77 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.51 -3.1 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -164.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.02 137.73 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 119.861 1.21 . . . . 0.0 110.664 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.1 108.11 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 110.622 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.53 138.38 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.03 135.26 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.847 -0.533 . . . . 0.0 112.222 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.1 t -82.01 77.54 8.81 Favored 'General case' 0 CA--C 1.567 1.629 0 O-C-N 121.61 -0.682 . . . . 0.0 112.594 170.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.05 -72.37 0.1 OUTLIER Glycine 0 N--CA 1.484 1.849 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.567 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.69 135.14 39.08 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -65.24 -11.27 39.31 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.424 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 86.6 mtt180 -90.74 -87.37 0.19 Allowed 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 120.049 1.295 . . . . 0.0 111.591 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.4 36.43 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 121.755 -0.591 . . . . 0.0 114.07 -172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.77 -72.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.132 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -151.2 161.47 42.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -163.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -87.87 121.27 30.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.4 164.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 CA--C 1.573 1.847 0 C-N-CA 123.426 0.69 . . . . 0.0 109.957 -178.67 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.8 p -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.26 -36.04 72.66 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.18 -37.92 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 9.6 pt20 -66.18 -30.34 70.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -53.97 -47.01 71.78 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 162.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.88 -46.54 81.8 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 168.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.34 -48.26 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -54.41 -50.39 67.71 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HD2' ' N ' ' A' ' 13' ' ' ASP . 24.2 m-20 -60.39 -34.32 73.74 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.66 -44.44 81.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.338 10.2 tt -61.06 -39.23 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 166.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -55.9 -49.43 73.45 Favored 'General case' 0 CA--C 1.584 2.279 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 163.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.05 -47.71 79.11 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -68.75 -32.83 72.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -55.91 -47.97 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-N 119.509 1.049 . . . . 0.0 113.027 160.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 t -65.88 -33.54 76.08 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.0 -39.52 69.17 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -127.18 -24.81 3.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -167.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -26.75 12.2 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -161.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -105.95 151.34 40.0 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-N 118.656 1.228 . . . . 0.0 114.166 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.55 161.05 22.22 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.471 2.114 . . . . 0.0 115.706 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.79 143.01 11.61 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.876 2.384 . . . . 0.0 115.21 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.0 p -79.32 161.23 26.39 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -52.0 -44.18 63.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.99 90.02 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -63.42 -46.44 86.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.2 mt -57.5 -48.82 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.412 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.19 95.1 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -65.31 -43.41 91.13 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -69.16 -47.79 64.01 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.14 -18.52 28.61 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.84 55.62 1.73 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 116.56 1.384 . . . . 0.0 116.56 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -102.3 106.81 17.67 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 117.696 0.748 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.32 -32.95 71.72 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -106.4 104.91 52.55 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.87 162.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -51.69 -29.23 32.53 Favored 'Trans proline' 0 N--CA 1.509 2.441 0 N-CA-C 120.131 3.089 . . . . 0.0 120.131 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -49.42 -40.03 35.04 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.87 72.28 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 169.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.64 90.66 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -65.31 -35.41 80.92 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 168.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.16 -39.38 94.5 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.372 1.897 . . . . 0.0 115.857 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -60.79 -42.22 97.15 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 163.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.16 -46.44 85.7 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 168.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -61.02 -41.96 97.55 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.82 91.29 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.75 -43.43 90.27 Favored 'General case' 0 CA--C 1.584 2.256 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 165.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.12 80.47 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -60.62 -40.45 91.94 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -64.49 -45.84 85.57 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 168.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.93 60.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.862 0 N-CA-C 116.897 1.519 . . . . 0.0 116.897 163.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.06 -38.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.12 134.25 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.921 1.691 . . . . 0.0 111.42 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.38 99.52 12.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.427 -0.796 . . . . 0.0 111.06 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.68 120.21 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 122.775 0.43 . . . . 0.0 110.444 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.15 128.47 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.8 p -85.78 79.34 9.32 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 121.293 -0.88 . . . . 0.0 112.591 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.09 -65.64 0.32 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 141.73 38.63 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -71.08 107.13 3.99 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.302 82.2 mtt-85 79.01 33.5 0.24 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.32 59.76 0.81 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 164.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mt -117.7 89.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -103.06 135.24 45.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 111.957 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.25 143.63 26.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.677 0.751 . . . . 0.0 112.51 -172.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.576 1.951 0 O-C-N 121.141 -0.974 . . . . 0.0 111.565 -179.568 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.523 0.4 OUTLIER . . . . . 0 CA--C 1.571 1.783 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -133.94 157.11 46.84 Favored 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 123.896 0.878 . . . . 0.0 110.449 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 -36.07 67.77 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -69.09 -47.17 65.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.2 -33.33 75.15 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -63.34 -39.18 93.83 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -57.25 -41.56 79.84 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 165.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.54 -47.32 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 163.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -58.12 -45.62 87.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -54.13 -40.97 67.85 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.45 -51.47 68.58 Favored 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 120.761 1.619 . . . . 0.0 115.362 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.15 -43.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -62.19 -44.69 96.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.34 -52.83 60.34 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 166.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -69.26 -36.21 76.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -54.92 -48.63 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 CA-C-N 119.524 1.056 . . . . 0.0 113.658 161.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -69.64 -34.15 73.62 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -98.6 -43.3 6.89 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 m -95.03 -44.65 7.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.48 -29.75 6.26 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 117.875 1.91 . . . . 0.0 117.875 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -100.12 155.4 36.47 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -74.34 123.08 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.381 2.054 . . . . 0.0 114.85 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.05 148.11 19.19 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 CA-C-N 123.017 2.113 . . . . 0.0 113.373 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -71.38 165.49 23.64 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 8.9 ptm180 -52.41 -32.16 37.75 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 162.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.1 96.97 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.9 -37.84 86.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 168.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.3 -48.22 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.785 1.175 . . . . 0.0 113.524 166.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.46 96.77 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -62.99 -47.11 84.57 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -78.37 -46.49 19.84 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.1 -22.08 39.43 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.725 2.121 . . . . 0.0 116.725 168.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.57 48.0 4.66 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 117.003 1.561 . . . . 0.0 117.003 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.07 93.38 8.6 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.148 0.974 . . . . 0.0 109.388 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -58.85 -32.91 69.86 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -94.5 106.08 21.81 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.244 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.21 -12.07 34.58 Favored 'Trans proline' 0 N--CA 1.51 2.458 0 N-CA-C 118.712 2.543 . . . . 0.0 118.712 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -58.47 -32.56 68.86 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 159.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.38 93.61 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.2 73.07 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.569 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 19.0 tt0 -64.42 -48.24 76.12 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 171.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.72 -39.25 93.32 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -61.88 -42.44 99.07 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 164.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.82 -40.86 85.38 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.22 -51.54 65.84 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.21 -38.79 68.89 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 167.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.74 -43.15 99.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.03 -39.75 95.67 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.9 -34.15 75.52 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.2 -39.82 94.78 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 161.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.37 51.13 0.18 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 117.176 1.631 . . . . 0.0 117.176 164.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 -8.29 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.082 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.06 145.71 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 121.892 2.133 . . . . 0.0 112.703 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.05 112.46 21.89 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.569 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -83.61 105.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 109.605 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.15 123.31 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-O 121.319 0.58 . . . . 0.0 112.046 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.3 t -82.07 73.87 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.62 -83.77 0.13 Allowed Glycine 0 N--CA 1.482 1.745 0 O-C-N 122.068 -0.395 . . . . 0.0 113.53 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.84 89.89 6.37 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 27.5 t -59.12 -11.86 4.25 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -80.39 15.88 1.48 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 165.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.14 43.73 1.62 Allowed Glycine 0 CA--C 1.552 2.364 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 155.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.2 tp -93.03 75.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.158 0.98 . . . . 0.0 111.235 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -91.85 135.51 33.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 112.38 -166.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -93.29 142.67 27.06 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.564 1.494 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.571 1.772 0 CA-C-O 121.22 0.533 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 157.7 29.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.187 -0.946 . . . . 0.0 112.872 168.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.2 50.46 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.15 -38.57 85.72 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -56.57 -47.82 78.69 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -62.83 -41.74 99.45 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.33 -50.59 69.25 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.02 -49.25 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.1 -47.28 85.33 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.84 -33.4 70.39 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -38.72 71.51 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 167.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt -55.4 -56.68 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 123.995 0.918 . . . . 0.0 112.732 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -68.13 -32.2 72.32 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HD2' ' NE ' ' A' ' 34' ' ' ARG . 36.7 t70 -55.56 -53.06 61.08 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 168.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -69.96 -37.63 75.85 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.34 -42.2 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-N 119.91 1.232 . . . . 0.0 113.421 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.84 -30.32 71.31 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 169.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.82 -50.08 7.41 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.3 m -107.01 -31.07 8.46 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.2 23.91 18.32 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -147.87 156.2 44.33 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-N 119.091 1.446 . . . . 0.0 112.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -57.48 137.43 81.42 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.65 143.2 14.84 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 122.448 1.91 . . . . 0.0 114.753 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -74.37 160.98 30.31 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 74.6 ttt180 -32.1 -55.19 0.31 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 166.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.96 75.53 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -56.19 -43.57 78.57 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.1 -56.39 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 118.927 0.785 . . . . 0.0 112.095 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.85 75.35 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -75.77 -25.86 56.84 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.437 ' NE ' ' HD2' ' A' ' 17' ' ' ASP . 14.6 tpt180 -70.0 -46.17 65.7 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.232 1.378 . . . . 0.0 114.547 166.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.55 -37.95 30.5 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.92 0.27 Allowed Glycine 0 CA--C 1.545 1.958 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -114.55 130.87 56.8 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 117.872 0.836 . . . . 0.0 109.647 165.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -70.79 -41.36 71.77 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -101.23 113.18 65.83 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.387 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -56.08 -19.67 27.62 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -58.0 -28.62 64.58 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.97 71.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.56 80.21 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.484 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 31.8 mt-10 -60.67 -40.98 94.11 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.24 -49.97 72.62 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.44 -39.23 77.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 tp -52.52 -44.6 65.86 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 166.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -57.93 -40.04 79.5 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 166.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.78 99.56 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 166.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.56 -45.16 81.43 Favored 'General case' 0 CA--C 1.59 2.503 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.28 92.45 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 174.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -56.2 -39.55 72.6 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 165.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -76.44 6.4 5.76 Favored 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 28.02 58.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.42 -37.77 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 118.55 1.175 . . . . 0.0 113.182 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.65 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-N 119.676 1.125 . . . . 0.0 111.409 169.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.36 127.04 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.166 163.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.6 103.88 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.65 81.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.988 0.899 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.3 t -88.37 72.46 8.94 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -166.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.39 -67.91 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 O-C-N 122.018 -0.427 . . . . 0.0 113.15 158.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.01 161.59 28.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 150.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.9 p -76.08 68.73 2.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.293 24.7 ptt180 -174.43 -110.49 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.744 1.617 . . . . 0.0 109.107 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.96 45.24 96.55 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mt -102.69 113.73 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 118.273 1.037 . . . . 0.0 110.37 -161.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -97.57 135.79 38.9 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 121.451 0.643 . . . . 0.0 111.94 162.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 109.91 17.86 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.275 0.63 . . . . 0.0 111.082 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 CA--C 1.572 1.819 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.57 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 121.997 0.903 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.0 p -80.76 145.55 31.45 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.028 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.3 66.12 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.73 -37.55 70.58 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -57.47 -46.32 83.8 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 121.02 1.736 . . . . 0.0 114.566 163.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -54.91 -47.29 74.54 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -53.37 -47.11 69.72 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 167.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.12 -47.77 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.24 -45.79 87.12 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -60.15 -37.2 79.4 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.22 -39.65 93.05 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 167.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -58.52 -45.62 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-N 119.405 1.002 . . . . 0.0 113.553 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -54.52 -51.34 65.46 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -60.9 -39.65 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -65.71 -47.71 74.45 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mm -57.51 -46.65 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 167.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -69.96 -12.63 61.75 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -70.74 -41.62 71.6 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 121.086 1.767 . . . . 0.0 115.022 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -149.11 -73.17 0.18 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.94 51.99 0.21 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 113.716 165.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -122.23 128.15 25.61 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.026 -164.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.22 153.85 76.43 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 CA-C-N 123.092 2.14 . . . . 0.0 115.417 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.52 161.97 27.9 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 CA-C-N 122.55 1.947 . . . . 0.0 114.441 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -95.62 158.27 15.53 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.217 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -54.94 -37.58 66.6 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.05 99.86 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 166.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.26 -41.04 96.24 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 167.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.85 -51.04 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 119.647 1.112 . . . . 0.0 113.54 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.76 89.43 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -80.46 -39.23 28.52 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -78.88 -41.4 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.16 -36.86 34.49 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 61.91 0.69 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.21 101.88 10.35 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.67 62.32 6.8 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.365 1.078 . . . . 0.0 113.427 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m 175.9 126.98 0.15 Allowed Pre-proline 0 CA--C 1.58 2.115 0 C-N-CA 125.89 1.676 . . . . 0.0 107.995 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -61.22 -42.65 33.93 Favored 'Trans proline' 0 N--CA 1.51 2.442 0 CA-C-N 123.119 2.15 . . . . 0.0 116.503 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.34 -30.88 67.07 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.97 75.32 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.68 95.81 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 166.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.42 -53.25 60.48 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.47 -32.05 69.43 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -65.72 -37.9 87.71 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.333 1.879 . . . . 0.0 115.217 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.56 -51.3 70.48 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -57.45 -40.63 78.87 Favored 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 115.564 1.691 . . . . 0.0 115.564 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.45 95.64 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 167.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.68 -38.87 82.69 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.21 97.07 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 165.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -62.14 -36.22 81.14 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -58.63 -24.5 61.19 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 162.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.24 66.31 1.16 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 118.892 0.769 . . . . 0.0 114.99 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.269 10.5 p -149.33 -52.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.2 pt -96.01 131.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 120.864 1.666 . . . . 0.0 113.358 -171.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.76 110.01 20.64 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.297 0.639 . . . . 0.0 110.437 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.3 125.59 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.74 125.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 112.678 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -84.19 74.66 10.27 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.12 -67.52 0.23 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.27 142.04 34.95 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -66.45 -30.49 70.85 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 118.469 2.766 . . . . 0.0 118.469 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -108.73 88.88 2.83 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 119.971 1.26 . . . . 0.0 110.617 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.54 72.76 0.14 Allowed Glycine 0 N--CA 1.486 1.988 0 O-C-N 121.862 -0.524 . . . . 0.0 114.044 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.92 101.99 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -119.34 129.17 54.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.923 -0.485 . . . . 0.0 112.003 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 134.33 37.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.572 1.817 0 CA-C-O 122.218 1.009 . . . . 0.0 110.664 -175.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.568 1.67 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 p -74.65 149.32 40.02 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.15 9.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.704 3.594 . . . . 0.0 120.704 -169.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.89 -45.82 40.27 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.48 -37.93 89.24 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 169.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -53.72 -40.97 66.53 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 164.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.11 -47.9 80.81 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 167.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.97 -49.04 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.645 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -55.48 -39.66 70.7 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.31 -45.64 90.76 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.39 -40.44 90.88 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 120.634 1.561 . . . . 0.0 114.909 170.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mt -60.58 -48.68 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -55.41 -48.22 74.71 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -59.27 -48.93 79.78 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -64.14 -41.12 97.31 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.4 mm -68.53 -50.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.494 1.043 . . . . 0.0 113.263 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -73.4 -38.02 65.75 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -88.56 -52.84 4.95 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 119.606 1.094 . . . . 0.0 113.448 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.46 -20.91 19.27 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 41.69 20.82 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 118.141 2.016 . . . . 0.0 118.141 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -149.23 142.67 16.19 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-N 118.893 1.346 . . . . 0.0 113.943 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.33 117.66 1.02 Allowed 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.121 1.881 . . . . 0.0 114.295 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.15 174.09 13.36 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 123.21 2.182 . . . . 0.0 117.644 -170.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -94.21 156.12 16.7 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.043 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -59.23 -28.19 66.45 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 166.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.94 96.58 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.498 ' HE2' ' NH2' ' A' ' 64' ' ' ARG . 21.2 mt-10 -62.68 -39.96 95.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 168.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.24 -51.08 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 123.734 0.814 . . . . 0.0 112.832 166.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.89 93.31 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -67.19 -45.89 75.55 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.73 -45.32 44.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.79 -14.49 34.39 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -171.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 63.61 1.21 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -117.44 120.83 39.32 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -55.95 -37.27 68.79 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -123.94 148.98 58.56 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.118 159.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -58.21 -12.63 13.55 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 164.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -58.06 -41.71 83.94 Favored 'General case' 0 CA--C 1.587 2.375 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 163.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.29 89.48 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.65 78.5 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 164.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -56.2 -36.95 68.98 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.34 -48.76 80.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -65.17 -38.19 89.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 168.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.59 -37.99 66.18 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -55.77 -57.03 13.74 Favored 'General case' 0 CA--C 1.574 1.897 0 CA-C-N 120.653 1.57 . . . . 0.0 114.811 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.98 75.64 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 168.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.79 -48.45 79.67 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.9 77.39 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -55.78 -41.98 74.86 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -71.83 -14.11 61.87 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.53 62.46 0.45 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 117.395 1.718 . . . . 0.0 117.395 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 m -141.74 -45.04 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.163 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 156.06 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 120.852 1.66 . . . . 0.0 114.548 -168.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.59 144.1 44.11 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 162.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.8 mt -114.11 120.09 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.65 106.59 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.677 0.751 . . . . 0.0 111.047 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.9 p -86.81 87.89 7.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 112.748 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.34 -65.86 0.42 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 169.55 18.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 170.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.1 p -91.66 -55.74 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' NH2' ' HE2' ' A' ' 30' ' ' GLU . 19.2 mmt180 -84.43 90.09 7.53 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.532 1.158 . . . . 0.0 112.225 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.3 44.83 0.16 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.6 mt -106.49 99.84 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -115.38 145.24 42.72 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.242 0.617 . . . . 0.0 112.006 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.13 123.1 18.98 Favored 'General case' 0 CA--C 1.579 2.093 0 O-C-N 122.05 -0.406 . . . . 0.0 111.853 166.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 122.608 1.194 . . . . 0.0 112.437 -177.804 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 CA--C 1.575 1.916 0 CA-C-O 121.419 0.628 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.5 p -71.16 159.45 34.65 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.92 75.22 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -70.19 -37.05 75.02 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -65.25 -38.52 90.58 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.721 1.6 . . . . 0.0 115.276 166.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -56.54 -40.91 75.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 164.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.59 -45.52 85.19 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -57.81 -50.33 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.07 -46.11 82.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -59.29 -30.17 68.13 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -64.8 -45.75 84.94 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.077 1.308 . . . . 0.0 114.345 165.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mm -55.68 -47.46 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 169.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -60.15 -46.51 89.43 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.31 -55.32 35.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.52 -34.42 75.83 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.78 -42.1 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.215 1.37 . . . . 0.0 112.716 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.1 t -63.21 -31.7 72.91 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 168.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -73.08 -44.31 60.7 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -120.43 -22.44 6.48 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -167.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.15 -30.74 6.85 Favored Glycine 0 CA--C 1.549 2.195 0 N-CA-C 117.886 1.915 . . . . 0.0 117.886 -163.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -104.69 138.88 19.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -60.93 135.86 62.09 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 N-CA-C 119.499 2.846 . . . . 0.0 119.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.5 123.43 6.5 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.46 2.107 . . . . 0.0 113.607 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -100.04 101.97 13.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -168.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.301 76.4 mtt85 70.85 -72.03 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 142.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.05 77.49 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 157.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -60.52 -40.54 91.82 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -62.72 -52.35 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 120.048 1.295 . . . . 0.0 112.664 166.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.74 81.96 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -71.39 -47.77 54.07 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.19 -43.12 87.7 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.27 -6.32 59.43 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.4 51.52 4.6 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.32 108.42 20.59 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 117.643 0.721 . . . . 0.0 109.641 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -80.46 50.3 1.27 Allowed 'General case' 0 CA--C 1.584 2.27 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 175.52 96.79 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 C-N-CA 126.673 1.989 . . . . 0.0 106.083 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -54.52 -30.54 65.16 Favored 'Trans proline' 0 N--CA 1.513 2.62 0 N-CA-C 120.048 3.057 . . . . 0.0 120.048 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -60.93 -35.53 76.95 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.35 79.64 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.76 -42.91 76.17 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 162.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.4 -34.89 78.97 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 173.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.33 -42.92 96.63 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -61.75 -45.03 95.65 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 165.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.54 -49.03 65.67 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -61.14 -46.71 89.43 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.88 74.43 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.64 -37.64 85.24 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.32 95.79 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 ttt-85 -54.39 -44.03 71.94 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.37 -7.24 23.35 Favored 'General case' 0 CA--C 1.592 2.569 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.42 53.23 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.929 2.332 . . . . 0.0 118.929 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.23 -25.28 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.66 128.99 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.868 1.213 . . . . 0.0 111.221 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.66 107.61 19.28 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.663 -0.648 . . . . 0.0 110.619 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -80.83 122.02 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.18 123.15 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.016 0.526 . . . . 0.0 110.032 -169.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 m -78.73 84.42 4.81 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 121.752 0.787 . . . . 0.0 112.417 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.58 -64.22 0.35 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.73 123.05 25.6 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 m -61.66 -57.04 13.55 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -81.66 79.49 8.22 Favored 'General case' 0 CA--C 1.577 1.988 0 CA-C-N 119.259 0.936 . . . . 0.0 110.375 159.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.38 0.49 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.215 -0.902 . . . . 0.0 114.016 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.34 86.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -109.3 157.14 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.469 1.128 . . . . 0.0 113.791 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.36 110.75 18.4 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -161.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.585 2.324 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 166.728 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 CA--C 1.575 1.931 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.1 p -75.69 147.78 39.16 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.833 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.34 44.01 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 119.004 2.965 . . . . 0.0 119.004 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -73.63 -39.42 64.53 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.78 -33.4 75.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.7 -45.3 85.88 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 163.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.96 -42.58 76.43 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 167.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.0 -45.06 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.203 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -55.91 -42.53 76.19 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -54.31 -46.17 72.77 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -55.89 -37.7 69.21 Favored 'General case' 0 CA--C 1.586 2.344 0 N-CA-C 116.901 2.185 . . . . 0.0 116.901 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.13 -53.59 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 119.826 1.194 . . . . 0.0 113.263 170.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -60.58 -46.61 89.58 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -64.11 -47.52 79.68 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -69.32 -37.62 77.83 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.7 mt -57.35 -47.64 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 120.526 1.512 . . . . 0.0 112.94 167.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -62.26 -25.89 68.09 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 168.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.27 -58.85 2.67 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.854 1.206 . . . . 0.0 113.388 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 m -151.03 68.83 0.94 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 119.899 1.227 . . . . 0.0 111.151 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.34 -49.51 3.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 121.084 3.194 . . . . 0.0 121.084 160.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.16 137.95 19.38 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -157.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.45 122.67 5.67 Favored 'Trans proline' 0 CA--C 1.572 2.403 0 C-N-CA 122.727 2.285 . . . . 0.0 114.822 172.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -55.99 157.07 17.75 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 N-CA-C 122.322 3.932 . . . . 0.0 122.322 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 p -115.92 -174.58 2.56 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.176 163.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -28.09 22.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -171.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.37 90.84 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 12.1 mp0 -76.12 -50.44 14.64 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 119.554 1.07 . . . . 0.0 112.915 165.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.6 mt -57.98 -49.61 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.45 76.4 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.46 -44.68 18.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -70.06 -40.23 75.21 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.27 -18.67 48.67 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 64.78 1.46 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -100.22 152.6 20.1 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.354 1.073 . . . . 0.0 113.027 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -56.02 -32.91 64.41 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 166.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m -163.21 159.21 18.33 Favored Pre-proline 0 CA--C 1.577 1.987 0 C-N-CA 124.088 0.955 . . . . 0.0 112.045 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -57.87 -30.44 89.54 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.914 2.236 . . . . 0.0 117.914 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.34 -45.04 88.88 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 167.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.54 88.81 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.61 -49.53 70.72 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.88 -30.37 68.86 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.6 -40.19 86.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -66.05 -42.22 89.79 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.68 -51.76 62.17 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.16 -48.38 78.68 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -46.89 74.56 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.05 -37.58 87.94 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.88 65.48 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -68.42 -24.36 64.74 Favored 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -69.02 -27.77 65.97 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 160.57 -54.27 0.33 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 168.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.25 -20.25 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -158.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -117.42 145.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 121.192 1.814 . . . . 0.0 112.939 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 34.1 tt0 -82.51 114.51 20.98 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.096 0.958 . . . . 0.0 113.549 -163.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.72 96.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.716 0.77 . . . . 0.0 111.155 -172.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.4 m -91.05 110.63 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 121.698 0.761 . . . . 0.0 112.311 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.8 p -83.22 81.51 8.67 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.009 -1.057 . . . . 0.0 112.831 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.07 -52.11 0.71 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.22 115.08 12.13 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 m -74.12 105.38 5.31 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.358 0.599 . . . . 0.0 111.32 170.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.56 ' NE ' ' HE2' ' A' ' 30' ' ' GLU 0.332 75.5 mtt85 72.92 50.31 0.15 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -166.006 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.48 5.14 24.79 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 164.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.252 9.8 tt -77.55 80.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.56 1.68 . . . . 0.0 114.612 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.454 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 59.5 ttp85 -82.67 144.99 29.88 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.388 1.075 . . . . 0.0 113.222 -168.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.0 125.32 25.96 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.991 -1.068 . . . . 0.0 113.535 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 121.874 0.845 . . . . 0.0 109.827 -173.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.568 1.642 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -81.23 160.04 24.39 Favored 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.169 -0.957 . . . . 0.0 113.092 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.17 -41.13 74.98 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -72.11 -29.61 64.26 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.67 -45.86 85.03 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.807 1.64 . . . . 0.0 114.714 159.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -44.23 87.62 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.14 -46.13 82.97 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.08 -46.95 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -56.56 -41.54 77.06 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.85 -40.14 79.42 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.29 -45.66 92.26 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.31 31.3 pt -63.23 -33.66 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -64.04 -50.44 68.41 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 120.652 1.569 . . . . 0.0 115.121 161.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -60.82 -47.54 85.87 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -67.69 -39.06 84.46 Favored 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.3 mm -57.37 -49.21 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.964 1.256 . . . . 0.0 113.122 165.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -62.89 -49.09 76.18 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -96.65 8.12 44.95 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -154.71 -54.91 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.561 -1.337 . . . . 0.0 111.489 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.04 38.91 1.1 Allowed Glycine 0 CA--C 1.545 1.913 0 N-CA-C 116.407 1.323 . . . . 0.0 116.407 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -144.21 135.56 12.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-N 118.782 1.291 . . . . 0.0 113.096 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -91.14 107.18 0.29 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 CA-C-N 122.944 2.087 . . . . 0.0 113.908 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.77 121.14 8.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.559 2.839 . . . . 0.0 115.582 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.416 ' HG1' ' NE ' ' A' ' 64' ' ' ARG . 45.9 p -109.41 118.82 37.66 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.286 98.1 mtt180 72.17 -65.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 155.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.24 23.74 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.78 -36.21 80.41 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.8 mm -60.44 -52.87 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.41 95.29 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -67.17 -42.57 84.05 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -76.79 -47.13 22.53 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.08 -10.86 56.39 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 43.95 7.54 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 117.677 1.831 . . . . 0.0 117.677 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -89.69 85.32 6.42 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 118.615 1.208 . . . . 0.0 110.101 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.98 -24.13 66.72 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.5 m -91.37 112.49 54.41 Favored Pre-proline 0 CA--C 1.568 1.671 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.785 163.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.96 -18.52 62.43 Favored 'Trans proline' 0 N--CA 1.51 2.477 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -55.54 -44.45 76.77 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 166.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.09 -44.17 74.66 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.28 86.43 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 172.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -41.86 85.24 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 170.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.15 -50.02 50.28 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 166.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -64.93 -38.68 91.75 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.22 -49.53 77.25 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 21.9 pttm -63.89 -36.42 83.88 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 168.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.49 87.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 168.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.92 -43.8 86.48 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 164.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.12 84.31 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ttm105 -59.25 -36.88 76.29 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.94 -51.28 69.92 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.23 16.26 3.23 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.72 -10.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -136.84 138.14 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-N 120.02 1.282 . . . . 0.0 112.049 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -100.11 128.94 46.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.545 0.688 . . . . 0.0 110.149 166.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.6 mm -90.53 115.63 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 C-N-CA 123.141 0.576 . . . . 0.0 109.556 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.79 92.98 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -79.98 85.0 5.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.33 -84.71 0.05 OUTLIER Glycine 0 N--CA 1.481 1.633 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.725 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.95 52.89 2.52 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.297 63.2 m 64.65 -73.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.416 ' NE ' ' HG1' ' A' ' 27' ' ' THR . 83.3 mtt180 -96.32 82.9 3.47 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 122.167 0.984 . . . . 0.0 111.589 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.77 95.5 0.28 Allowed Glycine 0 N--CA 1.48 1.629 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.293 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.0 120.03 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.537 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 60.3 mtt-85 -93.96 128.32 40.22 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 121.696 -0.627 . . . . 0.0 110.993 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -84.57 111.74 19.79 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 123.023 0.529 . . . . 0.0 112.023 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 CA--C 1.573 1.829 0 CA-C-O 121.775 0.798 . . . . 0.0 110.4 -177.675 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 CA--C 1.566 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.7 p -80.54 94.98 6.36 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.294 . . 49.45 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 119.459 3.133 . . . . 0.0 119.459 168.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -74.79 -31.19 61.67 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.04 -32.13 73.12 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 161.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -57.85 -42.32 84.2 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 163.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.19 -44.69 68.12 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 163.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.33 -43.58 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.73 -40.23 87.36 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.41 -40.84 92.4 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 165.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.86 -47.23 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.446 0.1 OUTLIER -64.62 -39.22 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 121.106 1.775 . . . . 0.0 115.414 174.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtp85 -59.59 -39.67 84.92 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.37 -49.03 77.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -63.36 -39.92 95.86 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.75 -47.22 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 118.977 0.808 . . . . 0.0 113.16 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -61.05 -30.82 70.55 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -84.29 -41.69 16.58 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -116.96 -22.39 8.49 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.21 -47.9 1.45 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -161.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -90.1 159.74 41.78 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.89 162.5 37.24 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.403 2.069 . . . . 0.0 116.731 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 166.91 22.12 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.675 2.25 . . . . 0.0 116.862 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -67.0 147.2 53.53 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.792 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -57.5 -32.78 67.35 Favored 'General case' 0 CA--C 1.591 2.532 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.18 80.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 165.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.77 -33.37 66.55 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 170.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -60.69 -48.5 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-N 119.376 0.989 . . . . 0.0 112.629 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.56 61.16 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -64.98 -54.09 35.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -75.97 -39.15 56.58 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.15 -18.67 59.01 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 56.34 1.37 Allowed Glycine 0 N--CA 1.481 1.695 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.88 116.69 32.37 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 117.583 0.691 . . . . 0.0 110.199 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -63.48 -33.43 75.55 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 157.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 t -94.97 103.01 10.39 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 123.791 0.837 . . . . 0.0 112.291 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.71 -23.55 56.04 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.406 2.041 . . . . 0.0 117.406 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -58.83 -40.73 85.05 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 161.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.16 96.42 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 167.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.11 71.34 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 173.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.55 -33.41 75.85 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.9 -46.98 84.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -65.81 -30.68 71.35 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 tp -60.39 -52.09 66.73 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 121.121 1.782 . . . . 0.0 114.929 166.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 61.7 pttt -62.79 -42.07 99.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.12 74.38 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 166.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.37 -38.79 81.74 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.05 87.6 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 163.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -61.82 -35.68 78.95 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -59.11 -32.93 70.27 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 163.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.11 34.74 1.1 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.565 2.186 . . . . 0.0 118.565 163.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.49 -4.63 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.13 153.34 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.191 0 CA-C-N 119.689 1.131 . . . . 0.0 111.82 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -112.66 122.69 48.42 Favored 'General case' 0 CA--C 1.571 1.763 0 O-C-N 121.745 -0.597 . . . . 0.0 109.545 163.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -88.68 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.63 92.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -85.66 100.23 11.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.632 0.729 . . . . 0.0 112.277 -157.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.83 -53.63 0.7 Allowed Glycine 0 N--CA 1.486 2.008 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.053 -160.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.53 113.09 12.55 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 117.481 0.64 . . . . 0.0 112.553 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.8 p -60.33 -46.19 90.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -91.26 84.95 5.7 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 159.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.12 71.61 0.22 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.05 111.34 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.824 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.84 135.21 37.9 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 111.995 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 tp -95.31 111.61 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.98 0.512 . . . . 0.0 111.346 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 121.746 0.784 . . . . 0.0 109.987 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 p -65.93 152.4 44.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -160.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.01 -40.37 58.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 120.406 3.484 . . . . 0.0 120.406 -165.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -39.38 34.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.96 -34.77 75.26 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 162.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.51 -41.28 96.5 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 167.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -57.42 -47.73 80.99 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 165.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.35 -49.34 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 165.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.0 -41.33 97.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.27 -40.87 95.72 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.93 -46.52 71.29 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.116 1.78 . . . . 0.0 114.983 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.262 3.6 tp -53.15 -46.98 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -62.81 -49.33 75.35 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 172.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.06 -44.17 97.78 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -72.85 -43.54 62.48 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.26 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 120.525 1.511 . . . . 0.0 114.776 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -59.94 -30.74 69.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 171.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -93.68 -47.63 6.71 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 p -93.33 -26.41 17.3 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.785 2.142 . . . . 0.0 116.785 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.91 3.76 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.25 141.58 24.18 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.7 132.63 8.88 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 122.187 1.817 . . . . 0.0 114.506 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -55.33 145.03 69.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 N-CA-C 118.272 2.374 . . . . 0.0 118.272 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 p -74.52 150.46 39.79 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.237 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' NE ' ' HE2' ' A' ' 44' ' ' GLU 0.26 16.6 ptt180 -58.82 -26.98 64.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 173.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.2 -40.83 70.94 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -56.93 -49.74 74.71 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 166.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.05 -45.58 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.09 -55.0 36.01 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 170.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.21 -37.16 63.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.96 -36.5 72.59 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.25 -11.81 59.98 Favored 'General case' 0 CA--C 1.584 2.268 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 168.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.72 54.2 4.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -83.82 146.23 28.23 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.451 1.119 . . . . 0.0 113.888 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.02 88.45 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.0 m -152.8 143.97 16.05 Favored Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.718 164.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.45 -30.7 16.25 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -59.05 -31.68 69.07 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.06 99.24 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 165.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.25 96.48 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 165.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.543 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 61.5 mt-10 -55.74 -46.52 77.8 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 164.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.37 -42.32 95.55 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -66.21 -36.95 84.39 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -58.89 -41.37 87.0 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.5 -47.13 82.98 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 170.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.54 79.01 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.8 tp -63.31 -41.41 98.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.0 99.85 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -50.9 -38.02 47.29 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -77.37 6.21 7.29 Favored 'General case' 0 CA--C 1.592 2.558 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.58 40.97 16.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.42 -44.04 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.538 -169.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -127.51 137.65 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 119.709 1.14 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.67 115.86 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 110.684 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.46 123.92 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.07 105.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 164.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.0 m -77.59 95.74 4.63 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -161.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.13 -60.25 0.51 Allowed Glycine 0 N--CA 1.484 1.847 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.576 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.25 123.85 25.32 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.9 p -61.55 -41.31 97.18 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -99.68 28.57 4.6 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 163.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.58 69.81 3.26 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.309 -1.494 . . . . 0.0 114.305 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.03 98.94 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -168.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -98.61 108.58 21.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 110.281 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . 0.299 2.3 pp -82.09 93.1 6.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 165.916 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.572 1.797 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -74.33 153.96 39.09 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.408 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -44.38 70.75 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -72.09 -33.29 67.77 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -56.55 -46.55 80.62 Favored 'General case' 0 CA--C 1.583 2.229 0 CA-C-N 120.502 1.501 . . . . 0.0 114.481 161.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -61.54 -40.05 93.28 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.93 -50.71 68.17 Favored 'General case' 0 CA--C 1.582 2.207 0 CA-C-N 121.004 1.729 . . . . 0.0 115.391 164.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.2 t -55.76 -50.01 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -59.62 -42.53 92.89 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.06 -38.14 75.74 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -44.01 97.69 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 120.597 1.544 . . . . 0.0 114.768 168.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -53.26 -53.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 166.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -62.87 -37.65 87.73 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.73 -47.79 83.39 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 170.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -66.04 -41.32 91.02 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 120.593 1.542 . . . . 0.0 115.031 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.2 mt -67.65 -44.93 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -65.09 -28.77 69.68 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -87.79 -45.93 9.9 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -105.56 -23.69 12.73 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.42 -47.43 1.34 Allowed Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -164.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -88.63 160.72 43.91 Favored Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 158.85 50.91 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.078 1.852 . . . . 0.0 116.059 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.07 164.87 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.263 1.976 . . . . 0.0 114.891 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.5 p -72.97 151.04 41.99 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.205 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -57.87 -25.15 60.37 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.15 94.45 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 160.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.18 -45.42 93.19 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.1 -50.46 78.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.302 0 CA-C-N 120.133 1.333 . . . . 0.0 112.359 170.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.41 81.89 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.43 -49.04 11.98 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -67.33 -40.14 85.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.2 -14.97 58.73 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.05 65.28 1.54 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.08 141.31 31.18 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 121.968 0.89 . . . . 0.0 112.91 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -35.34 79.78 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -136.42 142.29 38.92 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.307 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -61.55 -24.54 78.21 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 N-CA-C 118.006 2.272 . . . . 0.0 118.006 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -63.89 -28.31 69.75 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 167.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -45.47 92.37 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.17 73.77 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.43 -48.11 69.04 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 171.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.33 -30.78 68.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -62.36 -38.88 91.27 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 162.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.14 -43.22 99.22 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.5 -47.9 78.33 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 163.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.01 94.06 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.76 -38.02 77.53 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 164.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.5 -46.22 76.97 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 166.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -59.22 -34.98 72.83 Favored 'General case' 0 CA--C 1.582 2.186 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.88 -26.07 67.15 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 163.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.16 41.47 3.02 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -129.73 -41.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.216 0 CA-C-N 118.103 0.952 . . . . 0.0 113.315 -169.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -126.0 135.53 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.0 1.273 . . . . 0.0 110.914 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.12 118.05 31.94 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 110.015 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.44 125.39 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 121.045 0.45 . . . . 0.0 110.291 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.47 93.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -74.58 123.45 24.83 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -160.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.65 -47.03 1.09 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -161.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.87 119.63 22.33 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -58.19 -41.51 84.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 171.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -95.07 83.1 3.86 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.63 0.728 . . . . 0.0 109.821 161.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.39 67.01 0.33 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.7 mm -135.83 118.98 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -172.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -103.17 126.7 50.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.822 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.5 tp -91.71 121.28 33.21 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 CA--C 1.572 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 162.182 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 CA--C 1.569 1.692 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.6 p -67.15 155.94 37.48 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.06 61.18 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -74.25 -38.3 63.52 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -58.52 -44.96 89.7 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 120.823 1.647 . . . . 0.0 115.178 168.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -61.25 -41.28 96.63 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.46 -47.26 79.55 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 165.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.95 -44.68 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -61.58 -41.56 97.58 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 172.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.82 -46.59 89.93 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.75 -41.14 98.05 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.277 0.4 OUTLIER -58.17 -46.57 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 CA-C-N 120.548 1.522 . . . . 0.0 114.584 171.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -63.12 -49.5 74.15 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.54 -46.34 90.55 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -69.37 -36.3 76.7 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.26 -45.22 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 120.805 1.639 . . . . 0.0 112.899 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -64.43 -26.58 68.51 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.25 -54.07 4.67 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -102.45 -39.6 7.07 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.55 -46.53 1.12 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 115.839 1.096 . . . . 0.0 115.839 -170.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.2 ptp -87.61 156.67 53.13 Favored Pre-proline 0 CA--C 1.57 1.739 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.51 155.2 21.33 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 122.022 1.814 . . . . 0.0 116.4 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.99 94.39 0.98 Allowed 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.637 2.225 . . . . 0.0 112.932 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -84.4 81.87 8.64 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.299 2.3 tmt_? 66.73 -60.02 0.35 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.81 77.32 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.93 -31.99 70.04 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.69 -50.91 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.251 1.387 . . . . 0.0 113.156 165.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.01 94.76 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -69.61 -49.15 56.76 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -76.56 -40.09 50.84 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -91.41 -26.78 18.7 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 73.64 1.06 Allowed Glycine 0 N--CA 1.483 1.788 0 CA-C-N 119.532 1.06 . . . . 0.0 115.345 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -135.44 128.05 30.79 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 117.318 0.559 . . . . 0.0 111.418 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' NE ' ' HG ' ' A' ' 39' ' ' SER . 9.9 ptm180 -73.96 -45.71 48.52 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.451 ' HG ' ' NE ' ' A' ' 38' ' ' ARG . 31.3 m -118.25 151.31 49.15 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -167.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.54 -20.31 53.91 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 N-CA-C 118.392 2.42 . . . . 0.0 118.392 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -57.65 -16.24 10.01 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 164.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.61 -62.56 1.24 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.407 1.003 . . . . 0.0 112.686 160.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.02 91.67 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -80.16 -45.18 18.56 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.18 -29.25 67.2 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -60.37 -40.45 90.83 Favored 'General case' 0 CA--C 1.581 2.148 0 CA-C-N 122.622 2.464 . . . . 0.0 114.787 165.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.31 -44.82 93.87 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.82 -47.48 86.15 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.9 84.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 169.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.57 -43.91 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.49 98.8 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 166.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -56.42 -35.14 67.48 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 168.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -59.07 -34.24 71.73 Favored 'General case' 0 CA--C 1.591 2.552 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 163.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.82 56.09 0.56 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.301 3.9 p -132.81 -53.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.28 143.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.028 0 CA-C-N 119.643 1.11 . . . . 0.0 112.699 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 29.9 tt0 -66.79 143.61 56.8 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.252 155.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.48 114.34 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.62 105.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.685 0.755 . . . . 0.0 109.369 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 m -84.23 85.54 7.35 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.172 0.987 . . . . 0.0 112.281 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.26 -73.44 0.23 Allowed Glycine 0 N--CA 1.484 1.87 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.287 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 106.12 11.76 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 120.98 0.419 . . . . 0.0 111.454 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 m -60.34 -42.73 96.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 118.464 2.765 . . . . 0.0 118.464 -166.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -83.14 65.01 7.99 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 119.799 1.181 . . . . 0.0 113.361 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 76.42 0.27 Allowed Glycine 0 N--CA 1.48 1.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.869 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.29 106.34 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.663 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 74.0 mtm180 -124.64 141.28 52.21 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.021 0.528 . . . . 0.0 111.634 -167.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.28 106.64 6.91 Favored 'General case' 0 CA--C 1.574 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 112.795 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 173.279 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.624 2.6 pt? . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.83 138.17 28.49 Favored 'General case' 0 CA--C 1.57 1.75 0 C-N-CA 123.941 0.896 . . . . 0.0 109.304 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.66 53.08 1.28 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 -173.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -144.24 -54.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.03 1.332 . . . . 0.0 109.794 164.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -61.05 -34.78 75.41 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 163.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -57.18 -40.76 77.98 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 168.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.97 -42.42 80.13 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.43 -44.32 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 167.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -64.63 -41.87 95.87 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -55.94 -39.34 71.57 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 163.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.51 -34.23 77.46 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.0 mt -53.51 -57.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.515 1.507 . . . . 0.0 113.174 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.13 -32.21 73.53 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.3 -48.02 71.72 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.25 -38.31 89.94 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.173 1.806 . . . . 0.0 115.448 173.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.12 -38.64 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 166.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.1 m -66.31 -41.72 89.31 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 167.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.81 -26.91 62.59 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -148.33 -52.84 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 -174.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.98 18.45 0.96 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -148.11 148.79 30.65 Favored Pre-proline 0 CA--C 1.581 2.147 0 CA-C-N 118.853 1.326 . . . . 0.0 112.324 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 147.62 37.56 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 122.563 2.175 . . . . 0.0 115.796 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.38 160.63 35.46 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.779 2.319 . . . . 0.0 115.391 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -143.89 127.13 16.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.308 42.2 ttt85 62.91 -79.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 161.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.24 -44.5 59.4 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 64' ' ' ARG . 49.6 mt-10 -60.08 -42.07 93.81 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.33 -51.92 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-N 119.27 0.941 . . . . 0.0 112.984 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.24 94.84 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -74.59 -40.99 61.26 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -64.34 -42.72 96.11 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.3 mt -106.36 -26.51 11.46 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.66 86.48 1.68 Allowed Glycine 0 N--CA 1.485 1.925 0 CA-C-N 120.243 1.383 . . . . 0.0 114.139 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -120.72 137.55 54.43 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.561 0.696 . . . . 0.0 111.771 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -28.71 67.56 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -148.52 149.02 30.26 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-N 119.249 0.931 . . . . 0.0 113.074 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -62.43 -27.95 77.7 Favored 'Trans proline' 0 N--CA 1.509 2.398 0 N-CA-C 117.872 2.22 . . . . 0.0 117.872 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -65.89 -40.34 91.46 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.06 93.38 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.98 -47.16 68.41 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.48 -36.73 76.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 171.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.28 -33.06 74.51 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.385 1.902 . . . . 0.0 116.01 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -66.9 -36.04 81.38 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 120.99 1.723 . . . . 0.0 115.346 164.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.99 -46.13 82.48 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 161.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.0 -49.7 76.62 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.02 -43.21 60.84 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.86 -45.75 84.73 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 168.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.09 93.59 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.72 -39.34 77.03 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -69.89 -40.1 75.86 Favored 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 165.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.49 38.77 0.32 Allowed Glycine 0 N--CA 1.484 1.855 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 165.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.18 -28.84 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.14 146.93 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-O 121.963 0.887 . . . . 0.0 112.571 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -85.99 115.17 23.43 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.859 -0.526 . . . . 0.0 110.832 168.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.72 124.41 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.536 0.684 . . . . 0.0 109.528 -174.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.48 123.01 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -72.84 105.16 4.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.591 0.71 . . . . 0.0 112.804 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.29 -65.36 0.4 Allowed Glycine 0 N--CA 1.485 1.965 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.778 -167.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.89 119.63 24.18 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 169.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.1 p -79.31 65.2 4.42 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 30' ' ' GLU 0.269 15.7 ptm180 -161.42 -65.15 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.14 1.376 . . . . 0.0 111.553 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.55 -166.85 14.99 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -132.92 -72.82 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.441 -172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.89 147.88 39.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -158.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.61 126.59 31.12 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 CA--C 1.569 1.697 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.683 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.562 1.409 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.0 p -66.67 153.52 42.95 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 121.387 -0.82 . . . . 0.0 112.592 167.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.89 56.32 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 118.769 2.877 . . . . 0.0 118.769 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -70.82 -37.0 73.18 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -59.47 -44.45 93.02 Favored 'General case' 0 CA--C 1.584 2.257 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 162.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -57.91 -39.29 77.59 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.62 -47.6 83.85 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 165.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.09 -49.43 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.16 -48.27 79.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.06 -38.85 68.56 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -48.57 69.86 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.258 26.0 pt -59.46 -42.57 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.126 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 167.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -63.77 -39.04 93.3 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.67 -47.53 83.28 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -58.85 -49.22 78.56 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.13 -40.61 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -61.97 -48.86 78.48 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -85.84 -37.49 19.15 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -116.33 -17.79 10.65 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.94 -28.98 10.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.651 2.22 . . . . 0.0 118.651 -173.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -88.59 129.82 47.62 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.99 115.97 4.37 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.391 2.06 . . . . 0.0 115.427 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 160.33 37.21 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 123.562 2.308 . . . . 0.0 116.401 -170.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.2 p -86.89 163.97 16.86 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -40.5 -57.7 1.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.62 89.65 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 64' ' ' ARG . 37.1 tt0 -57.79 -43.49 85.63 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 171.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.69 -57.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.011 0.823 . . . . 0.0 112.615 168.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.6 85.49 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 118.278 2.695 . . . . 0.0 118.278 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.63 -34.4 75.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -73.02 -48.06 39.55 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.68 -38.4 58.77 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.02 61.85 0.28 Allowed Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -117.61 128.52 55.01 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.984 168.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -42.24 98.21 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 169.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 t -109.65 106.95 59.03 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.354 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -54.79 -19.55 19.34 Favored 'Trans proline' 0 N--CA 1.508 2.336 0 N-CA-C 121.832 3.743 . . . . 0.0 121.832 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -53.28 -31.82 45.67 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 170.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.34 55.44 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 165.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -51.5 69.58 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -70.18 -32.68 70.73 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.98 -44.2 97.24 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -63.25 -41.39 99.05 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tp -49.7 -44.33 48.08 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.97 -46.06 75.01 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.18 90.12 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 -41.68 92.84 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 166.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.75 94.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -56.8 -42.38 79.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 168.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.45 -8.59 52.13 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 167.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.14 -9.11 61.22 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 120.136 2.814 . . . . 0.0 120.136 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 p -85.12 -4.25 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.0 pt -142.78 143.75 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-N 119.973 1.261 . . . . 0.0 111.963 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.11 112.5 25.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 166.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -84.8 125.63 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.8 120.96 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.798 -0.564 . . . . 0.0 109.676 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -76.64 85.24 3.3 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.65 63.5 0.51 Allowed Glycine 0 N--CA 1.486 1.992 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.686 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.5 131.39 13.31 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 117.421 0.61 . . . . 0.0 111.925 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.1 t -78.85 103.62 8.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.784 -0.572 . . . . 0.0 110.938 167.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.427 ' CZ ' ' HE2' ' A' ' 30' ' ' GLU 0.262 79.3 mtt180 70.38 67.22 0.2 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.55 83.0 0.25 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 114.645 0.618 . . . . 0.0 114.645 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.97 117.93 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.44 118.73 23.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.702 . . . . 0.0 110.179 174.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.98 100.63 9.8 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 122.945 0.498 . . . . 0.0 110.99 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 CA--C 1.587 2.4 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 179.449 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 122.117 0.96 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -67.8 157.75 34.06 Favored 'General case' 0 CA--C 1.577 2.012 0 O-C-N 121.643 -0.661 . . . . 0.0 112.155 168.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 -54.78 28.34 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.651 2.463 . . . . 0.0 117.651 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -65.12 -35.01 79.78 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.67 -49.81 76.3 Favored 'General case' 0 CA--C 1.592 2.561 0 CA-C-N 120.235 1.38 . . . . 0.0 114.611 166.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -57.37 -43.29 83.45 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.05 -47.61 77.57 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 166.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.87 -49.26 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -58.17 -46.92 84.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -65.52 -28.82 69.46 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.22 -47.16 77.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.726 1.603 . . . . 0.0 114.519 169.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.287 15.6 tt -57.47 -45.26 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 165.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.77 -44.04 73.31 Favored 'General case' 0 CA--C 1.581 2.147 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 169.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -59.71 -51.31 70.3 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -40.96 98.99 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.01 -48.61 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 C-N-CA 123.702 0.801 . . . . 0.0 112.767 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -70.9 -34.6 71.72 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.29 -21.83 49.13 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.2 m -148.08 -53.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.193 0.906 . . . . 0.0 111.86 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.55 40.79 0.65 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -142.96 132.48 11.86 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 118.426 1.113 . . . . 0.0 113.51 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.88 123.62 3.69 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 122.501 1.929 . . . . 0.0 115.183 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.1 127.39 8.41 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.761 2.308 . . . . 0.0 113.882 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 172.42 13.38 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -49.54 -35.71 21.24 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 119.174 3.027 . . . . 0.0 119.174 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.89 -46.19 75.69 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 165.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 41.6 mt-10 -59.97 -45.35 92.96 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.82 -49.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 167.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.75 84.45 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 170.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -65.54 -51.38 60.28 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -83.95 -37.59 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.6 -16.32 39.68 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.84 66.03 1.52 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 120.092 1.314 . . . . 0.0 115.998 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.89 125.66 53.04 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -59.2 -16.07 18.51 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -148.99 155.23 40.41 Favored Pre-proline 0 CA--C 1.573 1.844 0 O-C-N 121.293 -0.879 . . . . 0.0 111.379 165.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -56.03 -28.73 70.78 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.88 -33.75 74.78 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.01 -39.11 83.26 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.61 89.32 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 162.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.86 -36.56 65.22 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 167.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -67.74 -39.72 84.2 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 166.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.71 -46.84 77.63 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.265 63.6 pttt -64.83 -39.25 93.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.82 88.75 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 166.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.62 -40.47 83.42 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 163.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.57 74.16 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 168.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -64.86 -38.79 92.14 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -66.63 -33.92 76.74 Favored 'General case' 0 CA--C 1.586 2.365 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 158.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.99 60.31 1.6 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.12 -39.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.015 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.55 162.97 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 118.769 0.713 . . . . 0.0 110.546 152.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.74 132.6 47.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.874 -1.141 . . . . 0.0 111.051 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.3 mt -90.85 116.45 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 O-C-N 121.787 -0.571 . . . . 0.0 109.877 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.1 t -80.87 96.71 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.2 m -77.59 96.02 4.7 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.871 0.844 . . . . 0.0 112.47 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.24 -53.22 0.56 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.272 -163.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.32 133.7 41.2 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.8 t -60.79 -54.47 44.8 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.562 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 91.9 mtt180 -93.97 71.64 4.04 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.179 0.9 . . . . 0.0 111.17 161.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.95 63.55 0.27 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 115.361 0.904 . . . . 0.0 115.361 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.5 mm -126.44 97.72 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.876 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -93.45 122.04 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 112.038 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -84.02 123.53 30.11 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.582 2.189 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 CA--C 1.579 2.095 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 t -78.5 159.29 28.29 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -34.18 -55.89 0.5 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 121.017 3.71 . . . . 0.0 121.017 -164.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -77.69 -37.02 50.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -67.03 -34.37 77.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 163.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -42.78 88.78 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 163.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.58 -44.38 80.97 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 167.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.85 -41.31 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 167.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -62.47 -43.65 98.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 168.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.4 -41.47 69.31 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 167.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -42.25 91.78 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 175.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.319 6.2 tp -58.91 -46.51 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 163.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -59.32 -43.63 92.67 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.77 -51.05 71.0 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -63.37 -37.86 88.89 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 174.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.3 -47.74 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 CA-C-N 118.751 0.705 . . . . 0.0 112.861 169.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -65.23 -37.54 87.57 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 172.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.8 -12.84 55.09 Favored 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -149.31 -56.88 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.786 1.175 . . . . 0.0 111.509 -176.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.49 -44.52 0.98 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -81.98 161.52 60.3 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.02 159.52 52.9 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 122.202 1.822 . . . . 0.0 115.356 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 159.25 35.71 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.993 1.795 . . . . 0.0 114.621 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.6 p -71.09 147.92 48.0 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.665 -0.647 . . . . 0.0 111.548 165.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -62.36 -28.63 69.89 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 175.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.18 93.09 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 160.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.85 -39.98 95.48 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 166.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.5 mt -56.59 -46.14 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.271 0 CA-C-N 120.162 1.346 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.88 -54.18 42.76 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 170.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -76.94 -38.4 53.45 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -66.48 -41.89 88.31 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.09 -20.09 42.26 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 48.68 2.77 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 178.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -100.37 100.32 11.08 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 117.758 0.779 . . . . 0.0 109.872 177.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 62.09 7.27 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 122.449 1.119 . . . . 0.0 112.88 174.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -177.82 119.08 0.25 Allowed Pre-proline 0 CA--C 1.577 2.018 0 C-N-CA 125.381 1.472 . . . . 0.0 107.849 -175.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.78 -27.15 52.18 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 N-CA-C 118.631 2.512 . . . . 0.0 118.631 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.27 -47.71 72.8 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 167.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.87 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -169.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.72 70.86 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -20.55 62.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.07 2.619 . . . . 0.0 118.07 171.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -70.87 -41.42 71.4 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 173.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -61.34 -34.49 75.37 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 162.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.08 -45.68 86.74 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.12 78.85 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 166.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.4 -39.18 91.87 Favored 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.63 98.39 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 164.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -61.55 -34.89 76.34 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 169.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -30.13 65.95 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 162.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.2 29.34 8.01 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.029 1.972 . . . . 0.0 118.029 -177.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.252 6.5 p -108.52 -38.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.6 pt -123.03 138.63 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 123.788 0.835 . . . . 0.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.62 113.72 27.34 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.41 0.624 . . . . 0.0 109.796 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.88 127.21 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.215 0.606 . . . . 0.0 109.501 -172.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.7 115.77 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 O-C-N 121.726 -0.609 . . . . 0.0 109.75 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.8 p -76.28 86.18 3.08 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 -68.66 0.33 Allowed Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.69 -172.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.52 112.31 11.72 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.8 m -70.0 -21.55 63.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 178.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -91.79 83.67 5.3 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 119.802 1.183 . . . . 0.0 108.649 152.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.99 64.65 0.26 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -172.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.9 101.58 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -84.25 113.32 21.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.282 -0.886 . . . . 0.0 110.893 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.3 tp -80.68 83.2 6.51 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.674 0.75 . . . . 0.0 111.615 172.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 1.5 pp . . . . . 0 CA--C 1.567 1.618 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 159.9 24.14 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -174.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.26 76.55 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 118.288 2.699 . . . . 0.0 118.288 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -71.74 -39.7 69.88 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 172.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.47 -28.87 69.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 165.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.49 -40.34 96.37 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 162.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -59.19 -44.75 92.22 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 164.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.23 -48.47 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 164.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.19 -40.69 96.61 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 175.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.26 -42.81 78.03 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 167.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.16 -34.18 77.45 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 166.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.24 -55.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 120.725 1.602 . . . . 0.0 113.564 166.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.91 -41.88 88.29 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.5 -52.99 62.85 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 167.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -68.28 -35.36 77.73 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.04 1.291 . . . . 0.0 112.826 166.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -67.73 -32.98 73.98 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 170.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -75.83 -40.1 55.5 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 172.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -124.44 -49.28 1.79 Allowed 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -174.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.68 -44.62 1.12 Allowed Glycine 0 CA--C 1.545 1.916 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -175.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -90.84 142.06 27.3 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -168.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.17 117.51 4.37 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.981 2.454 . . . . 0.0 116.754 172.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.68 119.25 5.38 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 CA-C-N 122.683 1.994 . . . . 0.0 114.931 -176.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 p -115.8 98.56 6.74 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.555 0.693 . . . . 0.0 110.225 -177.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.391 0.5 OUTLIER 65.09 -50.7 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.687 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.32 -47.11 79.38 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -176.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.661 ' HE2' ' NE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -82.71 -38.29 23.56 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 165.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.01 -57.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.08 77.11 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -80.95 -49.83 10.48 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.661 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 9.6 ttp180 -78.57 -31.74 47.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.9 mt -84.47 -18.95 34.23 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 167.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.44 72.9 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.078 1.308 . . . . 0.0 115.617 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.13 134.6 40.25 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 121.985 0.898 . . . . 0.0 112.934 -176.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -14.39 45.58 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 119.732 3.234 . . . . 0.0 119.732 170.367 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.6 m -157.05 143.71 13.33 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 119.716 1.143 . . . . 0.0 112.185 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.05 -43.98 34.38 Favored 'Trans proline' 0 N--CA 1.512 2.598 0 C-N-CA 122.927 2.418 . . . . 0.0 117.724 165.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.36 -32.83 73.68 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 172.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.11 82.25 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 169.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.86 78.77 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 167.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -57.99 -48.38 80.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 172.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -53.45 -48.61 68.66 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -61.63 -39.93 93.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 170.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.37 -42.11 77.29 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 164.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -67.95 -47.56 68.33 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.21 87.73 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 167.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 tp -64.13 -48.25 76.81 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.79 -38.72 70.31 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 166.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -55.84 -32.38 63.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 166.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -66.36 -16.25 63.92 Favored 'General case' 0 CA--C 1.586 2.33 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 165.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.17 69.05 1.18 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.537 1.062 . . . . 0.0 114.921 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.84 -29.47 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -171.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 145.48 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 121.135 1.789 . . . . 0.0 112.641 -177.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.81 113.0 23.89 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 121.819 -0.551 . . . . 0.0 110.216 170.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.94 134.46 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.08 145.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.472 0.653 . . . . 0.0 112.113 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.4 p -75.11 89.48 2.48 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.8 -82.14 0.2 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 -173.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.55 95.6 1.84 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.785 0.802 . . . . 0.0 112.035 170.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -77.97 14.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.8 mtm-85 -82.12 -70.52 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 111.778 156.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.94 -147.05 18.17 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.25 -58.86 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.685 -0.758 . . . . 0.0 111.546 -176.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -154.55 169.41 23.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -163.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.31 122.74 27.82 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.082 0.553 . . . . 0.0 110.849 165.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.565 1.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.631 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 CA--C 1.58 2.122 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -74.49 163.38 27.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.807 -1.183 . . . . 0.0 113.054 170.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.76 67.8 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.735 2.865 . . . . 0.0 118.735 -177.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -71.27 -38.0 71.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 167.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.63 -47.77 84.28 Favored 'General case' 0 CA--C 1.587 2.386 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.93 -38.3 90.52 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.267 10.8 pt-20 -62.59 -37.17 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 163.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.55 -49.07 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 119.798 1.181 . . . . 0.0 113.364 163.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -57.99 -49.22 77.58 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 171.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.95 -34.8 66.0 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 171.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.15 -49.15 62.87 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 170.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.293 7.0 tt -59.71 -42.49 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 168.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -56.22 -51.71 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 166.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.92 -52.26 66.51 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -63.49 -42.13 98.55 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.76 -47.26 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.581 1.082 . . . . 0.0 112.78 170.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 t -63.81 -30.34 71.44 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -92.76 -40.21 10.8 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -114.86 -26.16 7.91 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.85 -27.58 11.82 Favored Glycine 0 CA--C 1.547 2.035 0 N-CA-C 118.714 2.246 . . . . 0.0 118.714 -174.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 51.6 mtm -106.48 119.6 51.23 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 119.309 1.554 . . . . 0.0 114.456 -156.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -58.87 116.97 3.63 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 N-CA-C 119.743 2.939 . . . . 0.0 119.743 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.61 127.55 16.56 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.56 2.173 . . . . 0.0 114.647 170.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -90.88 -74.15 0.51 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -142.07 -37.52 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.78 56.41 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -60.48 -41.91 95.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.86 -49.06 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 169.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.54 95.25 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 170.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.66 -44.12 87.27 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -74.11 -49.19 24.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 177.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.9 -12.25 36.71 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.46 54.15 2.61 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 178.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -100.92 110.17 22.19 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -53.71 -33.91 57.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 -177.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -112.51 135.94 21.49 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.415 163.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.94 -31.1 26.02 Favored 'Trans proline' 0 N--CA 1.509 2.409 0 N-CA-C 118.826 2.587 . . . . 0.0 118.826 165.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -55.99 -33.12 64.55 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 167.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -44.48 79.99 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -47.56 81.21 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 165.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.05 -44.37 74.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.56 -36.15 82.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 173.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -62.61 -44.44 96.29 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 tt -53.13 -46.12 68.66 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 120.903 1.683 . . . . 0.0 115.478 167.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.65 -47.88 81.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.36 83.64 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.96 -52.44 60.65 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 163.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.95 93.32 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 tpt85 -62.71 -38.49 90.66 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.936 2.198 . . . . 0.0 116.936 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.0 -46.27 82.12 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 166.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.27 39.29 0.45 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.41 -16.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.059 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -135.87 131.1 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 CA-C-N 119.267 0.939 . . . . 0.0 110.381 177.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.64 119.21 33.74 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.99 102.91 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.819 0 CA-C-O 121.527 0.68 . . . . 0.0 109.365 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.09 94.62 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.0 m -84.94 100.36 11.57 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.872 0.844 . . . . 0.0 112.969 -160.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.32 -62.59 0.17 Allowed Glycine 0 N--CA 1.484 1.854 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.632 -172.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 142.09 35.04 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 168.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.7 m -57.83 -43.66 85.93 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -99.62 78.88 2.2 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 163.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.64 87.14 0.37 Allowed Glycine 0 N--CA 1.486 2.02 0 CA-C-N 116.266 -0.425 . . . . 0.0 113.348 -174.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -146.86 129.5 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -175.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -114.01 156.41 24.12 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.984 0.897 . . . . 0.0 112.867 170.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.8 mt -101.49 123.87 46.24 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -162.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.575 1.93 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 163.276 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.571 1.754 0 CA-C-O 121.572 0.701 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -75.08 162.78 28.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.568 -0.708 . . . . 0.0 112.895 168.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.08 -55.22 10.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -169.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -67.96 -30.07 69.27 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -63.39 -42.29 98.79 Favored 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 164.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -58.91 -47.11 86.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 167.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -51.54 -50.61 59.69 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 165.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.85 -50.82 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.79 -51.68 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 170.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -59.73 -33.84 72.15 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.55 -51.0 69.11 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 164.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.1 mt -55.59 -52.27 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 172.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -48.44 -50.01 32.9 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 168.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.44 -44.92 93.15 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -62.75 -41.02 99.01 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.12 -43.15 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.405 1.002 . . . . 0.0 113.593 167.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 t -55.17 -45.92 75.74 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.55 -41.45 10.24 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -96.8 -33.58 11.62 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.98 -39.16 3.01 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.7 ptp -94.78 150.56 38.08 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -169.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.09 120.82 6.2 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.278 1.985 . . . . 0.0 113.626 169.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.16 156.31 42.29 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.607 1.967 . . . . 0.0 116.856 -172.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 t -89.59 176.94 6.68 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.723 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -47.95 -44.59 30.35 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.328 3.085 . . . . 0.0 119.328 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.24 83.83 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.614 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 54.3 mt-10 -61.0 -48.04 83.68 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.7 -45.19 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 170.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.64 75.74 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 173.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -41.38 67.14 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp85 -81.13 -26.71 35.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -178.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.08 -51.94 6.3 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-N 120.614 1.552 . . . . 0.0 114.877 165.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.76 75.14 0.4 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.479 0.581 . . . . 0.0 113.86 -170.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -118.31 133.53 55.81 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 123.608 0.763 . . . . 0.0 109.537 172.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.534 ' NE ' ' HG ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -60.15 -42.76 95.56 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 163.138 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.534 ' HG ' ' NE ' ' A' ' 38' ' ' ARG . 48.9 m -109.62 113.31 58.02 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.293 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.91 -36.73 64.96 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 N-CA-C 118.568 2.488 . . . . 0.0 118.568 169.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -66.76 -25.85 66.69 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 171.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.49 85.2 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.76 -39.69 78.01 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 163.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -61.27 -53.23 59.5 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 168.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.66 -41.03 94.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 176.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -61.45 -44.64 96.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 165.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.8 tp -48.1 -51.39 24.76 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 121.22 1.827 . . . . 0.0 115.87 166.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -62.88 -52.12 64.32 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 172.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.61 81.15 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.27 -54.68 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 165.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.53 52.4 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 175.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.99 9.33 19.86 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -177.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.42 -47.36 82.25 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 120.742 -1.224 . . . . 0.0 113.464 144.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.14 60.7 0.04 OUTLIER Glycine 0 N--CA 1.48 1.576 0 C-N-CA 123.932 0.777 . . . . 0.0 114.068 174.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.77 -43.37 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.86 150.7 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.064 0.847 . . . . 0.0 110.989 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -96.77 117.91 32.07 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.211 0.605 . . . . 0.0 110.779 172.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.55 140.26 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.591 1.186 . . . . 0.0 110.047 176.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.93 134.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.415 172.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 m -72.59 97.03 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.477 -0.765 . . . . 0.0 112.58 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.24 -70.51 0.5 Allowed Glycine 0 N--CA 1.485 1.914 0 CA-C-N 115.547 -0.752 . . . . 0.0 113.004 -167.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 107.23 9.04 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.5 m -72.96 -14.23 61.41 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.614 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 55.8 mtt85 -82.47 102.82 11.58 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 145.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.45 -114.56 0.11 Allowed Glycine 0 N--CA 1.482 1.714 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -137.89 -65.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -134.48 136.26 43.04 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.099 1.318 . . . . 0.0 112.905 -161.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tt -89.83 119.41 30.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 156.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 1.6 pp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -167.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -72.95 157.74 36.83 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.83 -37.96 69.4 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 172.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -70.8 -33.37 70.65 Favored 'General case' 0 CA--C 1.579 2.077 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -58.33 -42.08 86.0 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 160.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -62.27 -40.78 97.34 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -51.27 -54.07 29.42 Favored 'General case' 0 CA--C 1.584 2.285 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 162.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.81 -49.39 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -55.36 -39.83 70.56 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 169.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.0 -45.88 76.21 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 171.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.72 -37.01 76.37 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 121.962 2.165 . . . . 0.0 116.569 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.291 0.2 OUTLIER -57.54 -48.83 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-N 120.376 1.444 . . . . 0.0 114.4 169.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.65 -47.98 83.82 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 166.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.49 -44.88 96.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -57.48 -39.61 76.8 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 171.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.37 -46.2 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 170.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 t -67.09 -27.37 67.3 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 168.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.11 -46.77 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -124.87 -39.41 2.27 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.02 -27.73 3.28 Favored Glycine 0 CA--C 1.548 2.101 0 N-CA-C 117.442 1.737 . . . . 0.0 117.442 -173.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.72 149.11 35.43 Favored Pre-proline 0 CA--C 1.579 2.078 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -164.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.39 113.91 1.76 Allowed 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 122.481 2.121 . . . . 0.0 114.241 172.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.05 160.43 23.8 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -168.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -105.99 -174.38 2.52 Favored 'General case' 0 CA--C 1.587 2.38 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.557 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.597 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 13.5 mtm180 -46.44 -30.33 2.12 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 120.16 3.393 . . . . 0.0 120.16 175.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.48 69.93 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 170.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.38 -46.87 8.1 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 163.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.29 -45.08 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 120.254 1.388 . . . . 0.0 114.311 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.65 69.58 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 171.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -74.11 -52.0 13.94 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -71.2 -37.4 72.11 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.0 mt -78.44 -8.95 59.07 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.84 51.99 4.04 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 117.46 1.744 . . . . 0.0 117.46 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.33 99.73 12.7 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 118.014 0.907 . . . . 0.0 111.265 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -60.01 -20.24 56.76 Favored 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 165.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.1 p -111.89 92.92 18.97 Favored Pre-proline 0 CA--C 1.572 1.792 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.597 162.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -55.94 -32.42 85.54 Favored 'Trans proline' 0 N--CA 1.512 2.562 0 N-CA-C 120.149 3.096 . . . . 0.0 120.149 -175.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -57.4 -34.64 69.1 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 170.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.32 63.18 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 172.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.96 -56.6 13.19 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 44.4 mt-10 -83.74 -18.68 37.03 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 -40.18 88.11 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.161 1.8 . . . . 0.0 115.005 165.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -61.67 -38.01 86.19 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 162.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.33 -41.48 80.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -61.44 -44.48 97.04 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 169.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.45 75.07 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 163.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.74 -41.01 97.09 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 167.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.97 -47.07 81.87 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 164.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -53.91 -45.79 71.27 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 170.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -66.7 -33.61 76.03 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 170.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.32 63.81 0.67 Allowed Glycine 0 N--CA 1.483 1.783 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -33.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.49 153.04 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-O 121.987 0.899 . . . . 0.0 111.338 169.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -105.28 104.23 13.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 110.514 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.93 110.77 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 O-C-N 121.483 -0.761 . . . . 0.0 109.018 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -94.39 138.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.474 0.71 . . . . 0.0 109.314 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.7 t -78.49 78.16 4.96 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 175.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.53 99.2 0.18 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.188 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 63.26 19.03 11.43 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 119.779 3.251 . . . . 0.0 119.779 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.371 51.9 p 71.97 -58.53 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -84.06 77.35 9.95 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 122.492 1.139 . . . . 0.0 111.914 172.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.42 77.39 0.26 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.261 174.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.48 115.61 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' NE ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.42 170.7 9.18 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' H ' ' NE ' ' A' ' 67' ' ' ARG . 10.1 mp -95.14 133.4 39.01 Favored 'General case' 0 CA--C 1.571 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 112.114 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.568 1.641 0 CA-C-O 121.809 0.814 . . . . 0.0 109.243 174.337 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.569 1.676 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.7 p -81.64 158.79 24.18 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.44 -40.13 71.17 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 174.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.446 ' NH1' ' HE2' ' A' ' 10' ' ' GLU . 23.7 mmm180 -64.52 -37.82 88.88 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 169.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -58.5 -45.56 88.5 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -64.85 -38.81 92.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 171.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HE2' ' NH1' ' A' ' 7' ' ' ARG . 44.4 mt-10 -51.44 -48.4 62.74 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 161.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.3 t -59.77 -47.76 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.81 -44.41 86.34 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 170.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 170.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 -44.72 69.15 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.083 1.765 . . . . 0.0 114.994 175.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.316 0.2 OUTLIER -56.04 -47.78 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.634 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 167.234 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -54.15 -53.14 57.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 167.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.51 -46.28 90.66 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 178.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.421 ' CD2' ' HE2' ' A' ' 30' ' ' GLU . 48.6 t60 -70.06 -34.83 73.71 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 174.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.06 -49.96 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 120.0 1.273 . . . . 0.0 113.412 161.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 t -68.38 -32.34 72.34 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 176.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -90.59 -48.66 6.94 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 m -102.39 -38.52 7.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.19 32.3 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 118.156 2.023 . . . . 0.0 118.156 -169.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 mtm -97.03 144.14 27.34 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-N 119.548 1.674 . . . . 0.0 113.732 -174.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.03 114.4 2.87 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 C-N-CA 122.418 2.078 . . . . 0.0 113.68 174.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.54 124.57 7.09 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 CA-C-N 122.492 1.926 . . . . 0.0 115.035 -175.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.412 ' HG1' ' NE ' ' A' ' 64' ' ' ARG . 17.8 p -90.43 179.39 5.88 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 175.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -31.4 -45.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 121.596 3.924 . . . . 0.0 121.596 -178.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.53 -44.48 78.24 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 175.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HE2' ' CD2' ' A' ' 18' ' ' HIS . 53.7 tt0 -71.44 -44.16 65.36 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 172.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -50.91 -46.92 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.24 97.64 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 169.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -64.27 -46.88 81.77 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.01 -43.07 30.54 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.94 -21.2 26.4 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 51.43 2.05 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 178.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -101.82 102.25 12.83 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.103 0.951 . . . . 0.0 108.906 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -55.31 -37.8 67.85 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 179.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.8 m -104.17 116.01 62.14 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.393 164.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -53.07 -17.97 8.97 Favored 'Trans proline' 0 N--CA 1.51 2.463 0 N-CA-C 120.577 3.26 . . . . 0.0 120.577 173.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.85 -28.15 69.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 165.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -38.13 89.95 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.72 94.76 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 163.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -55.56 -46.68 77.15 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 165.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.63 -49.53 72.6 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 174.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -70.21 -32.87 70.96 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.5 -54.85 41.03 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.503 1.956 . . . . 0.0 114.448 165.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.82 -44.04 94.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.49 94.71 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.03 -38.47 88.82 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.01 82.22 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 165.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -68.08 -27.14 66.24 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 173.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.93 -34.88 73.82 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 160.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.94 -37.09 1.11 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 173.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.57 4.81 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -156.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.82 144.94 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 CA-C-N 120.246 1.385 . . . . 0.0 113.192 167.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.551 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 2.1 tm-20 -105.58 113.61 27.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 167.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.53 116.9 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.08 107.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 122.187 0.994 . . . . 0.0 112.667 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -84.46 94.78 8.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.011 0.91 . . . . 0.0 111.978 -170.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.51 -77.1 0.28 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.784 -167.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.6 -20.13 65.32 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 174.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.33 18.8 m 77.65 -70.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 171.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.412 ' NE ' ' HG1' ' A' ' 27' ' ' THR . 51.2 mtt180 -84.75 72.65 10.71 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 123.114 1.435 . . . . 0.0 113.331 175.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.88 71.27 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.766 165.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.47 115.22 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -170.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.551 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 73.8 mtt180 -81.61 146.83 29.89 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.75 104.96 17.35 Favored 'General case' 0 CA--C 1.573 1.833 0 O-C-N 121.972 -0.455 . . . . 0.0 110.064 168.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.571 1.783 0 CA-C-O 121.732 0.777 . . . . 0.0 110.573 -179.837 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.9 p -75.07 159.1 32.11 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.17 -45.02 64.94 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.892 2.923 . . . . 0.0 118.892 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -69.07 -38.77 79.21 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 174.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 5.5 pt20 -70.31 -29.95 66.81 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 167.14 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -56.86 -47.76 79.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.99 -43.51 81.77 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.0 t -58.28 -48.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 168.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.51 -48.37 69.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 166.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.64 -37.42 73.3 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 170.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.43 -44.46 94.51 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 172.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.324 0.0 OUTLIER -61.98 -45.55 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 166.156 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -57.0 -46.89 81.97 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.85 -53.67 55.81 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 171.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -67.87 -36.55 80.48 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.32 -48.33 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-N 119.972 1.26 . . . . 0.0 112.563 167.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -63.23 -30.45 71.59 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 174.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -93.2 -42.92 9.1 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -107.98 -19.14 13.61 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.78 -48.39 1.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -173.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 149.86 43.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -62.14 148.05 93.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.412 2.075 . . . . 0.0 116.514 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.07 147.57 21.05 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.247 1.965 . . . . 0.0 115.243 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 p -75.23 165.33 25.36 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-O 122.492 1.139 . . . . 0.0 113.933 176.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.567 ' NE ' ' HG ' ' A' ' 63' ' ' SER . 3.4 mpt_? -52.03 -43.74 63.86 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 176.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.04 80.4 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 169.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.45 -49.5 77.32 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 120.294 1.406 . . . . 0.0 114.598 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.67 -44.7 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 171.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.02 -52.44 16.95 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -89.73 -37.32 14.63 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -167.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -64.24 -37.74 88.55 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.516 1.672 . . . . 0.0 115.516 172.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.97 -9.69 59.71 Favored 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 170.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.99 54.74 4.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 117.489 1.755 . . . . 0.0 117.489 178.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -96.65 135.83 38.03 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 121.78 0.8 . . . . 0.0 111.777 176.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -40.57 92.08 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 175.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.1 t -119.49 125.57 27.44 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.267 171.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.42 -36.7 49.25 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 N-CA-C 118.673 2.528 . . . . 0.0 118.673 165.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.22 -36.0 72.51 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 169.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.05 73.71 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 165.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.55 -48.86 71.52 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 172.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -33.05 72.56 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 165.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -60.78 -40.84 94.1 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 164.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.84 -49.44 73.29 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 164.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.1 -46.92 86.9 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 174.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.48 80.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 171.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.44 -46.87 53.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 169.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.82 76.73 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 172.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -55.56 -26.93 46.15 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 169.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -71.17 -50.95 27.82 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 170.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 165.0 -43.23 0.29 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 119.025 2.37 . . . . 0.0 119.025 -177.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.12 -35.1 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -168.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.5 155.81 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 C-N-CA 123.755 0.822 . . . . 0.0 110.688 172.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -112.06 145.6 39.44 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 112.221 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.96 151.1 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.187 0.994 . . . . 0.0 111.839 177.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.1 m -59.81 139.64 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -167.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 t -81.7 72.48 8.75 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 121.538 0.685 . . . . 0.0 112.759 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 -73.55 2.45 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -176.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.41 138.5 39.32 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.567 ' HG ' ' NE ' ' A' ' 28' ' ' ARG . 70.2 m -55.7 -34.39 65.04 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.573 3.175 . . . . 0.0 119.573 -174.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -89.2 69.06 8.24 Favored 'General case' 0 CA--C 1.581 2.166 0 CA-C-N 119.895 1.225 . . . . 0.0 112.369 172.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.59 43.13 0.85 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -179.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.4 mt -102.1 103.58 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -176.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.86 129.32 35.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -175.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -90.98 69.84 6.33 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.654 0.782 . . . . 0.0 112.428 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.33 1.8 pp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 120.186 3.402 . . . . 0.0 120.186 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 CA--C 1.572 1.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.6 p -64.04 154.32 34.66 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.85 46.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -63.41 -56.11 18.92 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 169.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.36 -33.73 76.17 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 174.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -58.06 -49.53 76.59 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 170.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.82 -27.13 66.45 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.65 -56.3 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 119.866 1.212 . . . . 0.0 112.764 160.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.43 -50.71 70.85 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 172.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.49 -44.4 96.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 tp -56.99 -37.83 72.18 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.4 -49.46 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.714 1.143 . . . . 0.0 113.119 169.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -56.88 -48.47 78.08 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.3 -53.02 62.65 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -74.18 -34.8 63.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -176.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -60.7 -42.95 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.575 0 CA-C-N 120.159 1.345 . . . . 0.0 112.637 163.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.61 -49.63 57.74 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -78.03 -15.7 58.71 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -143.21 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 112.469 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.93 -26.53 5.05 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 118.114 2.006 . . . . 0.0 118.114 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -97.54 152.04 37.96 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.66 121.31 6.62 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 C-N-CA 121.945 1.763 . . . . 0.0 114.6 -176.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.29 106.69 2.27 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.437 2.092 . . . . 0.0 112.325 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.305 7.3 t -84.96 -169.15 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -173.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -55.53 -39.37 70.46 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -168.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.57 86.37 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 168.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -60.03 -46.21 90.28 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 170.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.57 -58.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 123.909 0.884 . . . . 0.0 113.243 172.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.71 85.28 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -75.37 -32.85 60.95 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 171.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -53.22 18.53 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 171.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.72 -26.15 20.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.0 52.97 0.81 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -95.34 107.46 19.58 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 118.185 0.993 . . . . 0.0 110.053 170.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.48 53.53 2.69 Favored 'General case' 0 CA--C 1.584 2.262 0 O-C-N 121.29 -0.881 . . . . 0.0 113.078 169.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -178.32 111.32 0.22 Allowed Pre-proline 0 CA--C 1.577 2.015 0 C-N-CA 124.852 1.261 . . . . 0.0 109.158 -174.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.57 -38.7 75.87 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 N-CA-C 118.417 2.429 . . . . 0.0 118.417 169.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.88 -33.68 73.47 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 171.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -50.63 68.93 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.52 -48.83 76.4 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 170.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -43.48 92.73 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 171.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.86 -38.19 88.18 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 174.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -69.84 -35.65 74.92 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 168.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.45 -50.67 64.78 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.484 1.493 . . . . 0.0 114.659 160.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -51.6 -45.05 63.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 167.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.0 -39.09 65.75 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 169.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.98 -45.95 72.71 Favored 'General case' 0 CA--C 1.583 2.231 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 167.353 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.98 86.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 170.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -66.06 -37.75 86.6 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.42 -41.8 93.2 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 161.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 48.56 0.21 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 166.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.53 -35.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 pt -107.98 144.05 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 120.962 1.71 . . . . 0.0 113.412 -179.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.471 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 34.0 tt0 -96.21 115.35 27.29 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 172.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.35 122.93 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.5 116.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 167.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -94.88 91.53 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.976 176.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.04 -63.14 0.49 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 114.818 0.687 . . . . 0.0 114.818 -174.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.14 164.9 25.24 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 174.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -76.52 -67.06 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 177.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -89.54 78.85 6.99 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 122.795 1.283 . . . . 0.0 113.544 -169.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.22 66.34 0.31 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.246 171.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.5 mm -130.7 96.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -144.64 137.19 26.48 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -164.943 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 mt -76.19 136.31 39.75 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.82 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.574 1.891 0 CA-C-O 121.777 0.799 . . . . 0.0 110.057 174.893 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 121.412 0.625 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -105.45 65.39 0.72 Allowed 'General case' 0 CA--C 1.579 2.071 0 CA-C-O 121.651 0.738 . . . . 0.0 110.129 172.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.88 79.02 5.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.033 -1.042 . . . . 0.0 112.531 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.93 148.16 50.9 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.866 0.841 . . . . 0.0 111.964 -168.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -71.75 147.99 46.78 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.765 -0.585 . . . . 0.0 111.841 167.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.99 -39.77 56.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -66.97 -46.71 73.8 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -54.61 -45.96 73.75 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 164.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -58.99 -41.93 88.79 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.72 -40.0 95.67 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 165.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.93 -44.39 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 120.259 1.391 . . . . 0.0 113.7 167.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -54.2 -47.91 71.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.33 -39.28 86.51 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.63 -29.84 64.87 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 167.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm -58.89 -50.8 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.267 0 CA-C-N 120.036 1.289 . . . . 0.0 113.027 164.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -65.05 -46.06 82.83 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.36 -42.25 96.29 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -36.03 81.73 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.187 1.812 . . . . 0.0 115.301 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.91 -53.45 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 164.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -72.68 -37.24 67.96 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -92.38 1.13 57.41 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.2 m -150.07 -57.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.024 1.284 . . . . 0.0 111.218 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.57 -29.83 2.55 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -105.19 145.3 30.5 Favored Pre-proline 0 CA--C 1.569 1.707 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.39 146.89 22.37 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-N 122.421 1.9 . . . . 0.0 114.26 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 146.64 13.95 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.211 1.825 . . . . 0.0 116.535 -161.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.8 p -73.7 161.81 29.86 Favored 'General case' 0 CA--C 1.577 2.014 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.321 165.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -34.41 67.79 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.17 83.13 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 163.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 49.0 mt-10 -68.68 -40.77 79.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 169.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.13 -47.2 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.309 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 162.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.6 -35.7 72.85 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.72 -42.89 81.24 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.64 -55.34 5.43 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.275 1.398 . . . . 0.0 113.893 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.0 -20.67 60.26 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.24 58.97 2.49 Favored Glycine 0 N--CA 1.48 1.628 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -95.78 126.88 41.35 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -54.08 -28.24 37.83 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.071 2.989 . . . . 0.0 119.071 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.9 m -155.97 158.15 31.57 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 123.852 0.861 . . . . 0.0 111.335 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -46.36 -31.54 9.61 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 N-CA-C 120.375 3.183 . . . . 0.0 120.375 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -54.33 -34.42 61.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.732 2.864 . . . . 0.0 118.732 166.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.44 -40.79 42.13 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.44 84.61 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' HE2' ' NZ ' ' A' ' 48' ' ' LYS . 11.4 pt-20 -58.87 -34.8 72.02 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 169.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.44 -43.58 88.81 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -70.34 -41.96 72.51 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 169.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.24 -50.67 58.72 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' NZ ' ' HE2' ' A' ' 44' ' ' GLU . 15.5 ptpt -67.73 -37.73 82.61 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 169.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.15 89.57 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -57.09 -44.22 82.94 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 163.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.91 96.24 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.64 -40.03 82.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.72 -22.34 65.28 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.71 17.69 37.67 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.34 -21.45 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.2 pt -139.48 143.94 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.165 0 CA-C-N 120.511 1.505 . . . . 0.0 111.9 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 17.7 tt0 -110.82 111.01 21.87 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 124.811 1.245 . . . . 0.0 109.269 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.36 128.88 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.68 133.45 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -85.18 86.51 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.862 . . . . 0.0 112.146 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.23 -72.61 0.24 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.62 120.83 25.57 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.7 t -59.52 -35.7 74.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.639 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 74.0 mtt85 -97.89 84.28 3.3 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.163 0.892 . . . . 0.0 110.337 167.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.19 85.03 0.13 Allowed Glycine 0 N--CA 1.482 1.738 0 O-C-N 121.919 -0.488 . . . . 0.0 112.908 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.06 109.77 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 24.2 ttm180 -95.21 126.36 40.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.217 0.607 . . . . 0.0 109.751 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.46 125.49 29.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.808 -1.182 . . . . 0.0 113.565 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt -85.55 -50.31 7.35 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.37 154.28 27.83 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.623 0.725 . . . . 0.0 111.919 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.297 5.8 tp10 75.48 -68.03 0.22 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.659 1.184 . . . . 0.0 113.742 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 123.884 1.802 . . . . 0.0 111.18 -177.123 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 CA--C 1.562 1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.01 120.3 20.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.819 -0.551 . . . . 0.0 111.289 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.1 103.95 3.45 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.3 2.1 pt? -61.81 -61.96 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.1 p -138.14 143.05 40.15 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 154.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 119.402 3.112 . . . . 0.0 119.402 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -78.31 -25.71 46.68 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.28 6.7 pt20 -70.07 -34.91 73.78 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 121.607 2.003 . . . . 0.0 115.807 160.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -57.4 -41.77 80.97 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 162.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -54.84 -45.96 74.57 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.58 -48.2 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.39 -48.4 81.79 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.58 -37.7 73.63 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.33 -42.28 96.36 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 164.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.2 mt -57.76 -46.03 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.938 1.699 . . . . 0.0 113.483 170.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -62.36 -49.24 76.35 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.64 -56.87 12.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -58.88 -40.29 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -44.07 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 167.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -70.67 -24.03 62.61 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 118.691 2.849 . . . . 0.0 118.691 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.53 -47.33 3.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.573 1.149 . . . . 0.0 113.481 -167.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -85.59 -43.52 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.95 -39.87 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -96.22 151.13 37.97 Favored Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.96 124.04 9.79 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 122.185 1.816 . . . . 0.0 113.427 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.9 114.48 3.84 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.182 1.921 . . . . 0.0 115.607 -167.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 t -83.59 -172.73 4.31 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -33.2 -58.19 0.39 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.76 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.52 -40.32 89.1 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 172.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.8 mm -60.59 -52.11 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 119.922 1.237 . . . . 0.0 113.349 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.42 -48.68 66.59 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -72.74 -44.33 61.79 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.1 mt -86.67 -9.64 55.55 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.541 2.422 . . . . 0.0 117.541 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.39 61.04 3.08 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.63 103.37 16.08 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.862 0.839 . . . . 0.0 111.435 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' NE ' ' HG ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -70.56 -9.75 57.55 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 161.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.451 ' HG ' ' NE ' ' A' ' 38' ' ' ARG . 68.7 m -107.25 109.5 62.85 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 117.496 -1.24 . . . . 0.0 110.725 -169.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.73 -44.55 40.28 Favored 'Trans proline' 0 N--CA 1.509 2.422 0 N-CA-C 120.159 3.1 . . . . 0.0 120.159 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.01 -42.99 83.99 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.71 -47.45 73.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.5 -37.98 20.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.55 -35.54 80.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -60.13 -38.42 83.02 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 163.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.58 -45.81 92.57 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.06 -41.4 83.26 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.09 94.76 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 mt -57.68 -41.95 82.63 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 167.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.67 91.01 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 166.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -58.6 -40.97 84.72 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -71.89 -15.96 62.12 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.58 3.86 55.02 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.13 -17.8 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -130.79 129.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.052 1.297 . . . . 0.0 110.813 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -90.68 115.94 28.16 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.247 -0.908 . . . . 0.0 109.916 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.02 132.23 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.68 118.9 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.677 -0.639 . . . . 0.0 109.376 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.4 t -77.53 69.96 3.85 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.86 39.63 0.07 OUTLIER Glycine 0 CA--C 1.548 2.096 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.99 125.28 5.63 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.675 1.238 . . . . 0.0 110.231 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 m -59.53 -47.02 87.14 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -109.61 89.11 2.91 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.62 85.49 0.19 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 116.394 -0.366 . . . . 0.0 113.779 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.24 114.56 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.946 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -96.09 117.28 30.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.213 0.605 . . . . 0.0 110.757 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -74.99 105.17 5.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.22 81.61 7.29 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 122.621 1.201 . . . . 0.0 109.135 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -79.66 124.26 28.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -161.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.02 22.07 0.07 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 CA--C 1.559 1.305 0 CA-C-O 124.34 2.019 . . . . 0.0 108.449 -177.715 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -120.91 97.91 5.75 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.633 0.73 . . . . 0.0 110.677 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.62 89.2 7.89 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 121.538 0.685 . . . . 0.0 112.069 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 98.5 mt -120.81 118.79 30.9 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 121.418 0.628 . . . . 0.0 111.037 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -68.45 159.68 31.2 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.05 -45.96 52.69 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -71.08 -39.91 71.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -67.44 -33.98 76.26 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -56.8 -42.92 80.35 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 165.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -53.19 -43.77 67.43 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 164.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.29 -48.5 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -56.64 -47.03 80.62 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.1 -43.24 66.7 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 168.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -39.06 79.89 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.61 -48.49 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 CA-C-N 120.216 1.371 . . . . 0.0 113.457 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.689 ' NE ' ' HE2' ' A' ' 72' ' ' GLU . 13.9 mtp180 -59.45 -49.44 77.8 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 166.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.37 -49.48 73.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -62.07 -35.68 79.37 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.449 1.931 . . . . 0.0 115.978 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.52 -43.3 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 119.51 1.05 . . . . 0.0 113.029 165.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -64.82 -33.82 76.89 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.55 -47.18 12.44 Favored 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -102.56 -23.97 13.83 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.31 -34.37 4.62 Favored Glycine 0 CA--C 1.552 2.36 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 -159.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.13 154.6 40.55 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.82 152.3 63.73 Favored 'Trans proline' 0 CA--C 1.567 2.129 0 C-N-CA 122.056 1.837 . . . . 0.0 114.929 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.49 144.65 10.29 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.294 1.855 . . . . 0.0 115.094 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 58.6 p -76.47 161.33 28.73 Favored 'General case' 0 CA--C 1.577 2.011 0 O-C-N 121.877 -0.514 . . . . 0.0 112.285 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -50.69 -28.54 9.21 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.84 -36.53 80.51 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 163.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -62.02 -45.84 91.81 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 120.586 1.539 . . . . 0.0 114.518 163.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.04 -53.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 CA-C-N 119.799 1.181 . . . . 0.0 112.603 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.5 99.01 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -78.01 -48.21 16.68 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -70.26 -41.87 72.91 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.12 -17.6 27.37 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.74 62.32 1.95 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -90.82 148.2 22.68 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.426 1.108 . . . . 0.0 113.136 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -35.48 73.75 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -144.94 149.76 43.64 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.843 167.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.36 -33.06 21.58 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 N-CA-C 119.393 2.805 . . . . 0.0 119.393 163.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -65.78 -37.1 85.39 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 167.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.6 96.01 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.49 63.88 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 164.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.98 -34.4 76.48 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 171.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.81 -46.62 84.4 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -63.48 -39.32 94.15 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -53.89 -47.34 71.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 166.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -59.45 -35.75 74.64 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.37 -18.79 65.28 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 169.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.71 -46.0 84.18 Favored 'General case' 0 CA--C 1.592 2.594 0 CA-C-N 119.913 1.233 . . . . 0.0 113.668 159.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.05 175.38 4.52 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.296 1.6 mpt_? 75.74 -54.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.245 -0.909 . . . . 0.0 113.157 -173.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -61.6 -56.58 18.33 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 156.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.22 52.28 0.18 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 117.982 1.953 . . . . 0.0 117.982 169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.298 10.2 p -116.04 -20.64 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 168.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.24 155.61 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 122.218 2.281 . . . . 0.0 113.287 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.21 128.08 34.18 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.914 -0.491 . . . . 0.0 111.577 161.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.83 134.23 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.11 116.79 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.738 0.78 . . . . 0.0 111.917 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -85.53 100.85 12.2 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.738 -0.601 . . . . 0.0 112.267 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.42 -64.74 0.58 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.81 30.85 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.8 m -75.84 -38.84 57.64 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -134.33 100.12 4.58 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.612 1.096 . . . . 0.0 112.306 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.98 64.79 0.45 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.809 167.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.7 96.21 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -86.89 133.24 33.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 122.928 0.491 . . . . 0.0 112.103 169.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.47 125.19 28.94 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-O 121.737 0.78 . . . . 0.0 112.56 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -93.14 -61.61 1.54 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.957 0.903 . . . . 0.0 112.679 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -82.33 87.83 6.57 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 122.054 0.93 . . . . 0.0 108.816 163.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.19 -58.53 7.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -146.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.689 ' HE2' ' NE ' ' A' ' 16' ' ' ARG . 41.2 tt0 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 123.024 1.392 . . . . 0.0 108.475 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -93.49 67.93 4.05 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.121 0.962 . . . . 0.0 113.27 -162.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.99 100.68 11.6 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.328 0.651 . . . . 0.0 111.939 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.7 mt -84.94 118.27 24.44 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -170.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -66.09 154.89 38.38 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.59 -47.96 28.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -71.11 -41.71 70.23 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.49 -37.19 86.09 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.06 -49.2 77.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 170.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.23 -36.3 79.58 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.47 -50.6 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.465 1.03 . . . . 0.0 113.333 165.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -50.21 -51.68 42.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.55 -39.16 92.74 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.76 -46.27 86.02 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 121.263 1.847 . . . . 0.0 115.043 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.282 36.6 pt -59.06 -46.18 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -54.78 -51.05 66.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 165.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.28 -38.2 90.22 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -72.16 -30.18 64.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.59 -42.3 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.746 1.157 . . . . 0.0 112.908 160.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -64.89 -31.05 72.09 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.3 -43.24 57.59 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 p -125.96 -18.18 5.15 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.29 -43.14 1.95 Allowed Glycine 0 CA--C 1.546 1.978 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 -165.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.05 147.0 32.89 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.15 146.3 88.88 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 N-CA-C 118.886 2.61 . . . . 0.0 118.886 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.45 120.32 3.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.528 2.152 . . . . 0.0 112.58 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -89.21 82.02 6.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 111.624 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.323 23.5 tpt180 66.66 -52.59 0.44 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.07 50.48 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 -167.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.6 -31.17 71.03 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.8 mt -61.21 -53.97 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 CA-C-N 118.941 0.791 . . . . 0.0 112.129 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.88 85.21 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -72.02 -52.11 18.55 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.54 -40.91 28.45 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.63 -24.73 26.98 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.53 81.2 1.33 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 119.411 1.005 . . . . 0.0 114.718 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.72 102.9 8.71 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 117.678 0.739 . . . . 0.0 109.658 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -25.97 61.19 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -98.2 127.13 37.53 Favored Pre-proline 0 CA--C 1.566 1.56 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.327 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.31 -49.27 14.67 Favored 'Trans proline' 0 N--CA 1.508 2.37 0 N-CA-C 119.332 2.782 . . . . 0.0 119.332 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -94.27 75.63 3.97 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.156 0.979 . . . . 0.0 111.444 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.77 -48.61 0.96 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.034 168.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.11 -35.57 80.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.22 -45.87 92.78 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -61.89 -29.21 70.05 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -62.47 -47.42 84.11 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 120.317 1.417 . . . . 0.0 114.301 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.46 -43.31 79.42 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -60.29 -46.14 90.89 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.84 88.73 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 167.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.78 -43.19 94.52 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.13 -46.39 71.01 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -59.72 -40.22 87.28 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -65.11 -30.34 71.27 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 166.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.7 17.21 7.6 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.49 -13.95 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.79 134.55 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 119.863 1.211 . . . . 0.0 111.885 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.19 108.72 19.42 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.164 0.585 . . . . 0.0 110.563 168.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.4 mt -93.38 119.35 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.3 t -83.25 98.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -68.84 98.49 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.92 -55.68 0.68 Allowed Glycine 0 N--CA 1.486 2.009 0 CA-C-N 115.454 -0.794 . . . . 0.0 114.34 -163.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 116.96 23.63 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.6 p -53.68 -41.26 66.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -104.49 41.73 1.29 Allowed 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.62 72.8 0.3 Allowed Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.467 -0.771 . . . . 0.0 112.746 165.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.26 93.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -121.58 133.02 55.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.798 -0.564 . . . . 0.0 111.81 -155.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.92 114.78 11.45 Favored 'General case' 0 CA--C 1.578 2.038 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -165.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.42 86.73 6.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 121.839 0.828 . . . . 0.0 109.171 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.598 2.0 pp0? 58.78 -140.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.68 -70.94 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.933 0.788 . . . . 0.0 112.834 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 125.278 2.466 . . . . 0.0 109.436 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 CA--C 1.56 1.34 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -118.2 87.18 2.67 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.494 0.664 . . . . 0.0 110.955 -165.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.68 81.68 3.87 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.255 1.026 . . . . 0.0 113.06 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -111.56 146.01 38.11 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 p -75.88 157.26 33.49 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.54 72.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.508 ' NE ' ' HE2' ' A' ' 10' ' ' GLU . 13.5 mmt180 -71.8 -31.39 66.53 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -69.89 -31.25 68.95 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 161.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -60.62 -43.47 97.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 165.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HE2' ' NE ' ' A' ' 7' ' ' ARG . 45.6 mt-10 -55.06 -45.15 75.28 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 165.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.63 -50.23 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.13 -47.74 68.44 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.56 -44.22 89.62 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.48 -37.03 86.12 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.23 -48.62 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 118.05 -0.976 . . . . 0.0 113.208 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -51.23 -46.37 62.26 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -49.24 78.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -71.34 -27.68 63.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mm -51.48 -43.24 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.265 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 158.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -77.09 -35.44 56.52 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.32 -29.47 65.06 Favored 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -146.75 -49.7 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.129 0.971 . . . . 0.0 112.006 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.28 18.37 0.93 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 118.038 1.975 . . . . 0.0 118.038 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptp -155.96 159.18 31.73 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-N 119.652 1.726 . . . . 0.0 113.43 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.83 128.67 31.25 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 122.623 2.216 . . . . 0.0 115.015 160.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 175.18 11.71 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 123.831 2.404 . . . . 0.0 115.55 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.0 p -66.79 154.74 40.06 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 0.4 OUTLIER -61.2 -22.61 64.92 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 169.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.43 -46.64 69.31 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 160.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 42.4 mt-10 -57.6 -53.21 60.77 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.58 -43.11 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.17 -48.75 78.67 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -79.79 -35.06 39.09 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.68 -39.28 73.61 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 -20.19 21.75 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.95 49.16 2.52 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -105.27 111.36 24.07 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -83.05 56.91 3.66 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 m 171.59 114.17 0.05 OUTLIER Pre-proline 0 CA--C 1.582 2.197 0 C-N-CA 126.148 1.779 . . . . 0.0 107.685 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.7 -33.72 60.95 Favored 'Trans proline' 0 N--CA 1.511 2.523 0 N-CA-C 119.136 2.706 . . . . 0.0 119.136 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -65.95 -33.8 76.64 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.98 96.19 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -52.38 65.05 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 162.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 7.7 tp10 -53.2 -44.84 68.3 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.73 -38.05 66.65 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -72.61 -31.54 65.24 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 167.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.91 -40.17 87.93 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 121.272 1.851 . . . . 0.0 114.747 159.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -60.32 -51.51 69.22 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-N 120.032 1.287 . . . . 0.0 114.248 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.88 73.26 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 169.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.61 -39.03 81.01 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.76 88.72 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 164.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -65.49 -32.78 74.58 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -60.31 -12.62 9.58 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 157.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.69 13.71 66.77 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.51 -3.1 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -164.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.02 137.73 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 119.861 1.21 . . . . 0.0 110.664 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.1 108.11 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 110.622 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.53 138.38 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.03 135.26 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.847 -0.533 . . . . 0.0 112.222 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.1 t -82.01 77.54 8.81 Favored 'General case' 0 CA--C 1.567 1.629 0 O-C-N 121.61 -0.682 . . . . 0.0 112.594 170.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.05 -72.37 0.1 OUTLIER Glycine 0 N--CA 1.484 1.849 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.567 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.69 135.14 39.08 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -65.24 -11.27 39.31 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.424 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 86.6 mtt180 -90.74 -87.37 0.19 Allowed 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 120.049 1.295 . . . . 0.0 111.591 173.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.4 36.43 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 121.755 -0.591 . . . . 0.0 114.07 -172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.77 -72.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.132 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -151.2 161.47 42.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -163.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -87.87 121.27 30.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.4 164.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.73 114.98 27.66 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 123.426 0.69 . . . . 0.0 109.957 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 68.87 91.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.209 1.003 . . . . 0.0 113.585 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.88 108.86 11.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 171.312 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptm . . . . . 0 CA--C 1.561 1.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -79.89 101.73 8.74 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 112.007 170.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.88 121.7 36.75 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.95 155.29 19.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.8 p -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.26 -36.04 72.66 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.18 -37.92 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 9.6 pt20 -66.18 -30.34 70.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -53.97 -47.01 71.78 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 162.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.88 -46.54 81.8 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 168.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.34 -48.26 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -54.41 -50.39 67.71 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HD2' ' N ' ' A' ' 13' ' ' ASP . 24.2 m-20 -60.39 -34.32 73.74 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.66 -44.44 81.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.338 10.2 tt -61.06 -39.23 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 166.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -55.9 -49.43 73.45 Favored 'General case' 0 CA--C 1.584 2.279 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 163.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.05 -47.71 79.11 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -68.75 -32.83 72.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -55.91 -47.97 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-N 119.509 1.049 . . . . 0.0 113.027 160.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 t -65.88 -33.54 76.08 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.0 -39.52 69.17 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -127.18 -24.81 3.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -167.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -26.75 12.2 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -161.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -105.95 151.34 40.0 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-N 118.656 1.228 . . . . 0.0 114.166 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.55 161.05 22.22 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.471 2.114 . . . . 0.0 115.706 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.79 143.01 11.61 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.876 2.384 . . . . 0.0 115.21 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.0 p -79.32 161.23 26.39 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -52.0 -44.18 63.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.99 90.02 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -63.42 -46.44 86.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.2 mt -57.5 -48.82 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.412 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.19 95.1 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -65.31 -43.41 91.13 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -69.16 -47.79 64.01 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.14 -18.52 28.61 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.84 55.62 1.73 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 116.56 1.384 . . . . 0.0 116.56 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -102.3 106.81 17.67 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 117.696 0.748 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.32 -32.95 71.72 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -106.4 104.91 52.55 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.87 162.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -51.69 -29.23 32.53 Favored 'Trans proline' 0 N--CA 1.509 2.441 0 N-CA-C 120.131 3.089 . . . . 0.0 120.131 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -49.42 -40.03 35.04 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.87 72.28 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 169.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.64 90.66 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 167.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -65.31 -35.41 80.92 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 168.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.16 -39.38 94.5 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.372 1.897 . . . . 0.0 115.857 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -60.79 -42.22 97.15 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 163.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.16 -46.44 85.7 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 168.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -61.02 -41.96 97.55 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.82 91.29 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.75 -43.43 90.27 Favored 'General case' 0 CA--C 1.584 2.256 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 165.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.12 80.47 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -60.62 -40.45 91.94 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -64.49 -45.84 85.57 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 168.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.93 60.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.862 0 N-CA-C 116.897 1.519 . . . . 0.0 116.897 163.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.06 -38.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.12 134.25 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.921 1.691 . . . . 0.0 111.42 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.38 99.52 12.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.427 -0.796 . . . . 0.0 111.06 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.68 120.21 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 122.775 0.43 . . . . 0.0 110.444 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.15 128.47 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.8 p -85.78 79.34 9.32 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 121.293 -0.88 . . . . 0.0 112.591 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.09 -65.64 0.32 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 141.73 38.63 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -71.08 107.13 3.99 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.302 82.2 mtt-85 79.01 33.5 0.24 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.32 59.76 0.81 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 164.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.7 mt -117.7 89.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.617 ' NE ' ' HE2' ' A' ' 71' ' ' GLU . 16.8 mmm180 -103.06 135.24 45.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 111.957 -164.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.25 143.63 26.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.677 0.751 . . . . 0.0 112.51 -172.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.17 90.92 2.57 Favored 'General case' 0 CA--C 1.576 1.951 0 O-C-N 121.141 -0.974 . . . . 0.0 111.565 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.272 40.2 mt-30 84.16 76.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.454 -163.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.617 ' HE2' ' NE ' ' A' ' 67' ' ' ARG 0.266 20.2 pt-20 -84.2 82.18 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -164.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 123.884 1.802 . . . . 0.0 110.143 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtm . . . . . 0 CA--C 1.565 1.542 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.329 56.0 mtmt 74.77 -61.56 0.48 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.44 81.17 3.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 121.801 0.81 . . . . 0.0 112.988 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.523 0.4 OUTLIER 57.58 -173.26 0.08 Allowed 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -174.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -133.94 157.11 46.84 Favored 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 123.896 0.878 . . . . 0.0 110.449 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 -36.07 67.77 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -69.09 -47.17 65.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.2 -33.33 75.15 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -63.34 -39.18 93.83 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -57.25 -41.56 79.84 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 165.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.54 -47.32 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 163.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -58.12 -45.62 87.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -54.13 -40.97 67.85 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.45 -51.47 68.58 Favored 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 120.761 1.619 . . . . 0.0 115.362 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.15 -43.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -62.19 -44.69 96.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.34 -52.83 60.34 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 166.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -69.26 -36.21 76.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -54.92 -48.63 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 CA-C-N 119.524 1.056 . . . . 0.0 113.658 161.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -69.64 -34.15 73.62 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -98.6 -43.3 6.89 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 m -95.03 -44.65 7.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.48 -29.75 6.26 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 117.875 1.91 . . . . 0.0 117.875 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -100.12 155.4 36.47 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -74.34 123.08 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.381 2.054 . . . . 0.0 114.85 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.05 148.11 19.19 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 CA-C-N 123.017 2.113 . . . . 0.0 113.373 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -71.38 165.49 23.64 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 8.9 ptm180 -52.41 -32.16 37.75 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 162.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.1 96.97 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.9 -37.84 86.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 168.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.3 -48.22 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.785 1.175 . . . . 0.0 113.524 166.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.46 96.77 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -62.99 -47.11 84.57 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -78.37 -46.49 19.84 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.1 -22.08 39.43 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.725 2.121 . . . . 0.0 116.725 168.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.57 48.0 4.66 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 117.003 1.561 . . . . 0.0 117.003 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.07 93.38 8.6 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.148 0.974 . . . . 0.0 109.388 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -58.85 -32.91 69.86 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -94.5 106.08 21.81 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.244 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.21 -12.07 34.58 Favored 'Trans proline' 0 N--CA 1.51 2.458 0 N-CA-C 118.712 2.543 . . . . 0.0 118.712 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -58.47 -32.56 68.86 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 159.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.38 93.61 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.2 73.07 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.569 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 19.0 tt0 -64.42 -48.24 76.12 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 171.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.72 -39.25 93.32 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -61.88 -42.44 99.07 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 164.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.82 -40.86 85.38 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.22 -51.54 65.84 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.21 -38.79 68.89 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 167.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.74 -43.15 99.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.03 -39.75 95.67 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.9 -34.15 75.52 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.2 -39.82 94.78 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 161.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.37 51.13 0.18 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 117.176 1.631 . . . . 0.0 117.176 164.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 -8.29 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.082 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.06 145.71 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 121.892 2.133 . . . . 0.0 112.703 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.05 112.46 21.89 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.569 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -83.61 105.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 109.605 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.15 123.31 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-O 121.319 0.58 . . . . 0.0 112.046 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.3 t -82.07 73.87 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.62 -83.77 0.13 Allowed Glycine 0 N--CA 1.482 1.745 0 O-C-N 122.068 -0.395 . . . . 0.0 113.53 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.84 89.89 6.37 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 27.5 t -59.12 -11.86 4.25 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -80.39 15.88 1.48 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 165.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.14 43.73 1.62 Allowed Glycine 0 CA--C 1.552 2.364 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 155.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.2 tp -93.03 75.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.158 0.98 . . . . 0.0 111.235 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -91.85 135.51 33.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 112.38 -166.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -93.29 142.67 27.06 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.55 99.68 6.6 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 85.82 3.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -161.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -80.0 87.48 5.4 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.561 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 124.491 2.091 . . . . 0.0 112.81 -171.181 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.564 1.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.92 114.64 6.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.686 -0.634 . . . . 0.0 110.196 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.63 -61.82 1.78 Allowed 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 165.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.42 144.66 51.53 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 157.7 29.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.187 -0.946 . . . . 0.0 112.872 168.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.2 50.46 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.15 -38.57 85.72 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -56.57 -47.82 78.69 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -62.83 -41.74 99.45 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.33 -50.59 69.25 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.02 -49.25 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.1 -47.28 85.33 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.84 -33.4 70.39 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -38.72 71.51 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 167.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt -55.4 -56.68 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 123.995 0.918 . . . . 0.0 112.732 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -68.13 -32.2 72.32 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HD2' ' NE ' ' A' ' 34' ' ' ARG . 36.7 t70 -55.56 -53.06 61.08 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 168.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -69.96 -37.63 75.85 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.34 -42.2 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-N 119.91 1.232 . . . . 0.0 113.421 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.84 -30.32 71.31 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 169.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.82 -50.08 7.41 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.3 m -107.01 -31.07 8.46 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.2 23.91 18.32 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -147.87 156.2 44.33 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-N 119.091 1.446 . . . . 0.0 112.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -57.48 137.43 81.42 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.65 143.2 14.84 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 122.448 1.91 . . . . 0.0 114.753 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -74.37 160.98 30.31 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 74.6 ttt180 -32.1 -55.19 0.31 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 166.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.96 75.53 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -56.19 -43.57 78.57 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.1 -56.39 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 118.927 0.785 . . . . 0.0 112.095 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.85 75.35 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -75.77 -25.86 56.84 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.437 ' NE ' ' HD2' ' A' ' 17' ' ' ASP . 14.6 tpt180 -70.0 -46.17 65.7 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.232 1.378 . . . . 0.0 114.547 166.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.55 -37.95 30.5 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.92 0.27 Allowed Glycine 0 CA--C 1.545 1.958 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -114.55 130.87 56.8 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 117.872 0.836 . . . . 0.0 109.647 165.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -70.79 -41.36 71.77 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -101.23 113.18 65.83 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.387 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -56.08 -19.67 27.62 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -58.0 -28.62 64.58 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.97 71.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.56 80.21 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.484 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 31.8 mt-10 -60.67 -40.98 94.11 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.24 -49.97 72.62 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.44 -39.23 77.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 tp -52.52 -44.6 65.86 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 166.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -57.93 -40.04 79.5 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 166.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.78 99.56 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 166.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.56 -45.16 81.43 Favored 'General case' 0 CA--C 1.59 2.503 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.28 92.45 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 174.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -56.2 -39.55 72.6 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 165.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -76.44 6.4 5.76 Favored 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 28.02 58.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.42 -37.77 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 118.55 1.175 . . . . 0.0 113.182 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.65 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-N 119.676 1.125 . . . . 0.0 111.409 169.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.36 127.04 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.166 163.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.6 103.88 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.65 81.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.988 0.899 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.3 t -88.37 72.46 8.94 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -166.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.39 -67.91 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 O-C-N 122.018 -0.427 . . . . 0.0 113.15 158.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.01 161.59 28.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 150.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.9 p -76.08 68.73 2.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.293 24.7 ptt180 -174.43 -110.49 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.744 1.617 . . . . 0.0 109.107 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.96 45.24 96.55 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mt -102.69 113.73 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 118.273 1.037 . . . . 0.0 110.37 -161.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -97.57 135.79 38.9 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 121.451 0.643 . . . . 0.0 111.94 162.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 109.91 17.86 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.275 0.63 . . . . 0.0 111.082 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.48 -52.89 5.54 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -128.72 132.88 48.01 Favored 'General case' 0 CA--C 1.567 1.632 0 C-N-CA 123.907 0.883 . . . . 0.0 109.682 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -85.89 75.34 10.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.73 -1.231 . . . . 0.0 113.069 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 124.826 2.25 . . . . 0.0 111.811 179.584 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 CA--C 1.563 1.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -83.89 122.53 28.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.465 -0.772 . . . . 0.0 111.826 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.0 74.05 10.29 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.415 1.578 . . . . 0.0 114.448 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.06 139.38 40.01 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.904 157.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.0 p -80.76 145.55 31.45 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.028 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.3 66.12 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.73 -37.55 70.58 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -57.47 -46.32 83.8 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 121.02 1.736 . . . . 0.0 114.566 163.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -54.91 -47.29 74.54 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -53.37 -47.11 69.72 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 167.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.12 -47.77 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.24 -45.79 87.12 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -60.15 -37.2 79.4 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.22 -39.65 93.05 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 167.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -58.52 -45.62 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-N 119.405 1.002 . . . . 0.0 113.553 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -54.52 -51.34 65.46 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -60.9 -39.65 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -65.71 -47.71 74.45 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mm -57.51 -46.65 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 167.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -69.96 -12.63 61.75 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -70.74 -41.62 71.6 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 121.086 1.767 . . . . 0.0 115.022 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -149.11 -73.17 0.18 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.94 51.99 0.21 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 113.716 165.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -122.23 128.15 25.61 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.026 -164.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -66.22 153.85 76.43 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 CA-C-N 123.092 2.14 . . . . 0.0 115.417 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.52 161.97 27.9 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 CA-C-N 122.55 1.947 . . . . 0.0 114.441 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -95.62 158.27 15.53 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.217 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -54.94 -37.58 66.6 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.05 99.86 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 166.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.26 -41.04 96.24 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 167.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.85 -51.04 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 119.647 1.112 . . . . 0.0 113.54 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.76 89.43 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -80.46 -39.23 28.52 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -78.88 -41.4 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.16 -36.86 34.49 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 61.91 0.69 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.21 101.88 10.35 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.67 62.32 6.8 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.365 1.078 . . . . 0.0 113.427 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m 175.9 126.98 0.15 Allowed Pre-proline 0 CA--C 1.58 2.115 0 C-N-CA 125.89 1.676 . . . . 0.0 107.995 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -61.22 -42.65 33.93 Favored 'Trans proline' 0 N--CA 1.51 2.442 0 CA-C-N 123.119 2.15 . . . . 0.0 116.503 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.34 -30.88 67.07 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.97 75.32 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.68 95.81 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 166.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.42 -53.25 60.48 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.47 -32.05 69.43 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -65.72 -37.9 87.71 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.333 1.879 . . . . 0.0 115.217 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.56 -51.3 70.48 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -57.45 -40.63 78.87 Favored 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 115.564 1.691 . . . . 0.0 115.564 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.45 95.64 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 167.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.68 -38.87 82.69 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.21 97.07 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 165.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -62.14 -36.22 81.14 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -58.63 -24.5 61.19 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 162.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.24 66.31 1.16 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 118.892 0.769 . . . . 0.0 114.99 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.269 10.5 p -149.33 -52.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.2 pt -96.01 131.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 120.864 1.666 . . . . 0.0 113.358 -171.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.76 110.01 20.64 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.297 0.639 . . . . 0.0 110.437 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.3 125.59 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.74 125.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 112.678 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -84.19 74.66 10.27 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.12 -67.52 0.23 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.27 142.04 34.95 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -66.45 -30.49 70.85 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 118.469 2.766 . . . . 0.0 118.469 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -108.73 88.88 2.83 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 119.971 1.26 . . . . 0.0 110.617 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.54 72.76 0.14 Allowed Glycine 0 N--CA 1.486 1.988 0 O-C-N 121.862 -0.524 . . . . 0.0 114.044 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.92 101.99 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -119.34 129.17 54.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.923 -0.485 . . . . 0.0 112.003 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 134.33 37.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.18 84.69 2.3 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 122.218 1.009 . . . . 0.0 110.664 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.313 16.8 tt0 74.72 -53.84 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 162.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -62.9 -63.78 1.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.039 2.236 . . . . 0.0 117.039 -161.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 124.078 1.895 . . . . 0.0 114.291 -163.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.563 1.462 0 CA-C-O 121.033 0.444 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -79.2 67.34 4.89 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.52 87.12 7.01 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.914 -1.117 . . . . 0.0 111.527 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.57 106.54 10.61 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -160.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 p -74.65 149.32 40.02 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.15 9.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.704 3.594 . . . . 0.0 120.704 -169.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.89 -45.82 40.27 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.48 -37.93 89.24 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 169.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -53.72 -40.97 66.53 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 164.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.11 -47.9 80.81 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 167.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.97 -49.04 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.645 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -55.48 -39.66 70.7 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.31 -45.64 90.76 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.39 -40.44 90.88 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 120.634 1.561 . . . . 0.0 114.909 170.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mt -60.58 -48.68 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -55.41 -48.22 74.71 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -59.27 -48.93 79.78 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -64.14 -41.12 97.31 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.4 mm -68.53 -50.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.494 1.043 . . . . 0.0 113.263 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -73.4 -38.02 65.75 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -88.56 -52.84 4.95 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 119.606 1.094 . . . . 0.0 113.448 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.46 -20.91 19.27 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 41.69 20.82 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 118.141 2.016 . . . . 0.0 118.141 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -149.23 142.67 16.19 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-N 118.893 1.346 . . . . 0.0 113.943 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.33 117.66 1.02 Allowed 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.121 1.881 . . . . 0.0 114.295 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.15 174.09 13.36 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 123.21 2.182 . . . . 0.0 117.644 -170.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -94.21 156.12 16.7 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.043 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -59.23 -28.19 66.45 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 166.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.94 96.58 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.498 ' HE2' ' NH2' ' A' ' 64' ' ' ARG . 21.2 mt-10 -62.68 -39.96 95.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 168.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.24 -51.08 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 123.734 0.814 . . . . 0.0 112.832 166.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.89 93.31 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -67.19 -45.89 75.55 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -74.73 -45.32 44.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.79 -14.49 34.39 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -171.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 63.61 1.21 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -117.44 120.83 39.32 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -55.95 -37.27 68.79 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -123.94 148.98 58.56 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.118 159.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -58.21 -12.63 13.55 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 164.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -58.06 -41.71 83.94 Favored 'General case' 0 CA--C 1.587 2.375 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 163.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.29 89.48 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.65 78.5 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 164.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -56.2 -36.95 68.98 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.34 -48.76 80.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -65.17 -38.19 89.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 168.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.59 -37.99 66.18 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -55.77 -57.03 13.74 Favored 'General case' 0 CA--C 1.574 1.897 0 CA-C-N 120.653 1.57 . . . . 0.0 114.811 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.98 75.64 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 168.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.79 -48.45 79.67 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.9 77.39 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -55.78 -41.98 74.86 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -71.83 -14.11 61.87 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.53 62.46 0.45 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 117.395 1.718 . . . . 0.0 117.395 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 m -141.74 -45.04 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.163 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 156.06 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 120.852 1.66 . . . . 0.0 114.548 -168.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.59 144.1 44.11 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 162.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.8 mt -114.11 120.09 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.65 106.59 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.677 0.751 . . . . 0.0 111.047 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.9 p -86.81 87.89 7.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 112.748 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.34 -65.86 0.42 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 169.55 18.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 170.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.1 p -91.66 -55.74 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' NH2' ' HE2' ' A' ' 30' ' ' GLU . 19.2 mmt180 -84.43 90.09 7.53 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.532 1.158 . . . . 0.0 112.225 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.3 44.83 0.16 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.6 mt -106.49 99.84 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -115.38 145.24 42.72 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.242 0.617 . . . . 0.0 112.006 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.13 123.1 18.98 Favored 'General case' 0 CA--C 1.579 2.093 0 O-C-N 122.05 -0.406 . . . . 0.0 111.853 166.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.25 68.84 10.64 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.608 1.194 . . . . 0.0 112.437 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.37 29.6 tt0 55.78 -115.79 0.96 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.358 1.063 . . . . 0.0 113.298 -168.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.3 19.0 tt0 68.49 -62.38 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 124.673 2.178 . . . . 0.0 111.6 -176.129 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.561 1.397 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.6 76.4 8.52 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.37 112.59 25.54 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.668 -0.645 . . . . 0.0 112.7 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.76 127.38 32.66 Favored 'General case' 0 CA--C 1.575 1.916 0 CA-C-O 121.419 0.628 . . . . 0.0 112.674 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.5 p -71.16 159.45 34.65 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.92 75.22 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -70.19 -37.05 75.02 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -65.25 -38.52 90.58 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.721 1.6 . . . . 0.0 115.276 166.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -56.54 -40.91 75.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 164.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.59 -45.52 85.19 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -57.81 -50.33 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.07 -46.11 82.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -59.29 -30.17 68.13 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -64.8 -45.75 84.94 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.077 1.308 . . . . 0.0 114.345 165.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mm -55.68 -47.46 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 169.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -60.15 -46.51 89.43 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.31 -55.32 35.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.52 -34.42 75.83 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.78 -42.1 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.215 1.37 . . . . 0.0 112.716 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.1 t -63.21 -31.7 72.91 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 168.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -73.08 -44.31 60.7 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -120.43 -22.44 6.48 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -167.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.15 -30.74 6.85 Favored Glycine 0 CA--C 1.549 2.195 0 N-CA-C 117.886 1.915 . . . . 0.0 117.886 -163.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -104.69 138.88 19.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -60.93 135.86 62.09 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 N-CA-C 119.499 2.846 . . . . 0.0 119.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.5 123.43 6.5 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.46 2.107 . . . . 0.0 113.607 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -100.04 101.97 13.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -168.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.301 76.4 mtt85 70.85 -72.03 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 142.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.05 77.49 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 157.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -60.52 -40.54 91.82 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -62.72 -52.35 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 120.048 1.295 . . . . 0.0 112.664 166.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.74 81.96 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -71.39 -47.77 54.07 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.19 -43.12 87.7 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.27 -6.32 59.43 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.4 51.52 4.6 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.32 108.42 20.59 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 117.643 0.721 . . . . 0.0 109.641 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -80.46 50.3 1.27 Allowed 'General case' 0 CA--C 1.584 2.27 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 175.52 96.79 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 C-N-CA 126.673 1.989 . . . . 0.0 106.083 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -54.52 -30.54 65.16 Favored 'Trans proline' 0 N--CA 1.513 2.62 0 N-CA-C 120.048 3.057 . . . . 0.0 120.048 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -60.93 -35.53 76.95 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.35 79.64 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.76 -42.91 76.17 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 162.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.4 -34.89 78.97 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 173.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.33 -42.92 96.63 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -61.75 -45.03 95.65 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 165.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.54 -49.03 65.67 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -61.14 -46.71 89.43 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.88 74.43 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.64 -37.64 85.24 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.32 95.79 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 ttt-85 -54.39 -44.03 71.94 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.37 -7.24 23.35 Favored 'General case' 0 CA--C 1.592 2.569 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.42 53.23 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.929 2.332 . . . . 0.0 118.929 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.23 -25.28 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.66 128.99 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.868 1.213 . . . . 0.0 111.221 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.66 107.61 19.28 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.663 -0.648 . . . . 0.0 110.619 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -80.83 122.02 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.18 123.15 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.016 0.526 . . . . 0.0 110.032 -169.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 m -78.73 84.42 4.81 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 121.752 0.787 . . . . 0.0 112.417 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.58 -64.22 0.35 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.73 123.05 25.6 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 m -61.66 -57.04 13.55 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -81.66 79.49 8.22 Favored 'General case' 0 CA--C 1.577 1.988 0 CA-C-N 119.259 0.936 . . . . 0.0 110.375 159.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.38 0.49 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.215 -0.902 . . . . 0.0 114.016 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.34 86.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -109.3 157.14 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.469 1.128 . . . . 0.0 113.791 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.36 110.75 18.4 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -161.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt -82.56 -26.46 32.38 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 166.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.307 14.2 mm100 74.03 -14.68 0.65 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 120.51 3.522 . . . . 0.0 120.51 169.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.81 93.06 6.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.511 1.05 . . . . 0.0 112.529 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 125.08 2.372 . . . . 0.0 114.425 -171.733 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.94 81.9 7.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.55 102.56 14.76 Favored 'General case' 0 CA--C 1.559 1.291 0 O-C-N 121.704 -0.622 . . . . 0.0 111.253 174.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.13 131.92 44.28 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.1 p -75.69 147.78 39.16 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.833 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.34 44.01 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 119.004 2.965 . . . . 0.0 119.004 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -73.63 -39.42 64.53 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.78 -33.4 75.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.7 -45.3 85.88 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 163.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.96 -42.58 76.43 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 167.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.0 -45.06 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.203 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -55.91 -42.53 76.19 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -54.31 -46.17 72.77 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -55.89 -37.7 69.21 Favored 'General case' 0 CA--C 1.586 2.344 0 N-CA-C 116.901 2.185 . . . . 0.0 116.901 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.13 -53.59 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 119.826 1.194 . . . . 0.0 113.263 170.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -60.58 -46.61 89.58 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -64.11 -47.52 79.68 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -69.32 -37.62 77.83 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.7 mt -57.35 -47.64 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 120.526 1.512 . . . . 0.0 112.94 167.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -62.26 -25.89 68.09 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 168.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.27 -58.85 2.67 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.854 1.206 . . . . 0.0 113.388 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 m -151.03 68.83 0.94 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 119.899 1.227 . . . . 0.0 111.151 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.34 -49.51 3.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 121.084 3.194 . . . . 0.0 121.084 160.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.16 137.95 19.38 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -157.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.45 122.67 5.67 Favored 'Trans proline' 0 CA--C 1.572 2.403 0 C-N-CA 122.727 2.285 . . . . 0.0 114.822 172.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -55.99 157.07 17.75 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 N-CA-C 122.322 3.932 . . . . 0.0 122.322 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 p -115.92 -174.58 2.56 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.176 163.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -28.09 22.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -171.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.37 90.84 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 12.1 mp0 -76.12 -50.44 14.64 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 119.554 1.07 . . . . 0.0 112.915 165.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.6 mt -57.98 -49.61 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.45 76.4 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.46 -44.68 18.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -70.06 -40.23 75.21 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.27 -18.67 48.67 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 64.78 1.46 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -100.22 152.6 20.1 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.354 1.073 . . . . 0.0 113.027 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -56.02 -32.91 64.41 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 166.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m -163.21 159.21 18.33 Favored Pre-proline 0 CA--C 1.577 1.987 0 C-N-CA 124.088 0.955 . . . . 0.0 112.045 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -57.87 -30.44 89.54 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.914 2.236 . . . . 0.0 117.914 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.34 -45.04 88.88 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 167.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.54 88.81 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.61 -49.53 70.72 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.88 -30.37 68.86 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.6 -40.19 86.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -66.05 -42.22 89.79 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.68 -51.76 62.17 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.16 -48.38 78.68 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -46.89 74.56 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.05 -37.58 87.94 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.88 65.48 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -68.42 -24.36 64.74 Favored 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -69.02 -27.77 65.97 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 160.57 -54.27 0.33 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 168.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.25 -20.25 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -158.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -117.42 145.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 121.192 1.814 . . . . 0.0 112.939 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 34.1 tt0 -82.51 114.51 20.98 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.096 0.958 . . . . 0.0 113.549 -163.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.72 96.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.716 0.77 . . . . 0.0 111.155 -172.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.4 m -91.05 110.63 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 121.698 0.761 . . . . 0.0 112.311 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.8 p -83.22 81.51 8.67 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.009 -1.057 . . . . 0.0 112.831 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.07 -52.11 0.71 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.22 115.08 12.13 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 m -74.12 105.38 5.31 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.358 0.599 . . . . 0.0 111.32 170.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.56 ' NE ' ' HE2' ' A' ' 30' ' ' GLU 0.332 75.5 mtt85 72.92 50.31 0.15 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -166.006 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.48 5.14 24.79 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 164.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.252 9.8 tt -77.55 80.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.56 1.68 . . . . 0.0 114.612 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.454 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 59.5 ttp85 -82.67 144.99 29.88 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.388 1.075 . . . . 0.0 113.222 -168.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.0 125.32 25.96 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.991 -1.068 . . . . 0.0 113.535 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.5 mt -81.3 96.99 7.47 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.874 0.845 . . . . 0.0 109.827 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -48.83 111.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -168.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.27 128.17 11.79 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -165.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 CA--C 1.564 1.508 0 CA-C-O 123.587 1.66 . . . . 0.0 110.054 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.563 1.447 0 CA-C-O 121.585 0.707 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -88.62 97.13 10.94 Favored 'General case' 0 CA--C 1.567 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 110.678 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.84 83.27 4.19 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -170.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 163.11 16.35 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -81.23 160.04 24.39 Favored 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.169 -0.957 . . . . 0.0 113.092 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.17 -41.13 74.98 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -72.11 -29.61 64.26 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.67 -45.86 85.03 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.807 1.64 . . . . 0.0 114.714 159.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -44.23 87.62 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.14 -46.13 82.97 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.08 -46.95 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -56.56 -41.54 77.06 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.85 -40.14 79.42 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.29 -45.66 92.26 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.31 31.3 pt -63.23 -33.66 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -64.04 -50.44 68.41 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 120.652 1.569 . . . . 0.0 115.121 161.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -60.82 -47.54 85.87 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -67.69 -39.06 84.46 Favored 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.3 mm -57.37 -49.21 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.964 1.256 . . . . 0.0 113.122 165.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -62.89 -49.09 76.18 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -96.65 8.12 44.95 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -154.71 -54.91 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.561 -1.337 . . . . 0.0 111.489 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.04 38.91 1.1 Allowed Glycine 0 CA--C 1.545 1.913 0 N-CA-C 116.407 1.323 . . . . 0.0 116.407 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -144.21 135.56 12.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-N 118.782 1.291 . . . . 0.0 113.096 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -91.14 107.18 0.29 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 CA-C-N 122.944 2.087 . . . . 0.0 113.908 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.77 121.14 8.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.559 2.839 . . . . 0.0 115.582 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.416 ' HG1' ' NE ' ' A' ' 64' ' ' ARG . 45.9 p -109.41 118.82 37.66 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.286 98.1 mtt180 72.17 -65.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 155.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.24 23.74 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.78 -36.21 80.41 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.8 mm -60.44 -52.87 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.41 95.29 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -67.17 -42.57 84.05 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -76.79 -47.13 22.53 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.08 -10.86 56.39 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 43.95 7.54 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 117.677 1.831 . . . . 0.0 117.677 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -89.69 85.32 6.42 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 118.615 1.208 . . . . 0.0 110.101 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.98 -24.13 66.72 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.5 m -91.37 112.49 54.41 Favored Pre-proline 0 CA--C 1.568 1.671 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.785 163.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.96 -18.52 62.43 Favored 'Trans proline' 0 N--CA 1.51 2.477 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -55.54 -44.45 76.77 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 166.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.09 -44.17 74.66 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.28 86.43 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 172.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -41.86 85.24 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 170.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.15 -50.02 50.28 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 166.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -64.93 -38.68 91.75 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.22 -49.53 77.25 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 21.9 pttm -63.89 -36.42 83.88 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 168.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.49 87.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 168.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.92 -43.8 86.48 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 164.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.12 84.31 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ttm105 -59.25 -36.88 76.29 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.94 -51.28 69.92 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.23 16.26 3.23 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.72 -10.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -136.84 138.14 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-N 120.02 1.282 . . . . 0.0 112.049 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -100.11 128.94 46.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.545 0.688 . . . . 0.0 110.149 166.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.6 mm -90.53 115.63 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 C-N-CA 123.141 0.576 . . . . 0.0 109.556 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.79 92.98 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -79.98 85.0 5.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.33 -84.71 0.05 OUTLIER Glycine 0 N--CA 1.481 1.633 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.725 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.95 52.89 2.52 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.297 63.2 m 64.65 -73.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.416 ' NE ' ' HG1' ' A' ' 27' ' ' THR . 83.3 mtt180 -96.32 82.9 3.47 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 122.167 0.984 . . . . 0.0 111.589 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.77 95.5 0.28 Allowed Glycine 0 N--CA 1.48 1.629 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.293 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.0 120.03 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.537 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 60.3 mtt-85 -93.96 128.32 40.22 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 121.696 -0.627 . . . . 0.0 110.993 173.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -84.57 111.74 19.79 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 123.023 0.529 . . . . 0.0 112.023 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.29 87.09 3.8 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.775 0.798 . . . . 0.0 110.4 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 74.31 144.59 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.508 1.123 . . . . 0.0 113.777 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.74 80.74 2.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.672 1.225 . . . . 0.0 113.901 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 123.628 1.68 . . . . 0.0 108.755 -170.562 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.968 0.413 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -134.38 89.45 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.359 0.6 . . . . 0.0 110.362 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.12 69.18 4.4 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt -114.78 124.1 50.91 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 110.079 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.7 p -80.54 94.98 6.36 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.294 . . 49.45 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 119.459 3.133 . . . . 0.0 119.459 168.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -74.79 -31.19 61.67 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.04 -32.13 73.12 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 161.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -57.85 -42.32 84.2 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 163.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.19 -44.69 68.12 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 163.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.33 -43.58 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.73 -40.23 87.36 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.41 -40.84 92.4 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 165.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.86 -47.23 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.446 0.1 OUTLIER -64.62 -39.22 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 121.106 1.775 . . . . 0.0 115.414 174.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtp85 -59.59 -39.67 84.92 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.37 -49.03 77.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -63.36 -39.92 95.86 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.75 -47.22 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 118.977 0.808 . . . . 0.0 113.16 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -61.05 -30.82 70.55 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -84.29 -41.69 16.58 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -116.96 -22.39 8.49 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.21 -47.9 1.45 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -161.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -90.1 159.74 41.78 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.89 162.5 37.24 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.403 2.069 . . . . 0.0 116.731 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 166.91 22.12 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.675 2.25 . . . . 0.0 116.862 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -67.0 147.2 53.53 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.792 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -57.5 -32.78 67.35 Favored 'General case' 0 CA--C 1.591 2.532 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.18 80.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 165.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.77 -33.37 66.55 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 170.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -60.69 -48.5 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-N 119.376 0.989 . . . . 0.0 112.629 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.56 61.16 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -64.98 -54.09 35.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -75.97 -39.15 56.58 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.15 -18.67 59.01 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 56.34 1.37 Allowed Glycine 0 N--CA 1.481 1.695 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.88 116.69 32.37 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 117.583 0.691 . . . . 0.0 110.199 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -63.48 -33.43 75.55 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 157.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 t -94.97 103.01 10.39 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 123.791 0.837 . . . . 0.0 112.291 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.71 -23.55 56.04 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.406 2.041 . . . . 0.0 117.406 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -58.83 -40.73 85.05 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 161.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.16 96.42 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 167.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.11 71.34 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 173.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.55 -33.41 75.85 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.9 -46.98 84.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -65.81 -30.68 71.35 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 tp -60.39 -52.09 66.73 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 121.121 1.782 . . . . 0.0 114.929 166.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 61.7 pttt -62.79 -42.07 99.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.12 74.38 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 166.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.37 -38.79 81.74 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.05 87.6 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 163.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -61.82 -35.68 78.95 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -59.11 -32.93 70.27 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 163.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.11 34.74 1.1 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.565 2.186 . . . . 0.0 118.565 163.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.49 -4.63 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.13 153.34 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.191 0 CA-C-N 119.689 1.131 . . . . 0.0 111.82 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -112.66 122.69 48.42 Favored 'General case' 0 CA--C 1.571 1.763 0 O-C-N 121.745 -0.597 . . . . 0.0 109.545 163.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -88.68 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.63 92.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -85.66 100.23 11.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.632 0.729 . . . . 0.0 112.277 -157.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.83 -53.63 0.7 Allowed Glycine 0 N--CA 1.486 2.008 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.053 -160.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.53 113.09 12.55 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 117.481 0.64 . . . . 0.0 112.553 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.8 p -60.33 -46.19 90.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -91.26 84.95 5.7 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 159.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.12 71.61 0.22 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.05 111.34 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.824 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.84 135.21 37.9 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 111.995 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 tp -95.31 111.61 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.98 0.512 . . . . 0.0 111.346 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.91 88.41 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.746 0.784 . . . . 0.0 109.987 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -79.75 92.6 5.45 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.97 -46.87 3.68 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 125.126 2.393 . . . . 0.0 113.307 -178.024 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.559 1.315 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -88.41 108.55 19.43 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.647 0.737 . . . . 0.0 112.745 -172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.45 114.45 16.29 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.834 -0.541 . . . . 0.0 111.239 166.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp -127.12 156.6 41.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 p -65.93 152.4 44.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -160.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.01 -40.37 58.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 120.406 3.484 . . . . 0.0 120.406 -165.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -39.38 34.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.96 -34.77 75.26 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 162.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.51 -41.28 96.5 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 167.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -57.42 -47.73 80.99 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 165.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.35 -49.34 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 165.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.0 -41.33 97.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.27 -40.87 95.72 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.93 -46.52 71.29 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.116 1.78 . . . . 0.0 114.983 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.262 3.6 tp -53.15 -46.98 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -62.81 -49.33 75.35 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 172.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.06 -44.17 97.78 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -72.85 -43.54 62.48 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.26 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 120.525 1.511 . . . . 0.0 114.776 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -59.94 -30.74 69.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 171.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -93.68 -47.63 6.71 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 p -93.33 -26.41 17.3 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.785 2.142 . . . . 0.0 116.785 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.91 3.76 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.25 141.58 24.18 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.7 132.63 8.88 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 122.187 1.817 . . . . 0.0 114.506 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -55.33 145.03 69.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 N-CA-C 118.272 2.374 . . . . 0.0 118.272 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 p -74.52 150.46 39.79 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.237 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' NE ' ' HE2' ' A' ' 44' ' ' GLU 0.26 16.6 ptt180 -58.82 -26.98 64.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 173.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.2 -40.83 70.94 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -56.93 -49.74 74.71 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 166.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.05 -45.58 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.09 -55.0 36.01 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 170.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.21 -37.16 63.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.96 -36.5 72.59 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.25 -11.81 59.98 Favored 'General case' 0 CA--C 1.584 2.268 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 168.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.72 54.2 4.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -83.82 146.23 28.23 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.451 1.119 . . . . 0.0 113.888 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.02 88.45 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.0 m -152.8 143.97 16.05 Favored Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.718 164.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.45 -30.7 16.25 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -59.05 -31.68 69.07 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.06 99.24 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 165.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.25 96.48 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 165.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.543 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 61.5 mt-10 -55.74 -46.52 77.8 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 164.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.37 -42.32 95.55 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -66.21 -36.95 84.39 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -58.89 -41.37 87.0 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.5 -47.13 82.98 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 170.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.54 79.01 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.8 tp -63.31 -41.41 98.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.0 99.85 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -50.9 -38.02 47.29 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -77.37 6.21 7.29 Favored 'General case' 0 CA--C 1.592 2.558 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.58 40.97 16.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.42 -44.04 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.538 -169.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -127.51 137.65 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 119.709 1.14 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.67 115.86 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 110.684 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.46 123.92 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.07 105.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 164.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.0 m -77.59 95.74 4.63 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -161.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.13 -60.25 0.51 Allowed Glycine 0 N--CA 1.484 1.847 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.576 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.25 123.85 25.32 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.9 p -61.55 -41.31 97.18 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -99.68 28.57 4.6 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 163.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.58 69.81 3.26 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.309 -1.494 . . . . 0.0 114.305 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.03 98.94 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -168.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -98.61 108.58 21.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 110.281 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . 0.299 2.3 pp -82.09 93.1 6.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -64.4 -23.21 67.21 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 165.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.425 22.6 pt20 62.49 69.44 0.61 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.23 88.99 6.92 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 121.042 -1.036 . . . . 0.0 108.361 156.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . 0.298 4.3 tm-20 . . . . . 0 N--CA 1.506 2.334 0 CA-C-O 124.485 2.088 . . . . 0.0 111.263 -151.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 mtt . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.321 22.4 ttpp 75.98 -52.05 0.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 119.215 3.043 . . . . 0.0 119.215 165.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.17 84.55 7.01 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -168.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -82.02 154.18 25.8 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -74.33 153.96 39.09 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.408 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -44.38 70.75 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -72.09 -33.29 67.77 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -56.55 -46.55 80.62 Favored 'General case' 0 CA--C 1.583 2.229 0 CA-C-N 120.502 1.501 . . . . 0.0 114.481 161.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -61.54 -40.05 93.28 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.93 -50.71 68.17 Favored 'General case' 0 CA--C 1.582 2.207 0 CA-C-N 121.004 1.729 . . . . 0.0 115.391 164.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.2 t -55.76 -50.01 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -59.62 -42.53 92.89 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.06 -38.14 75.74 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -44.01 97.69 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 120.597 1.544 . . . . 0.0 114.768 168.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -53.26 -53.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 166.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -62.87 -37.65 87.73 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.73 -47.79 83.39 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 170.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -66.04 -41.32 91.02 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 120.593 1.542 . . . . 0.0 115.031 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.2 mt -67.65 -44.93 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -65.09 -28.77 69.68 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -87.79 -45.93 9.9 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -105.56 -23.69 12.73 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.42 -47.43 1.34 Allowed Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -164.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -88.63 160.72 43.91 Favored Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 158.85 50.91 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.078 1.852 . . . . 0.0 116.059 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.07 164.87 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.263 1.976 . . . . 0.0 114.891 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.5 p -72.97 151.04 41.99 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.205 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -57.87 -25.15 60.37 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.15 94.45 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 160.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.18 -45.42 93.19 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.1 -50.46 78.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.302 0 CA-C-N 120.133 1.333 . . . . 0.0 112.359 170.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.41 81.89 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.43 -49.04 11.98 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -67.33 -40.14 85.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.2 -14.97 58.73 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.05 65.28 1.54 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.08 141.31 31.18 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 121.968 0.89 . . . . 0.0 112.91 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -35.34 79.78 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -136.42 142.29 38.92 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.307 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -61.55 -24.54 78.21 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 N-CA-C 118.006 2.272 . . . . 0.0 118.006 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -63.89 -28.31 69.75 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 167.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -45.47 92.37 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.17 73.77 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.43 -48.11 69.04 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 171.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.33 -30.78 68.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -62.36 -38.88 91.27 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 162.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.14 -43.22 99.22 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.5 -47.9 78.33 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 163.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.01 94.06 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.76 -38.02 77.53 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 164.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.5 -46.22 76.97 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 166.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -59.22 -34.98 72.83 Favored 'General case' 0 CA--C 1.582 2.186 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.88 -26.07 67.15 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 163.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.16 41.47 3.02 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -129.73 -41.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.216 0 CA-C-N 118.103 0.952 . . . . 0.0 113.315 -169.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -126.0 135.53 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.0 1.273 . . . . 0.0 110.914 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.12 118.05 31.94 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 110.015 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.44 125.39 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 121.045 0.45 . . . . 0.0 110.291 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.47 93.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -74.58 123.45 24.83 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -160.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.65 -47.03 1.09 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -161.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.87 119.63 22.33 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -58.19 -41.51 84.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 171.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -95.07 83.1 3.86 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.63 0.728 . . . . 0.0 109.821 161.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.39 67.01 0.33 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.7 mm -135.83 118.98 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -172.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -103.17 126.7 50.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.822 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.5 tp -91.71 121.28 33.21 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -111.07 92.73 4.16 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 162.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -73.35 87.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -162.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.47 111.35 12.21 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.567 0.747 . . . . 0.0 109.123 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 124.761 2.219 . . . . 0.0 113.939 174.468 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 CA--C 1.56 1.348 0 CA-C-O 121.288 0.566 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -86.49 144.84 27.06 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 121.862 -0.524 . . . . 0.0 112.131 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.25 99.11 2.79 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.82 149.74 22.55 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.6 p -67.15 155.94 37.48 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.06 61.18 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -74.25 -38.3 63.52 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -58.52 -44.96 89.7 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 120.823 1.647 . . . . 0.0 115.178 168.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -61.25 -41.28 96.63 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.46 -47.26 79.55 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 165.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.95 -44.68 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -61.58 -41.56 97.58 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 172.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.82 -46.59 89.93 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.75 -41.14 98.05 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.277 0.4 OUTLIER -58.17 -46.57 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 CA-C-N 120.548 1.522 . . . . 0.0 114.584 171.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -63.12 -49.5 74.15 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.54 -46.34 90.55 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -69.37 -36.3 76.7 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.26 -45.22 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 120.805 1.639 . . . . 0.0 112.899 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -64.43 -26.58 68.51 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.25 -54.07 4.67 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -102.45 -39.6 7.07 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.55 -46.53 1.12 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 115.839 1.096 . . . . 0.0 115.839 -170.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.2 ptp -87.61 156.67 53.13 Favored Pre-proline 0 CA--C 1.57 1.739 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.51 155.2 21.33 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 122.022 1.814 . . . . 0.0 116.4 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.99 94.39 0.98 Allowed 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.637 2.225 . . . . 0.0 112.932 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -84.4 81.87 8.64 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.299 2.3 tmt_? 66.73 -60.02 0.35 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.81 77.32 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.93 -31.99 70.04 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.69 -50.91 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.251 1.387 . . . . 0.0 113.156 165.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.01 94.76 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -69.61 -49.15 56.76 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -76.56 -40.09 50.84 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -91.41 -26.78 18.7 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 73.64 1.06 Allowed Glycine 0 N--CA 1.483 1.788 0 CA-C-N 119.532 1.06 . . . . 0.0 115.345 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -135.44 128.05 30.79 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 117.318 0.559 . . . . 0.0 111.418 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' NE ' ' HG ' ' A' ' 39' ' ' SER . 9.9 ptm180 -73.96 -45.71 48.52 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.451 ' HG ' ' NE ' ' A' ' 38' ' ' ARG . 31.3 m -118.25 151.31 49.15 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -167.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.54 -20.31 53.91 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 N-CA-C 118.392 2.42 . . . . 0.0 118.392 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -57.65 -16.24 10.01 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 164.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.61 -62.56 1.24 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.407 1.003 . . . . 0.0 112.686 160.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.02 91.67 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -80.16 -45.18 18.56 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.18 -29.25 67.2 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -60.37 -40.45 90.83 Favored 'General case' 0 CA--C 1.581 2.148 0 CA-C-N 122.622 2.464 . . . . 0.0 114.787 165.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.31 -44.82 93.87 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.82 -47.48 86.15 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.9 84.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 169.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.57 -43.91 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.49 98.8 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 166.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -56.42 -35.14 67.48 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 168.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -59.07 -34.24 71.73 Favored 'General case' 0 CA--C 1.591 2.552 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 163.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.82 56.09 0.56 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.301 3.9 p -132.81 -53.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.28 143.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.028 0 CA-C-N 119.643 1.11 . . . . 0.0 112.699 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 29.9 tt0 -66.79 143.61 56.8 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.252 155.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.48 114.34 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.62 105.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.685 0.755 . . . . 0.0 109.369 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 m -84.23 85.54 7.35 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.172 0.987 . . . . 0.0 112.281 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.26 -73.44 0.23 Allowed Glycine 0 N--CA 1.484 1.87 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.287 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 106.12 11.76 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 120.98 0.419 . . . . 0.0 111.454 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 m -60.34 -42.73 96.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 118.464 2.765 . . . . 0.0 118.464 -166.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -83.14 65.01 7.99 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 119.799 1.181 . . . . 0.0 113.361 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 76.42 0.27 Allowed Glycine 0 N--CA 1.48 1.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.869 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.29 106.34 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.663 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 74.0 mtm180 -124.64 141.28 52.21 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.021 0.528 . . . . 0.0 111.634 -167.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.28 106.64 6.91 Favored 'General case' 0 CA--C 1.574 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 112.795 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.69 -48.0 56.98 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.51 -14.34 62.08 Favored 'General case' 0 CA--C 1.584 2.273 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.285 44.6 mt-10 74.0 -49.2 0.67 Allowed 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 CA--C 1.564 1.502 0 CA-C-O 124.369 2.033 . . . . 0.0 115.656 178.319 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 121.24 0.543 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.35 101.49 13.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 111.754 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.25 79.8 9.28 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.604 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.624 2.6 pt? 43.49 -92.95 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 -169.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.83 138.17 28.49 Favored 'General case' 0 CA--C 1.57 1.75 0 C-N-CA 123.941 0.896 . . . . 0.0 109.304 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.66 53.08 1.28 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 -173.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -144.24 -54.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.03 1.332 . . . . 0.0 109.794 164.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -61.05 -34.78 75.41 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 163.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -57.18 -40.76 77.98 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 168.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.97 -42.42 80.13 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.43 -44.32 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 167.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -64.63 -41.87 95.87 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -55.94 -39.34 71.57 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 163.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.51 -34.23 77.46 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.0 mt -53.51 -57.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.515 1.507 . . . . 0.0 113.174 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.13 -32.21 73.53 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.3 -48.02 71.72 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.25 -38.31 89.94 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.173 1.806 . . . . 0.0 115.448 173.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.12 -38.64 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 166.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.1 m -66.31 -41.72 89.31 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 167.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.81 -26.91 62.59 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -148.33 -52.84 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 -174.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.98 18.45 0.96 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -148.11 148.79 30.65 Favored Pre-proline 0 CA--C 1.581 2.147 0 CA-C-N 118.853 1.326 . . . . 0.0 112.324 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 147.62 37.56 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 122.563 2.175 . . . . 0.0 115.796 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.38 160.63 35.46 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.779 2.319 . . . . 0.0 115.391 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -143.89 127.13 16.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.308 42.2 ttt85 62.91 -79.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 161.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.24 -44.5 59.4 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 64' ' ' ARG . 49.6 mt-10 -60.08 -42.07 93.81 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.33 -51.92 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-N 119.27 0.941 . . . . 0.0 112.984 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.24 94.84 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -74.59 -40.99 61.26 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -64.34 -42.72 96.11 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.3 mt -106.36 -26.51 11.46 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.66 86.48 1.68 Allowed Glycine 0 N--CA 1.485 1.925 0 CA-C-N 120.243 1.383 . . . . 0.0 114.139 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -120.72 137.55 54.43 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.561 0.696 . . . . 0.0 111.771 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -28.71 67.56 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -148.52 149.02 30.26 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-N 119.249 0.931 . . . . 0.0 113.074 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -62.43 -27.95 77.7 Favored 'Trans proline' 0 N--CA 1.509 2.398 0 N-CA-C 117.872 2.22 . . . . 0.0 117.872 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -65.89 -40.34 91.46 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.06 93.38 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.98 -47.16 68.41 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.48 -36.73 76.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 171.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.28 -33.06 74.51 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.385 1.902 . . . . 0.0 116.01 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -66.9 -36.04 81.38 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 120.99 1.723 . . . . 0.0 115.346 164.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.99 -46.13 82.48 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 161.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.0 -49.7 76.62 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.02 -43.21 60.84 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.86 -45.75 84.73 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 168.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.09 93.59 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.72 -39.34 77.03 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -69.89 -40.1 75.86 Favored 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 165.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.49 38.77 0.32 Allowed Glycine 0 N--CA 1.484 1.855 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 165.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.18 -28.84 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.14 146.93 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-O 121.963 0.887 . . . . 0.0 112.571 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -85.99 115.17 23.43 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.859 -0.526 . . . . 0.0 110.832 168.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.72 124.41 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.536 0.684 . . . . 0.0 109.528 -174.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.48 123.01 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -72.84 105.16 4.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.591 0.71 . . . . 0.0 112.804 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.29 -65.36 0.4 Allowed Glycine 0 N--CA 1.485 1.965 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.778 -167.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.89 119.63 24.18 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 169.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.1 p -79.31 65.2 4.42 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 30' ' ' GLU 0.269 15.7 ptm180 -161.42 -65.15 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.14 1.376 . . . . 0.0 111.553 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.55 -166.85 14.99 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -132.92 -72.82 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.441 -172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.89 147.88 39.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -158.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.61 126.59 31.12 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.4 mt -124.03 92.56 3.7 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.254 15.2 pt20 -70.62 90.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 -163.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.5 109.15 12.42 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.929 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 123.411 1.577 . . . . 0.0 110.845 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 71.5 107.88 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.747 1.219 . . . . 0.0 112.304 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.58 89.34 4.5 Favored 'General case' 0 CA--C 1.563 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 113.053 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mp 68.87 109.21 0.05 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.0 p -66.67 153.52 42.95 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 121.387 -0.82 . . . . 0.0 112.592 167.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.89 56.32 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 118.769 2.877 . . . . 0.0 118.769 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -70.82 -37.0 73.18 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -59.47 -44.45 93.02 Favored 'General case' 0 CA--C 1.584 2.257 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 162.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -57.91 -39.29 77.59 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.62 -47.6 83.85 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 165.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.09 -49.43 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.16 -48.27 79.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.06 -38.85 68.56 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -48.57 69.86 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.258 26.0 pt -59.46 -42.57 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.126 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 167.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -63.77 -39.04 93.3 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.67 -47.53 83.28 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -58.85 -49.22 78.56 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.13 -40.61 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -61.97 -48.86 78.48 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -85.84 -37.49 19.15 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -116.33 -17.79 10.65 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.94 -28.98 10.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.651 2.22 . . . . 0.0 118.651 -173.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -88.59 129.82 47.62 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.99 115.97 4.37 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.391 2.06 . . . . 0.0 115.427 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 160.33 37.21 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 123.562 2.308 . . . . 0.0 116.401 -170.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.2 p -86.89 163.97 16.86 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -40.5 -57.7 1.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.62 89.65 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' HE2' ' CZ ' ' A' ' 64' ' ' ARG . 37.1 tt0 -57.79 -43.49 85.63 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 171.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.69 -57.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.011 0.823 . . . . 0.0 112.615 168.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.6 85.49 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 118.278 2.695 . . . . 0.0 118.278 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.63 -34.4 75.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -73.02 -48.06 39.55 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.68 -38.4 58.77 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.02 61.85 0.28 Allowed Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -117.61 128.52 55.01 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.984 168.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -42.24 98.21 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 169.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 t -109.65 106.95 59.03 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.354 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -54.79 -19.55 19.34 Favored 'Trans proline' 0 N--CA 1.508 2.336 0 N-CA-C 121.832 3.743 . . . . 0.0 121.832 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -53.28 -31.82 45.67 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 170.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.34 55.44 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 165.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -51.5 69.58 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -70.18 -32.68 70.73 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.98 -44.2 97.24 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -63.25 -41.39 99.05 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tp -49.7 -44.33 48.08 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.97 -46.06 75.01 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.18 90.12 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 -41.68 92.84 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 166.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.75 94.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -56.8 -42.38 79.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 168.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.45 -8.59 52.13 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 167.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.14 -9.11 61.22 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 120.136 2.814 . . . . 0.0 120.136 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 p -85.12 -4.25 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.0 pt -142.78 143.75 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-N 119.973 1.261 . . . . 0.0 111.963 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.11 112.5 25.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 166.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -84.8 125.63 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.8 120.96 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.798 -0.564 . . . . 0.0 109.676 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -76.64 85.24 3.3 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.65 63.5 0.51 Allowed Glycine 0 N--CA 1.486 1.992 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.686 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.5 131.39 13.31 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 117.421 0.61 . . . . 0.0 111.925 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.1 t -78.85 103.62 8.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.784 -0.572 . . . . 0.0 110.938 167.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.427 ' CZ ' ' HE2' ' A' ' 30' ' ' GLU 0.262 79.3 mtt180 70.38 67.22 0.2 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.55 83.0 0.25 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 114.645 0.618 . . . . 0.0 114.645 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.97 117.93 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.44 118.73 23.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.702 . . . . 0.0 110.179 174.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.98 100.63 9.8 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 122.945 0.498 . . . . 0.0 110.99 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.28 -10.67 59.57 Favored 'General case' 0 CA--C 1.587 2.4 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.311 5.0 tp-100 82.97 124.68 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.004 1.722 . . . . 0.0 115.355 167.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -84.77 -45.92 11.9 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 168.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 124.659 2.171 . . . . 0.0 110.355 -169.203 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 121.387 0.613 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -88.78 65.42 7.67 Favored 'General case' 0 CA--C 1.581 2.156 0 CA-C-O 121.981 0.896 . . . . 0.0 111.336 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.22 162.19 40.98 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.836 0.827 . . . . 0.0 112.481 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.5 mt -112.4 155.98 23.27 Favored 'General case' 0 CA--C 1.571 1.776 0 CA-C-O 122.117 0.96 . . . . 0.0 113.268 -177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -67.8 157.75 34.06 Favored 'General case' 0 CA--C 1.577 2.012 0 O-C-N 121.643 -0.661 . . . . 0.0 112.155 168.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 -54.78 28.34 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.651 2.463 . . . . 0.0 117.651 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -65.12 -35.01 79.78 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.67 -49.81 76.3 Favored 'General case' 0 CA--C 1.592 2.561 0 CA-C-N 120.235 1.38 . . . . 0.0 114.611 166.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -57.37 -43.29 83.45 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.05 -47.61 77.57 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 166.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.87 -49.26 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -58.17 -46.92 84.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -65.52 -28.82 69.46 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.22 -47.16 77.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.726 1.603 . . . . 0.0 114.519 169.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.287 15.6 tt -57.47 -45.26 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 165.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.77 -44.04 73.31 Favored 'General case' 0 CA--C 1.581 2.147 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 169.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -59.71 -51.31 70.3 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -40.96 98.99 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.01 -48.61 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 C-N-CA 123.702 0.801 . . . . 0.0 112.767 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -70.9 -34.6 71.72 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.29 -21.83 49.13 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.2 m -148.08 -53.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.193 0.906 . . . . 0.0 111.86 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.55 40.79 0.65 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -142.96 132.48 11.86 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 118.426 1.113 . . . . 0.0 113.51 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.88 123.62 3.69 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 122.501 1.929 . . . . 0.0 115.183 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.1 127.39 8.41 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.761 2.308 . . . . 0.0 113.882 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 172.42 13.38 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -49.54 -35.71 21.24 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 119.174 3.027 . . . . 0.0 119.174 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.89 -46.19 75.69 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 165.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 41.6 mt-10 -59.97 -45.35 92.96 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.82 -49.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 167.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.75 84.45 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 170.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -65.54 -51.38 60.28 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -83.95 -37.59 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.6 -16.32 39.68 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.84 66.03 1.52 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 120.092 1.314 . . . . 0.0 115.998 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.89 125.66 53.04 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -59.2 -16.07 18.51 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -148.99 155.23 40.41 Favored Pre-proline 0 CA--C 1.573 1.844 0 O-C-N 121.293 -0.879 . . . . 0.0 111.379 165.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -56.03 -28.73 70.78 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.88 -33.75 74.78 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.01 -39.11 83.26 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.61 89.32 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 162.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.86 -36.56 65.22 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 167.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -67.74 -39.72 84.2 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 166.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.71 -46.84 77.63 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.265 63.6 pttt -64.83 -39.25 93.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.82 88.75 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 166.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.62 -40.47 83.42 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 163.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.57 74.16 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 168.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -64.86 -38.79 92.14 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -66.63 -33.92 76.74 Favored 'General case' 0 CA--C 1.586 2.365 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 158.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.99 60.31 1.6 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.12 -39.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.015 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.55 162.97 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 118.769 0.713 . . . . 0.0 110.546 152.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.74 132.6 47.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.874 -1.141 . . . . 0.0 111.051 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.3 mt -90.85 116.45 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 O-C-N 121.787 -0.571 . . . . 0.0 109.877 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.1 t -80.87 96.71 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.2 m -77.59 96.02 4.7 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.871 0.844 . . . . 0.0 112.47 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.24 -53.22 0.56 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.272 -163.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.32 133.7 41.2 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.8 t -60.79 -54.47 44.8 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.562 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 91.9 mtt180 -93.97 71.64 4.04 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.179 0.9 . . . . 0.0 111.17 161.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.95 63.55 0.27 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 115.361 0.904 . . . . 0.0 115.361 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.5 mm -126.44 97.72 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.876 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -93.45 122.04 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 112.038 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -84.02 123.53 30.11 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.65 -3.51 9.28 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.389 15.4 mm100 76.1 -63.83 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.792 2.515 . . . . 0.0 117.792 171.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -146.03 144.18 29.9 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 122.149 0.976 . . . . 0.0 108.966 174.596 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.293 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.59 106.51 18.54 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.137 0.575 . . . . 0.0 112.003 175.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.52 125.52 29.19 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.899 -1.126 . . . . 0.0 111.419 162.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.9 mt -67.03 116.68 8.12 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 t -78.5 159.29 28.29 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -34.18 -55.89 0.5 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 121.017 3.71 . . . . 0.0 121.017 -164.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -77.69 -37.02 50.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -67.03 -34.37 77.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 163.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -42.78 88.78 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 163.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.58 -44.38 80.97 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 167.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.85 -41.31 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 167.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -62.47 -43.65 98.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 168.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.4 -41.47 69.31 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 167.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -42.25 91.78 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 175.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.319 6.2 tp -58.91 -46.51 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 163.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -59.32 -43.63 92.67 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.77 -51.05 71.0 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -63.37 -37.86 88.89 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 174.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.3 -47.74 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 CA-C-N 118.751 0.705 . . . . 0.0 112.861 169.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -65.23 -37.54 87.57 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 172.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.8 -12.84 55.09 Favored 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -149.31 -56.88 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.786 1.175 . . . . 0.0 111.509 -176.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.49 -44.52 0.98 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -81.98 161.52 60.3 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.02 159.52 52.9 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 122.202 1.822 . . . . 0.0 115.356 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 159.25 35.71 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.993 1.795 . . . . 0.0 114.621 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.6 p -71.09 147.92 48.0 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.665 -0.647 . . . . 0.0 111.548 165.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -62.36 -28.63 69.89 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 175.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.18 93.09 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 160.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.85 -39.98 95.48 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 166.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.5 mt -56.59 -46.14 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.271 0 CA-C-N 120.162 1.346 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.88 -54.18 42.76 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 170.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -76.94 -38.4 53.45 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -66.48 -41.89 88.31 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.09 -20.09 42.26 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 48.68 2.77 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 178.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -100.37 100.32 11.08 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 117.758 0.779 . . . . 0.0 109.872 177.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 62.09 7.27 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 122.449 1.119 . . . . 0.0 112.88 174.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -177.82 119.08 0.25 Allowed Pre-proline 0 CA--C 1.577 2.018 0 C-N-CA 125.381 1.472 . . . . 0.0 107.849 -175.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.78 -27.15 52.18 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 N-CA-C 118.631 2.512 . . . . 0.0 118.631 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.27 -47.71 72.8 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 167.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.87 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -169.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.72 70.86 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -20.55 62.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.07 2.619 . . . . 0.0 118.07 171.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -70.87 -41.42 71.4 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 173.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -61.34 -34.49 75.37 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 162.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.08 -45.68 86.74 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.12 78.85 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 166.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.4 -39.18 91.87 Favored 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.63 98.39 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 164.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -61.55 -34.89 76.34 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 169.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -30.13 65.95 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 162.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.2 29.34 8.01 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.029 1.972 . . . . 0.0 118.029 -177.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.252 6.5 p -108.52 -38.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.6 pt -123.03 138.63 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 123.788 0.835 . . . . 0.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.62 113.72 27.34 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.41 0.624 . . . . 0.0 109.796 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.88 127.21 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.215 0.606 . . . . 0.0 109.501 -172.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.7 115.77 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 O-C-N 121.726 -0.609 . . . . 0.0 109.75 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.8 p -76.28 86.18 3.08 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 -68.66 0.33 Allowed Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.69 -172.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.52 112.31 11.72 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.8 m -70.0 -21.55 63.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 178.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -91.79 83.67 5.3 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 119.802 1.183 . . . . 0.0 108.649 152.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.99 64.65 0.26 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -172.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.9 101.58 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -84.25 113.32 21.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.282 -0.886 . . . . 0.0 110.893 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.3 tp -80.68 83.2 6.51 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.674 0.75 . . . . 0.0 111.615 172.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 1.5 pp -80.31 -21.18 42.83 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -115.91 121.64 42.92 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -87.61 82.02 7.55 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-O 121.916 0.865 . . . . 0.0 110.983 -176.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 124.852 2.263 . . . . 0.0 111.857 -167.8 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.639 0.733 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.363 55.4 tttm 69.98 -77.84 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.35 90.98 8.62 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.273 1.035 . . . . 0.0 111.084 165.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.21 143.58 26.96 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -169.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 159.9 24.14 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -174.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.26 76.55 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 118.288 2.699 . . . . 0.0 118.288 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -71.74 -39.7 69.88 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 172.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.47 -28.87 69.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 165.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.49 -40.34 96.37 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 162.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -59.19 -44.75 92.22 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 164.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.23 -48.47 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 164.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.19 -40.69 96.61 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 175.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.26 -42.81 78.03 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 167.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.16 -34.18 77.45 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 166.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.24 -55.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 120.725 1.602 . . . . 0.0 113.564 166.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.91 -41.88 88.29 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.5 -52.99 62.85 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 167.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -68.28 -35.36 77.73 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.04 1.291 . . . . 0.0 112.826 166.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -67.73 -32.98 73.98 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 170.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -75.83 -40.1 55.5 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 172.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -124.44 -49.28 1.79 Allowed 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -174.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.68 -44.62 1.12 Allowed Glycine 0 CA--C 1.545 1.916 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -175.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -90.84 142.06 27.3 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -168.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.17 117.51 4.37 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.981 2.454 . . . . 0.0 116.754 172.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.68 119.25 5.38 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 CA-C-N 122.683 1.994 . . . . 0.0 114.931 -176.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 p -115.8 98.56 6.74 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.555 0.693 . . . . 0.0 110.225 -177.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.391 0.5 OUTLIER 65.09 -50.7 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.687 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.32 -47.11 79.38 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -176.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.661 ' HE2' ' NE ' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -82.71 -38.29 23.56 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 165.722 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.01 -57.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.08 77.11 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -80.95 -49.83 10.48 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.661 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 9.6 ttp180 -78.57 -31.74 47.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.9 mt -84.47 -18.95 34.23 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 167.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.44 72.9 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.078 1.308 . . . . 0.0 115.617 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.13 134.6 40.25 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 121.985 0.898 . . . . 0.0 112.934 -176.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -14.39 45.58 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 119.732 3.234 . . . . 0.0 119.732 170.367 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.6 m -157.05 143.71 13.33 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 119.716 1.143 . . . . 0.0 112.185 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.05 -43.98 34.38 Favored 'Trans proline' 0 N--CA 1.512 2.598 0 C-N-CA 122.927 2.418 . . . . 0.0 117.724 165.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.36 -32.83 73.68 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 172.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.11 82.25 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 169.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.86 78.77 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 167.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -57.99 -48.38 80.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 172.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -53.45 -48.61 68.66 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -61.63 -39.93 93.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 170.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.37 -42.11 77.29 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 164.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -67.95 -47.56 68.33 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.21 87.73 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 167.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 tp -64.13 -48.25 76.81 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.79 -38.72 70.31 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 166.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -55.84 -32.38 63.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 166.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -66.36 -16.25 63.92 Favored 'General case' 0 CA--C 1.586 2.33 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 165.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.17 69.05 1.18 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.537 1.062 . . . . 0.0 114.921 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.84 -29.47 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -171.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 145.48 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 121.135 1.789 . . . . 0.0 112.641 -177.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.81 113.0 23.89 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 121.819 -0.551 . . . . 0.0 110.216 170.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.94 134.46 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.08 145.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.472 0.653 . . . . 0.0 112.113 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.4 p -75.11 89.48 2.48 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.8 -82.14 0.2 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 -173.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.55 95.6 1.84 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.785 0.802 . . . . 0.0 112.035 170.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -77.97 14.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.8 mtm-85 -82.12 -70.52 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 111.778 156.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.94 -147.05 18.17 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.25 -58.86 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.685 -0.758 . . . . 0.0 111.546 -176.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -154.55 169.41 23.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -163.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.31 122.74 27.82 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.082 0.553 . . . . 0.0 110.849 165.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -101.25 113.28 26.2 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.429 16.2 pt20 63.25 -15.32 0.07 Allowed 'General case' 0 N--CA 1.502 2.147 1 N-CA-C 122.261 4.171 . . . . 0.0 122.261 171.632 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.335 17.1 tt0 73.64 -38.48 0.41 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 -177.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 124.375 2.036 . . . . 0.0 110.045 173.571 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.56 1.35 0 CA-C-O 121.396 0.617 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -81.6 135.25 35.56 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.74 -0.6 . . . . 0.0 111.845 172.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.17 77.33 2.99 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.9 mt 65.87 145.96 0.03 OUTLIER 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -172.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -74.49 163.38 27.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.807 -1.183 . . . . 0.0 113.054 170.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.76 67.8 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.735 2.865 . . . . 0.0 118.735 -177.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -71.27 -38.0 71.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 167.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.63 -47.77 84.28 Favored 'General case' 0 CA--C 1.587 2.386 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.93 -38.3 90.52 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.267 10.8 pt-20 -62.59 -37.17 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 163.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.55 -49.07 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 119.798 1.181 . . . . 0.0 113.364 163.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -57.99 -49.22 77.58 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 171.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.95 -34.8 66.0 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 171.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.15 -49.15 62.87 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 170.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.293 7.0 tt -59.71 -42.49 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 168.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -56.22 -51.71 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 166.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.92 -52.26 66.51 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -63.49 -42.13 98.55 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.76 -47.26 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.581 1.082 . . . . 0.0 112.78 170.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 t -63.81 -30.34 71.44 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -92.76 -40.21 10.8 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -114.86 -26.16 7.91 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.85 -27.58 11.82 Favored Glycine 0 CA--C 1.547 2.035 0 N-CA-C 118.714 2.246 . . . . 0.0 118.714 -174.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 51.6 mtm -106.48 119.6 51.23 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 119.309 1.554 . . . . 0.0 114.456 -156.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -58.87 116.97 3.63 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 N-CA-C 119.743 2.939 . . . . 0.0 119.743 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.61 127.55 16.56 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.56 2.173 . . . . 0.0 114.647 170.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -90.88 -74.15 0.51 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -142.07 -37.52 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.78 56.41 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -60.48 -41.91 95.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.86 -49.06 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 169.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.54 95.25 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 170.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.66 -44.12 87.27 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -74.11 -49.19 24.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 177.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.9 -12.25 36.71 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.46 54.15 2.61 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 178.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -100.92 110.17 22.19 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -53.71 -33.91 57.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 -177.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -112.51 135.94 21.49 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.415 163.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.94 -31.1 26.02 Favored 'Trans proline' 0 N--CA 1.509 2.409 0 N-CA-C 118.826 2.587 . . . . 0.0 118.826 165.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -55.99 -33.12 64.55 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 167.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -44.48 79.99 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -47.56 81.21 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 165.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.05 -44.37 74.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.56 -36.15 82.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 173.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -62.61 -44.44 96.29 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 tt -53.13 -46.12 68.66 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 120.903 1.683 . . . . 0.0 115.478 167.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.65 -47.88 81.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.36 83.64 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.96 -52.44 60.65 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 163.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.95 93.32 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 tpt85 -62.71 -38.49 90.66 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.936 2.198 . . . . 0.0 116.936 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.622 ' NZ ' ' HE2' ' A' ' 71' ' ' GLU . 13.6 tmtt? -65.0 -46.27 82.12 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 166.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.27 39.29 0.45 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.41 -16.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.059 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -135.87 131.1 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 CA-C-N 119.267 0.939 . . . . 0.0 110.381 177.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.64 119.21 33.74 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.99 102.91 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.819 0 CA-C-O 121.527 0.68 . . . . 0.0 109.365 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.09 94.62 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.0 m -84.94 100.36 11.57 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.872 0.844 . . . . 0.0 112.969 -160.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.32 -62.59 0.17 Allowed Glycine 0 N--CA 1.484 1.854 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.632 -172.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 142.09 35.04 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 168.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.7 m -57.83 -43.66 85.93 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -99.62 78.88 2.2 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 163.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.64 87.14 0.37 Allowed Glycine 0 N--CA 1.486 2.02 0 CA-C-N 116.266 -0.425 . . . . 0.0 113.348 -174.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -146.86 129.5 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -175.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -114.01 156.41 24.12 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.984 0.897 . . . . 0.0 112.867 170.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.8 mt -101.49 123.87 46.24 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -162.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -99.43 105.88 17.87 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 163.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -71.7 96.71 1.63 Allowed 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -158.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.622 ' HE2' ' NZ ' ' A' ' 53' ' ' LYS . 2.4 tp10 -84.12 80.4 9.2 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.851 167.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 124.871 2.272 . . . . 0.0 112.039 -171.426 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.564 1.497 0 CA-C-O 121.404 0.621 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -93.75 170.74 9.34 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.26 96.15 9.41 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 120.842 -1.161 . . . . 0.0 113.728 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.71 123.7 47.5 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 121.572 0.701 . . . . 0.0 111.673 -174.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -75.08 162.78 28.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.568 -0.708 . . . . 0.0 112.895 168.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.08 -55.22 10.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -169.248 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -67.96 -30.07 69.27 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -63.39 -42.29 98.79 Favored 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 164.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -58.91 -47.11 86.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 167.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -51.54 -50.61 59.69 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 165.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.85 -50.82 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.79 -51.68 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 170.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -59.73 -33.84 72.15 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.55 -51.0 69.11 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 164.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.1 mt -55.59 -52.27 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 172.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -48.44 -50.01 32.9 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 168.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.44 -44.92 93.15 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -62.75 -41.02 99.01 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.12 -43.15 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.405 1.002 . . . . 0.0 113.593 167.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 t -55.17 -45.92 75.74 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.55 -41.45 10.24 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -96.8 -33.58 11.62 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.98 -39.16 3.01 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.7 ptp -94.78 150.56 38.08 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -169.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.09 120.82 6.2 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.278 1.985 . . . . 0.0 113.626 169.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.16 156.31 42.29 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.607 1.967 . . . . 0.0 116.856 -172.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 t -89.59 176.94 6.68 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.723 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -47.95 -44.59 30.35 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.328 3.085 . . . . 0.0 119.328 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.24 83.83 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.614 ' HE2' ' NE ' ' A' ' 64' ' ' ARG . 54.3 mt-10 -61.0 -48.04 83.68 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.7 -45.19 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 170.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.64 75.74 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 173.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -41.38 67.14 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp85 -81.13 -26.71 35.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -178.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.08 -51.94 6.3 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-N 120.614 1.552 . . . . 0.0 114.877 165.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.76 75.14 0.4 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.479 0.581 . . . . 0.0 113.86 -170.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -118.31 133.53 55.81 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 123.608 0.763 . . . . 0.0 109.537 172.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.534 ' NE ' ' HG ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -60.15 -42.76 95.56 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 163.138 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.534 ' HG ' ' NE ' ' A' ' 38' ' ' ARG . 48.9 m -109.62 113.31 58.02 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.293 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.91 -36.73 64.96 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 N-CA-C 118.568 2.488 . . . . 0.0 118.568 169.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -66.76 -25.85 66.69 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 171.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.49 85.2 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.76 -39.69 78.01 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 163.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -61.27 -53.23 59.5 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 168.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.66 -41.03 94.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 176.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -61.45 -44.64 96.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 165.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.8 tp -48.1 -51.39 24.76 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 121.22 1.827 . . . . 0.0 115.87 166.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -62.88 -52.12 64.32 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 172.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.61 81.15 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.27 -54.68 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 165.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.53 52.4 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 175.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.99 9.33 19.86 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -177.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.42 -47.36 82.25 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 120.742 -1.224 . . . . 0.0 113.464 144.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.14 60.7 0.04 OUTLIER Glycine 0 N--CA 1.48 1.576 0 C-N-CA 123.932 0.777 . . . . 0.0 114.068 174.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.77 -43.37 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.86 150.7 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.064 0.847 . . . . 0.0 110.989 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -96.77 117.91 32.07 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.211 0.605 . . . . 0.0 110.779 172.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.55 140.26 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.591 1.186 . . . . 0.0 110.047 176.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.93 134.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.415 172.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 m -72.59 97.03 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.477 -0.765 . . . . 0.0 112.58 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.24 -70.51 0.5 Allowed Glycine 0 N--CA 1.485 1.914 0 CA-C-N 115.547 -0.752 . . . . 0.0 113.004 -167.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 107.23 9.04 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.5 m -72.96 -14.23 61.41 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.614 ' NE ' ' HE2' ' A' ' 30' ' ' GLU . 55.8 mtt85 -82.47 102.82 11.58 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 145.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.45 -114.56 0.11 Allowed Glycine 0 N--CA 1.482 1.714 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -137.89 -65.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -134.48 136.26 43.04 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.099 1.318 . . . . 0.0 112.905 -161.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tt -89.83 119.41 30.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 156.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 1.6 pp -82.36 63.22 6.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -167.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.287 50.3 mm-40 67.21 7.58 5.57 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.3 -23.13 60.23 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 177.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 123.26 1.505 . . . . 0.0 114.991 173.66 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 CA--C 1.564 1.499 0 CA-C-O 121.372 0.606 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 78.06 9.57 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.12 111.61 6.9 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.9 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.92 155.89 20.73 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -72.95 157.74 36.83 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.83 -37.96 69.4 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 172.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -70.8 -33.37 70.65 Favored 'General case' 0 CA--C 1.579 2.077 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -58.33 -42.08 86.0 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 160.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -62.27 -40.78 97.34 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -51.27 -54.07 29.42 Favored 'General case' 0 CA--C 1.584 2.285 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 162.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.81 -49.39 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -55.36 -39.83 70.56 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 169.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.0 -45.88 76.21 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 171.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.72 -37.01 76.37 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 121.962 2.165 . . . . 0.0 116.569 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.291 0.2 OUTLIER -57.54 -48.83 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-N 120.376 1.444 . . . . 0.0 114.4 169.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.65 -47.98 83.82 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 166.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.49 -44.88 96.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -57.48 -39.61 76.8 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 171.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.37 -46.2 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 170.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 t -67.09 -27.37 67.3 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 168.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.11 -46.77 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -124.87 -39.41 2.27 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.02 -27.73 3.28 Favored Glycine 0 CA--C 1.548 2.101 0 N-CA-C 117.442 1.737 . . . . 0.0 117.442 -173.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.72 149.11 35.43 Favored Pre-proline 0 CA--C 1.579 2.078 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -164.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.39 113.91 1.76 Allowed 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 122.481 2.121 . . . . 0.0 114.241 172.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.05 160.43 23.8 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -168.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -105.99 -174.38 2.52 Favored 'General case' 0 CA--C 1.587 2.38 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.557 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.597 ' NE ' ' HE2' ' A' ' 44' ' ' GLU . 13.5 mtm180 -46.44 -30.33 2.12 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 120.16 3.393 . . . . 0.0 120.16 175.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.48 69.93 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 170.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.38 -46.87 8.1 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 163.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.29 -45.08 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 120.254 1.388 . . . . 0.0 114.311 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.65 69.58 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 171.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -74.11 -52.0 13.94 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -71.2 -37.4 72.11 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.0 mt -78.44 -8.95 59.07 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.84 51.99 4.04 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 117.46 1.744 . . . . 0.0 117.46 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.33 99.73 12.7 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 118.014 0.907 . . . . 0.0 111.265 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -60.01 -20.24 56.76 Favored 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 165.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.1 p -111.89 92.92 18.97 Favored Pre-proline 0 CA--C 1.572 1.792 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.597 162.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -55.94 -32.42 85.54 Favored 'Trans proline' 0 N--CA 1.512 2.562 0 N-CA-C 120.149 3.096 . . . . 0.0 120.149 -175.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -57.4 -34.64 69.1 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 170.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.32 63.18 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 172.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.96 -56.6 13.19 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.597 ' HE2' ' NE ' ' A' ' 28' ' ' ARG . 44.4 mt-10 -83.74 -18.68 37.03 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 -40.18 88.11 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.161 1.8 . . . . 0.0 115.005 165.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -61.67 -38.01 86.19 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 162.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.33 -41.48 80.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -61.44 -44.48 97.04 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 169.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.45 75.07 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 163.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.74 -41.01 97.09 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 167.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.97 -47.07 81.87 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 164.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -53.91 -45.79 71.27 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 170.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -66.7 -33.61 76.03 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 170.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.32 63.81 0.67 Allowed Glycine 0 N--CA 1.483 1.783 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -33.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.49 153.04 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-O 121.987 0.899 . . . . 0.0 111.338 169.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -105.28 104.23 13.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 110.514 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.93 110.77 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 O-C-N 121.483 -0.761 . . . . 0.0 109.018 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -94.39 138.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.474 0.71 . . . . 0.0 109.314 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.7 t -78.49 78.16 4.96 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 175.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.53 99.2 0.18 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.188 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 63.26 19.03 11.43 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 119.779 3.251 . . . . 0.0 119.779 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.371 51.9 p 71.97 -58.53 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -84.06 77.35 9.95 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 122.492 1.139 . . . . 0.0 111.914 172.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.42 77.39 0.26 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.261 174.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.48 115.61 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' NE ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.42 170.7 9.18 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' H ' ' NE ' ' A' ' 67' ' ' ARG . 10.1 mp -95.14 133.4 39.01 Favored 'General case' 0 CA--C 1.571 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 112.114 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.43 104.35 10.26 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-O 121.809 0.814 . . . . 0.0 109.243 174.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -75.94 84.37 2.86 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.851 0.834 . . . . 0.0 113.154 173.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -137.14 -72.06 0.44 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.039 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 125.38 2.514 . . . . 0.0 111.946 177.698 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 CA--C 1.566 1.576 0 CA-C-O 121.306 0.574 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -146.76 84.15 1.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . 0.356 . . 70.44 -65.2 0.34 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -165.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 164.83 21.44 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 160.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.7 p -81.64 158.79 24.18 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.44 -40.13 71.17 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 174.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.446 ' NH1' ' HE2' ' A' ' 10' ' ' GLU . 23.7 mmm180 -64.52 -37.82 88.88 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 169.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -58.5 -45.56 88.5 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -64.85 -38.81 92.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 171.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' HE2' ' NH1' ' A' ' 7' ' ' ARG . 44.4 mt-10 -51.44 -48.4 62.74 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 161.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.3 t -59.77 -47.76 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.81 -44.41 86.34 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 170.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 170.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 -44.72 69.15 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.083 1.765 . . . . 0.0 114.994 175.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.316 0.2 OUTLIER -56.04 -47.78 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.634 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 167.234 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.646 ' NE ' ' HE2' ' A' ' 72' ' ' GLU . 64.2 ttp85 -54.15 -53.14 57.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 167.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.51 -46.28 90.66 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 178.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.421 ' CD2' ' HE2' ' A' ' 30' ' ' GLU . 48.6 t60 -70.06 -34.83 73.71 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 174.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.06 -49.96 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 120.0 1.273 . . . . 0.0 113.412 161.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 t -68.38 -32.34 72.34 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 176.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -90.59 -48.66 6.94 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 m -102.39 -38.52 7.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.19 32.3 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 118.156 2.023 . . . . 0.0 118.156 -169.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 mtm -97.03 144.14 27.34 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-N 119.548 1.674 . . . . 0.0 113.732 -174.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.03 114.4 2.87 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 C-N-CA 122.418 2.078 . . . . 0.0 113.68 174.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.54 124.57 7.09 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 CA-C-N 122.492 1.926 . . . . 0.0 115.035 -175.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.412 ' HG1' ' NE ' ' A' ' 64' ' ' ARG . 17.8 p -90.43 179.39 5.88 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 175.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -31.4 -45.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 121.596 3.924 . . . . 0.0 121.596 -178.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.53 -44.48 78.24 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 175.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HE2' ' CD2' ' A' ' 18' ' ' HIS . 53.7 tt0 -71.44 -44.16 65.36 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 172.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -50.91 -46.92 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.24 97.64 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 169.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -64.27 -46.88 81.77 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.01 -43.07 30.54 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.94 -21.2 26.4 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 51.43 2.05 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 178.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -101.82 102.25 12.83 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.103 0.951 . . . . 0.0 108.906 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -55.31 -37.8 67.85 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 179.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.8 m -104.17 116.01 62.14 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.393 164.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -53.07 -17.97 8.97 Favored 'Trans proline' 0 N--CA 1.51 2.463 0 N-CA-C 120.577 3.26 . . . . 0.0 120.577 173.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.85 -28.15 69.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 165.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -38.13 89.95 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.72 94.76 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 163.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -55.56 -46.68 77.15 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 165.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.63 -49.53 72.6 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 174.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -70.21 -32.87 70.96 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.5 -54.85 41.03 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.503 1.956 . . . . 0.0 114.448 165.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.82 -44.04 94.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.49 94.71 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.03 -38.47 88.82 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.01 82.22 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 165.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -68.08 -27.14 66.24 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 173.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.93 -34.88 73.82 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 160.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.94 -37.09 1.11 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 173.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.57 4.81 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -156.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.82 144.94 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 CA-C-N 120.246 1.385 . . . . 0.0 113.192 167.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.551 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 2.1 tm-20 -105.58 113.61 27.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 167.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.53 116.9 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.08 107.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 122.187 0.994 . . . . 0.0 112.667 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -84.46 94.78 8.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.011 0.91 . . . . 0.0 111.978 -170.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.51 -77.1 0.28 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.784 -167.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.6 -20.13 65.32 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 174.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.33 18.8 m 77.65 -70.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 171.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' NE ' ' HG1' ' A' ' 27' ' ' THR . 51.2 mtt180 -84.75 72.65 10.71 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 123.114 1.435 . . . . 0.0 113.331 175.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.88 71.27 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.766 165.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.47 115.22 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -170.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.551 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 73.8 mtt180 -81.61 146.83 29.89 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.75 104.96 17.35 Favored 'General case' 0 CA--C 1.573 1.833 0 O-C-N 121.972 -0.455 . . . . 0.0 110.064 168.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -93.39 88.85 6.11 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.732 0.777 . . . . 0.0 110.573 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.255 2.9 mp0 78.73 125.86 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 124.537 1.135 . . . . 0.0 113.109 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -95.61 169.45 10.02 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 122.251 1.024 . . . . 0.0 113.074 -177.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.646 ' HE2' ' NE ' ' A' ' 16' ' ' ARG . 3.2 mp0 . . . . . 0 CA--C 1.574 1.867 0 CA-C-O 124.345 2.021 . . . . 0.0 114.122 -168.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.561 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -143.29 83.76 1.79 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.811 0.815 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.0 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.073 -1.017 . . . . 0.0 109.58 164.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.87 139.27 51.21 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -153.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.9 p -75.07 159.1 32.11 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.17 -45.02 64.94 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.892 2.923 . . . . 0.0 118.892 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -69.07 -38.77 79.21 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 174.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 5.5 pt20 -70.31 -29.95 66.81 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 167.14 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -56.86 -47.76 79.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.99 -43.51 81.77 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.0 t -58.28 -48.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 168.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.51 -48.37 69.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 166.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.64 -37.42 73.3 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 170.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.43 -44.46 94.51 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 172.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.324 0.0 OUTLIER -61.98 -45.55 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 166.156 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -57.0 -46.89 81.97 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.85 -53.67 55.81 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 171.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -67.87 -36.55 80.48 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.32 -48.33 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-N 119.972 1.26 . . . . 0.0 112.563 167.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -63.23 -30.45 71.59 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 174.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -93.2 -42.92 9.1 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -107.98 -19.14 13.61 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.78 -48.39 1.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -173.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 149.86 43.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -62.14 148.05 93.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.412 2.075 . . . . 0.0 116.514 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.07 147.57 21.05 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.247 1.965 . . . . 0.0 115.243 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 p -75.23 165.33 25.36 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-O 122.492 1.139 . . . . 0.0 113.933 176.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.567 ' NE ' ' HG ' ' A' ' 63' ' ' SER . 3.4 mpt_? -52.03 -43.74 63.86 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 176.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.04 80.4 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 169.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.45 -49.5 77.32 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 120.294 1.406 . . . . 0.0 114.598 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.67 -44.7 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 171.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.02 -52.44 16.95 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -89.73 -37.32 14.63 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -167.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -64.24 -37.74 88.55 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.516 1.672 . . . . 0.0 115.516 172.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.97 -9.69 59.71 Favored 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 170.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.99 54.74 4.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 117.489 1.755 . . . . 0.0 117.489 178.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -96.65 135.83 38.03 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 121.78 0.8 . . . . 0.0 111.777 176.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -40.57 92.08 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 175.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.1 t -119.49 125.57 27.44 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.267 171.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.42 -36.7 49.25 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 N-CA-C 118.673 2.528 . . . . 0.0 118.673 165.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.22 -36.0 72.51 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 169.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.05 73.71 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 165.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.55 -48.86 71.52 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 172.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -33.05 72.56 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 165.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -60.78 -40.84 94.1 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 164.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.84 -49.44 73.29 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 164.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.1 -46.92 86.9 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 174.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.48 80.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 171.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.44 -46.87 53.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 169.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.82 76.73 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 172.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -55.56 -26.93 46.15 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 169.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -71.17 -50.95 27.82 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 170.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 165.0 -43.23 0.29 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 119.025 2.37 . . . . 0.0 119.025 -177.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.12 -35.1 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -168.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.5 155.81 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 C-N-CA 123.755 0.822 . . . . 0.0 110.688 172.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -112.06 145.6 39.44 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 112.221 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.96 151.1 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.187 0.994 . . . . 0.0 111.839 177.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.1 m -59.81 139.64 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -167.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 t -81.7 72.48 8.75 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 121.538 0.685 . . . . 0.0 112.759 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 -73.55 2.45 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -176.54 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.41 138.5 39.32 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.567 ' HG ' ' NE ' ' A' ' 28' ' ' ARG . 70.2 m -55.7 -34.39 65.04 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.573 3.175 . . . . 0.0 119.573 -174.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -89.2 69.06 8.24 Favored 'General case' 0 CA--C 1.581 2.166 0 CA-C-N 119.895 1.225 . . . . 0.0 112.369 172.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.59 43.13 0.85 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -179.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.4 mt -102.1 103.58 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -176.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.86 129.32 35.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -175.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -90.98 69.84 6.33 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.654 0.782 . . . . 0.0 112.428 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.33 1.8 pp -74.97 -23.87 58.36 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 120.186 3.402 . . . . 0.0 120.186 -167.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -98.49 -60.85 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -90.62 63.45 5.45 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.658 0.742 . . . . 0.0 112.491 178.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 123.881 1.801 . . . . 0.0 114.928 -165.476 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 mtp . . . . . 0 CA--C 1.567 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.411 32.6 mmtp 75.17 -106.78 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 124.446 1.099 . . . . 0.0 113.88 -178.646 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.64 103.18 6.94 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 118.919 0.781 . . . . 0.0 111.928 -174.156 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.26 121.23 40.59 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.001 0.52 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.6 p -64.04 154.32 34.66 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.85 46.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -63.41 -56.11 18.92 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 169.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.36 -33.73 76.17 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 174.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -58.06 -49.53 76.59 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 170.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.82 -27.13 66.45 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.65 -56.3 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 119.866 1.212 . . . . 0.0 112.764 160.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.43 -50.71 70.85 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 172.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.49 -44.4 96.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 tp -56.99 -37.83 72.18 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.058 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.4 -49.46 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.714 1.143 . . . . 0.0 113.119 169.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -56.88 -48.47 78.08 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.3 -53.02 62.65 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -74.18 -34.8 63.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -176.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -60.7 -42.95 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.575 0 CA-C-N 120.159 1.345 . . . . 0.0 112.637 163.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.61 -49.63 57.74 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -78.03 -15.7 58.71 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -143.21 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 112.469 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.93 -26.53 5.05 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 118.114 2.006 . . . . 0.0 118.114 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -97.54 152.04 37.96 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.66 121.31 6.62 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 C-N-CA 121.945 1.763 . . . . 0.0 114.6 -176.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.29 106.69 2.27 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.437 2.092 . . . . 0.0 112.325 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.305 7.3 t -84.96 -169.15 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -173.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -55.53 -39.37 70.46 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -168.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.57 86.37 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 168.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -60.03 -46.21 90.28 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 170.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.57 -58.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 123.909 0.884 . . . . 0.0 113.243 172.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.71 85.28 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -75.37 -32.85 60.95 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 171.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -53.22 18.53 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 171.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.72 -26.15 20.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -178.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.0 52.97 0.81 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -95.34 107.46 19.58 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 118.185 0.993 . . . . 0.0 110.053 170.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.48 53.53 2.69 Favored 'General case' 0 CA--C 1.584 2.262 0 O-C-N 121.29 -0.881 . . . . 0.0 113.078 169.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -178.32 111.32 0.22 Allowed Pre-proline 0 CA--C 1.577 2.015 0 C-N-CA 124.852 1.261 . . . . 0.0 109.158 -174.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.57 -38.7 75.87 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 N-CA-C 118.417 2.429 . . . . 0.0 118.417 169.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.88 -33.68 73.47 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 171.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -50.63 68.93 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.52 -48.83 76.4 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 170.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -43.48 92.73 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 171.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.86 -38.19 88.18 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 174.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -69.84 -35.65 74.92 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 168.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.45 -50.67 64.78 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.484 1.493 . . . . 0.0 114.659 160.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -51.6 -45.05 63.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 167.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.0 -39.09 65.75 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 169.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.98 -45.95 72.71 Favored 'General case' 0 CA--C 1.583 2.231 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 167.353 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.98 86.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 170.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -66.06 -37.75 86.6 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.42 -41.8 93.2 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 161.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 48.56 0.21 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 166.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.53 -35.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 pt -107.98 144.05 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 120.962 1.71 . . . . 0.0 113.412 -179.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.471 ' HE2' ' NE ' ' A' ' 67' ' ' ARG . 34.0 tt0 -96.21 115.35 27.29 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 172.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.35 122.93 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.5 116.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 167.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -94.88 91.53 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.976 176.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.04 -63.14 0.49 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 114.818 0.687 . . . . 0.0 114.818 -174.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.14 164.9 25.24 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 174.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -76.52 -67.06 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 177.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -89.54 78.85 6.99 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 122.795 1.283 . . . . 0.0 113.544 -169.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.22 66.34 0.31 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.246 171.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.5 mm -130.7 96.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.471 ' NE ' ' HE2' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -144.64 137.19 26.48 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -164.943 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 mt -76.19 136.31 39.75 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.82 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -78.61 85.54 4.65 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 121.777 0.799 . . . . 0.0 110.057 174.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.299 4.2 tp60 75.48 124.83 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.059 -156.029 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -82.92 67.28 8.93 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-O 121.932 0.872 . . . . 0.0 113.334 -175.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 123.446 1.593 . . . . 0.0 110.267 -173.436 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 CA--C 1.568 1.664 0 CA-C-O 121.866 0.841 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -71.75 147.99 46.78 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.765 -0.585 . . . . 0.0 111.841 167.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.99 -39.77 56.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -66.97 -46.71 73.8 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -54.61 -45.96 73.75 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 164.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -58.99 -41.93 88.79 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.72 -40.0 95.67 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 165.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.93 -44.39 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 120.259 1.391 . . . . 0.0 113.7 167.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -54.2 -47.91 71.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.33 -39.28 86.51 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD21 ' HE ' ' A' ' 34' ' ' ARG . 36.5 mt -57.63 -29.84 64.87 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm -58.89 -50.8 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.267 0 CA-C-N 120.036 1.289 . . . . 0.0 113.027 164.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -65.05 -46.06 82.83 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.36 -42.25 96.29 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -36.03 81.73 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.187 1.812 . . . . 0.0 115.301 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.91 -53.45 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 164.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -72.68 -37.24 67.96 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -92.38 1.13 57.41 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.2 m -150.07 -57.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.024 1.284 . . . . 0.0 111.218 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.57 -29.83 2.55 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -105.19 145.3 30.5 Favored Pre-proline 0 CA--C 1.569 1.707 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.39 146.89 22.37 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-N 122.421 1.9 . . . . 0.0 114.26 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 146.64 13.95 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.211 1.825 . . . . 0.0 116.535 -161.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.8 p -73.7 161.81 29.86 Favored 'General case' 0 CA--C 1.577 2.014 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.321 165.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -34.41 67.79 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.17 83.13 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 163.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.68 -40.77 79.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 169.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.13 -47.2 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.309 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 162.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.6 -35.7 72.85 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.72 -42.89 81.24 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HE ' HD21 ' A' ' 14' ' ' LEU . 2.5 tmm_? -77.64 -55.34 5.43 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.275 1.398 . . . . 0.0 113.893 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.0 -20.67 60.26 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.24 58.97 2.49 Favored Glycine 0 N--CA 1.48 1.628 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -95.78 126.88 41.35 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -54.08 -28.24 37.83 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.071 2.989 . . . . 0.0 119.071 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.9 m -155.97 158.15 31.57 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 123.852 0.861 . . . . 0.0 111.335 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -46.36 -31.54 9.61 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 N-CA-C 120.375 3.183 . . . . 0.0 120.375 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -54.33 -34.42 61.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.732 2.864 . . . . 0.0 118.732 166.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.44 -40.79 42.13 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.44 84.61 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.87 -34.8 72.02 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.44 -43.58 88.81 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -70.34 -41.96 72.51 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 169.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.24 -50.67 58.72 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -67.73 -37.73 82.61 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.15 89.57 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -57.09 -44.22 82.94 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 163.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.91 96.24 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.64 -40.03 82.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.72 -22.34 65.28 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.71 17.69 37.67 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.34 -21.45 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.2 pt -139.48 143.94 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.165 0 CA-C-N 120.511 1.505 . . . . 0.0 111.9 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.82 111.01 21.87 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 124.811 1.245 . . . . 0.0 109.269 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.36 128.88 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.68 133.45 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -85.18 86.51 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.862 . . . . 0.0 112.146 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.23 -72.61 0.24 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.62 120.83 25.57 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.7 t -59.52 -35.7 74.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -97.89 84.28 3.3 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.163 0.892 . . . . 0.0 110.337 167.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.19 85.03 0.13 Allowed Glycine 0 N--CA 1.482 1.738 0 O-C-N 121.919 -0.488 . . . . 0.0 112.908 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.06 109.77 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -95.21 126.36 40.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.217 0.607 . . . . 0.0 109.751 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.46 125.49 29.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.808 -1.182 . . . . 0.0 113.565 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.574 1.886 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.3 2.1 pt? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.1 p -138.14 143.05 40.15 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 154.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 119.402 3.112 . . . . 0.0 119.402 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -78.31 -25.71 46.68 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.28 6.7 pt20 -70.07 -34.91 73.78 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 121.607 2.003 . . . . 0.0 115.807 160.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -57.4 -41.77 80.97 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 162.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -54.84 -45.96 74.57 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.58 -48.2 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.39 -48.4 81.79 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.58 -37.7 73.63 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.33 -42.28 96.36 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 164.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.2 mt -57.76 -46.03 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.938 1.699 . . . . 0.0 113.483 170.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -62.36 -49.24 76.35 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.64 -56.87 12.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -58.88 -40.29 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -44.07 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 167.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -70.67 -24.03 62.61 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 118.691 2.849 . . . . 0.0 118.691 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.53 -47.33 3.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.573 1.149 . . . . 0.0 113.481 -167.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -85.59 -43.52 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.95 -39.87 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -96.22 151.13 37.97 Favored Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.96 124.04 9.79 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 122.185 1.816 . . . . 0.0 113.427 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.9 114.48 3.84 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.182 1.921 . . . . 0.0 115.607 -167.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 t -83.59 -172.73 4.31 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -33.2 -58.19 0.39 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.76 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.52 -40.32 89.1 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 172.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.8 mm -60.59 -52.11 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 119.922 1.237 . . . . 0.0 113.349 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.42 -48.68 66.59 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -72.74 -44.33 61.79 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.1 mt -86.67 -9.64 55.55 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.541 2.422 . . . . 0.0 117.541 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.39 61.04 3.08 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.63 103.37 16.08 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.862 0.839 . . . . 0.0 111.435 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -9.75 57.55 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 161.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -107.25 109.5 62.85 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 117.496 -1.24 . . . . 0.0 110.725 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.73 -44.55 40.28 Favored 'Trans proline' 0 N--CA 1.509 2.422 0 N-CA-C 120.159 3.1 . . . . 0.0 120.159 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.01 -42.99 83.99 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.71 -47.45 73.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.5 -37.98 20.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.55 -35.54 80.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -60.13 -38.42 83.02 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 163.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.58 -45.81 92.57 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.06 -41.4 83.26 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.09 94.76 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 mt -57.68 -41.95 82.63 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 167.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.67 91.01 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 166.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -58.6 -40.97 84.72 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -71.89 -15.96 62.12 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.58 3.86 55.02 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.13 -17.8 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -130.79 129.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.052 1.297 . . . . 0.0 110.813 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -90.68 115.94 28.16 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.247 -0.908 . . . . 0.0 109.916 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.02 132.23 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.68 118.9 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.677 -0.639 . . . . 0.0 109.376 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.4 t -77.53 69.96 3.85 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.86 39.63 0.07 OUTLIER Glycine 0 CA--C 1.548 2.096 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.99 125.28 5.63 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.675 1.238 . . . . 0.0 110.231 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 m -59.53 -47.02 87.14 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -109.61 89.11 2.91 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.62 85.49 0.19 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 116.394 -0.366 . . . . 0.0 113.779 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.24 114.56 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.946 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -96.09 117.28 30.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.213 0.605 . . . . 0.0 110.757 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -74.99 105.17 5.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.571 1.753 0 CA-C-O 122.621 1.201 . . . . 0.0 109.135 171.763 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 98.5 mt . . . . . 0 CA--C 1.568 1.64 0 CA-C-O 121.418 0.628 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -68.45 159.68 31.2 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.05 -45.96 52.69 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -71.08 -39.91 71.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -67.44 -33.98 76.26 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -56.8 -42.92 80.35 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 165.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -53.19 -43.77 67.43 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 164.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.29 -48.5 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -56.64 -47.03 80.62 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.1 -43.24 66.7 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 168.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -39.06 79.89 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.61 -48.49 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 CA-C-N 120.216 1.371 . . . . 0.0 113.457 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.45 -49.44 77.8 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 166.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.37 -49.48 73.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -62.07 -35.68 79.37 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.449 1.931 . . . . 0.0 115.978 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.52 -43.3 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 119.51 1.05 . . . . 0.0 113.029 165.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -64.82 -33.82 76.89 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.55 -47.18 12.44 Favored 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -102.56 -23.97 13.83 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.31 -34.37 4.62 Favored Glycine 0 CA--C 1.552 2.36 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 -159.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.13 154.6 40.55 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.82 152.3 63.73 Favored 'Trans proline' 0 CA--C 1.567 2.129 0 C-N-CA 122.056 1.837 . . . . 0.0 114.929 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.49 144.65 10.29 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.294 1.855 . . . . 0.0 115.094 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 58.6 p -76.47 161.33 28.73 Favored 'General case' 0 CA--C 1.577 2.011 0 O-C-N 121.877 -0.514 . . . . 0.0 112.285 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -50.69 -28.54 9.21 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.84 -36.53 80.51 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 163.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -62.02 -45.84 91.81 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 120.586 1.539 . . . . 0.0 114.518 163.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.04 -53.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 CA-C-N 119.799 1.181 . . . . 0.0 112.603 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.5 99.01 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -78.01 -48.21 16.68 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -70.26 -41.87 72.91 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.12 -17.6 27.37 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.74 62.32 1.95 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -90.82 148.2 22.68 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.426 1.108 . . . . 0.0 113.136 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -35.48 73.75 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -144.94 149.76 43.64 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.843 167.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.36 -33.06 21.58 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 N-CA-C 119.393 2.805 . . . . 0.0 119.393 163.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -65.78 -37.1 85.39 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 167.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.6 96.01 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.49 63.88 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 164.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.98 -34.4 76.48 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 171.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.81 -46.62 84.4 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -63.48 -39.32 94.15 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -53.89 -47.34 71.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 166.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -59.45 -35.75 74.64 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.37 -18.79 65.28 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 169.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.71 -46.0 84.18 Favored 'General case' 0 CA--C 1.592 2.594 0 CA-C-N 119.913 1.233 . . . . 0.0 113.668 159.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.05 175.38 4.52 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.296 1.6 mpt_? 75.74 -54.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.245 -0.909 . . . . 0.0 113.157 -173.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -61.6 -56.58 18.33 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 156.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.22 52.28 0.18 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 117.982 1.953 . . . . 0.0 117.982 169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.298 10.2 p -116.04 -20.64 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 168.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.24 155.61 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 122.218 2.281 . . . . 0.0 113.287 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.21 128.08 34.18 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.914 -0.491 . . . . 0.0 111.577 161.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.83 134.23 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.11 116.79 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.738 0.78 . . . . 0.0 111.917 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -85.53 100.85 12.2 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.738 -0.601 . . . . 0.0 112.267 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.42 -64.74 0.58 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.81 30.85 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.8 m -75.84 -38.84 57.64 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -134.33 100.12 4.58 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.612 1.096 . . . . 0.0 112.306 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.98 64.79 0.45 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.809 167.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.7 96.21 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -86.89 133.24 33.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 122.928 0.491 . . . . 0.0 112.103 169.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.47 125.19 28.94 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-O 121.737 0.78 . . . . 0.0 112.56 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.564 1.518 0 C-N-CA 123.957 0.903 . . . . 0.0 112.679 -171.199 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 CA--C 1.567 1.609 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -66.09 154.89 38.38 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.59 -47.96 28.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -71.11 -41.71 70.23 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.49 -37.19 86.09 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.06 -49.2 77.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 170.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.23 -36.3 79.58 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.47 -50.6 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.465 1.03 . . . . 0.0 113.333 165.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -50.21 -51.68 42.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.55 -39.16 92.74 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.76 -46.27 86.02 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 121.263 1.847 . . . . 0.0 115.043 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.282 36.6 pt -59.06 -46.18 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -54.78 -51.05 66.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 165.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.28 -38.2 90.22 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -72.16 -30.18 64.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.59 -42.3 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.746 1.157 . . . . 0.0 112.908 160.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -64.89 -31.05 72.09 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.3 -43.24 57.59 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 p -125.96 -18.18 5.15 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.29 -43.14 1.95 Allowed Glycine 0 CA--C 1.546 1.978 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 -165.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.05 147.0 32.89 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.15 146.3 88.88 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 N-CA-C 118.886 2.61 . . . . 0.0 118.886 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.45 120.32 3.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.528 2.152 . . . . 0.0 112.58 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -89.21 82.02 6.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 111.624 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.323 23.5 tpt180 66.66 -52.59 0.44 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.07 50.48 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 -167.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.6 -31.17 71.03 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.8 mt -61.21 -53.97 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 CA-C-N 118.941 0.791 . . . . 0.0 112.129 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.88 85.21 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -72.02 -52.11 18.55 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.54 -40.91 28.45 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.63 -24.73 26.98 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.53 81.2 1.33 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 119.411 1.005 . . . . 0.0 114.718 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.72 102.9 8.71 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 117.678 0.739 . . . . 0.0 109.658 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -25.97 61.19 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -98.2 127.13 37.53 Favored Pre-proline 0 CA--C 1.566 1.56 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.327 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.31 -49.27 14.67 Favored 'Trans proline' 0 N--CA 1.508 2.37 0 N-CA-C 119.332 2.782 . . . . 0.0 119.332 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -94.27 75.63 3.97 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.156 0.979 . . . . 0.0 111.444 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.77 -48.61 0.96 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.034 168.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.11 -35.57 80.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.22 -45.87 92.78 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -61.89 -29.21 70.05 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -62.47 -47.42 84.11 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 120.317 1.417 . . . . 0.0 114.301 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.46 -43.31 79.42 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -60.29 -46.14 90.89 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.84 88.73 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 167.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.78 -43.19 94.52 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.13 -46.39 71.01 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -59.72 -40.22 87.28 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -65.11 -30.34 71.27 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 166.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.7 17.21 7.6 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.49 -13.95 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.79 134.55 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 119.863 1.211 . . . . 0.0 111.885 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.19 108.72 19.42 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.164 0.585 . . . . 0.0 110.563 168.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.4 mt -93.38 119.35 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.3 t -83.25 98.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -68.84 98.49 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.92 -55.68 0.68 Allowed Glycine 0 N--CA 1.486 2.009 0 CA-C-N 115.454 -0.794 . . . . 0.0 114.34 -163.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 116.96 23.63 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.6 p -53.68 -41.26 66.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -104.49 41.73 1.29 Allowed 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.62 72.8 0.3 Allowed Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.467 -0.771 . . . . 0.0 112.746 165.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.26 93.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -121.58 133.02 55.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.798 -0.564 . . . . 0.0 111.81 -155.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.92 114.78 11.45 Favored 'General case' 0 CA--C 1.578 2.038 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -165.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 CA--C 1.572 1.798 0 CA-C-O 121.839 0.828 . . . . 0.0 109.171 173.352 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.559 1.322 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 p -75.88 157.26 33.49 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.54 72.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -71.8 -31.39 66.53 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -69.89 -31.25 68.95 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 161.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -60.62 -43.47 97.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 165.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -55.06 -45.15 75.28 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 165.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.63 -50.23 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.13 -47.74 68.44 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.56 -44.22 89.62 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.48 -37.03 86.12 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.23 -48.62 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 118.05 -0.976 . . . . 0.0 113.208 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -51.23 -46.37 62.26 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -49.24 78.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -71.34 -27.68 63.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mm -51.48 -43.24 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.265 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 158.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -77.09 -35.44 56.52 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.32 -29.47 65.06 Favored 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -146.75 -49.7 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.129 0.971 . . . . 0.0 112.006 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.28 18.37 0.93 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 118.038 1.975 . . . . 0.0 118.038 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptp -155.96 159.18 31.73 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-N 119.652 1.726 . . . . 0.0 113.43 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.83 128.67 31.25 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 122.623 2.216 . . . . 0.0 115.015 160.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 175.18 11.71 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 123.831 2.404 . . . . 0.0 115.55 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.0 p -66.79 154.74 40.06 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -22.61 64.92 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.43 -46.64 69.31 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 160.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.6 -53.21 60.77 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.58 -43.11 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.17 -48.75 78.67 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -79.79 -35.06 39.09 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.68 -39.28 73.61 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 -20.19 21.75 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.95 49.16 2.52 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -105.27 111.36 24.07 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -83.05 56.91 3.66 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 m 171.59 114.17 0.05 OUTLIER Pre-proline 0 CA--C 1.582 2.197 0 C-N-CA 126.148 1.779 . . . . 0.0 107.685 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.7 -33.72 60.95 Favored 'Trans proline' 0 N--CA 1.511 2.523 0 N-CA-C 119.136 2.706 . . . . 0.0 119.136 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -65.95 -33.8 76.64 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.98 96.19 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -52.38 65.05 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 162.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.2 -44.84 68.3 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.73 -38.05 66.65 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -72.61 -31.54 65.24 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 167.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.91 -40.17 87.93 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 121.272 1.851 . . . . 0.0 114.747 159.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -60.32 -51.51 69.22 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-N 120.032 1.287 . . . . 0.0 114.248 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.88 73.26 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 169.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.61 -39.03 81.01 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.76 88.72 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 164.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -65.49 -32.78 74.58 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -60.31 -12.62 9.58 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 157.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.69 13.71 66.77 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.51 -3.1 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -164.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.02 137.73 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 119.861 1.21 . . . . 0.0 110.664 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.1 108.11 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 110.622 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.53 138.38 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.03 135.26 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.847 -0.533 . . . . 0.0 112.222 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.1 t -82.01 77.54 8.81 Favored 'General case' 0 CA--C 1.567 1.629 0 O-C-N 121.61 -0.682 . . . . 0.0 112.594 170.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.05 -72.37 0.1 OUTLIER Glycine 0 N--CA 1.484 1.849 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.567 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.69 135.14 39.08 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -65.24 -11.27 39.31 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -90.74 -87.37 0.19 Allowed 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 120.049 1.295 . . . . 0.0 111.591 173.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.4 36.43 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 121.755 -0.591 . . . . 0.0 114.07 -172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.77 -72.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.132 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -151.2 161.47 42.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -163.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -87.87 121.27 30.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.4 164.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 CA--C 1.573 1.847 0 C-N-CA 123.426 0.69 . . . . 0.0 109.957 -178.67 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.8 p -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.26 -36.04 72.66 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.18 -37.92 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 9.6 pt20 -66.18 -30.34 70.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -53.97 -47.01 71.78 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 162.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.88 -46.54 81.8 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 168.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.34 -48.26 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -54.41 -50.39 67.71 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.39 -34.32 73.74 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.66 -44.44 81.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.338 10.2 tt -61.06 -39.23 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 166.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -55.9 -49.43 73.45 Favored 'General case' 0 CA--C 1.584 2.279 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 163.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.05 -47.71 79.11 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -68.75 -32.83 72.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -55.91 -47.97 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-N 119.509 1.049 . . . . 0.0 113.027 160.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 t -65.88 -33.54 76.08 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.0 -39.52 69.17 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -127.18 -24.81 3.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -167.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -26.75 12.2 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -161.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -105.95 151.34 40.0 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-N 118.656 1.228 . . . . 0.0 114.166 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 66' ' ' ILE . 91.9 Cg_endo -80.55 161.05 22.22 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.471 2.114 . . . . 0.0 115.706 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.79 143.01 11.61 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.876 2.384 . . . . 0.0 115.21 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.0 p -79.32 161.23 26.39 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -52.0 -44.18 63.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.99 90.02 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -63.42 -46.44 86.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.2 mt -57.5 -48.82 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.412 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.19 95.1 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -65.31 -43.41 91.13 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -69.16 -47.79 64.01 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.14 -18.52 28.61 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.84 55.62 1.73 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 116.56 1.384 . . . . 0.0 116.56 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -102.3 106.81 17.67 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 117.696 0.748 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.32 -32.95 71.72 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -106.4 104.91 52.55 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.87 162.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -51.69 -29.23 32.53 Favored 'Trans proline' 0 N--CA 1.509 2.441 0 N-CA-C 120.131 3.089 . . . . 0.0 120.131 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -49.42 -40.03 35.04 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.87 72.28 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 169.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.64 90.66 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -65.31 -35.41 80.92 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 168.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.16 -39.38 94.5 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.372 1.897 . . . . 0.0 115.857 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -60.79 -42.22 97.15 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 163.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.16 -46.44 85.7 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 168.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -61.02 -41.96 97.55 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.82 91.29 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.75 -43.43 90.27 Favored 'General case' 0 CA--C 1.584 2.256 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 165.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.12 80.47 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -60.62 -40.45 91.94 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -64.49 -45.84 85.57 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 168.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.93 60.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.862 0 N-CA-C 116.897 1.519 . . . . 0.0 116.897 163.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.06 -38.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.12 134.25 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.921 1.691 . . . . 0.0 111.42 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.38 99.52 12.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.427 -0.796 . . . . 0.0 111.06 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.68 120.21 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 122.775 0.43 . . . . 0.0 110.444 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.15 128.47 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.8 p -85.78 79.34 9.32 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 121.293 -0.88 . . . . 0.0 112.591 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.09 -65.64 0.32 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 141.73 38.63 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -71.08 107.13 3.99 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.302 82.2 mtt-85 79.01 33.5 0.24 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.32 59.76 0.81 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 164.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' A' ' 25' ' ' PRO . 33.7 mt -117.7 89.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -103.06 135.24 45.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 111.957 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.25 143.63 26.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.677 0.751 . . . . 0.0 112.51 -172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.576 1.951 0 O-C-N 121.141 -0.974 . . . . 0.0 111.565 -179.568 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.523 0.4 OUTLIER . . . . . 0 CA--C 1.571 1.783 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -133.94 157.11 46.84 Favored 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 123.896 0.878 . . . . 0.0 110.449 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 -36.07 67.77 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -69.09 -47.17 65.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.2 -33.33 75.15 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -63.34 -39.18 93.83 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -57.25 -41.56 79.84 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 165.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.54 -47.32 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 163.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -58.12 -45.62 87.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -54.13 -40.97 67.85 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.45 -51.47 68.58 Favored 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 120.761 1.619 . . . . 0.0 115.362 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.15 -43.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -62.19 -44.69 96.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.34 -52.83 60.34 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 166.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -69.26 -36.21 76.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -54.92 -48.63 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 CA-C-N 119.524 1.056 . . . . 0.0 113.658 161.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -69.64 -34.15 73.62 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -98.6 -43.3 6.89 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 m -95.03 -44.65 7.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.48 -29.75 6.26 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 117.875 1.91 . . . . 0.0 117.875 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -100.12 155.4 36.47 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -74.34 123.08 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.381 2.054 . . . . 0.0 114.85 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.05 148.11 19.19 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 CA-C-N 123.017 2.113 . . . . 0.0 113.373 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -71.38 165.49 23.64 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 44' ' ' GLU . 8.9 ptm180 -52.41 -32.16 37.75 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 162.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.1 96.97 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.9 -37.84 86.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 168.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.3 -48.22 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.785 1.175 . . . . 0.0 113.524 166.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.46 96.77 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -62.99 -47.11 84.57 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -78.37 -46.49 19.84 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.1 -22.08 39.43 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.725 2.121 . . . . 0.0 116.725 168.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.57 48.0 4.66 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 117.003 1.561 . . . . 0.0 117.003 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.07 93.38 8.6 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.148 0.974 . . . . 0.0 109.388 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -58.85 -32.91 69.86 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -94.5 106.08 21.81 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.244 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.21 -12.07 34.58 Favored 'Trans proline' 0 N--CA 1.51 2.458 0 N-CA-C 118.712 2.543 . . . . 0.0 118.712 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -58.47 -32.56 68.86 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 159.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.38 93.61 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.2 73.07 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 19.0 tt0 -64.42 -48.24 76.12 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 171.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.72 -39.25 93.32 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -61.88 -42.44 99.07 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 164.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.82 -40.86 85.38 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.22 -51.54 65.84 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.21 -38.79 68.89 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 167.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.74 -43.15 99.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.03 -39.75 95.67 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.9 -34.15 75.52 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.2 -39.82 94.78 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 161.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.37 51.13 0.18 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 117.176 1.631 . . . . 0.0 117.176 164.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 -8.29 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.082 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.06 145.71 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 121.892 2.133 . . . . 0.0 112.703 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.05 112.46 21.89 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.569 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -83.61 105.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 109.605 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.15 123.31 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-O 121.319 0.58 . . . . 0.0 112.046 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.3 t -82.07 73.87 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.62 -83.77 0.13 Allowed Glycine 0 N--CA 1.482 1.745 0 O-C-N 122.068 -0.395 . . . . 0.0 113.53 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.84 89.89 6.37 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 27.5 t -59.12 -11.86 4.25 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -80.39 15.88 1.48 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 165.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.14 43.73 1.62 Allowed Glycine 0 CA--C 1.552 2.364 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 155.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.2 tp -93.03 75.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.158 0.98 . . . . 0.0 111.235 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -91.85 135.51 33.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 112.38 -166.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -93.29 142.67 27.06 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.564 1.494 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.571 1.772 0 CA-C-O 121.22 0.533 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 157.7 29.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.187 -0.946 . . . . 0.0 112.872 168.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.2 50.46 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.15 -38.57 85.72 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -56.57 -47.82 78.69 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -62.83 -41.74 99.45 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.33 -50.59 69.25 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.02 -49.25 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.1 -47.28 85.33 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.84 -33.4 70.39 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -38.72 71.51 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 167.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt -55.4 -56.68 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 123.995 0.918 . . . . 0.0 112.732 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -68.13 -32.2 72.32 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -55.56 -53.06 61.08 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -69.96 -37.63 75.85 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.34 -42.2 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-N 119.91 1.232 . . . . 0.0 113.421 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.84 -30.32 71.31 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 169.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.82 -50.08 7.41 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.3 m -107.01 -31.07 8.46 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.2 23.91 18.32 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -147.87 156.2 44.33 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-N 119.091 1.446 . . . . 0.0 112.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -57.48 137.43 81.42 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.65 143.2 14.84 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 122.448 1.91 . . . . 0.0 114.753 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -74.37 160.98 30.31 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -32.1 -55.19 0.31 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 166.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.96 75.53 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -56.19 -43.57 78.57 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.1 -56.39 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 118.927 0.785 . . . . 0.0 112.095 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.85 75.35 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -75.77 -25.86 56.84 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.0 -46.17 65.7 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.232 1.378 . . . . 0.0 114.547 166.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.55 -37.95 30.5 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.92 0.27 Allowed Glycine 0 CA--C 1.545 1.958 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -114.55 130.87 56.8 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 117.872 0.836 . . . . 0.0 109.647 165.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -70.79 -41.36 71.77 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -101.23 113.18 65.83 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.387 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -56.08 -19.67 27.62 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -58.0 -28.62 64.58 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.97 71.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.56 80.21 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.67 -40.98 94.11 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.24 -49.97 72.62 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.44 -39.23 77.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 tp -52.52 -44.6 65.86 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 166.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -57.93 -40.04 79.5 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 166.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.78 99.56 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 166.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.56 -45.16 81.43 Favored 'General case' 0 CA--C 1.59 2.503 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.28 92.45 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 174.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -56.2 -39.55 72.6 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 165.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -76.44 6.4 5.76 Favored 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 28.02 58.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.42 -37.77 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 118.55 1.175 . . . . 0.0 113.182 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.65 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-N 119.676 1.125 . . . . 0.0 111.409 169.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.36 127.04 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.166 163.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.6 103.88 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.65 81.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.988 0.899 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.3 t -88.37 72.46 8.94 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -166.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.39 -67.91 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 O-C-N 122.018 -0.427 . . . . 0.0 113.15 158.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.01 161.59 28.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 150.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.9 p -76.08 68.73 2.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.293 24.7 ptt180 -174.43 -110.49 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.744 1.617 . . . . 0.0 109.107 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.96 45.24 96.55 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mt -102.69 113.73 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 118.273 1.037 . . . . 0.0 110.37 -161.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -97.57 135.79 38.9 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 121.451 0.643 . . . . 0.0 111.94 162.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 109.91 17.86 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.275 0.63 . . . . 0.0 111.082 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 CA--C 1.572 1.819 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.57 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 121.997 0.903 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.0 p -80.76 145.55 31.45 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.028 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.3 66.12 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.73 -37.55 70.58 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -57.47 -46.32 83.8 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 121.02 1.736 . . . . 0.0 114.566 163.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -54.91 -47.29 74.54 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -53.37 -47.11 69.72 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 167.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.12 -47.77 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.24 -45.79 87.12 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -60.15 -37.2 79.4 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.22 -39.65 93.05 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 167.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -58.52 -45.62 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-N 119.405 1.002 . . . . 0.0 113.553 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -54.52 -51.34 65.46 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -60.9 -39.65 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -65.71 -47.71 74.45 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mm -57.51 -46.65 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 167.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -69.96 -12.63 61.75 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -70.74 -41.62 71.6 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 121.086 1.767 . . . . 0.0 115.022 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -149.11 -73.17 0.18 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.94 51.99 0.21 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 113.716 165.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -122.23 128.15 25.61 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.026 -164.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HB3' ' H ' ' A' ' 66' ' ' ILE . 36.8 Cg_exo -66.22 153.85 76.43 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 CA-C-N 123.092 2.14 . . . . 0.0 115.417 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.52 161.97 27.9 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 CA-C-N 122.55 1.947 . . . . 0.0 114.441 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -95.62 158.27 15.53 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.217 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -54.94 -37.58 66.6 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.05 99.86 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 166.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.26 -41.04 96.24 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 167.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.85 -51.04 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 119.647 1.112 . . . . 0.0 113.54 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.76 89.43 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -80.46 -39.23 28.52 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -78.88 -41.4 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.16 -36.86 34.49 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 61.91 0.69 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.21 101.88 10.35 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.67 62.32 6.8 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.365 1.078 . . . . 0.0 113.427 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m 175.9 126.98 0.15 Allowed Pre-proline 0 CA--C 1.58 2.115 0 C-N-CA 125.89 1.676 . . . . 0.0 107.995 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -61.22 -42.65 33.93 Favored 'Trans proline' 0 N--CA 1.51 2.442 0 CA-C-N 123.119 2.15 . . . . 0.0 116.503 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.34 -30.88 67.07 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.97 75.32 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.68 95.81 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 166.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.42 -53.25 60.48 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.47 -32.05 69.43 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -65.72 -37.9 87.71 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.333 1.879 . . . . 0.0 115.217 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.56 -51.3 70.48 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -57.45 -40.63 78.87 Favored 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 115.564 1.691 . . . . 0.0 115.564 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.45 95.64 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 167.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.68 -38.87 82.69 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.21 97.07 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 165.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -62.14 -36.22 81.14 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -58.63 -24.5 61.19 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 162.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.24 66.31 1.16 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 118.892 0.769 . . . . 0.0 114.99 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.269 10.5 p -149.33 -52.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.2 pt -96.01 131.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 120.864 1.666 . . . . 0.0 113.358 -171.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.76 110.01 20.64 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.297 0.639 . . . . 0.0 110.437 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.3 125.59 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.74 125.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 112.678 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -84.19 74.66 10.27 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.12 -67.52 0.23 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.27 142.04 34.95 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -66.45 -30.49 70.85 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 118.469 2.766 . . . . 0.0 118.469 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -108.73 88.88 2.83 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 119.971 1.26 . . . . 0.0 110.617 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.54 72.76 0.14 Allowed Glycine 0 N--CA 1.486 1.988 0 O-C-N 121.862 -0.524 . . . . 0.0 114.044 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.432 ' H ' ' HB3' ' A' ' 25' ' ' PRO . 66.4 mt -131.92 101.99 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -119.34 129.17 54.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.923 -0.485 . . . . 0.0 112.003 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 134.33 37.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.572 1.817 0 CA-C-O 122.218 1.009 . . . . 0.0 110.664 -175.297 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.568 1.67 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 p -74.65 149.32 40.02 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.15 9.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.704 3.594 . . . . 0.0 120.704 -169.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.89 -45.82 40.27 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.48 -37.93 89.24 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 169.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -53.72 -40.97 66.53 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 164.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.11 -47.9 80.81 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 167.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.97 -49.04 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.645 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -55.48 -39.66 70.7 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.31 -45.64 90.76 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.495 HD23 ' HE ' ' A' ' 34' ' ' ARG . 2.9 tm? -60.39 -40.44 90.88 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 120.634 1.561 . . . . 0.0 114.909 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mt -60.58 -48.68 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -55.41 -48.22 74.71 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -59.27 -48.93 79.78 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -64.14 -41.12 97.31 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.4 mm -68.53 -50.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.494 1.043 . . . . 0.0 113.263 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -73.4 -38.02 65.75 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -88.56 -52.84 4.95 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 119.606 1.094 . . . . 0.0 113.448 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.46 -20.91 19.27 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 41.69 20.82 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 118.141 2.016 . . . . 0.0 118.141 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -149.23 142.67 16.19 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-N 118.893 1.346 . . . . 0.0 113.943 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.33 117.66 1.02 Allowed 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.121 1.881 . . . . 0.0 114.295 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.15 174.09 13.36 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 123.21 2.182 . . . . 0.0 117.644 -170.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -94.21 156.12 16.7 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.043 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -59.23 -28.19 66.45 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 166.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.94 96.58 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.68 -39.96 95.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 168.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.24 -51.08 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 123.734 0.814 . . . . 0.0 112.832 166.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.89 93.31 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -67.19 -45.89 75.55 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.495 ' HE ' HD23 ' A' ' 14' ' ' LEU . 2.8 tmm_? -74.73 -45.32 44.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.79 -14.49 34.39 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -171.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 63.61 1.21 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -117.44 120.83 39.32 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -55.95 -37.27 68.79 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -123.94 148.98 58.56 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.118 159.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -58.21 -12.63 13.55 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 164.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -58.06 -41.71 83.94 Favored 'General case' 0 CA--C 1.587 2.375 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 163.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.29 89.48 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.65 78.5 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 164.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -56.2 -36.95 68.98 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.34 -48.76 80.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -65.17 -38.19 89.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 168.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.59 -37.99 66.18 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -55.77 -57.03 13.74 Favored 'General case' 0 CA--C 1.574 1.897 0 CA-C-N 120.653 1.57 . . . . 0.0 114.811 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.98 75.64 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 168.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.79 -48.45 79.67 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.9 77.39 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -55.78 -41.98 74.86 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -71.83 -14.11 61.87 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.53 62.46 0.45 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 117.395 1.718 . . . . 0.0 117.395 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 m -141.74 -45.04 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.163 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 156.06 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 120.852 1.66 . . . . 0.0 114.548 -168.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.59 144.1 44.11 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 162.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.8 mt -114.11 120.09 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.65 106.59 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.677 0.751 . . . . 0.0 111.047 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.9 p -86.81 87.89 7.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 112.748 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.34 -65.86 0.42 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 169.55 18.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 170.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.1 p -91.66 -55.74 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -84.43 90.09 7.53 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.532 1.158 . . . . 0.0 112.225 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.3 44.83 0.16 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.6 mt -106.49 99.84 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -115.38 145.24 42.72 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.242 0.617 . . . . 0.0 112.006 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.13 123.1 18.98 Favored 'General case' 0 CA--C 1.579 2.093 0 O-C-N 122.05 -0.406 . . . . 0.0 111.853 166.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 122.608 1.194 . . . . 0.0 112.437 -177.804 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 CA--C 1.575 1.916 0 CA-C-O 121.419 0.628 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.5 p -71.16 159.45 34.65 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.92 75.22 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -70.19 -37.05 75.02 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -65.25 -38.52 90.58 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.721 1.6 . . . . 0.0 115.276 166.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -56.54 -40.91 75.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 164.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.59 -45.52 85.19 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -57.81 -50.33 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.07 -46.11 82.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -59.29 -30.17 68.13 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -64.8 -45.75 84.94 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.077 1.308 . . . . 0.0 114.345 165.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mm -55.68 -47.46 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 169.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -60.15 -46.51 89.43 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.31 -55.32 35.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.52 -34.42 75.83 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.78 -42.1 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.215 1.37 . . . . 0.0 112.716 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.1 t -63.21 -31.7 72.91 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 168.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -73.08 -44.31 60.7 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -120.43 -22.44 6.48 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -167.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.15 -30.74 6.85 Favored Glycine 0 CA--C 1.549 2.195 0 N-CA-C 117.886 1.915 . . . . 0.0 117.886 -163.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -104.69 138.88 19.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -60.93 135.86 62.09 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 N-CA-C 119.499 2.846 . . . . 0.0 119.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.5 123.43 6.5 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.46 2.107 . . . . 0.0 113.607 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -100.04 101.97 13.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -168.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.301 76.4 mtt85 70.85 -72.03 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 142.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.05 77.49 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 157.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -60.52 -40.54 91.82 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -62.72 -52.35 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 120.048 1.295 . . . . 0.0 112.664 166.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.74 81.96 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -71.39 -47.77 54.07 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.19 -43.12 87.7 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.27 -6.32 59.43 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.4 51.52 4.6 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.32 108.42 20.59 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 117.643 0.721 . . . . 0.0 109.641 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -80.46 50.3 1.27 Allowed 'General case' 0 CA--C 1.584 2.27 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 175.52 96.79 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 C-N-CA 126.673 1.989 . . . . 0.0 106.083 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -54.52 -30.54 65.16 Favored 'Trans proline' 0 N--CA 1.513 2.62 0 N-CA-C 120.048 3.057 . . . . 0.0 120.048 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -60.93 -35.53 76.95 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.35 79.64 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.76 -42.91 76.17 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 162.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.4 -34.89 78.97 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 173.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.33 -42.92 96.63 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -61.75 -45.03 95.65 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 165.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.54 -49.03 65.67 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -61.14 -46.71 89.43 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.88 74.43 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.64 -37.64 85.24 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.32 95.79 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 ttt-85 -54.39 -44.03 71.94 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.37 -7.24 23.35 Favored 'General case' 0 CA--C 1.592 2.569 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.42 53.23 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.929 2.332 . . . . 0.0 118.929 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.23 -25.28 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.66 128.99 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.868 1.213 . . . . 0.0 111.221 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.66 107.61 19.28 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.663 -0.648 . . . . 0.0 110.619 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -80.83 122.02 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.18 123.15 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.016 0.526 . . . . 0.0 110.032 -169.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 m -78.73 84.42 4.81 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 121.752 0.787 . . . . 0.0 112.417 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.58 -64.22 0.35 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.73 123.05 25.6 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 m -61.66 -57.04 13.55 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -81.66 79.49 8.22 Favored 'General case' 0 CA--C 1.577 1.988 0 CA-C-N 119.259 0.936 . . . . 0.0 110.375 159.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.38 0.49 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.215 -0.902 . . . . 0.0 114.016 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.34 86.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -109.3 157.14 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.469 1.128 . . . . 0.0 113.791 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.36 110.75 18.4 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -161.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.585 2.324 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 166.728 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 CA--C 1.575 1.931 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.1 p -75.69 147.78 39.16 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.833 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.34 44.01 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 119.004 2.965 . . . . 0.0 119.004 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -73.63 -39.42 64.53 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.78 -33.4 75.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.7 -45.3 85.88 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 163.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.96 -42.58 76.43 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 167.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.0 -45.06 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.203 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -55.91 -42.53 76.19 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -54.31 -46.17 72.77 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -55.89 -37.7 69.21 Favored 'General case' 0 CA--C 1.586 2.344 0 N-CA-C 116.901 2.185 . . . . 0.0 116.901 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.13 -53.59 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 119.826 1.194 . . . . 0.0 113.263 170.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -60.58 -46.61 89.58 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -64.11 -47.52 79.68 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -69.32 -37.62 77.83 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.7 mt -57.35 -47.64 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 120.526 1.512 . . . . 0.0 112.94 167.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -62.26 -25.89 68.09 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 168.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.27 -58.85 2.67 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.854 1.206 . . . . 0.0 113.388 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 m -151.03 68.83 0.94 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 119.899 1.227 . . . . 0.0 111.151 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.34 -49.51 3.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 121.084 3.194 . . . . 0.0 121.084 160.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.16 137.95 19.38 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -157.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.45 122.67 5.67 Favored 'Trans proline' 0 CA--C 1.572 2.403 0 C-N-CA 122.727 2.285 . . . . 0.0 114.822 172.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -55.99 157.07 17.75 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 N-CA-C 122.322 3.932 . . . . 0.0 122.322 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 p -115.92 -174.58 2.56 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.176 163.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -28.09 22.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -171.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.37 90.84 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -76.12 -50.44 14.64 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 119.554 1.07 . . . . 0.0 112.915 165.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.6 mt -57.98 -49.61 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.45 76.4 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.46 -44.68 18.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -70.06 -40.23 75.21 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.27 -18.67 48.67 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 64.78 1.46 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -100.22 152.6 20.1 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.354 1.073 . . . . 0.0 113.027 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -56.02 -32.91 64.41 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 166.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m -163.21 159.21 18.33 Favored Pre-proline 0 CA--C 1.577 1.987 0 C-N-CA 124.088 0.955 . . . . 0.0 112.045 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -57.87 -30.44 89.54 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.914 2.236 . . . . 0.0 117.914 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.34 -45.04 88.88 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 167.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.54 88.81 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.61 -49.53 70.72 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.88 -30.37 68.86 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.6 -40.19 86.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -66.05 -42.22 89.79 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.68 -51.76 62.17 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.16 -48.38 78.68 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -46.89 74.56 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.05 -37.58 87.94 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.88 65.48 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -68.42 -24.36 64.74 Favored 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -69.02 -27.77 65.97 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 160.57 -54.27 0.33 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 168.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.25 -20.25 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -158.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -117.42 145.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 121.192 1.814 . . . . 0.0 112.939 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.51 114.51 20.98 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.096 0.958 . . . . 0.0 113.549 -163.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.72 96.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.716 0.77 . . . . 0.0 111.155 -172.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.4 m -91.05 110.63 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 121.698 0.761 . . . . 0.0 112.311 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.8 p -83.22 81.51 8.67 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.009 -1.057 . . . . 0.0 112.831 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.07 -52.11 0.71 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.22 115.08 12.13 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 m -74.12 105.38 5.31 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.358 0.599 . . . . 0.0 111.32 170.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.332 75.5 mtt85 72.92 50.31 0.15 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -166.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.48 5.14 24.79 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 164.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.252 9.8 tt -77.55 80.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.56 1.68 . . . . 0.0 114.612 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -82.67 144.99 29.88 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.388 1.075 . . . . 0.0 113.222 -168.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.0 125.32 25.96 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.991 -1.068 . . . . 0.0 113.535 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 121.874 0.845 . . . . 0.0 109.827 -173.929 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.568 1.642 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -81.23 160.04 24.39 Favored 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.169 -0.957 . . . . 0.0 113.092 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.17 -41.13 74.98 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -72.11 -29.61 64.26 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.67 -45.86 85.03 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.807 1.64 . . . . 0.0 114.714 159.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -44.23 87.62 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.14 -46.13 82.97 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.08 -46.95 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -56.56 -41.54 77.06 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.85 -40.14 79.42 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.29 -45.66 92.26 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.31 31.3 pt -63.23 -33.66 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -64.04 -50.44 68.41 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 120.652 1.569 . . . . 0.0 115.121 161.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -60.82 -47.54 85.87 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -67.69 -39.06 84.46 Favored 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.3 mm -57.37 -49.21 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.964 1.256 . . . . 0.0 113.122 165.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -62.89 -49.09 76.18 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -96.65 8.12 44.95 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -154.71 -54.91 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.561 -1.337 . . . . 0.0 111.489 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.04 38.91 1.1 Allowed Glycine 0 CA--C 1.545 1.913 0 N-CA-C 116.407 1.323 . . . . 0.0 116.407 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -144.21 135.56 12.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-N 118.782 1.291 . . . . 0.0 113.096 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 90.6 Cg_endo -91.14 107.18 0.29 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 CA-C-N 122.944 2.087 . . . . 0.0 113.908 175.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 36.2 Cg_endo -63.77 121.14 8.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.559 2.839 . . . . 0.0 115.582 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.48 ' H ' ' HE ' ' A' ' 64' ' ' ARG . 45.9 p -109.41 118.82 37.66 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.286 98.1 mtt180 72.17 -65.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 155.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.24 23.74 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.78 -36.21 80.41 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.8 mm -60.44 -52.87 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.41 95.29 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -67.17 -42.57 84.05 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -76.79 -47.13 22.53 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.08 -10.86 56.39 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 43.95 7.54 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 117.677 1.831 . . . . 0.0 117.677 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -89.69 85.32 6.42 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 118.615 1.208 . . . . 0.0 110.101 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.98 -24.13 66.72 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.5 m -91.37 112.49 54.41 Favored Pre-proline 0 CA--C 1.568 1.671 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.785 163.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.96 -18.52 62.43 Favored 'Trans proline' 0 N--CA 1.51 2.477 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -55.54 -44.45 76.77 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 166.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.09 -44.17 74.66 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.28 86.43 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 172.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -41.86 85.24 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 170.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.15 -50.02 50.28 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 166.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -64.93 -38.68 91.75 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.22 -49.53 77.25 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 21.9 pttm -63.89 -36.42 83.88 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 168.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.49 87.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 168.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.92 -43.8 86.48 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 164.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.12 84.31 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ttm105 -59.25 -36.88 76.29 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.94 -51.28 69.92 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.23 16.26 3.23 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.72 -10.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -136.84 138.14 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-N 120.02 1.282 . . . . 0.0 112.049 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.11 128.94 46.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.545 0.688 . . . . 0.0 110.149 166.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.6 mm -90.53 115.63 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 C-N-CA 123.141 0.576 . . . . 0.0 109.556 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.79 92.98 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -79.98 85.0 5.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.33 -84.71 0.05 OUTLIER Glycine 0 N--CA 1.481 1.633 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.725 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.95 52.89 2.52 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.297 63.2 m 64.65 -73.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.48 ' HE ' ' H ' ' A' ' 27' ' ' THR . 83.3 mtt180 -96.32 82.9 3.47 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 122.167 0.984 . . . . 0.0 111.589 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.77 95.5 0.28 Allowed Glycine 0 N--CA 1.48 1.629 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.293 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.0 120.03 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -93.96 128.32 40.22 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 121.696 -0.627 . . . . 0.0 110.993 173.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -84.57 111.74 19.79 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 123.023 0.529 . . . . 0.0 112.023 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 CA--C 1.573 1.829 0 CA-C-O 121.775 0.798 . . . . 0.0 110.4 -177.675 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 CA--C 1.566 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.7 p -80.54 94.98 6.36 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.294 . . 49.45 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 119.459 3.133 . . . . 0.0 119.459 168.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -74.79 -31.19 61.67 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.04 -32.13 73.12 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 161.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -57.85 -42.32 84.2 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 163.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.19 -44.69 68.12 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 163.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.33 -43.58 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.73 -40.23 87.36 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.41 -40.84 92.4 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 165.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.86 -47.23 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.446 0.1 OUTLIER -64.62 -39.22 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 121.106 1.775 . . . . 0.0 115.414 174.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtp85 -59.59 -39.67 84.92 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.37 -49.03 77.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -63.36 -39.92 95.86 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.75 -47.22 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 118.977 0.808 . . . . 0.0 113.16 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -61.05 -30.82 70.55 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -84.29 -41.69 16.58 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -116.96 -22.39 8.49 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.21 -47.9 1.45 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -161.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -90.1 159.74 41.78 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.89 162.5 37.24 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.403 2.069 . . . . 0.0 116.731 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 166.91 22.12 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.675 2.25 . . . . 0.0 116.862 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -67.0 147.2 53.53 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.792 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -57.5 -32.78 67.35 Favored 'General case' 0 CA--C 1.591 2.532 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.18 80.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 165.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.77 -33.37 66.55 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 170.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -60.69 -48.5 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-N 119.376 0.989 . . . . 0.0 112.629 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.56 61.16 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -64.98 -54.09 35.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -75.97 -39.15 56.58 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.15 -18.67 59.01 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 56.34 1.37 Allowed Glycine 0 N--CA 1.481 1.695 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.88 116.69 32.37 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 117.583 0.691 . . . . 0.0 110.199 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -63.48 -33.43 75.55 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 157.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 t -94.97 103.01 10.39 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 123.791 0.837 . . . . 0.0 112.291 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.71 -23.55 56.04 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.406 2.041 . . . . 0.0 117.406 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -58.83 -40.73 85.05 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 161.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.16 96.42 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 167.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.11 71.34 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 173.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.55 -33.41 75.85 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.9 -46.98 84.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -65.81 -30.68 71.35 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 tp -60.39 -52.09 66.73 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 121.121 1.782 . . . . 0.0 114.929 166.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 61.7 pttt -62.79 -42.07 99.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.12 74.38 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 166.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.37 -38.79 81.74 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.05 87.6 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 163.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -61.82 -35.68 78.95 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -59.11 -32.93 70.27 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 163.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.11 34.74 1.1 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.565 2.186 . . . . 0.0 118.565 163.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.49 -4.63 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.13 153.34 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.191 0 CA-C-N 119.689 1.131 . . . . 0.0 111.82 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -112.66 122.69 48.42 Favored 'General case' 0 CA--C 1.571 1.763 0 O-C-N 121.745 -0.597 . . . . 0.0 109.545 163.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -88.68 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.63 92.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -85.66 100.23 11.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.632 0.729 . . . . 0.0 112.277 -157.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.83 -53.63 0.7 Allowed Glycine 0 N--CA 1.486 2.008 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.053 -160.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.53 113.09 12.55 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 117.481 0.64 . . . . 0.0 112.553 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.8 p -60.33 -46.19 90.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -91.26 84.95 5.7 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 159.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.12 71.61 0.22 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.05 111.34 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.824 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.84 135.21 37.9 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 111.995 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 tp -95.31 111.61 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.98 0.512 . . . . 0.0 111.346 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 121.746 0.784 . . . . 0.0 109.987 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 p -65.93 152.4 44.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -160.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.01 -40.37 58.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 120.406 3.484 . . . . 0.0 120.406 -165.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -39.38 34.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.96 -34.77 75.26 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 162.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.51 -41.28 96.5 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 167.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -57.42 -47.73 80.99 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 165.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.35 -49.34 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 165.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.0 -41.33 97.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.27 -40.87 95.72 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.93 -46.52 71.29 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.116 1.78 . . . . 0.0 114.983 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.262 3.6 tp -53.15 -46.98 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -62.81 -49.33 75.35 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 172.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.06 -44.17 97.78 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -72.85 -43.54 62.48 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.26 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 120.525 1.511 . . . . 0.0 114.776 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -59.94 -30.74 69.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 171.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -93.68 -47.63 6.71 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 p -93.33 -26.41 17.3 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.785 2.142 . . . . 0.0 116.785 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.91 3.76 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.25 141.58 24.18 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.7 132.63 8.88 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 122.187 1.817 . . . . 0.0 114.506 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -55.33 145.03 69.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 N-CA-C 118.272 2.374 . . . . 0.0 118.272 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 p -74.52 150.46 39.79 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.237 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.26 16.6 ptt180 -58.82 -26.98 64.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.2 -40.83 70.94 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -56.93 -49.74 74.71 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 166.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.05 -45.58 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.09 -55.0 36.01 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 170.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.21 -37.16 63.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.96 -36.5 72.59 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.25 -11.81 59.98 Favored 'General case' 0 CA--C 1.584 2.268 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 168.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.72 54.2 4.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -83.82 146.23 28.23 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.451 1.119 . . . . 0.0 113.888 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.02 88.45 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.0 m -152.8 143.97 16.05 Favored Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.718 164.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.45 -30.7 16.25 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -59.05 -31.68 69.07 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.06 99.24 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 165.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.25 96.48 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 165.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -55.74 -46.52 77.8 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 164.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.37 -42.32 95.55 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -66.21 -36.95 84.39 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -58.89 -41.37 87.0 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.5 -47.13 82.98 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 170.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.54 79.01 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.8 tp -63.31 -41.41 98.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.0 99.85 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -50.9 -38.02 47.29 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -77.37 6.21 7.29 Favored 'General case' 0 CA--C 1.592 2.558 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.58 40.97 16.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.42 -44.04 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.538 -169.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -127.51 137.65 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 119.709 1.14 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.67 115.86 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 110.684 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.46 123.92 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.07 105.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 164.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.0 m -77.59 95.74 4.63 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -161.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.13 -60.25 0.51 Allowed Glycine 0 N--CA 1.484 1.847 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.576 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.25 123.85 25.32 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.9 p -61.55 -41.31 97.18 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -99.68 28.57 4.6 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 163.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.58 69.81 3.26 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.309 -1.494 . . . . 0.0 114.305 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.03 98.94 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -168.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -98.61 108.58 21.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 110.281 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . 0.299 2.3 pp -82.09 93.1 6.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.1 pt? . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 165.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.572 1.797 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -74.33 153.96 39.09 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.408 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -44.38 70.75 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -72.09 -33.29 67.77 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -56.55 -46.55 80.62 Favored 'General case' 0 CA--C 1.583 2.229 0 CA-C-N 120.502 1.501 . . . . 0.0 114.481 161.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -61.54 -40.05 93.28 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.93 -50.71 68.17 Favored 'General case' 0 CA--C 1.582 2.207 0 CA-C-N 121.004 1.729 . . . . 0.0 115.391 164.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.2 t -55.76 -50.01 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -59.62 -42.53 92.89 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.06 -38.14 75.74 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -44.01 97.69 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 120.597 1.544 . . . . 0.0 114.768 168.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -53.26 -53.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 166.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -62.87 -37.65 87.73 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.73 -47.79 83.39 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 170.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -66.04 -41.32 91.02 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 120.593 1.542 . . . . 0.0 115.031 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.2 mt -67.65 -44.93 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -65.09 -28.77 69.68 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -87.79 -45.93 9.9 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -105.56 -23.69 12.73 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.42 -47.43 1.34 Allowed Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -164.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -88.63 160.72 43.91 Favored Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 158.85 50.91 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.078 1.852 . . . . 0.0 116.059 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.07 164.87 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.263 1.976 . . . . 0.0 114.891 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.5 p -72.97 151.04 41.99 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.205 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -57.87 -25.15 60.37 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.15 94.45 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 160.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.18 -45.42 93.19 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.1 -50.46 78.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.302 0 CA-C-N 120.133 1.333 . . . . 0.0 112.359 170.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.41 81.89 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.43 -49.04 11.98 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -67.33 -40.14 85.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.2 -14.97 58.73 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.05 65.28 1.54 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.08 141.31 31.18 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 121.968 0.89 . . . . 0.0 112.91 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -35.34 79.78 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -136.42 142.29 38.92 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.307 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -61.55 -24.54 78.21 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 N-CA-C 118.006 2.272 . . . . 0.0 118.006 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -63.89 -28.31 69.75 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 167.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -45.47 92.37 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.17 73.77 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.43 -48.11 69.04 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 171.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.33 -30.78 68.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -62.36 -38.88 91.27 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 162.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.14 -43.22 99.22 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.5 -47.9 78.33 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 163.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.01 94.06 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.76 -38.02 77.53 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 164.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.5 -46.22 76.97 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 166.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -59.22 -34.98 72.83 Favored 'General case' 0 CA--C 1.582 2.186 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.88 -26.07 67.15 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 163.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.16 41.47 3.02 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -129.73 -41.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.216 0 CA-C-N 118.103 0.952 . . . . 0.0 113.315 -169.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -126.0 135.53 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.0 1.273 . . . . 0.0 110.914 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.12 118.05 31.94 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 110.015 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.44 125.39 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 121.045 0.45 . . . . 0.0 110.291 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.47 93.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -74.58 123.45 24.83 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -160.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.65 -47.03 1.09 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -161.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.87 119.63 22.33 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -58.19 -41.51 84.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 171.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -95.07 83.1 3.86 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.63 0.728 . . . . 0.0 109.821 161.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.39 67.01 0.33 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.7 mm -135.83 118.98 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -172.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -103.17 126.7 50.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.822 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.5 tp -91.71 121.28 33.21 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 CA--C 1.572 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 162.182 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 CA--C 1.569 1.692 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.6 p -67.15 155.94 37.48 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.06 61.18 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -74.25 -38.3 63.52 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 169.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -58.52 -44.96 89.7 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 120.823 1.647 . . . . 0.0 115.178 168.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -61.25 -41.28 96.63 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.46 -47.26 79.55 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 165.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.95 -44.68 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -61.58 -41.56 97.58 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 172.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.82 -46.59 89.93 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.75 -41.14 98.05 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.277 0.4 OUTLIER -58.17 -46.57 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 CA-C-N 120.548 1.522 . . . . 0.0 114.584 171.26 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -63.12 -49.5 74.15 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.54 -46.34 90.55 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -69.37 -36.3 76.7 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.26 -45.22 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 120.805 1.639 . . . . 0.0 112.899 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -64.43 -26.58 68.51 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.25 -54.07 4.67 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -102.45 -39.6 7.07 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.55 -46.53 1.12 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 115.839 1.096 . . . . 0.0 115.839 -170.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.2 ptp -87.61 156.67 53.13 Favored Pre-proline 0 CA--C 1.57 1.739 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.51 155.2 21.33 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 122.022 1.814 . . . . 0.0 116.4 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.99 94.39 0.98 Allowed 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.637 2.225 . . . . 0.0 112.932 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -84.4 81.87 8.64 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.299 2.3 tmt_? 66.73 -60.02 0.35 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.81 77.32 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.93 -31.99 70.04 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.69 -50.91 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.251 1.387 . . . . 0.0 113.156 165.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.01 94.76 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -69.61 -49.15 56.76 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -76.56 -40.09 50.84 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -91.41 -26.78 18.7 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 73.64 1.06 Allowed Glycine 0 N--CA 1.483 1.788 0 CA-C-N 119.532 1.06 . . . . 0.0 115.345 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -135.44 128.05 30.79 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 117.318 0.559 . . . . 0.0 111.418 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -73.96 -45.71 48.52 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 m -118.25 151.31 49.15 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -167.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.54 -20.31 53.91 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 N-CA-C 118.392 2.42 . . . . 0.0 118.392 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -57.65 -16.24 10.01 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 164.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.61 -62.56 1.24 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.407 1.003 . . . . 0.0 112.686 160.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.02 91.67 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -80.16 -45.18 18.56 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.18 -29.25 67.2 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -60.37 -40.45 90.83 Favored 'General case' 0 CA--C 1.581 2.148 0 CA-C-N 122.622 2.464 . . . . 0.0 114.787 165.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.31 -44.82 93.87 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.82 -47.48 86.15 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.9 84.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 169.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.57 -43.91 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.49 98.8 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 166.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -56.42 -35.14 67.48 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 168.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -59.07 -34.24 71.73 Favored 'General case' 0 CA--C 1.591 2.552 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 163.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.82 56.09 0.56 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.301 3.9 p -132.81 -53.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.28 143.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.028 0 CA-C-N 119.643 1.11 . . . . 0.0 112.699 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.79 143.61 56.8 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.252 155.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.48 114.34 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.62 105.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.685 0.755 . . . . 0.0 109.369 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 m -84.23 85.54 7.35 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.172 0.987 . . . . 0.0 112.281 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.26 -73.44 0.23 Allowed Glycine 0 N--CA 1.484 1.87 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.287 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 106.12 11.76 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 120.98 0.419 . . . . 0.0 111.454 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 m -60.34 -42.73 96.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 118.464 2.765 . . . . 0.0 118.464 -166.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -83.14 65.01 7.99 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 119.799 1.181 . . . . 0.0 113.361 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 76.42 0.27 Allowed Glycine 0 N--CA 1.48 1.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.869 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.29 106.34 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -124.64 141.28 52.21 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.021 0.528 . . . . 0.0 111.634 -167.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.28 106.64 6.91 Favored 'General case' 0 CA--C 1.574 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 112.795 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 173.279 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 5' ' ' THR 0.624 2.6 pt? . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HG ' ' A' ' 4' ' ' LEU . 20.0 p -143.83 138.17 28.49 Favored 'General case' 0 CA--C 1.57 1.75 0 C-N-CA 123.941 0.896 . . . . 0.0 109.304 170.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.66 53.08 1.28 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 -173.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -144.24 -54.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.03 1.332 . . . . 0.0 109.794 164.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -61.05 -34.78 75.41 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 163.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -57.18 -40.76 77.98 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 168.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.97 -42.42 80.13 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.43 -44.32 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 167.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -64.63 -41.87 95.87 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -55.94 -39.34 71.57 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 163.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.51 -34.23 77.46 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.0 mt -53.51 -57.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.515 1.507 . . . . 0.0 113.174 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.13 -32.21 73.53 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.3 -48.02 71.72 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.25 -38.31 89.94 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.173 1.806 . . . . 0.0 115.448 173.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.12 -38.64 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 166.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.1 m -66.31 -41.72 89.31 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 167.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.81 -26.91 62.59 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -148.33 -52.84 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 -174.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.98 18.45 0.96 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -148.11 148.79 30.65 Favored Pre-proline 0 CA--C 1.581 2.147 0 CA-C-N 118.853 1.326 . . . . 0.0 112.324 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 147.62 37.56 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 122.563 2.175 . . . . 0.0 115.796 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.38 160.63 35.46 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.779 2.319 . . . . 0.0 115.391 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -143.89 127.13 16.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.308 42.2 ttt85 62.91 -79.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 161.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.24 -44.5 59.4 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.08 -42.07 93.81 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.33 -51.92 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-N 119.27 0.941 . . . . 0.0 112.984 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.24 94.84 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -74.59 -40.99 61.26 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -64.34 -42.72 96.11 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.3 mt -106.36 -26.51 11.46 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.66 86.48 1.68 Allowed Glycine 0 N--CA 1.485 1.925 0 CA-C-N 120.243 1.383 . . . . 0.0 114.139 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -120.72 137.55 54.43 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.561 0.696 . . . . 0.0 111.771 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -28.71 67.56 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -148.52 149.02 30.26 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-N 119.249 0.931 . . . . 0.0 113.074 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -62.43 -27.95 77.7 Favored 'Trans proline' 0 N--CA 1.509 2.398 0 N-CA-C 117.872 2.22 . . . . 0.0 117.872 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -65.89 -40.34 91.46 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.06 93.38 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.98 -47.16 68.41 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.48 -36.73 76.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 171.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.28 -33.06 74.51 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.385 1.902 . . . . 0.0 116.01 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -66.9 -36.04 81.38 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 120.99 1.723 . . . . 0.0 115.346 164.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.99 -46.13 82.48 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 161.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.0 -49.7 76.62 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.02 -43.21 60.84 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.86 -45.75 84.73 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 168.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.09 93.59 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.72 -39.34 77.03 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -69.89 -40.1 75.86 Favored 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 165.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.49 38.77 0.32 Allowed Glycine 0 N--CA 1.484 1.855 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 165.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.18 -28.84 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.14 146.93 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-O 121.963 0.887 . . . . 0.0 112.571 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -85.99 115.17 23.43 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.859 -0.526 . . . . 0.0 110.832 168.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.72 124.41 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.536 0.684 . . . . 0.0 109.528 -174.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.48 123.01 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -72.84 105.16 4.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.591 0.71 . . . . 0.0 112.804 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.29 -65.36 0.4 Allowed Glycine 0 N--CA 1.485 1.965 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.778 -167.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.89 119.63 24.18 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 169.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.1 p -79.31 65.2 4.42 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 15.7 ptm180 -161.42 -65.15 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.14 1.376 . . . . 0.0 111.553 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.55 -166.85 14.99 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -132.92 -72.82 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.441 -172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.89 147.88 39.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -158.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.61 126.59 31.12 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 CA--C 1.569 1.697 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.683 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.562 1.409 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.0 p -66.67 153.52 42.95 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 121.387 -0.82 . . . . 0.0 112.592 167.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.89 56.32 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 118.769 2.877 . . . . 0.0 118.769 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -70.82 -37.0 73.18 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -59.47 -44.45 93.02 Favored 'General case' 0 CA--C 1.584 2.257 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 162.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -57.91 -39.29 77.59 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.62 -47.6 83.85 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 165.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.09 -49.43 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.16 -48.27 79.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.06 -38.85 68.56 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -48.57 69.86 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.258 26.0 pt -59.46 -42.57 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.126 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 167.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -63.77 -39.04 93.3 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.67 -47.53 83.28 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -58.85 -49.22 78.56 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.13 -40.61 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -61.97 -48.86 78.48 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -85.84 -37.49 19.15 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -116.33 -17.79 10.65 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.94 -28.98 10.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.651 2.22 . . . . 0.0 118.651 -173.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -88.59 129.82 47.62 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.99 115.97 4.37 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.391 2.06 . . . . 0.0 115.427 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 160.33 37.21 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 123.562 2.308 . . . . 0.0 116.401 -170.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.2 p -86.89 163.97 16.86 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -40.5 -57.7 1.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.62 89.65 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.79 -43.49 85.63 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.69 -57.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.011 0.823 . . . . 0.0 112.615 168.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.6 85.49 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 118.278 2.695 . . . . 0.0 118.278 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.63 -34.4 75.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -73.02 -48.06 39.55 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.68 -38.4 58.77 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.02 61.85 0.28 Allowed Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -117.61 128.52 55.01 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.984 168.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HE ' ' H ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -63.62 -42.24 98.21 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 169.071 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.472 ' H ' ' HE ' ' A' ' 38' ' ' ARG . 10.1 t -109.65 106.95 59.03 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.354 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -54.79 -19.55 19.34 Favored 'Trans proline' 0 N--CA 1.508 2.336 0 N-CA-C 121.832 3.743 . . . . 0.0 121.832 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -53.28 -31.82 45.67 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 170.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.34 55.44 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 165.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -51.5 69.58 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -70.18 -32.68 70.73 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.98 -44.2 97.24 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -63.25 -41.39 99.05 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tp -49.7 -44.33 48.08 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.97 -46.06 75.01 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.18 90.12 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 -41.68 92.84 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 166.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.75 94.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -56.8 -42.38 79.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 168.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.45 -8.59 52.13 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 167.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.14 -9.11 61.22 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 120.136 2.814 . . . . 0.0 120.136 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 p -85.12 -4.25 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.0 pt -142.78 143.75 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-N 119.973 1.261 . . . . 0.0 111.963 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.11 112.5 25.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 166.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -84.8 125.63 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.8 120.96 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.798 -0.564 . . . . 0.0 109.676 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -76.64 85.24 3.3 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.65 63.5 0.51 Allowed Glycine 0 N--CA 1.486 1.992 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.686 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.5 131.39 13.31 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 117.421 0.61 . . . . 0.0 111.925 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.1 t -78.85 103.62 8.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.784 -0.572 . . . . 0.0 110.938 167.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.262 79.3 mtt180 70.38 67.22 0.2 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.55 83.0 0.25 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 114.645 0.618 . . . . 0.0 114.645 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.97 117.93 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.44 118.73 23.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.702 . . . . 0.0 110.179 174.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.98 100.63 9.8 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 122.945 0.498 . . . . 0.0 110.99 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 CA--C 1.587 2.4 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 179.449 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 122.117 0.96 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -67.8 157.75 34.06 Favored 'General case' 0 CA--C 1.577 2.012 0 O-C-N 121.643 -0.661 . . . . 0.0 112.155 168.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 -54.78 28.34 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.651 2.463 . . . . 0.0 117.651 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -65.12 -35.01 79.78 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.67 -49.81 76.3 Favored 'General case' 0 CA--C 1.592 2.561 0 CA-C-N 120.235 1.38 . . . . 0.0 114.611 166.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -57.37 -43.29 83.45 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.05 -47.61 77.57 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 166.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.87 -49.26 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -58.17 -46.92 84.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -65.52 -28.82 69.46 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.22 -47.16 77.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.726 1.603 . . . . 0.0 114.519 169.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.287 15.6 tt -57.47 -45.26 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 165.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.77 -44.04 73.31 Favored 'General case' 0 CA--C 1.581 2.147 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 169.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -59.71 -51.31 70.3 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -40.96 98.99 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.01 -48.61 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 C-N-CA 123.702 0.801 . . . . 0.0 112.767 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -70.9 -34.6 71.72 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.29 -21.83 49.13 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.2 m -148.08 -53.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.193 0.906 . . . . 0.0 111.86 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.55 40.79 0.65 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -142.96 132.48 11.86 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 118.426 1.113 . . . . 0.0 113.51 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.88 123.62 3.69 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 122.501 1.929 . . . . 0.0 115.183 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.1 127.39 8.41 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.761 2.308 . . . . 0.0 113.882 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 172.42 13.38 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -49.54 -35.71 21.24 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 119.174 3.027 . . . . 0.0 119.174 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.89 -46.19 75.69 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 165.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.97 -45.35 92.96 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.82 -49.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 167.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.75 84.45 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 170.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -65.54 -51.38 60.28 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -83.95 -37.59 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.6 -16.32 39.68 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.84 66.03 1.52 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 120.092 1.314 . . . . 0.0 115.998 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.89 125.66 53.04 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -59.2 -16.07 18.51 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -148.99 155.23 40.41 Favored Pre-proline 0 CA--C 1.573 1.844 0 O-C-N 121.293 -0.879 . . . . 0.0 111.379 165.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -56.03 -28.73 70.78 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.88 -33.75 74.78 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.01 -39.11 83.26 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.61 89.32 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 162.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.86 -36.56 65.22 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 167.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -67.74 -39.72 84.2 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 166.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.71 -46.84 77.63 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.265 63.6 pttt -64.83 -39.25 93.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.82 88.75 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 166.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.62 -40.47 83.42 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 163.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.57 74.16 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 168.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -64.86 -38.79 92.14 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -66.63 -33.92 76.74 Favored 'General case' 0 CA--C 1.586 2.365 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 158.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.99 60.31 1.6 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.12 -39.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.015 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.55 162.97 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 118.769 0.713 . . . . 0.0 110.546 152.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.74 132.6 47.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.874 -1.141 . . . . 0.0 111.051 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.3 mt -90.85 116.45 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 O-C-N 121.787 -0.571 . . . . 0.0 109.877 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.1 t -80.87 96.71 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.2 m -77.59 96.02 4.7 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.871 0.844 . . . . 0.0 112.47 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.24 -53.22 0.56 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.272 -163.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.32 133.7 41.2 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.8 t -60.79 -54.47 44.8 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -93.97 71.64 4.04 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.179 0.9 . . . . 0.0 111.17 161.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.95 63.55 0.27 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 115.361 0.904 . . . . 0.0 115.361 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.5 mm -126.44 97.72 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.876 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -93.45 122.04 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 112.038 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -84.02 123.53 30.11 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.582 2.189 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 CA--C 1.579 2.095 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 t -78.5 159.29 28.29 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -34.18 -55.89 0.5 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 121.017 3.71 . . . . 0.0 121.017 -164.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -77.69 -37.02 50.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -67.03 -34.37 77.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 163.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -42.78 88.78 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 163.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.58 -44.38 80.97 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 167.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.85 -41.31 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 167.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -62.47 -43.65 98.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 168.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.4 -41.47 69.31 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 167.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -42.25 91.78 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 175.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.319 6.2 tp -58.91 -46.51 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 163.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -59.32 -43.63 92.67 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.77 -51.05 71.0 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -63.37 -37.86 88.89 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 174.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.3 -47.74 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 CA-C-N 118.751 0.705 . . . . 0.0 112.861 169.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -65.23 -37.54 87.57 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 172.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.8 -12.84 55.09 Favored 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -149.31 -56.88 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.786 1.175 . . . . 0.0 111.509 -176.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.49 -44.52 0.98 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -81.98 161.52 60.3 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.02 159.52 52.9 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 122.202 1.822 . . . . 0.0 115.356 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 159.25 35.71 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.993 1.795 . . . . 0.0 114.621 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.6 p -71.09 147.92 48.0 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.665 -0.647 . . . . 0.0 111.548 165.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -62.36 -28.63 69.89 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 175.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.18 93.09 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 160.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.85 -39.98 95.48 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 166.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.5 mt -56.59 -46.14 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.271 0 CA-C-N 120.162 1.346 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.88 -54.18 42.76 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 170.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -76.94 -38.4 53.45 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -66.48 -41.89 88.31 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.09 -20.09 42.26 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 48.68 2.77 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 178.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -100.37 100.32 11.08 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 117.758 0.779 . . . . 0.0 109.872 177.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 62.09 7.27 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 122.449 1.119 . . . . 0.0 112.88 174.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -177.82 119.08 0.25 Allowed Pre-proline 0 CA--C 1.577 2.018 0 C-N-CA 125.381 1.472 . . . . 0.0 107.849 -175.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.78 -27.15 52.18 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 N-CA-C 118.631 2.512 . . . . 0.0 118.631 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.27 -47.71 72.8 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 167.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.87 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -169.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.72 70.86 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -20.55 62.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.07 2.619 . . . . 0.0 118.07 171.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -70.87 -41.42 71.4 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 173.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -61.34 -34.49 75.37 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 162.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.08 -45.68 86.74 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.785 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.12 78.85 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 166.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.4 -39.18 91.87 Favored 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.63 98.39 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 164.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -61.55 -34.89 76.34 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 169.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -30.13 65.95 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 162.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.2 29.34 8.01 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.029 1.972 . . . . 0.0 118.029 -177.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.252 6.5 p -108.52 -38.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.6 pt -123.03 138.63 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 123.788 0.835 . . . . 0.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.62 113.72 27.34 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.41 0.624 . . . . 0.0 109.796 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.88 127.21 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.215 0.606 . . . . 0.0 109.501 -172.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.7 115.77 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 O-C-N 121.726 -0.609 . . . . 0.0 109.75 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.8 p -76.28 86.18 3.08 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 -68.66 0.33 Allowed Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.69 -172.219 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.52 112.31 11.72 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.509 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.8 m -70.0 -21.55 63.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 178.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -91.79 83.67 5.3 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 119.802 1.183 . . . . 0.0 108.649 152.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.99 64.65 0.26 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -172.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.9 101.58 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -84.25 113.32 21.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.282 -0.886 . . . . 0.0 110.893 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.3 tp -80.68 83.2 6.51 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.674 0.75 . . . . 0.0 111.615 172.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 1.5 pp . . . . . 0 CA--C 1.567 1.618 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 159.9 24.14 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -174.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.26 76.55 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 118.288 2.699 . . . . 0.0 118.288 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -71.74 -39.7 69.88 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 172.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.47 -28.87 69.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 165.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.49 -40.34 96.37 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 162.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -59.19 -44.75 92.22 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 164.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.23 -48.47 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 164.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.19 -40.69 96.61 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 175.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.26 -42.81 78.03 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 167.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.16 -34.18 77.45 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 166.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.24 -55.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 120.725 1.602 . . . . 0.0 113.564 166.087 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.91 -41.88 88.29 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.5 -52.99 62.85 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 167.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -68.28 -35.36 77.73 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.04 1.291 . . . . 0.0 112.826 166.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -67.73 -32.98 73.98 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 170.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -75.83 -40.1 55.5 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 172.303 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -124.44 -49.28 1.79 Allowed 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -174.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.68 -44.62 1.12 Allowed Glycine 0 CA--C 1.545 1.916 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -175.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -90.84 142.06 27.3 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -168.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.17 117.51 4.37 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.981 2.454 . . . . 0.0 116.754 172.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.68 119.25 5.38 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 CA-C-N 122.683 1.994 . . . . 0.0 114.931 -176.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 p -115.8 98.56 6.74 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.555 0.693 . . . . 0.0 110.225 -177.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.391 0.5 OUTLIER 65.09 -50.7 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.687 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.32 -47.11 79.38 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -176.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.71 -38.29 23.56 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 165.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.01 -57.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.08 77.11 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -80.95 -49.83 10.48 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -78.57 -31.74 47.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.9 mt -84.47 -18.95 34.23 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 167.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.44 72.9 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.078 1.308 . . . . 0.0 115.617 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.13 134.6 40.25 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 121.985 0.898 . . . . 0.0 112.934 -176.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -14.39 45.58 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 119.732 3.234 . . . . 0.0 119.732 170.367 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.6 m -157.05 143.71 13.33 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 119.716 1.143 . . . . 0.0 112.185 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.05 -43.98 34.38 Favored 'Trans proline' 0 N--CA 1.512 2.598 0 C-N-CA 122.927 2.418 . . . . 0.0 117.724 165.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.36 -32.83 73.68 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 172.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.11 82.25 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 169.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.86 78.77 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 167.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -57.99 -48.38 80.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 172.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -53.45 -48.61 68.66 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -61.63 -39.93 93.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 170.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.37 -42.11 77.29 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 164.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -67.95 -47.56 68.33 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.21 87.73 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 167.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 tp -64.13 -48.25 76.81 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.79 -38.72 70.31 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 166.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -55.84 -32.38 63.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 166.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -66.36 -16.25 63.92 Favored 'General case' 0 CA--C 1.586 2.33 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 165.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.17 69.05 1.18 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.537 1.062 . . . . 0.0 114.921 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.84 -29.47 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -171.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 145.48 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 121.135 1.789 . . . . 0.0 112.641 -177.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.81 113.0 23.89 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 121.819 -0.551 . . . . 0.0 110.216 170.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.94 134.46 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.08 145.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.472 0.653 . . . . 0.0 112.113 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.4 p -75.11 89.48 2.48 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.8 -82.14 0.2 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 -173.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.55 95.6 1.84 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.785 0.802 . . . . 0.0 112.035 170.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -77.97 14.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.8 mtm-85 -82.12 -70.52 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 111.778 156.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.94 -147.05 18.17 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.25 -58.86 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.685 -0.758 . . . . 0.0 111.546 -176.152 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -154.55 169.41 23.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -163.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.31 122.74 27.82 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.082 0.553 . . . . 0.0 110.849 165.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.565 1.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.631 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 CA--C 1.58 2.122 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -74.49 163.38 27.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.807 -1.183 . . . . 0.0 113.054 170.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.76 67.8 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.735 2.865 . . . . 0.0 118.735 -177.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -71.27 -38.0 71.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 167.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.63 -47.77 84.28 Favored 'General case' 0 CA--C 1.587 2.386 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.93 -38.3 90.52 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.267 10.8 pt-20 -62.59 -37.17 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 163.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.55 -49.07 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 119.798 1.181 . . . . 0.0 113.364 163.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -57.99 -49.22 77.58 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 171.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.95 -34.8 66.0 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 171.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.15 -49.15 62.87 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 170.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.293 7.0 tt -59.71 -42.49 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 168.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -56.22 -51.71 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 166.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.92 -52.26 66.51 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -63.49 -42.13 98.55 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.76 -47.26 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.581 1.082 . . . . 0.0 112.78 170.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 t -63.81 -30.34 71.44 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -92.76 -40.21 10.8 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -114.86 -26.16 7.91 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.85 -27.58 11.82 Favored Glycine 0 CA--C 1.547 2.035 0 N-CA-C 118.714 2.246 . . . . 0.0 118.714 -174.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 51.6 mtm -106.48 119.6 51.23 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 119.309 1.554 . . . . 0.0 114.456 -156.596 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -58.87 116.97 3.63 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 N-CA-C 119.743 2.939 . . . . 0.0 119.743 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.61 127.55 16.56 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.56 2.173 . . . . 0.0 114.647 170.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -90.88 -74.15 0.51 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -142.07 -37.52 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.78 56.41 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -60.48 -41.91 95.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.86 -49.06 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 169.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.54 95.25 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 170.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.66 -44.12 87.27 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -74.11 -49.19 24.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 177.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.9 -12.25 36.71 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.46 54.15 2.61 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 178.557 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -100.92 110.17 22.19 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -53.71 -33.91 57.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 -177.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -112.51 135.94 21.49 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.415 163.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.94 -31.1 26.02 Favored 'Trans proline' 0 N--CA 1.509 2.409 0 N-CA-C 118.826 2.587 . . . . 0.0 118.826 165.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -55.99 -33.12 64.55 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 167.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -44.48 79.99 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -47.56 81.21 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 165.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.05 -44.37 74.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.163 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.56 -36.15 82.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 173.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -62.61 -44.44 96.29 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 tt -53.13 -46.12 68.66 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 120.903 1.683 . . . . 0.0 115.478 167.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.65 -47.88 81.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.36 83.64 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.96 -52.44 60.65 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 163.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.95 93.32 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 tpt85 -62.71 -38.49 90.66 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.936 2.198 . . . . 0.0 116.936 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.0 -46.27 82.12 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 166.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.27 39.29 0.45 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.41 -16.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.059 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.174 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -135.87 131.1 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 CA-C-N 119.267 0.939 . . . . 0.0 110.381 177.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.64 119.21 33.74 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.99 102.91 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.819 0 CA-C-O 121.527 0.68 . . . . 0.0 109.365 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.09 94.62 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.0 m -84.94 100.36 11.57 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.872 0.844 . . . . 0.0 112.969 -160.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.32 -62.59 0.17 Allowed Glycine 0 N--CA 1.484 1.854 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.632 -172.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 142.09 35.04 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 168.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.7 m -57.83 -43.66 85.93 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -99.62 78.88 2.2 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 163.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.64 87.14 0.37 Allowed Glycine 0 N--CA 1.486 2.02 0 CA-C-N 116.266 -0.425 . . . . 0.0 113.348 -174.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -146.86 129.5 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -175.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -114.01 156.41 24.12 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.984 0.897 . . . . 0.0 112.867 170.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.8 mt -101.49 123.87 46.24 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -162.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.575 1.93 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 163.276 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.571 1.754 0 CA-C-O 121.572 0.701 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -75.08 162.78 28.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.568 -0.708 . . . . 0.0 112.895 168.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.08 -55.22 10.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -169.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -67.96 -30.07 69.27 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -63.39 -42.29 98.79 Favored 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 164.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -58.91 -47.11 86.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 167.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -51.54 -50.61 59.69 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 165.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.85 -50.82 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.79 -51.68 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 170.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -59.73 -33.84 72.15 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.55 -51.0 69.11 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 164.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.1 mt -55.59 -52.27 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 172.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -48.44 -50.01 32.9 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 168.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.44 -44.92 93.15 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -62.75 -41.02 99.01 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.12 -43.15 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.405 1.002 . . . . 0.0 113.593 167.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 t -55.17 -45.92 75.74 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.55 -41.45 10.24 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -96.8 -33.58 11.62 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.98 -39.16 3.01 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.7 ptp -94.78 150.56 38.08 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -169.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.09 120.82 6.2 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.278 1.985 . . . . 0.0 113.626 169.45 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.16 156.31 42.29 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.607 1.967 . . . . 0.0 116.856 -172.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 t -89.59 176.94 6.68 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.723 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -47.95 -44.59 30.35 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.328 3.085 . . . . 0.0 119.328 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.24 83.83 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -61.0 -48.04 83.68 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.123 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.7 -45.19 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 170.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.64 75.74 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 173.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -41.38 67.14 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp85 -81.13 -26.71 35.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -178.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.08 -51.94 6.3 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-N 120.614 1.552 . . . . 0.0 114.877 165.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.76 75.14 0.4 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.479 0.581 . . . . 0.0 113.86 -170.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -118.31 133.53 55.81 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 123.608 0.763 . . . . 0.0 109.537 172.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -42.76 95.56 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 163.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.9 m -109.62 113.31 58.02 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.293 -175.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.91 -36.73 64.96 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 N-CA-C 118.568 2.488 . . . . 0.0 118.568 169.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -66.76 -25.85 66.69 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 171.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.49 85.2 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.44 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.76 -39.69 78.01 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 163.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -61.27 -53.23 59.5 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 168.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.66 -41.03 94.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 176.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -61.45 -44.64 96.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 165.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.8 tp -48.1 -51.39 24.76 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 121.22 1.827 . . . . 0.0 115.87 166.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -62.88 -52.12 64.32 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 172.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.61 81.15 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.27 -54.68 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 165.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.53 52.4 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 175.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.99 9.33 19.86 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -177.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.42 -47.36 82.25 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 120.742 -1.224 . . . . 0.0 113.464 144.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.14 60.7 0.04 OUTLIER Glycine 0 N--CA 1.48 1.576 0 C-N-CA 123.932 0.777 . . . . 0.0 114.068 174.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.77 -43.37 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.86 150.7 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.064 0.847 . . . . 0.0 110.989 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -96.77 117.91 32.07 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.211 0.605 . . . . 0.0 110.779 172.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.55 140.26 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.591 1.186 . . . . 0.0 110.047 176.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.93 134.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.415 172.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 m -72.59 97.03 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.477 -0.765 . . . . 0.0 112.58 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.24 -70.51 0.5 Allowed Glycine 0 N--CA 1.485 1.914 0 CA-C-N 115.547 -0.752 . . . . 0.0 113.004 -167.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 107.23 9.04 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.5 m -72.96 -14.23 61.41 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -82.47 102.82 11.58 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 145.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.45 -114.56 0.11 Allowed Glycine 0 N--CA 1.482 1.714 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -137.89 -65.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -134.48 136.26 43.04 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.099 1.318 . . . . 0.0 112.905 -161.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tt -89.83 119.41 30.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 156.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 1.6 pp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -167.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -72.95 157.74 36.83 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.83 -37.96 69.4 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 172.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -70.8 -33.37 70.65 Favored 'General case' 0 CA--C 1.579 2.077 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -58.33 -42.08 86.0 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 160.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -62.27 -40.78 97.34 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -51.27 -54.07 29.42 Favored 'General case' 0 CA--C 1.584 2.285 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 162.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.81 -49.39 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -55.36 -39.83 70.56 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 169.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.0 -45.88 76.21 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 171.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.72 -37.01 76.37 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 121.962 2.165 . . . . 0.0 116.569 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.291 0.2 OUTLIER -57.54 -48.83 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-N 120.376 1.444 . . . . 0.0 114.4 169.969 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.65 -47.98 83.82 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 166.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.49 -44.88 96.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -57.48 -39.61 76.8 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 171.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.37 -46.2 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 170.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 t -67.09 -27.37 67.3 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 168.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.11 -46.77 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -124.87 -39.41 2.27 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.248 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.02 -27.73 3.28 Favored Glycine 0 CA--C 1.548 2.101 0 N-CA-C 117.442 1.737 . . . . 0.0 117.442 -173.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.72 149.11 35.43 Favored Pre-proline 0 CA--C 1.579 2.078 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -164.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.39 113.91 1.76 Allowed 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 122.481 2.121 . . . . 0.0 114.241 172.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.05 160.43 23.8 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -168.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -105.99 -174.38 2.52 Favored 'General case' 0 CA--C 1.587 2.38 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.557 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -46.44 -30.33 2.12 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 120.16 3.393 . . . . 0.0 120.16 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.48 69.93 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 170.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.38 -46.87 8.1 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 163.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.29 -45.08 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 120.254 1.388 . . . . 0.0 114.311 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.65 69.58 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 171.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -74.11 -52.0 13.94 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -71.2 -37.4 72.11 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.0 mt -78.44 -8.95 59.07 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.84 51.99 4.04 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 117.46 1.744 . . . . 0.0 117.46 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.33 99.73 12.7 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 118.014 0.907 . . . . 0.0 111.265 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -60.01 -20.24 56.76 Favored 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 165.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.1 p -111.89 92.92 18.97 Favored Pre-proline 0 CA--C 1.572 1.792 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.597 162.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -55.94 -32.42 85.54 Favored 'Trans proline' 0 N--CA 1.512 2.562 0 N-CA-C 120.149 3.096 . . . . 0.0 120.149 -175.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -57.4 -34.64 69.1 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 170.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.32 63.18 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 172.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.96 -56.6 13.19 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.74 -18.68 37.03 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 -40.18 88.11 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.161 1.8 . . . . 0.0 115.005 165.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -61.67 -38.01 86.19 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 162.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.33 -41.48 80.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -61.44 -44.48 97.04 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 169.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.45 75.07 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 163.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.74 -41.01 97.09 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 167.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.97 -47.07 81.87 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 164.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -53.91 -45.79 71.27 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 170.554 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -66.7 -33.61 76.03 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 170.102 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.32 63.81 0.67 Allowed Glycine 0 N--CA 1.483 1.783 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -33.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.49 153.04 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-O 121.987 0.899 . . . . 0.0 111.338 169.134 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -105.28 104.23 13.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 110.514 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.93 110.77 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 O-C-N 121.483 -0.761 . . . . 0.0 109.018 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -94.39 138.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.474 0.71 . . . . 0.0 109.314 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.7 t -78.49 78.16 4.96 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 175.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.53 99.2 0.18 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.188 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 63.26 19.03 11.43 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 119.779 3.251 . . . . 0.0 119.779 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.371 51.9 p 71.97 -58.53 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -84.06 77.35 9.95 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 122.492 1.139 . . . . 0.0 111.914 172.295 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.42 77.39 0.26 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.261 174.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.48 115.61 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.61 ' HE ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.42 170.7 9.18 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.61 ' H ' ' HE ' ' A' ' 67' ' ' ARG . 10.1 mp -95.14 133.4 39.01 Favored 'General case' 0 CA--C 1.571 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 112.114 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.568 1.641 0 CA-C-O 121.809 0.814 . . . . 0.0 109.243 174.337 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.569 1.676 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.7 p -81.64 158.79 24.18 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.44 -40.13 71.17 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 174.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -64.52 -37.82 88.88 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -58.5 -45.56 88.5 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -64.85 -38.81 92.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 171.401 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -51.44 -48.4 62.74 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 161.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.3 t -59.77 -47.76 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.81 -44.41 86.34 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 170.11 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 170.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 -44.72 69.15 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.083 1.765 . . . . 0.0 114.994 175.869 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.316 0.2 OUTLIER -56.04 -47.78 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.634 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 167.234 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -54.15 -53.14 57.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 167.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.51 -46.28 90.66 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 178.486 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -70.06 -34.83 73.71 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.06 -49.96 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 120.0 1.273 . . . . 0.0 113.412 161.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 t -68.38 -32.34 72.34 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 176.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -90.59 -48.66 6.94 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 m -102.39 -38.52 7.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.19 32.3 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 118.156 2.023 . . . . 0.0 118.156 -169.287 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 mtm -97.03 144.14 27.34 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-N 119.548 1.674 . . . . 0.0 113.732 -174.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.03 114.4 2.87 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 C-N-CA 122.418 2.078 . . . . 0.0 113.68 174.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.54 124.57 7.09 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 CA-C-N 122.492 1.926 . . . . 0.0 115.035 -175.632 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 p -90.43 179.39 5.88 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -31.4 -45.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 121.596 3.924 . . . . 0.0 121.596 -178.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.53 -44.48 78.24 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 175.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -71.44 -44.16 65.36 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 172.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -50.91 -46.92 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.24 97.64 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 169.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -64.27 -46.88 81.77 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.01 -43.07 30.54 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.94 -21.2 26.4 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 51.43 2.05 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 178.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -101.82 102.25 12.83 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.103 0.951 . . . . 0.0 108.906 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -55.31 -37.8 67.85 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 179.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.8 m -104.17 116.01 62.14 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.393 164.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -53.07 -17.97 8.97 Favored 'Trans proline' 0 N--CA 1.51 2.463 0 N-CA-C 120.577 3.26 . . . . 0.0 120.577 173.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.85 -28.15 69.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 165.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -38.13 89.95 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.72 94.76 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 163.423 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -55.56 -46.68 77.15 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 165.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.63 -49.53 72.6 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 174.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -70.21 -32.87 70.96 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.5 -54.85 41.03 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.503 1.956 . . . . 0.0 114.448 165.155 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.82 -44.04 94.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.638 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.49 94.71 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.03 -38.47 88.82 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.407 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.01 82.22 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 165.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -68.08 -27.14 66.24 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 173.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.93 -34.88 73.82 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 160.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.94 -37.09 1.11 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 173.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.57 4.81 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -156.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.82 144.94 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 CA-C-N 120.246 1.385 . . . . 0.0 113.192 167.572 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -105.58 113.61 27.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.53 116.9 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.08 107.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 122.187 0.994 . . . . 0.0 112.667 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -84.46 94.78 8.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.011 0.91 . . . . 0.0 111.978 -170.18 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.51 -77.1 0.28 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.784 -167.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.6 -20.13 65.32 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 174.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.33 18.8 m 77.65 -70.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 171.486 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -84.75 72.65 10.71 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 123.114 1.435 . . . . 0.0 113.331 175.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.88 71.27 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.766 165.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.47 115.22 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -170.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -81.61 146.83 29.89 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.75 104.96 17.35 Favored 'General case' 0 CA--C 1.573 1.833 0 O-C-N 121.972 -0.455 . . . . 0.0 110.064 168.112 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.571 1.783 0 CA-C-O 121.732 0.777 . . . . 0.0 110.573 -179.837 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.9 p -75.07 159.1 32.11 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.17 -45.02 64.94 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.892 2.923 . . . . 0.0 118.892 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -69.07 -38.77 79.21 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 174.675 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 5.5 pt20 -70.31 -29.95 66.81 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 167.14 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -56.86 -47.76 79.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.99 -43.51 81.77 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.0 t -58.28 -48.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 168.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.51 -48.37 69.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 166.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.64 -37.42 73.3 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 170.268 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.43 -44.46 94.51 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 172.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.324 0.0 OUTLIER -61.98 -45.55 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 166.156 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -57.0 -46.89 81.97 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.85 -53.67 55.81 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 171.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -67.87 -36.55 80.48 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.32 -48.33 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-N 119.972 1.26 . . . . 0.0 112.563 167.396 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -63.23 -30.45 71.59 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 174.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -93.2 -42.92 9.1 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -107.98 -19.14 13.61 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.78 -48.39 1.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -173.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 149.86 43.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -62.14 148.05 93.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.412 2.075 . . . . 0.0 116.514 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.07 147.57 21.05 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.247 1.965 . . . . 0.0 115.243 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 p -75.23 165.33 25.36 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-O 122.492 1.139 . . . . 0.0 113.933 176.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -52.03 -43.74 63.86 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 176.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.04 80.4 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 169.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.45 -49.5 77.32 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 120.294 1.406 . . . . 0.0 114.598 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.67 -44.7 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 171.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.02 -52.44 16.95 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.095 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -89.73 -37.32 14.63 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -167.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -64.24 -37.74 88.55 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.516 1.672 . . . . 0.0 115.516 172.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.97 -9.69 59.71 Favored 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 170.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.99 54.74 4.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 117.489 1.755 . . . . 0.0 117.489 178.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -96.65 135.83 38.03 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 121.78 0.8 . . . . 0.0 111.777 176.136 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -40.57 92.08 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 175.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.1 t -119.49 125.57 27.44 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.267 171.221 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.42 -36.7 49.25 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 N-CA-C 118.673 2.528 . . . . 0.0 118.673 165.237 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.22 -36.0 72.51 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 169.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.05 73.71 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 165.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.55 -48.86 71.52 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 172.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -33.05 72.56 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.656 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 165.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -60.78 -40.84 94.1 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 164.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.84 -49.44 73.29 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 164.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.1 -46.92 86.9 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 174.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.48 80.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 171.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.44 -46.87 53.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 169.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.82 76.73 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 172.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -55.56 -26.93 46.15 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 169.532 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -71.17 -50.95 27.82 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 170.307 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 165.0 -43.23 0.29 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 119.025 2.37 . . . . 0.0 119.025 -177.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.12 -35.1 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -168.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.5 155.81 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 C-N-CA 123.755 0.822 . . . . 0.0 110.688 172.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -112.06 145.6 39.44 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 112.221 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.96 151.1 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.187 0.994 . . . . 0.0 111.839 177.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.1 m -59.81 139.64 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -167.218 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 t -81.7 72.48 8.75 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 121.538 0.685 . . . . 0.0 112.759 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 -73.55 2.45 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -176.54 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.41 138.5 39.32 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 m -55.7 -34.39 65.04 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.573 3.175 . . . . 0.0 119.573 -174.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -89.2 69.06 8.24 Favored 'General case' 0 CA--C 1.581 2.166 0 CA-C-N 119.895 1.225 . . . . 0.0 112.369 172.001 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.59 43.13 0.85 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -179.05 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.4 mt -102.1 103.58 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -176.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.86 129.32 35.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -175.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -90.98 69.84 6.33 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.654 0.782 . . . . 0.0 112.428 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.33 1.8 pp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 120.186 3.402 . . . . 0.0 120.186 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 CA--C 1.572 1.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.6 p -64.04 154.32 34.66 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.85 46.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -63.41 -56.11 18.92 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 169.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.36 -33.73 76.17 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 174.115 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -58.06 -49.53 76.59 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 170.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.82 -27.13 66.45 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.65 -56.3 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 119.866 1.212 . . . . 0.0 112.764 160.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.43 -50.71 70.85 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 172.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.49 -44.4 96.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 tp -56.99 -37.83 72.18 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.058 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.4 -49.46 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.714 1.143 . . . . 0.0 113.119 169.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -56.88 -48.47 78.08 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.3 -53.02 62.65 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -74.18 -34.8 63.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -176.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -60.7 -42.95 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.575 0 CA-C-N 120.159 1.345 . . . . 0.0 112.637 163.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.61 -49.63 57.74 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -78.03 -15.7 58.71 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -143.21 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 112.469 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.93 -26.53 5.05 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 118.114 2.006 . . . . 0.0 118.114 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -97.54 152.04 37.96 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.66 121.31 6.62 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 C-N-CA 121.945 1.763 . . . . 0.0 114.6 -176.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.29 106.69 2.27 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.437 2.092 . . . . 0.0 112.325 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.305 7.3 t -84.96 -169.15 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -173.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -55.53 -39.37 70.46 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -168.063 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.57 86.37 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 168.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -60.03 -46.21 90.28 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 170.441 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.57 -58.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 123.909 0.884 . . . . 0.0 113.243 172.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.71 85.28 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -75.37 -32.85 60.95 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 171.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -53.22 18.53 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 171.776 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.72 -26.15 20.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.0 52.97 0.81 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -95.34 107.46 19.58 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 118.185 0.993 . . . . 0.0 110.053 170.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.48 53.53 2.69 Favored 'General case' 0 CA--C 1.584 2.262 0 O-C-N 121.29 -0.881 . . . . 0.0 113.078 169.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -178.32 111.32 0.22 Allowed Pre-proline 0 CA--C 1.577 2.015 0 C-N-CA 124.852 1.261 . . . . 0.0 109.158 -174.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.57 -38.7 75.87 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 N-CA-C 118.417 2.429 . . . . 0.0 118.417 169.557 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.88 -33.68 73.47 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 171.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -50.63 68.93 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.52 -48.83 76.4 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 170.296 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -43.48 92.73 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 171.408 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.86 -38.19 88.18 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 174.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -69.84 -35.65 74.92 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 168.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.45 -50.67 64.78 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.484 1.493 . . . . 0.0 114.659 160.297 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -51.6 -45.05 63.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 167.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.0 -39.09 65.75 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 169.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.98 -45.95 72.71 Favored 'General case' 0 CA--C 1.583 2.231 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 167.353 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.98 86.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 170.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -66.06 -37.75 86.6 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.42 -41.8 93.2 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 161.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 48.56 0.21 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 166.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.53 -35.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 pt -107.98 144.05 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 120.962 1.71 . . . . 0.0 113.412 -179.576 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.21 115.35 27.29 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 172.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.35 122.93 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.136 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.5 116.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 167.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -94.88 91.53 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.976 176.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.04 -63.14 0.49 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 114.818 0.687 . . . . 0.0 114.818 -174.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.14 164.9 25.24 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 174.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -76.52 -67.06 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 177.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -89.54 78.85 6.99 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 122.795 1.283 . . . . 0.0 113.544 -169.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.22 66.34 0.31 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.246 171.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.5 mm -130.7 96.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.64 137.19 26.48 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -164.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 mt -76.19 136.31 39.75 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.82 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.574 1.891 0 CA-C-O 121.777 0.799 . . . . 0.0 110.057 174.893 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 121.412 0.625 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -105.45 65.39 0.72 Allowed 'General case' 0 CA--C 1.579 2.071 0 CA-C-O 121.651 0.738 . . . . 0.0 110.129 172.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.88 79.02 5.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.033 -1.042 . . . . 0.0 112.531 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.93 148.16 50.9 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.866 0.841 . . . . 0.0 111.964 -168.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -71.75 147.99 46.78 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.765 -0.585 . . . . 0.0 111.841 167.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.99 -39.77 56.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -66.97 -46.71 73.8 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -54.61 -45.96 73.75 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 164.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -58.99 -41.93 88.79 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.72 -40.0 95.67 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 165.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.93 -44.39 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 120.259 1.391 . . . . 0.0 113.7 167.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -54.2 -47.91 71.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.33 -39.28 86.51 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD21 ' HE ' ' A' ' 34' ' ' ARG . 36.5 mt -57.63 -29.84 64.87 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm -58.89 -50.8 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.267 0 CA-C-N 120.036 1.289 . . . . 0.0 113.027 164.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -65.05 -46.06 82.83 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.36 -42.25 96.29 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -36.03 81.73 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.187 1.812 . . . . 0.0 115.301 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.91 -53.45 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 164.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -72.68 -37.24 67.96 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -92.38 1.13 57.41 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.2 m -150.07 -57.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.024 1.284 . . . . 0.0 111.218 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.57 -29.83 2.55 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -105.19 145.3 30.5 Favored Pre-proline 0 CA--C 1.569 1.707 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.39 146.89 22.37 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-N 122.421 1.9 . . . . 0.0 114.26 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 146.64 13.95 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.211 1.825 . . . . 0.0 116.535 -161.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.8 p -73.7 161.81 29.86 Favored 'General case' 0 CA--C 1.577 2.014 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.321 165.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -34.41 67.79 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.17 83.13 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 163.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.68 -40.77 79.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 169.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.13 -47.2 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.309 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 162.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.6 -35.7 72.85 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.72 -42.89 81.24 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HE ' HD21 ' A' ' 14' ' ' LEU . 2.5 tmm_? -77.64 -55.34 5.43 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.275 1.398 . . . . 0.0 113.893 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.0 -20.67 60.26 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.24 58.97 2.49 Favored Glycine 0 N--CA 1.48 1.628 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -95.78 126.88 41.35 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -54.08 -28.24 37.83 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.071 2.989 . . . . 0.0 119.071 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.9 m -155.97 158.15 31.57 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 123.852 0.861 . . . . 0.0 111.335 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -46.36 -31.54 9.61 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 N-CA-C 120.375 3.183 . . . . 0.0 120.375 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -54.33 -34.42 61.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.732 2.864 . . . . 0.0 118.732 166.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.44 -40.79 42.13 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.44 84.61 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.87 -34.8 72.02 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.44 -43.58 88.81 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -70.34 -41.96 72.51 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 169.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.24 -50.67 58.72 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -67.73 -37.73 82.61 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.15 89.57 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -57.09 -44.22 82.94 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 163.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.91 96.24 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.64 -40.03 82.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.72 -22.34 65.28 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.71 17.69 37.67 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.34 -21.45 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.2 pt -139.48 143.94 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.165 0 CA-C-N 120.511 1.505 . . . . 0.0 111.9 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.82 111.01 21.87 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 124.811 1.245 . . . . 0.0 109.269 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.36 128.88 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.68 133.45 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -85.18 86.51 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.862 . . . . 0.0 112.146 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.23 -72.61 0.24 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.62 120.83 25.57 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.7 t -59.52 -35.7 74.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -97.89 84.28 3.3 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.163 0.892 . . . . 0.0 110.337 167.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.19 85.03 0.13 Allowed Glycine 0 N--CA 1.482 1.738 0 O-C-N 121.919 -0.488 . . . . 0.0 112.908 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.06 109.77 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -95.21 126.36 40.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.217 0.607 . . . . 0.0 109.751 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.46 125.49 29.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.808 -1.182 . . . . 0.0 113.565 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt -85.55 -50.31 7.35 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.37 154.28 27.83 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.623 0.725 . . . . 0.0 111.919 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.297 5.8 tp10 75.48 -68.03 0.22 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.659 1.184 . . . . 0.0 113.742 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 123.884 1.802 . . . . 0.0 111.18 -177.123 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 CA--C 1.562 1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.01 120.3 20.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.819 -0.551 . . . . 0.0 111.289 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.1 103.95 3.45 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.3 2.1 pt? -61.81 -61.96 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.1 p -138.14 143.05 40.15 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 154.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 119.402 3.112 . . . . 0.0 119.402 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -78.31 -25.71 46.68 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.28 6.7 pt20 -70.07 -34.91 73.78 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 121.607 2.003 . . . . 0.0 115.807 160.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -57.4 -41.77 80.97 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 162.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -54.84 -45.96 74.57 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.58 -48.2 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.39 -48.4 81.79 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.58 -37.7 73.63 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.33 -42.28 96.36 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 164.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.2 mt -57.76 -46.03 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.938 1.699 . . . . 0.0 113.483 170.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -62.36 -49.24 76.35 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.64 -56.87 12.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -58.88 -40.29 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -44.07 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 167.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -70.67 -24.03 62.61 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 118.691 2.849 . . . . 0.0 118.691 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.53 -47.33 3.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.573 1.149 . . . . 0.0 113.481 -167.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -85.59 -43.52 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.95 -39.87 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -96.22 151.13 37.97 Favored Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.96 124.04 9.79 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 122.185 1.816 . . . . 0.0 113.427 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.9 114.48 3.84 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.182 1.921 . . . . 0.0 115.607 -167.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 t -83.59 -172.73 4.31 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -33.2 -58.19 0.39 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.76 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.52 -40.32 89.1 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 172.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.8 mm -60.59 -52.11 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 119.922 1.237 . . . . 0.0 113.349 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.42 -48.68 66.59 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -72.74 -44.33 61.79 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.1 mt -86.67 -9.64 55.55 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.541 2.422 . . . . 0.0 117.541 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.39 61.04 3.08 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.63 103.37 16.08 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.862 0.839 . . . . 0.0 111.435 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -9.75 57.55 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 161.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -107.25 109.5 62.85 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 117.496 -1.24 . . . . 0.0 110.725 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.73 -44.55 40.28 Favored 'Trans proline' 0 N--CA 1.509 2.422 0 N-CA-C 120.159 3.1 . . . . 0.0 120.159 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.01 -42.99 83.99 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.71 -47.45 73.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.5 -37.98 20.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.55 -35.54 80.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -60.13 -38.42 83.02 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 163.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.58 -45.81 92.57 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.06 -41.4 83.26 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.09 94.76 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 mt -57.68 -41.95 82.63 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 167.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.67 91.01 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 166.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -58.6 -40.97 84.72 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -71.89 -15.96 62.12 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.58 3.86 55.02 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.13 -17.8 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -130.79 129.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.052 1.297 . . . . 0.0 110.813 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -90.68 115.94 28.16 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.247 -0.908 . . . . 0.0 109.916 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.02 132.23 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.68 118.9 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.677 -0.639 . . . . 0.0 109.376 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.4 t -77.53 69.96 3.85 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.86 39.63 0.07 OUTLIER Glycine 0 CA--C 1.548 2.096 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.99 125.28 5.63 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.675 1.238 . . . . 0.0 110.231 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 m -59.53 -47.02 87.14 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -109.61 89.11 2.91 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.62 85.49 0.19 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 116.394 -0.366 . . . . 0.0 113.779 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.24 114.56 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.946 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -96.09 117.28 30.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.213 0.605 . . . . 0.0 110.757 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -74.99 105.17 5.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.22 81.61 7.29 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 122.621 1.201 . . . . 0.0 109.135 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -79.66 124.26 28.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -161.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.02 22.07 0.07 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 CA--C 1.559 1.305 0 CA-C-O 124.34 2.019 . . . . 0.0 108.449 -177.715 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -120.91 97.91 5.75 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.633 0.73 . . . . 0.0 110.677 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.62 89.2 7.89 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 121.538 0.685 . . . . 0.0 112.069 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 98.5 mt -120.81 118.79 30.9 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 121.418 0.628 . . . . 0.0 111.037 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -68.45 159.68 31.2 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.05 -45.96 52.69 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -71.08 -39.91 71.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -67.44 -33.98 76.26 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -56.8 -42.92 80.35 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 165.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -53.19 -43.77 67.43 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 164.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.29 -48.5 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -56.64 -47.03 80.62 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.1 -43.24 66.7 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 168.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -39.06 79.89 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.61 -48.49 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 CA-C-N 120.216 1.371 . . . . 0.0 113.457 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.45 -49.44 77.8 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 166.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.37 -49.48 73.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -62.07 -35.68 79.37 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.449 1.931 . . . . 0.0 115.978 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.52 -43.3 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 119.51 1.05 . . . . 0.0 113.029 165.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -64.82 -33.82 76.89 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.55 -47.18 12.44 Favored 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -102.56 -23.97 13.83 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.31 -34.37 4.62 Favored Glycine 0 CA--C 1.552 2.36 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 -159.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.13 154.6 40.55 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.82 152.3 63.73 Favored 'Trans proline' 0 CA--C 1.567 2.129 0 C-N-CA 122.056 1.837 . . . . 0.0 114.929 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.49 144.65 10.29 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.294 1.855 . . . . 0.0 115.094 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 58.6 p -76.47 161.33 28.73 Favored 'General case' 0 CA--C 1.577 2.011 0 O-C-N 121.877 -0.514 . . . . 0.0 112.285 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -50.69 -28.54 9.21 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.84 -36.53 80.51 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 163.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -62.02 -45.84 91.81 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 120.586 1.539 . . . . 0.0 114.518 163.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.04 -53.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 CA-C-N 119.799 1.181 . . . . 0.0 112.603 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.5 99.01 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -78.01 -48.21 16.68 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -70.26 -41.87 72.91 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.12 -17.6 27.37 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.74 62.32 1.95 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -90.82 148.2 22.68 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.426 1.108 . . . . 0.0 113.136 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -35.48 73.75 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -144.94 149.76 43.64 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.843 167.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.36 -33.06 21.58 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 N-CA-C 119.393 2.805 . . . . 0.0 119.393 163.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -65.78 -37.1 85.39 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 167.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.6 96.01 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.49 63.88 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 164.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.98 -34.4 76.48 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 171.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.81 -46.62 84.4 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -63.48 -39.32 94.15 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -53.89 -47.34 71.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 166.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -59.45 -35.75 74.64 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.37 -18.79 65.28 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 169.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.71 -46.0 84.18 Favored 'General case' 0 CA--C 1.592 2.594 0 CA-C-N 119.913 1.233 . . . . 0.0 113.668 159.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.05 175.38 4.52 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.296 1.6 mpt_? 75.74 -54.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.245 -0.909 . . . . 0.0 113.157 -173.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -61.6 -56.58 18.33 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 156.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.22 52.28 0.18 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 117.982 1.953 . . . . 0.0 117.982 169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.298 10.2 p -116.04 -20.64 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 168.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.24 155.61 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 122.218 2.281 . . . . 0.0 113.287 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.21 128.08 34.18 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.914 -0.491 . . . . 0.0 111.577 161.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.83 134.23 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.11 116.79 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.738 0.78 . . . . 0.0 111.917 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -85.53 100.85 12.2 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.738 -0.601 . . . . 0.0 112.267 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.42 -64.74 0.58 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.81 30.85 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.8 m -75.84 -38.84 57.64 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -134.33 100.12 4.58 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.612 1.096 . . . . 0.0 112.306 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.98 64.79 0.45 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.809 167.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.7 96.21 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -86.89 133.24 33.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 122.928 0.491 . . . . 0.0 112.103 169.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.47 125.19 28.94 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-O 121.737 0.78 . . . . 0.0 112.56 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -93.14 -61.61 1.54 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.957 0.903 . . . . 0.0 112.679 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -82.33 87.83 6.57 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 122.054 0.93 . . . . 0.0 108.816 163.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.19 -58.53 7.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -146.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 123.024 1.392 . . . . 0.0 108.475 175.709 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -93.49 67.93 4.05 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.121 0.962 . . . . 0.0 113.27 -162.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.99 100.68 11.6 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.328 0.651 . . . . 0.0 111.939 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.7 mt -84.94 118.27 24.44 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -170.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -66.09 154.89 38.38 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.59 -47.96 28.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -71.11 -41.71 70.23 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -65.49 -37.19 86.09 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -58.06 -49.2 77.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 170.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.23 -36.3 79.58 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.47 -50.6 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.465 1.03 . . . . 0.0 113.333 165.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -50.21 -51.68 42.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.55 -39.16 92.74 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.76 -46.27 86.02 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 121.263 1.847 . . . . 0.0 115.043 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.282 36.6 pt -59.06 -46.18 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -54.78 -51.05 66.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 165.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.28 -38.2 90.22 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -72.16 -30.18 64.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.59 -42.3 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.746 1.157 . . . . 0.0 112.908 160.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -64.89 -31.05 72.09 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.3 -43.24 57.59 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 p -125.96 -18.18 5.15 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.29 -43.14 1.95 Allowed Glycine 0 CA--C 1.546 1.978 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 -165.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.05 147.0 32.89 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.15 146.3 88.88 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 N-CA-C 118.886 2.61 . . . . 0.0 118.886 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.45 120.32 3.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.528 2.152 . . . . 0.0 112.58 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -89.21 82.02 6.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 111.624 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.323 23.5 tpt180 66.66 -52.59 0.44 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.07 50.48 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 -167.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.6 -31.17 71.03 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.8 mt -61.21 -53.97 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 CA-C-N 118.941 0.791 . . . . 0.0 112.129 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.88 85.21 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -72.02 -52.11 18.55 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.54 -40.91 28.45 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.63 -24.73 26.98 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.53 81.2 1.33 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 119.411 1.005 . . . . 0.0 114.718 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.72 102.9 8.71 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 117.678 0.739 . . . . 0.0 109.658 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -25.97 61.19 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -98.2 127.13 37.53 Favored Pre-proline 0 CA--C 1.566 1.56 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.327 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.31 -49.27 14.67 Favored 'Trans proline' 0 N--CA 1.508 2.37 0 N-CA-C 119.332 2.782 . . . . 0.0 119.332 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -94.27 75.63 3.97 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.156 0.979 . . . . 0.0 111.444 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.77 -48.61 0.96 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.034 168.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.11 -35.57 80.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.22 -45.87 92.78 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -61.89 -29.21 70.05 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -62.47 -47.42 84.11 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 120.317 1.417 . . . . 0.0 114.301 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.46 -43.31 79.42 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -60.29 -46.14 90.89 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.84 88.73 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 167.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.78 -43.19 94.52 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.13 -46.39 71.01 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -59.72 -40.22 87.28 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -65.11 -30.34 71.27 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 166.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.7 17.21 7.6 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.49 -13.95 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.79 134.55 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 119.863 1.211 . . . . 0.0 111.885 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.19 108.72 19.42 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.164 0.585 . . . . 0.0 110.563 168.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.4 mt -93.38 119.35 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.3 t -83.25 98.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -68.84 98.49 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.92 -55.68 0.68 Allowed Glycine 0 N--CA 1.486 2.009 0 CA-C-N 115.454 -0.794 . . . . 0.0 114.34 -163.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 116.96 23.63 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.6 p -53.68 -41.26 66.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -104.49 41.73 1.29 Allowed 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.62 72.8 0.3 Allowed Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.467 -0.771 . . . . 0.0 112.746 165.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.26 93.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -121.58 133.02 55.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.798 -0.564 . . . . 0.0 111.81 -155.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.92 114.78 11.45 Favored 'General case' 0 CA--C 1.578 2.038 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -165.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.42 86.73 6.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 121.839 0.828 . . . . 0.0 109.171 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.598 2.0 pp0? 58.78 -140.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.68 -70.94 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.933 0.788 . . . . 0.0 112.834 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 125.278 2.466 . . . . 0.0 109.436 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 CA--C 1.56 1.34 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -118.2 87.18 2.67 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.494 0.664 . . . . 0.0 110.955 -165.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.68 81.68 3.87 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.255 1.026 . . . . 0.0 113.06 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -111.56 146.01 38.11 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 p -75.88 157.26 33.49 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.54 72.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -71.8 -31.39 66.53 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -69.89 -31.25 68.95 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 161.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -60.62 -43.47 97.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 165.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -55.06 -45.15 75.28 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 165.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.63 -50.23 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.13 -47.74 68.44 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.56 -44.22 89.62 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.48 -37.03 86.12 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.23 -48.62 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 118.05 -0.976 . . . . 0.0 113.208 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -51.23 -46.37 62.26 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -49.24 78.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -71.34 -27.68 63.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mm -51.48 -43.24 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.265 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 158.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -77.09 -35.44 56.52 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.32 -29.47 65.06 Favored 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -146.75 -49.7 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.129 0.971 . . . . 0.0 112.006 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.28 18.37 0.93 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 118.038 1.975 . . . . 0.0 118.038 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptp -155.96 159.18 31.73 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-N 119.652 1.726 . . . . 0.0 113.43 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.83 128.67 31.25 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 122.623 2.216 . . . . 0.0 115.015 160.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 175.18 11.71 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 123.831 2.404 . . . . 0.0 115.55 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.0 p -66.79 154.74 40.06 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -22.61 64.92 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.43 -46.64 69.31 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 160.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.6 -53.21 60.77 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.58 -43.11 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.17 -48.75 78.67 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -79.79 -35.06 39.09 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.68 -39.28 73.61 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 -20.19 21.75 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.95 49.16 2.52 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -105.27 111.36 24.07 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -83.05 56.91 3.66 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 m 171.59 114.17 0.05 OUTLIER Pre-proline 0 CA--C 1.582 2.197 0 C-N-CA 126.148 1.779 . . . . 0.0 107.685 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.7 -33.72 60.95 Favored 'Trans proline' 0 N--CA 1.511 2.523 0 N-CA-C 119.136 2.706 . . . . 0.0 119.136 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -65.95 -33.8 76.64 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.98 96.19 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -52.38 65.05 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 162.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.2 -44.84 68.3 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.73 -38.05 66.65 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -72.61 -31.54 65.24 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 167.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.91 -40.17 87.93 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 121.272 1.851 . . . . 0.0 114.747 159.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -60.32 -51.51 69.22 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-N 120.032 1.287 . . . . 0.0 114.248 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.88 73.26 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 169.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.61 -39.03 81.01 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.76 88.72 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 164.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -65.49 -32.78 74.58 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -60.31 -12.62 9.58 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 157.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.69 13.71 66.77 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.51 -3.1 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -164.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.02 137.73 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 119.861 1.21 . . . . 0.0 110.664 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.1 108.11 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 110.622 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.53 138.38 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.03 135.26 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.847 -0.533 . . . . 0.0 112.222 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.1 t -82.01 77.54 8.81 Favored 'General case' 0 CA--C 1.567 1.629 0 O-C-N 121.61 -0.682 . . . . 0.0 112.594 170.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.05 -72.37 0.1 OUTLIER Glycine 0 N--CA 1.484 1.849 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.567 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.69 135.14 39.08 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -65.24 -11.27 39.31 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -90.74 -87.37 0.19 Allowed 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 120.049 1.295 . . . . 0.0 111.591 173.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.4 36.43 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 121.755 -0.591 . . . . 0.0 114.07 -172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.77 -72.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.132 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -151.2 161.47 42.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -163.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -87.87 121.27 30.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.4 164.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.73 114.98 27.66 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 123.426 0.69 . . . . 0.0 109.957 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 68.87 91.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.209 1.003 . . . . 0.0 113.585 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.88 108.86 11.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 171.312 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptm . . . . . 0 CA--C 1.561 1.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -79.89 101.73 8.74 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 112.007 170.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.88 121.7 36.75 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.95 155.29 19.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.8 p -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.26 -36.04 72.66 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.18 -37.92 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 9.6 pt20 -66.18 -30.34 70.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -53.97 -47.01 71.78 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 162.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.88 -46.54 81.8 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 168.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.34 -48.26 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -54.41 -50.39 67.71 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.39 -34.32 73.74 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.66 -44.44 81.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.338 10.2 tt -61.06 -39.23 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 166.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -55.9 -49.43 73.45 Favored 'General case' 0 CA--C 1.584 2.279 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 163.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.05 -47.71 79.11 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -68.75 -32.83 72.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -55.91 -47.97 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-N 119.509 1.049 . . . . 0.0 113.027 160.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 t -65.88 -33.54 76.08 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.0 -39.52 69.17 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -127.18 -24.81 3.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -167.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -26.75 12.2 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -161.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -105.95 151.34 40.0 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-N 118.656 1.228 . . . . 0.0 114.166 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 66' ' ' ILE . 91.9 Cg_endo -80.55 161.05 22.22 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.471 2.114 . . . . 0.0 115.706 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.79 143.01 11.61 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.876 2.384 . . . . 0.0 115.21 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.0 p -79.32 161.23 26.39 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -52.0 -44.18 63.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.99 90.02 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -63.42 -46.44 86.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.2 mt -57.5 -48.82 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.412 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.19 95.1 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -65.31 -43.41 91.13 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -69.16 -47.79 64.01 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.14 -18.52 28.61 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.84 55.62 1.73 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 116.56 1.384 . . . . 0.0 116.56 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -102.3 106.81 17.67 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 117.696 0.748 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.32 -32.95 71.72 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -106.4 104.91 52.55 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.87 162.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -51.69 -29.23 32.53 Favored 'Trans proline' 0 N--CA 1.509 2.441 0 N-CA-C 120.131 3.089 . . . . 0.0 120.131 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -49.42 -40.03 35.04 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.87 72.28 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 169.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.64 90.66 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 167.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -65.31 -35.41 80.92 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 168.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.16 -39.38 94.5 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.372 1.897 . . . . 0.0 115.857 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -60.79 -42.22 97.15 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 163.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.16 -46.44 85.7 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 168.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -61.02 -41.96 97.55 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.82 91.29 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.75 -43.43 90.27 Favored 'General case' 0 CA--C 1.584 2.256 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 165.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.12 80.47 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -60.62 -40.45 91.94 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -64.49 -45.84 85.57 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 168.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.93 60.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.862 0 N-CA-C 116.897 1.519 . . . . 0.0 116.897 163.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.06 -38.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.12 134.25 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.921 1.691 . . . . 0.0 111.42 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.38 99.52 12.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.427 -0.796 . . . . 0.0 111.06 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.68 120.21 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 122.775 0.43 . . . . 0.0 110.444 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.15 128.47 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.8 p -85.78 79.34 9.32 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 121.293 -0.88 . . . . 0.0 112.591 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.09 -65.64 0.32 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 141.73 38.63 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -71.08 107.13 3.99 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.302 82.2 mtt-85 79.01 33.5 0.24 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.32 59.76 0.81 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 164.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' A' ' 25' ' ' PRO . 33.7 mt -117.7 89.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -103.06 135.24 45.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 111.957 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.25 143.63 26.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.677 0.751 . . . . 0.0 112.51 -172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.17 90.92 2.57 Favored 'General case' 0 CA--C 1.576 1.951 0 O-C-N 121.141 -0.974 . . . . 0.0 111.565 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.272 40.2 mt-30 84.16 76.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.454 -163.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.266 20.2 pt-20 -84.2 82.18 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -164.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 123.884 1.802 . . . . 0.0 110.143 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtm . . . . . 0 CA--C 1.565 1.542 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.329 56.0 mtmt 74.77 -61.56 0.48 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.44 81.17 3.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 121.801 0.81 . . . . 0.0 112.988 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.523 0.4 OUTLIER 57.58 -173.26 0.08 Allowed 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -174.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -133.94 157.11 46.84 Favored 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 123.896 0.878 . . . . 0.0 110.449 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 -36.07 67.77 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -69.09 -47.17 65.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.2 -33.33 75.15 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -63.34 -39.18 93.83 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -57.25 -41.56 79.84 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 165.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.54 -47.32 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 163.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -58.12 -45.62 87.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -54.13 -40.97 67.85 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.45 -51.47 68.58 Favored 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 120.761 1.619 . . . . 0.0 115.362 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.15 -43.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -62.19 -44.69 96.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.34 -52.83 60.34 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 166.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -69.26 -36.21 76.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -54.92 -48.63 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 CA-C-N 119.524 1.056 . . . . 0.0 113.658 161.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -69.64 -34.15 73.62 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -98.6 -43.3 6.89 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 m -95.03 -44.65 7.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.48 -29.75 6.26 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 117.875 1.91 . . . . 0.0 117.875 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -100.12 155.4 36.47 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -74.34 123.08 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.381 2.054 . . . . 0.0 114.85 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.05 148.11 19.19 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 CA-C-N 123.017 2.113 . . . . 0.0 113.373 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -71.38 165.49 23.64 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 44' ' ' GLU . 8.9 ptm180 -52.41 -32.16 37.75 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 162.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.1 96.97 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.9 -37.84 86.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 168.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.3 -48.22 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.785 1.175 . . . . 0.0 113.524 166.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.46 96.77 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -62.99 -47.11 84.57 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -78.37 -46.49 19.84 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.1 -22.08 39.43 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.725 2.121 . . . . 0.0 116.725 168.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.57 48.0 4.66 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 117.003 1.561 . . . . 0.0 117.003 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.07 93.38 8.6 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.148 0.974 . . . . 0.0 109.388 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -58.85 -32.91 69.86 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -94.5 106.08 21.81 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.244 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.21 -12.07 34.58 Favored 'Trans proline' 0 N--CA 1.51 2.458 0 N-CA-C 118.712 2.543 . . . . 0.0 118.712 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -58.47 -32.56 68.86 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 159.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.38 93.61 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.2 73.07 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 19.0 tt0 -64.42 -48.24 76.12 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 171.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.72 -39.25 93.32 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -61.88 -42.44 99.07 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 164.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.82 -40.86 85.38 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.22 -51.54 65.84 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.21 -38.79 68.89 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 167.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.74 -43.15 99.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.03 -39.75 95.67 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.9 -34.15 75.52 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.2 -39.82 94.78 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 161.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.37 51.13 0.18 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 117.176 1.631 . . . . 0.0 117.176 164.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 -8.29 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.082 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.06 145.71 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 121.892 2.133 . . . . 0.0 112.703 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.05 112.46 21.89 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.569 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -83.61 105.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 109.605 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.15 123.31 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-O 121.319 0.58 . . . . 0.0 112.046 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.3 t -82.07 73.87 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.62 -83.77 0.13 Allowed Glycine 0 N--CA 1.482 1.745 0 O-C-N 122.068 -0.395 . . . . 0.0 113.53 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.84 89.89 6.37 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 27.5 t -59.12 -11.86 4.25 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -80.39 15.88 1.48 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 165.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.14 43.73 1.62 Allowed Glycine 0 CA--C 1.552 2.364 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 155.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.2 tp -93.03 75.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.158 0.98 . . . . 0.0 111.235 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -91.85 135.51 33.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 112.38 -166.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -93.29 142.67 27.06 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.55 99.68 6.6 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 85.82 3.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -161.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -80.0 87.48 5.4 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.561 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 124.491 2.091 . . . . 0.0 112.81 -171.181 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.564 1.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.92 114.64 6.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.686 -0.634 . . . . 0.0 110.196 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.63 -61.82 1.78 Allowed 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 165.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.42 144.66 51.53 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 157.7 29.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.187 -0.946 . . . . 0.0 112.872 168.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.2 50.46 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.15 -38.57 85.72 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -56.57 -47.82 78.69 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -62.83 -41.74 99.45 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.33 -50.59 69.25 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.02 -49.25 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.1 -47.28 85.33 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.84 -33.4 70.39 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -38.72 71.51 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 167.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt -55.4 -56.68 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 123.995 0.918 . . . . 0.0 112.732 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -68.13 -32.2 72.32 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -55.56 -53.06 61.08 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -69.96 -37.63 75.85 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.34 -42.2 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-N 119.91 1.232 . . . . 0.0 113.421 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.84 -30.32 71.31 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 169.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.82 -50.08 7.41 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.3 m -107.01 -31.07 8.46 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.2 23.91 18.32 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -147.87 156.2 44.33 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-N 119.091 1.446 . . . . 0.0 112.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -57.48 137.43 81.42 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.65 143.2 14.84 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 122.448 1.91 . . . . 0.0 114.753 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -74.37 160.98 30.31 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -32.1 -55.19 0.31 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 166.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.96 75.53 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -56.19 -43.57 78.57 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.1 -56.39 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 118.927 0.785 . . . . 0.0 112.095 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.85 75.35 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -75.77 -25.86 56.84 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.0 -46.17 65.7 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.232 1.378 . . . . 0.0 114.547 166.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.55 -37.95 30.5 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.92 0.27 Allowed Glycine 0 CA--C 1.545 1.958 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -114.55 130.87 56.8 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 117.872 0.836 . . . . 0.0 109.647 165.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -70.79 -41.36 71.77 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -101.23 113.18 65.83 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.387 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -56.08 -19.67 27.62 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -58.0 -28.62 64.58 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.97 71.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.56 80.21 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.67 -40.98 94.11 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.24 -49.97 72.62 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.44 -39.23 77.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 tp -52.52 -44.6 65.86 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 166.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -57.93 -40.04 79.5 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 166.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.78 99.56 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 166.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.56 -45.16 81.43 Favored 'General case' 0 CA--C 1.59 2.503 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.28 92.45 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 174.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -56.2 -39.55 72.6 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 165.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -76.44 6.4 5.76 Favored 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 28.02 58.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.42 -37.77 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 118.55 1.175 . . . . 0.0 113.182 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.65 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-N 119.676 1.125 . . . . 0.0 111.409 169.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.36 127.04 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.166 163.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.6 103.88 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.65 81.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.988 0.899 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.3 t -88.37 72.46 8.94 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -166.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.39 -67.91 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 O-C-N 122.018 -0.427 . . . . 0.0 113.15 158.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.01 161.59 28.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 150.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.9 p -76.08 68.73 2.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.293 24.7 ptt180 -174.43 -110.49 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.744 1.617 . . . . 0.0 109.107 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.96 45.24 96.55 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mt -102.69 113.73 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 118.273 1.037 . . . . 0.0 110.37 -161.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -97.57 135.79 38.9 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 121.451 0.643 . . . . 0.0 111.94 162.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 109.91 17.86 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.275 0.63 . . . . 0.0 111.082 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.48 -52.89 5.54 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -128.72 132.88 48.01 Favored 'General case' 0 CA--C 1.567 1.632 0 C-N-CA 123.907 0.883 . . . . 0.0 109.682 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -85.89 75.34 10.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.73 -1.231 . . . . 0.0 113.069 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 124.826 2.25 . . . . 0.0 111.811 179.584 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 CA--C 1.563 1.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -83.89 122.53 28.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.465 -0.772 . . . . 0.0 111.826 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.0 74.05 10.29 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.415 1.578 . . . . 0.0 114.448 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.06 139.38 40.01 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.904 157.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.0 p -80.76 145.55 31.45 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.028 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.3 66.12 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.73 -37.55 70.58 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -57.47 -46.32 83.8 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 121.02 1.736 . . . . 0.0 114.566 163.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -54.91 -47.29 74.54 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -53.37 -47.11 69.72 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 167.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.12 -47.77 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.24 -45.79 87.12 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -60.15 -37.2 79.4 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.22 -39.65 93.05 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 167.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -58.52 -45.62 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-N 119.405 1.002 . . . . 0.0 113.553 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -54.52 -51.34 65.46 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -60.9 -39.65 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -65.71 -47.71 74.45 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mm -57.51 -46.65 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 167.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -69.96 -12.63 61.75 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -70.74 -41.62 71.6 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 121.086 1.767 . . . . 0.0 115.022 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -149.11 -73.17 0.18 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.94 51.99 0.21 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 113.716 165.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -122.23 128.15 25.61 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.026 -164.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HB3' ' H ' ' A' ' 66' ' ' ILE . 36.8 Cg_exo -66.22 153.85 76.43 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 CA-C-N 123.092 2.14 . . . . 0.0 115.417 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.52 161.97 27.9 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 CA-C-N 122.55 1.947 . . . . 0.0 114.441 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -95.62 158.27 15.53 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.217 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -54.94 -37.58 66.6 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.05 99.86 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 166.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.26 -41.04 96.24 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 167.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.85 -51.04 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 119.647 1.112 . . . . 0.0 113.54 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.76 89.43 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -80.46 -39.23 28.52 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -78.88 -41.4 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.16 -36.86 34.49 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 61.91 0.69 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.21 101.88 10.35 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.67 62.32 6.8 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.365 1.078 . . . . 0.0 113.427 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m 175.9 126.98 0.15 Allowed Pre-proline 0 CA--C 1.58 2.115 0 C-N-CA 125.89 1.676 . . . . 0.0 107.995 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -61.22 -42.65 33.93 Favored 'Trans proline' 0 N--CA 1.51 2.442 0 CA-C-N 123.119 2.15 . . . . 0.0 116.503 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.34 -30.88 67.07 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.97 75.32 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.68 95.81 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 166.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.42 -53.25 60.48 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.47 -32.05 69.43 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -65.72 -37.9 87.71 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.333 1.879 . . . . 0.0 115.217 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.56 -51.3 70.48 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -57.45 -40.63 78.87 Favored 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 115.564 1.691 . . . . 0.0 115.564 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.45 95.64 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 167.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.68 -38.87 82.69 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.21 97.07 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 165.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -62.14 -36.22 81.14 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -58.63 -24.5 61.19 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 162.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.24 66.31 1.16 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 118.892 0.769 . . . . 0.0 114.99 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.269 10.5 p -149.33 -52.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.2 pt -96.01 131.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 120.864 1.666 . . . . 0.0 113.358 -171.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.76 110.01 20.64 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.297 0.639 . . . . 0.0 110.437 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.3 125.59 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.74 125.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 112.678 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -84.19 74.66 10.27 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.12 -67.52 0.23 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.27 142.04 34.95 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -66.45 -30.49 70.85 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 118.469 2.766 . . . . 0.0 118.469 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -108.73 88.88 2.83 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 119.971 1.26 . . . . 0.0 110.617 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.54 72.76 0.14 Allowed Glycine 0 N--CA 1.486 1.988 0 O-C-N 121.862 -0.524 . . . . 0.0 114.044 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.432 ' H ' ' HB3' ' A' ' 25' ' ' PRO . 66.4 mt -131.92 101.99 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -119.34 129.17 54.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.923 -0.485 . . . . 0.0 112.003 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 134.33 37.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.18 84.69 2.3 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 122.218 1.009 . . . . 0.0 110.664 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.313 16.8 tt0 74.72 -53.84 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 162.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -62.9 -63.78 1.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.039 2.236 . . . . 0.0 117.039 -161.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 124.078 1.895 . . . . 0.0 114.291 -163.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.563 1.462 0 CA-C-O 121.033 0.444 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -79.2 67.34 4.89 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.52 87.12 7.01 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.914 -1.117 . . . . 0.0 111.527 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.57 106.54 10.61 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -160.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 p -74.65 149.32 40.02 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.15 9.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.704 3.594 . . . . 0.0 120.704 -169.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.89 -45.82 40.27 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.48 -37.93 89.24 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 169.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -53.72 -40.97 66.53 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 164.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.11 -47.9 80.81 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 167.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.97 -49.04 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.645 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -55.48 -39.66 70.7 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.31 -45.64 90.76 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.495 HD23 ' HE ' ' A' ' 34' ' ' ARG . 2.9 tm? -60.39 -40.44 90.88 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 120.634 1.561 . . . . 0.0 114.909 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mt -60.58 -48.68 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -55.41 -48.22 74.71 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -59.27 -48.93 79.78 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -64.14 -41.12 97.31 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.4 mm -68.53 -50.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.494 1.043 . . . . 0.0 113.263 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -73.4 -38.02 65.75 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -88.56 -52.84 4.95 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 119.606 1.094 . . . . 0.0 113.448 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.46 -20.91 19.27 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 41.69 20.82 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 118.141 2.016 . . . . 0.0 118.141 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -149.23 142.67 16.19 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-N 118.893 1.346 . . . . 0.0 113.943 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.33 117.66 1.02 Allowed 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.121 1.881 . . . . 0.0 114.295 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.15 174.09 13.36 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 123.21 2.182 . . . . 0.0 117.644 -170.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -94.21 156.12 16.7 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.043 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -59.23 -28.19 66.45 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 166.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.94 96.58 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.68 -39.96 95.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 168.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.24 -51.08 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 123.734 0.814 . . . . 0.0 112.832 166.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.89 93.31 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -67.19 -45.89 75.55 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.495 ' HE ' HD23 ' A' ' 14' ' ' LEU . 2.8 tmm_? -74.73 -45.32 44.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.79 -14.49 34.39 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -171.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 63.61 1.21 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -117.44 120.83 39.32 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -55.95 -37.27 68.79 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -123.94 148.98 58.56 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.118 159.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -58.21 -12.63 13.55 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 164.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -58.06 -41.71 83.94 Favored 'General case' 0 CA--C 1.587 2.375 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 163.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.29 89.48 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.65 78.5 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 164.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -56.2 -36.95 68.98 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.34 -48.76 80.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -65.17 -38.19 89.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 168.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.59 -37.99 66.18 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -55.77 -57.03 13.74 Favored 'General case' 0 CA--C 1.574 1.897 0 CA-C-N 120.653 1.57 . . . . 0.0 114.811 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.98 75.64 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 168.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.79 -48.45 79.67 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.9 77.39 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -55.78 -41.98 74.86 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -71.83 -14.11 61.87 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.53 62.46 0.45 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 117.395 1.718 . . . . 0.0 117.395 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 m -141.74 -45.04 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.163 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 156.06 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 120.852 1.66 . . . . 0.0 114.548 -168.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.59 144.1 44.11 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 162.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.8 mt -114.11 120.09 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.65 106.59 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.677 0.751 . . . . 0.0 111.047 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.9 p -86.81 87.89 7.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 112.748 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.34 -65.86 0.42 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 169.55 18.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 170.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.1 p -91.66 -55.74 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -84.43 90.09 7.53 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.532 1.158 . . . . 0.0 112.225 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.3 44.83 0.16 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.6 mt -106.49 99.84 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -115.38 145.24 42.72 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.242 0.617 . . . . 0.0 112.006 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.13 123.1 18.98 Favored 'General case' 0 CA--C 1.579 2.093 0 O-C-N 122.05 -0.406 . . . . 0.0 111.853 166.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.25 68.84 10.64 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.608 1.194 . . . . 0.0 112.437 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.37 29.6 tt0 55.78 -115.79 0.96 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.358 1.063 . . . . 0.0 113.298 -168.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.3 19.0 tt0 68.49 -62.38 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 124.673 2.178 . . . . 0.0 111.6 -176.129 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.561 1.397 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.6 76.4 8.52 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.37 112.59 25.54 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.668 -0.645 . . . . 0.0 112.7 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.76 127.38 32.66 Favored 'General case' 0 CA--C 1.575 1.916 0 CA-C-O 121.419 0.628 . . . . 0.0 112.674 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.5 p -71.16 159.45 34.65 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.92 75.22 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -70.19 -37.05 75.02 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -65.25 -38.52 90.58 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.721 1.6 . . . . 0.0 115.276 166.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -56.54 -40.91 75.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 164.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.59 -45.52 85.19 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -57.81 -50.33 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.07 -46.11 82.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -59.29 -30.17 68.13 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -64.8 -45.75 84.94 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.077 1.308 . . . . 0.0 114.345 165.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mm -55.68 -47.46 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 169.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -60.15 -46.51 89.43 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.31 -55.32 35.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.52 -34.42 75.83 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.78 -42.1 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.215 1.37 . . . . 0.0 112.716 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.1 t -63.21 -31.7 72.91 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 168.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -73.08 -44.31 60.7 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -120.43 -22.44 6.48 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -167.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.15 -30.74 6.85 Favored Glycine 0 CA--C 1.549 2.195 0 N-CA-C 117.886 1.915 . . . . 0.0 117.886 -163.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -104.69 138.88 19.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -60.93 135.86 62.09 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 N-CA-C 119.499 2.846 . . . . 0.0 119.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.5 123.43 6.5 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.46 2.107 . . . . 0.0 113.607 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -100.04 101.97 13.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -168.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.301 76.4 mtt85 70.85 -72.03 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 142.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.05 77.49 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 157.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -60.52 -40.54 91.82 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -62.72 -52.35 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 120.048 1.295 . . . . 0.0 112.664 166.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.74 81.96 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -71.39 -47.77 54.07 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.19 -43.12 87.7 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.27 -6.32 59.43 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.4 51.52 4.6 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.32 108.42 20.59 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 117.643 0.721 . . . . 0.0 109.641 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -80.46 50.3 1.27 Allowed 'General case' 0 CA--C 1.584 2.27 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 175.52 96.79 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 C-N-CA 126.673 1.989 . . . . 0.0 106.083 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -54.52 -30.54 65.16 Favored 'Trans proline' 0 N--CA 1.513 2.62 0 N-CA-C 120.048 3.057 . . . . 0.0 120.048 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -60.93 -35.53 76.95 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.35 79.64 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.76 -42.91 76.17 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 162.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.4 -34.89 78.97 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 173.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.33 -42.92 96.63 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -61.75 -45.03 95.65 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 165.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.54 -49.03 65.67 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -61.14 -46.71 89.43 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.88 74.43 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.64 -37.64 85.24 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.32 95.79 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 ttt-85 -54.39 -44.03 71.94 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.37 -7.24 23.35 Favored 'General case' 0 CA--C 1.592 2.569 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.42 53.23 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.929 2.332 . . . . 0.0 118.929 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.23 -25.28 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.66 128.99 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.868 1.213 . . . . 0.0 111.221 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.66 107.61 19.28 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.663 -0.648 . . . . 0.0 110.619 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -80.83 122.02 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.18 123.15 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.016 0.526 . . . . 0.0 110.032 -169.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 m -78.73 84.42 4.81 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 121.752 0.787 . . . . 0.0 112.417 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.58 -64.22 0.35 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.73 123.05 25.6 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 m -61.66 -57.04 13.55 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -81.66 79.49 8.22 Favored 'General case' 0 CA--C 1.577 1.988 0 CA-C-N 119.259 0.936 . . . . 0.0 110.375 159.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.38 0.49 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.215 -0.902 . . . . 0.0 114.016 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.34 86.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -109.3 157.14 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.469 1.128 . . . . 0.0 113.791 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.36 110.75 18.4 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -161.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt -82.56 -26.46 32.38 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 166.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.307 14.2 mm100 74.03 -14.68 0.65 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 120.51 3.522 . . . . 0.0 120.51 169.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.81 93.06 6.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.511 1.05 . . . . 0.0 112.529 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 125.08 2.372 . . . . 0.0 114.425 -171.733 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.94 81.9 7.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.55 102.56 14.76 Favored 'General case' 0 CA--C 1.559 1.291 0 O-C-N 121.704 -0.622 . . . . 0.0 111.253 174.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.13 131.92 44.28 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.1 p -75.69 147.78 39.16 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.833 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.34 44.01 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 119.004 2.965 . . . . 0.0 119.004 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -73.63 -39.42 64.53 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.78 -33.4 75.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.7 -45.3 85.88 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 163.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.96 -42.58 76.43 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 167.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.0 -45.06 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.203 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -55.91 -42.53 76.19 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -54.31 -46.17 72.77 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -55.89 -37.7 69.21 Favored 'General case' 0 CA--C 1.586 2.344 0 N-CA-C 116.901 2.185 . . . . 0.0 116.901 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.13 -53.59 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 119.826 1.194 . . . . 0.0 113.263 170.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -60.58 -46.61 89.58 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -64.11 -47.52 79.68 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -69.32 -37.62 77.83 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.7 mt -57.35 -47.64 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 120.526 1.512 . . . . 0.0 112.94 167.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -62.26 -25.89 68.09 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 168.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.27 -58.85 2.67 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.854 1.206 . . . . 0.0 113.388 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 m -151.03 68.83 0.94 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 119.899 1.227 . . . . 0.0 111.151 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.34 -49.51 3.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 121.084 3.194 . . . . 0.0 121.084 160.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.16 137.95 19.38 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -157.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.45 122.67 5.67 Favored 'Trans proline' 0 CA--C 1.572 2.403 0 C-N-CA 122.727 2.285 . . . . 0.0 114.822 172.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -55.99 157.07 17.75 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 N-CA-C 122.322 3.932 . . . . 0.0 122.322 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 p -115.92 -174.58 2.56 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.176 163.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -28.09 22.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -171.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.37 90.84 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -76.12 -50.44 14.64 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 119.554 1.07 . . . . 0.0 112.915 165.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.6 mt -57.98 -49.61 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.45 76.4 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.46 -44.68 18.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -70.06 -40.23 75.21 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.27 -18.67 48.67 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 64.78 1.46 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -100.22 152.6 20.1 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.354 1.073 . . . . 0.0 113.027 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -56.02 -32.91 64.41 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 166.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m -163.21 159.21 18.33 Favored Pre-proline 0 CA--C 1.577 1.987 0 C-N-CA 124.088 0.955 . . . . 0.0 112.045 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -57.87 -30.44 89.54 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.914 2.236 . . . . 0.0 117.914 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.34 -45.04 88.88 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 167.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.54 88.81 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.61 -49.53 70.72 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.88 -30.37 68.86 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.6 -40.19 86.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -66.05 -42.22 89.79 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.68 -51.76 62.17 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.16 -48.38 78.68 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -46.89 74.56 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.05 -37.58 87.94 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.88 65.48 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -68.42 -24.36 64.74 Favored 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -69.02 -27.77 65.97 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 160.57 -54.27 0.33 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 168.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.25 -20.25 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -158.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -117.42 145.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 121.192 1.814 . . . . 0.0 112.939 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.51 114.51 20.98 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.096 0.958 . . . . 0.0 113.549 -163.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.72 96.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.716 0.77 . . . . 0.0 111.155 -172.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.4 m -91.05 110.63 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 121.698 0.761 . . . . 0.0 112.311 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.8 p -83.22 81.51 8.67 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.009 -1.057 . . . . 0.0 112.831 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.07 -52.11 0.71 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.22 115.08 12.13 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 m -74.12 105.38 5.31 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.358 0.599 . . . . 0.0 111.32 170.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.332 75.5 mtt85 72.92 50.31 0.15 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -166.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.48 5.14 24.79 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 164.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.252 9.8 tt -77.55 80.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.56 1.68 . . . . 0.0 114.612 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -82.67 144.99 29.88 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.388 1.075 . . . . 0.0 113.222 -168.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.0 125.32 25.96 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.991 -1.068 . . . . 0.0 113.535 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.5 mt -81.3 96.99 7.47 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.874 0.845 . . . . 0.0 109.827 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -48.83 111.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -168.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.27 128.17 11.79 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -165.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 CA--C 1.564 1.508 0 CA-C-O 123.587 1.66 . . . . 0.0 110.054 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.563 1.447 0 CA-C-O 121.585 0.707 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -88.62 97.13 10.94 Favored 'General case' 0 CA--C 1.567 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 110.678 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.84 83.27 4.19 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -170.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 163.11 16.35 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -81.23 160.04 24.39 Favored 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.169 -0.957 . . . . 0.0 113.092 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.17 -41.13 74.98 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -72.11 -29.61 64.26 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.67 -45.86 85.03 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.807 1.64 . . . . 0.0 114.714 159.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -44.23 87.62 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.14 -46.13 82.97 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.08 -46.95 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -56.56 -41.54 77.06 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.85 -40.14 79.42 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.29 -45.66 92.26 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.31 31.3 pt -63.23 -33.66 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -64.04 -50.44 68.41 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 120.652 1.569 . . . . 0.0 115.121 161.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -60.82 -47.54 85.87 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -67.69 -39.06 84.46 Favored 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.3 mm -57.37 -49.21 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.964 1.256 . . . . 0.0 113.122 165.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -62.89 -49.09 76.18 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -96.65 8.12 44.95 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -154.71 -54.91 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.561 -1.337 . . . . 0.0 111.489 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.04 38.91 1.1 Allowed Glycine 0 CA--C 1.545 1.913 0 N-CA-C 116.407 1.323 . . . . 0.0 116.407 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -144.21 135.56 12.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-N 118.782 1.291 . . . . 0.0 113.096 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 90.6 Cg_endo -91.14 107.18 0.29 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 CA-C-N 122.944 2.087 . . . . 0.0 113.908 175.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 36.2 Cg_endo -63.77 121.14 8.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.559 2.839 . . . . 0.0 115.582 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.48 ' H ' ' HE ' ' A' ' 64' ' ' ARG . 45.9 p -109.41 118.82 37.66 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.286 98.1 mtt180 72.17 -65.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 155.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.24 23.74 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.78 -36.21 80.41 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.8 mm -60.44 -52.87 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.41 95.29 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -67.17 -42.57 84.05 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -76.79 -47.13 22.53 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.08 -10.86 56.39 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 43.95 7.54 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 117.677 1.831 . . . . 0.0 117.677 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -89.69 85.32 6.42 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 118.615 1.208 . . . . 0.0 110.101 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.98 -24.13 66.72 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.5 m -91.37 112.49 54.41 Favored Pre-proline 0 CA--C 1.568 1.671 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.785 163.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.96 -18.52 62.43 Favored 'Trans proline' 0 N--CA 1.51 2.477 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -55.54 -44.45 76.77 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 166.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.09 -44.17 74.66 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.28 86.43 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 172.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -41.86 85.24 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 170.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.15 -50.02 50.28 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 166.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -64.93 -38.68 91.75 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.22 -49.53 77.25 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 21.9 pttm -63.89 -36.42 83.88 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 168.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.49 87.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 168.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.92 -43.8 86.48 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 164.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.12 84.31 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ttm105 -59.25 -36.88 76.29 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.94 -51.28 69.92 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.23 16.26 3.23 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.72 -10.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -136.84 138.14 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-N 120.02 1.282 . . . . 0.0 112.049 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.11 128.94 46.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.545 0.688 . . . . 0.0 110.149 166.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.6 mm -90.53 115.63 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 C-N-CA 123.141 0.576 . . . . 0.0 109.556 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.79 92.98 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -79.98 85.0 5.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.33 -84.71 0.05 OUTLIER Glycine 0 N--CA 1.481 1.633 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.725 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.95 52.89 2.52 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.297 63.2 m 64.65 -73.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.48 ' HE ' ' H ' ' A' ' 27' ' ' THR . 83.3 mtt180 -96.32 82.9 3.47 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 122.167 0.984 . . . . 0.0 111.589 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.77 95.5 0.28 Allowed Glycine 0 N--CA 1.48 1.629 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.293 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.0 120.03 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -93.96 128.32 40.22 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 121.696 -0.627 . . . . 0.0 110.993 173.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -84.57 111.74 19.79 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 123.023 0.529 . . . . 0.0 112.023 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.29 87.09 3.8 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.775 0.798 . . . . 0.0 110.4 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 74.31 144.59 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.508 1.123 . . . . 0.0 113.777 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.74 80.74 2.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.672 1.225 . . . . 0.0 113.901 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 123.628 1.68 . . . . 0.0 108.755 -170.562 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.968 0.413 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -134.38 89.45 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.359 0.6 . . . . 0.0 110.362 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.12 69.18 4.4 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt -114.78 124.1 50.91 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 110.079 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.7 p -80.54 94.98 6.36 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.294 . . 49.45 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 119.459 3.133 . . . . 0.0 119.459 168.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -74.79 -31.19 61.67 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.04 -32.13 73.12 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 161.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -57.85 -42.32 84.2 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 163.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.19 -44.69 68.12 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 163.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.33 -43.58 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.73 -40.23 87.36 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.41 -40.84 92.4 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 165.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.86 -47.23 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.446 0.1 OUTLIER -64.62 -39.22 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 121.106 1.775 . . . . 0.0 115.414 174.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtp85 -59.59 -39.67 84.92 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.37 -49.03 77.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -63.36 -39.92 95.86 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.75 -47.22 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 118.977 0.808 . . . . 0.0 113.16 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -61.05 -30.82 70.55 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -84.29 -41.69 16.58 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -116.96 -22.39 8.49 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.21 -47.9 1.45 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -161.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -90.1 159.74 41.78 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.89 162.5 37.24 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.403 2.069 . . . . 0.0 116.731 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 166.91 22.12 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.675 2.25 . . . . 0.0 116.862 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -67.0 147.2 53.53 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.792 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -57.5 -32.78 67.35 Favored 'General case' 0 CA--C 1.591 2.532 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.18 80.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 165.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.77 -33.37 66.55 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 170.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -60.69 -48.5 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-N 119.376 0.989 . . . . 0.0 112.629 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.56 61.16 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -64.98 -54.09 35.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -75.97 -39.15 56.58 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.15 -18.67 59.01 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 56.34 1.37 Allowed Glycine 0 N--CA 1.481 1.695 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.88 116.69 32.37 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 117.583 0.691 . . . . 0.0 110.199 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -63.48 -33.43 75.55 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 157.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 t -94.97 103.01 10.39 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 123.791 0.837 . . . . 0.0 112.291 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.71 -23.55 56.04 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.406 2.041 . . . . 0.0 117.406 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -58.83 -40.73 85.05 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 161.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.16 96.42 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 167.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.11 71.34 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 173.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.55 -33.41 75.85 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.9 -46.98 84.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -65.81 -30.68 71.35 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 tp -60.39 -52.09 66.73 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 121.121 1.782 . . . . 0.0 114.929 166.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 61.7 pttt -62.79 -42.07 99.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.12 74.38 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 166.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.37 -38.79 81.74 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.05 87.6 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 163.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -61.82 -35.68 78.95 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -59.11 -32.93 70.27 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 163.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.11 34.74 1.1 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.565 2.186 . . . . 0.0 118.565 163.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.49 -4.63 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.13 153.34 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.191 0 CA-C-N 119.689 1.131 . . . . 0.0 111.82 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -112.66 122.69 48.42 Favored 'General case' 0 CA--C 1.571 1.763 0 O-C-N 121.745 -0.597 . . . . 0.0 109.545 163.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -88.68 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.63 92.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -85.66 100.23 11.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.632 0.729 . . . . 0.0 112.277 -157.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.83 -53.63 0.7 Allowed Glycine 0 N--CA 1.486 2.008 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.053 -160.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.53 113.09 12.55 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 117.481 0.64 . . . . 0.0 112.553 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.8 p -60.33 -46.19 90.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -91.26 84.95 5.7 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 159.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.12 71.61 0.22 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.05 111.34 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.824 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.84 135.21 37.9 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 111.995 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 tp -95.31 111.61 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.98 0.512 . . . . 0.0 111.346 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.91 88.41 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.746 0.784 . . . . 0.0 109.987 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -79.75 92.6 5.45 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.97 -46.87 3.68 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 125.126 2.393 . . . . 0.0 113.307 -178.024 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.559 1.315 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -88.41 108.55 19.43 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.647 0.737 . . . . 0.0 112.745 -172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.45 114.45 16.29 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.834 -0.541 . . . . 0.0 111.239 166.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp -127.12 156.6 41.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 p -65.93 152.4 44.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -160.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.01 -40.37 58.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 120.406 3.484 . . . . 0.0 120.406 -165.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -39.38 34.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.96 -34.77 75.26 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 162.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.51 -41.28 96.5 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 167.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -57.42 -47.73 80.99 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 165.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.35 -49.34 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 165.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.0 -41.33 97.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.27 -40.87 95.72 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.93 -46.52 71.29 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.116 1.78 . . . . 0.0 114.983 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.262 3.6 tp -53.15 -46.98 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -62.81 -49.33 75.35 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 172.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.06 -44.17 97.78 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -72.85 -43.54 62.48 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.26 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 120.525 1.511 . . . . 0.0 114.776 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -59.94 -30.74 69.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 171.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -93.68 -47.63 6.71 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 p -93.33 -26.41 17.3 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.785 2.142 . . . . 0.0 116.785 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.91 3.76 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.25 141.58 24.18 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.7 132.63 8.88 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 122.187 1.817 . . . . 0.0 114.506 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -55.33 145.03 69.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 N-CA-C 118.272 2.374 . . . . 0.0 118.272 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 p -74.52 150.46 39.79 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.237 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.26 16.6 ptt180 -58.82 -26.98 64.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.2 -40.83 70.94 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -56.93 -49.74 74.71 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 166.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.05 -45.58 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.09 -55.0 36.01 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 170.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.21 -37.16 63.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.96 -36.5 72.59 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.25 -11.81 59.98 Favored 'General case' 0 CA--C 1.584 2.268 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 168.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.72 54.2 4.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -83.82 146.23 28.23 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.451 1.119 . . . . 0.0 113.888 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.02 88.45 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.0 m -152.8 143.97 16.05 Favored Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.718 164.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.45 -30.7 16.25 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -59.05 -31.68 69.07 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.06 99.24 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 165.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.25 96.48 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 165.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -55.74 -46.52 77.8 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 164.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.37 -42.32 95.55 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -66.21 -36.95 84.39 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -58.89 -41.37 87.0 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.5 -47.13 82.98 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 170.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.54 79.01 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.8 tp -63.31 -41.41 98.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.0 99.85 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -50.9 -38.02 47.29 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -77.37 6.21 7.29 Favored 'General case' 0 CA--C 1.592 2.558 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.58 40.97 16.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.42 -44.04 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.538 -169.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -127.51 137.65 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 119.709 1.14 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.67 115.86 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 110.684 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.46 123.92 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.07 105.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 164.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.0 m -77.59 95.74 4.63 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -161.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.13 -60.25 0.51 Allowed Glycine 0 N--CA 1.484 1.847 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.576 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.25 123.85 25.32 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.9 p -61.55 -41.31 97.18 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -99.68 28.57 4.6 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 163.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.58 69.81 3.26 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.309 -1.494 . . . . 0.0 114.305 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.03 98.94 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -168.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -98.61 108.58 21.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 110.281 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . 0.299 2.3 pp -82.09 93.1 6.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.1 pt? -64.4 -23.21 67.21 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 165.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.425 22.6 pt20 62.49 69.44 0.61 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.23 88.99 6.92 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 121.042 -1.036 . . . . 0.0 108.361 156.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . 0.298 4.3 tm-20 . . . . . 0 N--CA 1.506 2.334 0 CA-C-O 124.485 2.088 . . . . 0.0 111.263 -151.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 mtt . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.321 22.4 ttpp 75.98 -52.05 0.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 119.215 3.043 . . . . 0.0 119.215 165.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.17 84.55 7.01 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -168.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -82.02 154.18 25.8 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -74.33 153.96 39.09 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.408 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -44.38 70.75 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -72.09 -33.29 67.77 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -56.55 -46.55 80.62 Favored 'General case' 0 CA--C 1.583 2.229 0 CA-C-N 120.502 1.501 . . . . 0.0 114.481 161.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -61.54 -40.05 93.28 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.93 -50.71 68.17 Favored 'General case' 0 CA--C 1.582 2.207 0 CA-C-N 121.004 1.729 . . . . 0.0 115.391 164.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.2 t -55.76 -50.01 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -59.62 -42.53 92.89 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.06 -38.14 75.74 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -44.01 97.69 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 120.597 1.544 . . . . 0.0 114.768 168.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -53.26 -53.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 166.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -62.87 -37.65 87.73 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.73 -47.79 83.39 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 170.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -66.04 -41.32 91.02 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 120.593 1.542 . . . . 0.0 115.031 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.2 mt -67.65 -44.93 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -65.09 -28.77 69.68 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -87.79 -45.93 9.9 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -105.56 -23.69 12.73 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.42 -47.43 1.34 Allowed Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -164.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -88.63 160.72 43.91 Favored Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 158.85 50.91 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.078 1.852 . . . . 0.0 116.059 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.07 164.87 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.263 1.976 . . . . 0.0 114.891 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.5 p -72.97 151.04 41.99 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.205 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -57.87 -25.15 60.37 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.15 94.45 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 160.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.18 -45.42 93.19 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.1 -50.46 78.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.302 0 CA-C-N 120.133 1.333 . . . . 0.0 112.359 170.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.41 81.89 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.43 -49.04 11.98 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -67.33 -40.14 85.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.2 -14.97 58.73 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.05 65.28 1.54 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.08 141.31 31.18 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 121.968 0.89 . . . . 0.0 112.91 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -35.34 79.78 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -136.42 142.29 38.92 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.307 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -61.55 -24.54 78.21 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 N-CA-C 118.006 2.272 . . . . 0.0 118.006 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -63.89 -28.31 69.75 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 167.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -45.47 92.37 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.17 73.77 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.43 -48.11 69.04 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 171.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.33 -30.78 68.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -62.36 -38.88 91.27 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 162.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.14 -43.22 99.22 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.5 -47.9 78.33 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 163.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.01 94.06 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.76 -38.02 77.53 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 164.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.5 -46.22 76.97 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 166.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -59.22 -34.98 72.83 Favored 'General case' 0 CA--C 1.582 2.186 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.88 -26.07 67.15 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 163.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.16 41.47 3.02 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -129.73 -41.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.216 0 CA-C-N 118.103 0.952 . . . . 0.0 113.315 -169.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -126.0 135.53 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.0 1.273 . . . . 0.0 110.914 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.12 118.05 31.94 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 110.015 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.44 125.39 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 121.045 0.45 . . . . 0.0 110.291 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.47 93.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -74.58 123.45 24.83 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -160.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.65 -47.03 1.09 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -161.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.87 119.63 22.33 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -58.19 -41.51 84.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 171.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -95.07 83.1 3.86 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.63 0.728 . . . . 0.0 109.821 161.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.39 67.01 0.33 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.7 mm -135.83 118.98 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -172.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -103.17 126.7 50.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.822 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.5 tp -91.71 121.28 33.21 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -111.07 92.73 4.16 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 162.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -73.35 87.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -162.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.47 111.35 12.21 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.567 0.747 . . . . 0.0 109.123 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 124.761 2.219 . . . . 0.0 113.939 174.468 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 CA--C 1.56 1.348 0 CA-C-O 121.288 0.566 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -86.49 144.84 27.06 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 121.862 -0.524 . . . . 0.0 112.131 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.25 99.11 2.79 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.82 149.74 22.55 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.6 p -67.15 155.94 37.48 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.06 61.18 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -74.25 -38.3 63.52 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 169.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -58.52 -44.96 89.7 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 120.823 1.647 . . . . 0.0 115.178 168.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -61.25 -41.28 96.63 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.46 -47.26 79.55 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 165.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.95 -44.68 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -61.58 -41.56 97.58 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 172.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.82 -46.59 89.93 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.75 -41.14 98.05 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.277 0.4 OUTLIER -58.17 -46.57 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 CA-C-N 120.548 1.522 . . . . 0.0 114.584 171.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -63.12 -49.5 74.15 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.54 -46.34 90.55 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -69.37 -36.3 76.7 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.26 -45.22 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 120.805 1.639 . . . . 0.0 112.899 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -64.43 -26.58 68.51 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.25 -54.07 4.67 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -102.45 -39.6 7.07 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.55 -46.53 1.12 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 115.839 1.096 . . . . 0.0 115.839 -170.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.2 ptp -87.61 156.67 53.13 Favored Pre-proline 0 CA--C 1.57 1.739 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.51 155.2 21.33 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 122.022 1.814 . . . . 0.0 116.4 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.99 94.39 0.98 Allowed 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.637 2.225 . . . . 0.0 112.932 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -84.4 81.87 8.64 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.299 2.3 tmt_? 66.73 -60.02 0.35 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.81 77.32 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.93 -31.99 70.04 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.69 -50.91 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.251 1.387 . . . . 0.0 113.156 165.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.01 94.76 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -69.61 -49.15 56.76 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -76.56 -40.09 50.84 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -91.41 -26.78 18.7 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 73.64 1.06 Allowed Glycine 0 N--CA 1.483 1.788 0 CA-C-N 119.532 1.06 . . . . 0.0 115.345 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -135.44 128.05 30.79 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 117.318 0.559 . . . . 0.0 111.418 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -73.96 -45.71 48.52 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 m -118.25 151.31 49.15 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -167.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.54 -20.31 53.91 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 N-CA-C 118.392 2.42 . . . . 0.0 118.392 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -57.65 -16.24 10.01 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 164.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.61 -62.56 1.24 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.407 1.003 . . . . 0.0 112.686 160.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.02 91.67 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -80.16 -45.18 18.56 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.18 -29.25 67.2 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -60.37 -40.45 90.83 Favored 'General case' 0 CA--C 1.581 2.148 0 CA-C-N 122.622 2.464 . . . . 0.0 114.787 165.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.31 -44.82 93.87 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.82 -47.48 86.15 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.9 84.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 169.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.57 -43.91 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.49 98.8 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 166.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -56.42 -35.14 67.48 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 168.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -59.07 -34.24 71.73 Favored 'General case' 0 CA--C 1.591 2.552 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 163.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.82 56.09 0.56 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.301 3.9 p -132.81 -53.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.28 143.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.028 0 CA-C-N 119.643 1.11 . . . . 0.0 112.699 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.79 143.61 56.8 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.252 155.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.48 114.34 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.62 105.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.685 0.755 . . . . 0.0 109.369 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 m -84.23 85.54 7.35 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.172 0.987 . . . . 0.0 112.281 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.26 -73.44 0.23 Allowed Glycine 0 N--CA 1.484 1.87 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.287 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 106.12 11.76 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 120.98 0.419 . . . . 0.0 111.454 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 m -60.34 -42.73 96.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 118.464 2.765 . . . . 0.0 118.464 -166.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -83.14 65.01 7.99 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 119.799 1.181 . . . . 0.0 113.361 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 76.42 0.27 Allowed Glycine 0 N--CA 1.48 1.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.869 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.29 106.34 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -124.64 141.28 52.21 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.021 0.528 . . . . 0.0 111.634 -167.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.28 106.64 6.91 Favored 'General case' 0 CA--C 1.574 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 112.795 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.69 -48.0 56.98 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.51 -14.34 62.08 Favored 'General case' 0 CA--C 1.584 2.273 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.285 44.6 mt-10 74.0 -49.2 0.67 Allowed 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 CA--C 1.564 1.502 0 CA-C-O 124.369 2.033 . . . . 0.0 115.656 178.319 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 121.24 0.543 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.35 101.49 13.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 111.754 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.25 79.8 9.28 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.604 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 5' ' ' THR 0.624 2.6 pt? 43.49 -92.95 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 -169.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HG ' ' A' ' 4' ' ' LEU . 20.0 p -143.83 138.17 28.49 Favored 'General case' 0 CA--C 1.57 1.75 0 C-N-CA 123.941 0.896 . . . . 0.0 109.304 170.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.66 53.08 1.28 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 -173.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -144.24 -54.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.03 1.332 . . . . 0.0 109.794 164.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -61.05 -34.78 75.41 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 163.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -57.18 -40.76 77.98 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 168.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.97 -42.42 80.13 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.43 -44.32 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 167.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -64.63 -41.87 95.87 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -55.94 -39.34 71.57 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 163.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.51 -34.23 77.46 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.0 mt -53.51 -57.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.515 1.507 . . . . 0.0 113.174 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.13 -32.21 73.53 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.3 -48.02 71.72 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.25 -38.31 89.94 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.173 1.806 . . . . 0.0 115.448 173.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.12 -38.64 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 166.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.1 m -66.31 -41.72 89.31 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 167.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.81 -26.91 62.59 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -148.33 -52.84 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 -174.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.98 18.45 0.96 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -148.11 148.79 30.65 Favored Pre-proline 0 CA--C 1.581 2.147 0 CA-C-N 118.853 1.326 . . . . 0.0 112.324 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 147.62 37.56 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 122.563 2.175 . . . . 0.0 115.796 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.38 160.63 35.46 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.779 2.319 . . . . 0.0 115.391 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -143.89 127.13 16.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.308 42.2 ttt85 62.91 -79.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 161.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.24 -44.5 59.4 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.08 -42.07 93.81 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.33 -51.92 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-N 119.27 0.941 . . . . 0.0 112.984 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.24 94.84 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -74.59 -40.99 61.26 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -64.34 -42.72 96.11 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.3 mt -106.36 -26.51 11.46 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.66 86.48 1.68 Allowed Glycine 0 N--CA 1.485 1.925 0 CA-C-N 120.243 1.383 . . . . 0.0 114.139 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -120.72 137.55 54.43 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.561 0.696 . . . . 0.0 111.771 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -28.71 67.56 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -148.52 149.02 30.26 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-N 119.249 0.931 . . . . 0.0 113.074 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -62.43 -27.95 77.7 Favored 'Trans proline' 0 N--CA 1.509 2.398 0 N-CA-C 117.872 2.22 . . . . 0.0 117.872 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -65.89 -40.34 91.46 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.06 93.38 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.98 -47.16 68.41 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.48 -36.73 76.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 171.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.28 -33.06 74.51 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.385 1.902 . . . . 0.0 116.01 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -66.9 -36.04 81.38 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 120.99 1.723 . . . . 0.0 115.346 164.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.99 -46.13 82.48 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 161.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.0 -49.7 76.62 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.02 -43.21 60.84 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.86 -45.75 84.73 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 168.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.09 93.59 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.72 -39.34 77.03 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -69.89 -40.1 75.86 Favored 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 165.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.49 38.77 0.32 Allowed Glycine 0 N--CA 1.484 1.855 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 165.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.18 -28.84 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.14 146.93 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-O 121.963 0.887 . . . . 0.0 112.571 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -85.99 115.17 23.43 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.859 -0.526 . . . . 0.0 110.832 168.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.72 124.41 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.536 0.684 . . . . 0.0 109.528 -174.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.48 123.01 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -72.84 105.16 4.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.591 0.71 . . . . 0.0 112.804 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.29 -65.36 0.4 Allowed Glycine 0 N--CA 1.485 1.965 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.778 -167.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.89 119.63 24.18 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 169.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.1 p -79.31 65.2 4.42 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 15.7 ptm180 -161.42 -65.15 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.14 1.376 . . . . 0.0 111.553 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.55 -166.85 14.99 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -132.92 -72.82 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.441 -172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.89 147.88 39.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -158.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.61 126.59 31.12 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.4 mt -124.03 92.56 3.7 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.254 19.5 pt20 -70.62 90.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 -163.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.5 109.15 12.42 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.929 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 123.411 1.577 . . . . 0.0 110.845 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 71.5 107.88 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.747 1.219 . . . . 0.0 112.304 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.58 89.34 4.5 Favored 'General case' 0 CA--C 1.563 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 113.053 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mp 68.87 109.21 0.05 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.0 p -66.67 153.52 42.95 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 121.387 -0.82 . . . . 0.0 112.592 167.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.89 56.32 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 118.769 2.877 . . . . 0.0 118.769 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -70.82 -37.0 73.18 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -59.47 -44.45 93.02 Favored 'General case' 0 CA--C 1.584 2.257 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 162.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -57.91 -39.29 77.59 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.62 -47.6 83.85 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 165.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.09 -49.43 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.16 -48.27 79.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.06 -38.85 68.56 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -48.57 69.86 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.258 26.0 pt -59.46 -42.57 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.126 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 167.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -63.77 -39.04 93.3 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.67 -47.53 83.28 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -58.85 -49.22 78.56 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.13 -40.61 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -61.97 -48.86 78.48 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -85.84 -37.49 19.15 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -116.33 -17.79 10.65 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.94 -28.98 10.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.651 2.22 . . . . 0.0 118.651 -173.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -88.59 129.82 47.62 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.99 115.97 4.37 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.391 2.06 . . . . 0.0 115.427 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 160.33 37.21 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 123.562 2.308 . . . . 0.0 116.401 -170.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.2 p -86.89 163.97 16.86 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -40.5 -57.7 1.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.62 89.65 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.79 -43.49 85.63 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.69 -57.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.011 0.823 . . . . 0.0 112.615 168.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.6 85.49 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 118.278 2.695 . . . . 0.0 118.278 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.63 -34.4 75.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -73.02 -48.06 39.55 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.68 -38.4 58.77 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.02 61.85 0.28 Allowed Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -117.61 128.52 55.01 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.984 168.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HE ' ' H ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -63.62 -42.24 98.21 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 169.071 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.472 ' H ' ' HE ' ' A' ' 38' ' ' ARG . 10.1 t -109.65 106.95 59.03 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.354 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -54.79 -19.55 19.34 Favored 'Trans proline' 0 N--CA 1.508 2.336 0 N-CA-C 121.832 3.743 . . . . 0.0 121.832 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -53.28 -31.82 45.67 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 170.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.34 55.44 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 165.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -51.5 69.58 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -70.18 -32.68 70.73 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.98 -44.2 97.24 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -63.25 -41.39 99.05 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tp -49.7 -44.33 48.08 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.97 -46.06 75.01 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.18 90.12 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 -41.68 92.84 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 166.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.75 94.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -56.8 -42.38 79.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 168.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.45 -8.59 52.13 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 167.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.14 -9.11 61.22 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 120.136 2.814 . . . . 0.0 120.136 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 p -85.12 -4.25 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.0 pt -142.78 143.75 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-N 119.973 1.261 . . . . 0.0 111.963 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.11 112.5 25.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 166.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -84.8 125.63 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.8 120.96 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.798 -0.564 . . . . 0.0 109.676 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -76.64 85.24 3.3 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.65 63.5 0.51 Allowed Glycine 0 N--CA 1.486 1.992 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.686 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.5 131.39 13.31 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 117.421 0.61 . . . . 0.0 111.925 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.1 t -78.85 103.62 8.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.784 -0.572 . . . . 0.0 110.938 167.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.262 79.3 mtt180 70.38 67.22 0.2 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.55 83.0 0.25 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 114.645 0.618 . . . . 0.0 114.645 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.97 117.93 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.44 118.73 23.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.702 . . . . 0.0 110.179 174.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.98 100.63 9.8 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 122.945 0.498 . . . . 0.0 110.99 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.28 -10.67 59.57 Favored 'General case' 0 CA--C 1.587 2.4 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.311 5.0 tp-100 82.97 124.68 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.004 1.722 . . . . 0.0 115.355 167.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -84.77 -45.92 11.9 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 168.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 124.659 2.171 . . . . 0.0 110.355 -169.203 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 121.387 0.613 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -88.78 65.42 7.67 Favored 'General case' 0 CA--C 1.581 2.156 0 CA-C-O 121.981 0.896 . . . . 0.0 111.336 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.22 162.19 40.98 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.836 0.827 . . . . 0.0 112.481 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.5 mt -112.4 155.98 23.27 Favored 'General case' 0 CA--C 1.571 1.776 0 CA-C-O 122.117 0.96 . . . . 0.0 113.268 -177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -67.8 157.75 34.06 Favored 'General case' 0 CA--C 1.577 2.012 0 O-C-N 121.643 -0.661 . . . . 0.0 112.155 168.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 -54.78 28.34 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.651 2.463 . . . . 0.0 117.651 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -65.12 -35.01 79.78 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.67 -49.81 76.3 Favored 'General case' 0 CA--C 1.592 2.561 0 CA-C-N 120.235 1.38 . . . . 0.0 114.611 166.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -57.37 -43.29 83.45 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.05 -47.61 77.57 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 166.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.87 -49.26 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -58.17 -46.92 84.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -65.52 -28.82 69.46 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.22 -47.16 77.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.726 1.603 . . . . 0.0 114.519 169.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.287 15.6 tt -57.47 -45.26 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 165.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.77 -44.04 73.31 Favored 'General case' 0 CA--C 1.581 2.147 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 169.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -59.71 -51.31 70.3 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -40.96 98.99 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.01 -48.61 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 C-N-CA 123.702 0.801 . . . . 0.0 112.767 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -70.9 -34.6 71.72 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.29 -21.83 49.13 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.2 m -148.08 -53.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.193 0.906 . . . . 0.0 111.86 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.55 40.79 0.65 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -142.96 132.48 11.86 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 118.426 1.113 . . . . 0.0 113.51 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.88 123.62 3.69 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 122.501 1.929 . . . . 0.0 115.183 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.1 127.39 8.41 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.761 2.308 . . . . 0.0 113.882 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 172.42 13.38 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -49.54 -35.71 21.24 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 119.174 3.027 . . . . 0.0 119.174 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.89 -46.19 75.69 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 165.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.97 -45.35 92.96 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.82 -49.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 167.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.75 84.45 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 170.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -65.54 -51.38 60.28 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -83.95 -37.59 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.6 -16.32 39.68 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.84 66.03 1.52 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 120.092 1.314 . . . . 0.0 115.998 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.89 125.66 53.04 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -59.2 -16.07 18.51 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -148.99 155.23 40.41 Favored Pre-proline 0 CA--C 1.573 1.844 0 O-C-N 121.293 -0.879 . . . . 0.0 111.379 165.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -56.03 -28.73 70.78 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.88 -33.75 74.78 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.01 -39.11 83.26 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.61 89.32 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 162.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.86 -36.56 65.22 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 167.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -67.74 -39.72 84.2 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 166.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.71 -46.84 77.63 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.265 63.6 pttt -64.83 -39.25 93.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.82 88.75 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 166.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.62 -40.47 83.42 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 163.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.57 74.16 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 168.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -64.86 -38.79 92.14 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -66.63 -33.92 76.74 Favored 'General case' 0 CA--C 1.586 2.365 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 158.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.99 60.31 1.6 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.12 -39.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.015 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.55 162.97 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 118.769 0.713 . . . . 0.0 110.546 152.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.74 132.6 47.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.874 -1.141 . . . . 0.0 111.051 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.3 mt -90.85 116.45 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 O-C-N 121.787 -0.571 . . . . 0.0 109.877 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.1 t -80.87 96.71 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.2 m -77.59 96.02 4.7 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.871 0.844 . . . . 0.0 112.47 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.24 -53.22 0.56 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.272 -163.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.32 133.7 41.2 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.8 t -60.79 -54.47 44.8 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -93.97 71.64 4.04 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.179 0.9 . . . . 0.0 111.17 161.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.95 63.55 0.27 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 115.361 0.904 . . . . 0.0 115.361 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.5 mm -126.44 97.72 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.876 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -93.45 122.04 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 112.038 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -84.02 123.53 30.11 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.65 -3.51 9.28 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.389 15.4 mm100 76.1 -63.83 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.792 2.515 . . . . 0.0 117.792 171.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -146.03 144.18 29.9 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 122.149 0.976 . . . . 0.0 108.966 174.596 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.293 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.59 106.51 18.54 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.137 0.575 . . . . 0.0 112.003 175.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.52 125.52 29.19 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.899 -1.126 . . . . 0.0 111.419 162.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.9 mt -67.03 116.68 8.12 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 t -78.5 159.29 28.29 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -34.18 -55.89 0.5 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 121.017 3.71 . . . . 0.0 121.017 -164.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -77.69 -37.02 50.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -67.03 -34.37 77.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 163.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -42.78 88.78 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 163.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.58 -44.38 80.97 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 167.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.85 -41.31 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 167.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -62.47 -43.65 98.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 168.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.4 -41.47 69.31 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 167.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -42.25 91.78 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 175.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.319 6.2 tp -58.91 -46.51 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 163.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -59.32 -43.63 92.67 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.77 -51.05 71.0 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -63.37 -37.86 88.89 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 174.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.3 -47.74 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 CA-C-N 118.751 0.705 . . . . 0.0 112.861 169.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -65.23 -37.54 87.57 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 172.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.8 -12.84 55.09 Favored 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -149.31 -56.88 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.786 1.175 . . . . 0.0 111.509 -176.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.49 -44.52 0.98 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -81.98 161.52 60.3 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.02 159.52 52.9 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 122.202 1.822 . . . . 0.0 115.356 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 159.25 35.71 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.993 1.795 . . . . 0.0 114.621 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.6 p -71.09 147.92 48.0 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.665 -0.647 . . . . 0.0 111.548 165.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -62.36 -28.63 69.89 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 175.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.18 93.09 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 160.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.85 -39.98 95.48 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 166.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.5 mt -56.59 -46.14 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.271 0 CA-C-N 120.162 1.346 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.88 -54.18 42.76 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 170.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -76.94 -38.4 53.45 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -66.48 -41.89 88.31 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.09 -20.09 42.26 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 48.68 2.77 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 178.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -100.37 100.32 11.08 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 117.758 0.779 . . . . 0.0 109.872 177.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 62.09 7.27 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 122.449 1.119 . . . . 0.0 112.88 174.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -177.82 119.08 0.25 Allowed Pre-proline 0 CA--C 1.577 2.018 0 C-N-CA 125.381 1.472 . . . . 0.0 107.849 -175.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.78 -27.15 52.18 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 N-CA-C 118.631 2.512 . . . . 0.0 118.631 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.27 -47.71 72.8 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 167.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.87 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -169.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.72 70.86 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -20.55 62.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.07 2.619 . . . . 0.0 118.07 171.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -70.87 -41.42 71.4 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 173.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -61.34 -34.49 75.37 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 162.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.08 -45.68 86.74 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.785 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.12 78.85 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 166.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.4 -39.18 91.87 Favored 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.63 98.39 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 164.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -61.55 -34.89 76.34 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 169.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -30.13 65.95 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 162.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.2 29.34 8.01 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.029 1.972 . . . . 0.0 118.029 -177.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.252 6.5 p -108.52 -38.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.6 pt -123.03 138.63 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 123.788 0.835 . . . . 0.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.62 113.72 27.34 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.41 0.624 . . . . 0.0 109.796 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.88 127.21 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.215 0.606 . . . . 0.0 109.501 -172.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.7 115.77 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 O-C-N 121.726 -0.609 . . . . 0.0 109.75 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.8 p -76.28 86.18 3.08 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 -68.66 0.33 Allowed Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.69 -172.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.52 112.31 11.72 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.509 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.8 m -70.0 -21.55 63.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 178.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -91.79 83.67 5.3 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 119.802 1.183 . . . . 0.0 108.649 152.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.99 64.65 0.26 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -172.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.9 101.58 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -84.25 113.32 21.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.282 -0.886 . . . . 0.0 110.893 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.3 tp -80.68 83.2 6.51 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.674 0.75 . . . . 0.0 111.615 172.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 1.5 pp -80.31 -21.18 42.83 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -115.91 121.64 42.92 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -87.61 82.02 7.55 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-O 121.916 0.865 . . . . 0.0 110.983 -176.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 124.852 2.263 . . . . 0.0 111.857 -167.8 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.639 0.733 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.363 55.4 tttm 69.98 -77.84 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.35 90.98 8.62 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.273 1.035 . . . . 0.0 111.084 165.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.21 143.58 26.96 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -169.007 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 159.9 24.14 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -174.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.26 76.55 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 118.288 2.699 . . . . 0.0 118.288 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -71.74 -39.7 69.88 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 172.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.47 -28.87 69.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 165.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.49 -40.34 96.37 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 162.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -59.19 -44.75 92.22 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 164.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.23 -48.47 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 164.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.19 -40.69 96.61 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 175.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.26 -42.81 78.03 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 167.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.16 -34.18 77.45 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 166.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.24 -55.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 120.725 1.602 . . . . 0.0 113.564 166.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.91 -41.88 88.29 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.5 -52.99 62.85 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 167.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -68.28 -35.36 77.73 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.04 1.291 . . . . 0.0 112.826 166.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -67.73 -32.98 73.98 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 170.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -75.83 -40.1 55.5 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 172.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -124.44 -49.28 1.79 Allowed 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -174.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.68 -44.62 1.12 Allowed Glycine 0 CA--C 1.545 1.916 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -175.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -90.84 142.06 27.3 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -168.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.17 117.51 4.37 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.981 2.454 . . . . 0.0 116.754 172.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.68 119.25 5.38 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 CA-C-N 122.683 1.994 . . . . 0.0 114.931 -176.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 p -115.8 98.56 6.74 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.555 0.693 . . . . 0.0 110.225 -177.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.391 0.5 OUTLIER 65.09 -50.7 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.687 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.32 -47.11 79.38 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -176.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.71 -38.29 23.56 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 165.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.01 -57.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.08 77.11 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -80.95 -49.83 10.48 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -78.57 -31.74 47.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.9 mt -84.47 -18.95 34.23 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 167.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.44 72.9 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.078 1.308 . . . . 0.0 115.617 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.13 134.6 40.25 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 121.985 0.898 . . . . 0.0 112.934 -176.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -14.39 45.58 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 119.732 3.234 . . . . 0.0 119.732 170.367 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.6 m -157.05 143.71 13.33 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 119.716 1.143 . . . . 0.0 112.185 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.05 -43.98 34.38 Favored 'Trans proline' 0 N--CA 1.512 2.598 0 C-N-CA 122.927 2.418 . . . . 0.0 117.724 165.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.36 -32.83 73.68 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 172.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.11 82.25 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 169.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.86 78.77 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 167.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -57.99 -48.38 80.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 172.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -53.45 -48.61 68.66 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -61.63 -39.93 93.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 170.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.37 -42.11 77.29 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 164.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -67.95 -47.56 68.33 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.21 87.73 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 167.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 tp -64.13 -48.25 76.81 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.79 -38.72 70.31 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 166.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -55.84 -32.38 63.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 166.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -66.36 -16.25 63.92 Favored 'General case' 0 CA--C 1.586 2.33 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 165.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.17 69.05 1.18 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.537 1.062 . . . . 0.0 114.921 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.84 -29.47 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -171.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 145.48 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 121.135 1.789 . . . . 0.0 112.641 -177.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.81 113.0 23.89 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 121.819 -0.551 . . . . 0.0 110.216 170.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.94 134.46 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.08 145.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.472 0.653 . . . . 0.0 112.113 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.4 p -75.11 89.48 2.48 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.8 -82.14 0.2 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 -173.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.55 95.6 1.84 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.785 0.802 . . . . 0.0 112.035 170.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -77.97 14.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.8 mtm-85 -82.12 -70.52 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 111.778 156.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.94 -147.05 18.17 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.25 -58.86 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.685 -0.758 . . . . 0.0 111.546 -176.152 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -154.55 169.41 23.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -163.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.31 122.74 27.82 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.082 0.553 . . . . 0.0 110.849 165.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -101.25 113.28 26.2 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.429 16.2 pt20 63.25 -15.32 0.07 Allowed 'General case' 0 N--CA 1.502 2.147 1 N-CA-C 122.261 4.171 . . . . 0.0 122.261 171.632 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.335 17.1 tt0 73.64 -38.48 0.41 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 -177.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 124.375 2.036 . . . . 0.0 110.045 173.571 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.56 1.35 0 CA-C-O 121.396 0.617 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -81.6 135.25 35.56 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.74 -0.6 . . . . 0.0 111.845 172.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.17 77.33 2.99 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.9 mt 65.87 145.96 0.03 OUTLIER 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -172.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -74.49 163.38 27.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.807 -1.183 . . . . 0.0 113.054 170.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.76 67.8 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.735 2.865 . . . . 0.0 118.735 -177.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -71.27 -38.0 71.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 167.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.63 -47.77 84.28 Favored 'General case' 0 CA--C 1.587 2.386 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.93 -38.3 90.52 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.267 10.8 pt-20 -62.59 -37.17 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 163.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.55 -49.07 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 119.798 1.181 . . . . 0.0 113.364 163.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -57.99 -49.22 77.58 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 171.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.95 -34.8 66.0 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 171.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.15 -49.15 62.87 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 170.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.293 7.0 tt -59.71 -42.49 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 168.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -56.22 -51.71 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 166.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.92 -52.26 66.51 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -63.49 -42.13 98.55 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.76 -47.26 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.581 1.082 . . . . 0.0 112.78 170.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 t -63.81 -30.34 71.44 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -92.76 -40.21 10.8 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -114.86 -26.16 7.91 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.85 -27.58 11.82 Favored Glycine 0 CA--C 1.547 2.035 0 N-CA-C 118.714 2.246 . . . . 0.0 118.714 -174.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 51.6 mtm -106.48 119.6 51.23 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 119.309 1.554 . . . . 0.0 114.456 -156.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -58.87 116.97 3.63 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 N-CA-C 119.743 2.939 . . . . 0.0 119.743 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.61 127.55 16.56 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.56 2.173 . . . . 0.0 114.647 170.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -90.88 -74.15 0.51 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -142.07 -37.52 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.78 56.41 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -60.48 -41.91 95.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.86 -49.06 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 169.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.54 95.25 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 170.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.66 -44.12 87.27 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -74.11 -49.19 24.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 177.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.9 -12.25 36.71 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.46 54.15 2.61 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 178.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -100.92 110.17 22.19 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -53.71 -33.91 57.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 -177.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -112.51 135.94 21.49 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.415 163.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.94 -31.1 26.02 Favored 'Trans proline' 0 N--CA 1.509 2.409 0 N-CA-C 118.826 2.587 . . . . 0.0 118.826 165.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -55.99 -33.12 64.55 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 167.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -44.48 79.99 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -47.56 81.21 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 165.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.05 -44.37 74.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.163 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.56 -36.15 82.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 173.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -62.61 -44.44 96.29 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 tt -53.13 -46.12 68.66 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 120.903 1.683 . . . . 0.0 115.478 167.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.65 -47.88 81.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.36 83.64 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.96 -52.44 60.65 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 163.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.95 93.32 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 tpt85 -62.71 -38.49 90.66 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.936 2.198 . . . . 0.0 116.936 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.0 -46.27 82.12 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 166.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.27 39.29 0.45 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.41 -16.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.059 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.174 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -135.87 131.1 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 CA-C-N 119.267 0.939 . . . . 0.0 110.381 177.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.64 119.21 33.74 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.99 102.91 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.819 0 CA-C-O 121.527 0.68 . . . . 0.0 109.365 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.09 94.62 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.0 m -84.94 100.36 11.57 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.872 0.844 . . . . 0.0 112.969 -160.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.32 -62.59 0.17 Allowed Glycine 0 N--CA 1.484 1.854 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.632 -172.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 142.09 35.04 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 168.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.7 m -57.83 -43.66 85.93 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -99.62 78.88 2.2 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 163.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.64 87.14 0.37 Allowed Glycine 0 N--CA 1.486 2.02 0 CA-C-N 116.266 -0.425 . . . . 0.0 113.348 -174.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -146.86 129.5 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -175.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -114.01 156.41 24.12 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.984 0.897 . . . . 0.0 112.867 170.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.8 mt -101.49 123.87 46.24 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -162.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -99.43 105.88 17.87 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 163.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -71.7 96.71 1.63 Allowed 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -158.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -84.12 80.4 9.2 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.851 167.17 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 124.871 2.272 . . . . 0.0 112.039 -171.426 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.564 1.497 0 CA-C-O 121.404 0.621 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -93.75 170.74 9.34 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.26 96.15 9.41 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 120.842 -1.161 . . . . 0.0 113.728 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.71 123.7 47.5 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 121.572 0.701 . . . . 0.0 111.673 -174.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -75.08 162.78 28.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.568 -0.708 . . . . 0.0 112.895 168.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.08 -55.22 10.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -169.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -67.96 -30.07 69.27 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -63.39 -42.29 98.79 Favored 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 164.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -58.91 -47.11 86.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 167.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -51.54 -50.61 59.69 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 165.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.85 -50.82 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.79 -51.68 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 170.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -59.73 -33.84 72.15 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.55 -51.0 69.11 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 164.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.1 mt -55.59 -52.27 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 172.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -48.44 -50.01 32.9 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 168.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.44 -44.92 93.15 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -62.75 -41.02 99.01 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.12 -43.15 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.405 1.002 . . . . 0.0 113.593 167.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 t -55.17 -45.92 75.74 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.55 -41.45 10.24 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -96.8 -33.58 11.62 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.98 -39.16 3.01 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.7 ptp -94.78 150.56 38.08 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -169.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.09 120.82 6.2 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.278 1.985 . . . . 0.0 113.626 169.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.16 156.31 42.29 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.607 1.967 . . . . 0.0 116.856 -172.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 t -89.59 176.94 6.68 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.723 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -47.95 -44.59 30.35 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.328 3.085 . . . . 0.0 119.328 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.24 83.83 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -61.0 -48.04 83.68 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.123 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.7 -45.19 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 170.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.64 75.74 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 173.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -41.38 67.14 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp85 -81.13 -26.71 35.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -178.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.08 -51.94 6.3 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-N 120.614 1.552 . . . . 0.0 114.877 165.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.76 75.14 0.4 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.479 0.581 . . . . 0.0 113.86 -170.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -118.31 133.53 55.81 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 123.608 0.763 . . . . 0.0 109.537 172.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -42.76 95.56 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 163.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.9 m -109.62 113.31 58.02 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.293 -175.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.91 -36.73 64.96 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 N-CA-C 118.568 2.488 . . . . 0.0 118.568 169.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -66.76 -25.85 66.69 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 171.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.49 85.2 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.76 -39.69 78.01 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 163.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -61.27 -53.23 59.5 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 168.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.66 -41.03 94.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 176.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -61.45 -44.64 96.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 165.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.8 tp -48.1 -51.39 24.76 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 121.22 1.827 . . . . 0.0 115.87 166.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -62.88 -52.12 64.32 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 172.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.61 81.15 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.27 -54.68 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 165.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.53 52.4 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 175.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.99 9.33 19.86 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -177.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.42 -47.36 82.25 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 120.742 -1.224 . . . . 0.0 113.464 144.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.14 60.7 0.04 OUTLIER Glycine 0 N--CA 1.48 1.576 0 C-N-CA 123.932 0.777 . . . . 0.0 114.068 174.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.77 -43.37 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.86 150.7 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.064 0.847 . . . . 0.0 110.989 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -96.77 117.91 32.07 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.211 0.605 . . . . 0.0 110.779 172.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.55 140.26 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.591 1.186 . . . . 0.0 110.047 176.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.93 134.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.415 172.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 m -72.59 97.03 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.477 -0.765 . . . . 0.0 112.58 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.24 -70.51 0.5 Allowed Glycine 0 N--CA 1.485 1.914 0 CA-C-N 115.547 -0.752 . . . . 0.0 113.004 -167.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 107.23 9.04 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.5 m -72.96 -14.23 61.41 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -82.47 102.82 11.58 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 145.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.45 -114.56 0.11 Allowed Glycine 0 N--CA 1.482 1.714 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -137.89 -65.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -134.48 136.26 43.04 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.099 1.318 . . . . 0.0 112.905 -161.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tt -89.83 119.41 30.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 156.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 1.6 pp -82.36 63.22 6.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -167.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.287 50.3 mm-40 67.21 7.58 5.57 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.3 -23.13 60.23 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 177.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 123.26 1.505 . . . . 0.0 114.991 173.66 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 CA--C 1.564 1.499 0 CA-C-O 121.372 0.606 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 78.06 9.57 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.12 111.61 6.9 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.9 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.92 155.89 20.73 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -72.95 157.74 36.83 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.83 -37.96 69.4 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 172.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -70.8 -33.37 70.65 Favored 'General case' 0 CA--C 1.579 2.077 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -58.33 -42.08 86.0 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 160.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -62.27 -40.78 97.34 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -51.27 -54.07 29.42 Favored 'General case' 0 CA--C 1.584 2.285 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 162.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.81 -49.39 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -55.36 -39.83 70.56 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 169.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.0 -45.88 76.21 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 171.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.72 -37.01 76.37 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 121.962 2.165 . . . . 0.0 116.569 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.291 0.2 OUTLIER -57.54 -48.83 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-N 120.376 1.444 . . . . 0.0 114.4 169.969 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.65 -47.98 83.82 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 166.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.49 -44.88 96.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -57.48 -39.61 76.8 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 171.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.37 -46.2 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 170.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 t -67.09 -27.37 67.3 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 168.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.11 -46.77 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -124.87 -39.41 2.27 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.02 -27.73 3.28 Favored Glycine 0 CA--C 1.548 2.101 0 N-CA-C 117.442 1.737 . . . . 0.0 117.442 -173.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.72 149.11 35.43 Favored Pre-proline 0 CA--C 1.579 2.078 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -164.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.39 113.91 1.76 Allowed 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 122.481 2.121 . . . . 0.0 114.241 172.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.05 160.43 23.8 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -168.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -105.99 -174.38 2.52 Favored 'General case' 0 CA--C 1.587 2.38 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.557 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -46.44 -30.33 2.12 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 120.16 3.393 . . . . 0.0 120.16 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.48 69.93 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 170.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.38 -46.87 8.1 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 163.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.29 -45.08 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 120.254 1.388 . . . . 0.0 114.311 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.65 69.58 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 171.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -74.11 -52.0 13.94 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -71.2 -37.4 72.11 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.0 mt -78.44 -8.95 59.07 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.84 51.99 4.04 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 117.46 1.744 . . . . 0.0 117.46 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.33 99.73 12.7 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 118.014 0.907 . . . . 0.0 111.265 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -60.01 -20.24 56.76 Favored 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 165.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.1 p -111.89 92.92 18.97 Favored Pre-proline 0 CA--C 1.572 1.792 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.597 162.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -55.94 -32.42 85.54 Favored 'Trans proline' 0 N--CA 1.512 2.562 0 N-CA-C 120.149 3.096 . . . . 0.0 120.149 -175.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -57.4 -34.64 69.1 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 170.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.32 63.18 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 172.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.96 -56.6 13.19 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.74 -18.68 37.03 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 -40.18 88.11 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.161 1.8 . . . . 0.0 115.005 165.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -61.67 -38.01 86.19 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 162.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.33 -41.48 80.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -61.44 -44.48 97.04 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 169.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.45 75.07 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 163.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.74 -41.01 97.09 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 167.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.97 -47.07 81.87 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 164.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -53.91 -45.79 71.27 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 170.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -66.7 -33.61 76.03 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 170.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.32 63.81 0.67 Allowed Glycine 0 N--CA 1.483 1.783 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -33.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.49 153.04 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-O 121.987 0.899 . . . . 0.0 111.338 169.134 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -105.28 104.23 13.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 110.514 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.93 110.77 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 O-C-N 121.483 -0.761 . . . . 0.0 109.018 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -94.39 138.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.474 0.71 . . . . 0.0 109.314 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.7 t -78.49 78.16 4.96 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 175.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.53 99.2 0.18 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.188 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 63.26 19.03 11.43 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 119.779 3.251 . . . . 0.0 119.779 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.371 51.9 p 71.97 -58.53 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -84.06 77.35 9.95 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 122.492 1.139 . . . . 0.0 111.914 172.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.42 77.39 0.26 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.261 174.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.48 115.61 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.61 ' HE ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.42 170.7 9.18 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.61 ' H ' ' HE ' ' A' ' 67' ' ' ARG . 10.1 mp -95.14 133.4 39.01 Favored 'General case' 0 CA--C 1.571 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 112.114 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.43 104.35 10.26 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-O 121.809 0.814 . . . . 0.0 109.243 174.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -75.94 84.37 2.86 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.851 0.834 . . . . 0.0 113.154 173.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -137.14 -72.06 0.44 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.039 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 125.38 2.514 . . . . 0.0 111.946 177.698 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 CA--C 1.566 1.576 0 CA-C-O 121.306 0.574 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -146.76 84.15 1.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.486 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . 0.356 . . 70.44 -65.2 0.34 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -165.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 164.83 21.44 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 160.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.7 p -81.64 158.79 24.18 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.44 -40.13 71.17 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 174.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -64.52 -37.82 88.88 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -58.5 -45.56 88.5 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -64.85 -38.81 92.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 171.401 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -51.44 -48.4 62.74 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 161.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.3 t -59.77 -47.76 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.81 -44.41 86.34 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 170.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 170.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 -44.72 69.15 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.083 1.765 . . . . 0.0 114.994 175.869 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.316 0.2 OUTLIER -56.04 -47.78 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.634 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 167.234 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -54.15 -53.14 57.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 167.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.51 -46.28 90.66 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 178.486 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -70.06 -34.83 73.71 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.06 -49.96 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 120.0 1.273 . . . . 0.0 113.412 161.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 t -68.38 -32.34 72.34 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 176.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -90.59 -48.66 6.94 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 m -102.39 -38.52 7.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.19 32.3 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 118.156 2.023 . . . . 0.0 118.156 -169.287 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 mtm -97.03 144.14 27.34 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-N 119.548 1.674 . . . . 0.0 113.732 -174.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.03 114.4 2.87 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 C-N-CA 122.418 2.078 . . . . 0.0 113.68 174.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.54 124.57 7.09 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 CA-C-N 122.492 1.926 . . . . 0.0 115.035 -175.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 p -90.43 179.39 5.88 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -31.4 -45.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 121.596 3.924 . . . . 0.0 121.596 -178.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.53 -44.48 78.24 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 175.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -71.44 -44.16 65.36 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 172.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -50.91 -46.92 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.24 97.64 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 169.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -64.27 -46.88 81.77 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.01 -43.07 30.54 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.94 -21.2 26.4 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 51.43 2.05 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 178.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -101.82 102.25 12.83 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.103 0.951 . . . . 0.0 108.906 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -55.31 -37.8 67.85 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 179.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.8 m -104.17 116.01 62.14 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.393 164.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -53.07 -17.97 8.97 Favored 'Trans proline' 0 N--CA 1.51 2.463 0 N-CA-C 120.577 3.26 . . . . 0.0 120.577 173.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.85 -28.15 69.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 165.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -38.13 89.95 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.72 94.76 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 163.423 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -55.56 -46.68 77.15 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 165.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.63 -49.53 72.6 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 174.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -70.21 -32.87 70.96 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.5 -54.85 41.03 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.503 1.956 . . . . 0.0 114.448 165.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.82 -44.04 94.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.49 94.71 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.03 -38.47 88.82 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.01 82.22 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 165.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -68.08 -27.14 66.24 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 173.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.93 -34.88 73.82 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 160.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.94 -37.09 1.11 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 173.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.57 4.81 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -156.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.82 144.94 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 CA-C-N 120.246 1.385 . . . . 0.0 113.192 167.572 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -105.58 113.61 27.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.53 116.9 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.08 107.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 122.187 0.994 . . . . 0.0 112.667 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -84.46 94.78 8.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.011 0.91 . . . . 0.0 111.978 -170.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.51 -77.1 0.28 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.784 -167.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.6 -20.13 65.32 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 174.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.33 18.8 m 77.65 -70.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 171.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -84.75 72.65 10.71 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 123.114 1.435 . . . . 0.0 113.331 175.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.88 71.27 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.766 165.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.47 115.22 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -170.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -81.61 146.83 29.89 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.75 104.96 17.35 Favored 'General case' 0 CA--C 1.573 1.833 0 O-C-N 121.972 -0.455 . . . . 0.0 110.064 168.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -93.39 88.85 6.11 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.732 0.777 . . . . 0.0 110.573 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.255 2.9 mp0 78.73 125.86 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 124.537 1.135 . . . . 0.0 113.109 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -95.61 169.45 10.02 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 122.251 1.024 . . . . 0.0 113.074 -177.14 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.574 1.867 0 CA-C-O 124.345 2.021 . . . . 0.0 114.122 -168.669 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.561 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -143.29 83.76 1.79 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.811 0.815 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.0 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.073 -1.017 . . . . 0.0 109.58 164.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.87 139.27 51.21 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -153.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.9 p -75.07 159.1 32.11 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.17 -45.02 64.94 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.892 2.923 . . . . 0.0 118.892 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -69.07 -38.77 79.21 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 174.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 5.5 pt20 -70.31 -29.95 66.81 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 167.14 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -56.86 -47.76 79.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.99 -43.51 81.77 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.0 t -58.28 -48.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 168.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.51 -48.37 69.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 166.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.64 -37.42 73.3 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 170.268 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.43 -44.46 94.51 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 172.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.324 0.0 OUTLIER -61.98 -45.55 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 166.156 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -57.0 -46.89 81.97 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.85 -53.67 55.81 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 171.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -67.87 -36.55 80.48 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.32 -48.33 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-N 119.972 1.26 . . . . 0.0 112.563 167.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -63.23 -30.45 71.59 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 174.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -93.2 -42.92 9.1 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -107.98 -19.14 13.61 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.78 -48.39 1.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -173.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 149.86 43.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -62.14 148.05 93.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.412 2.075 . . . . 0.0 116.514 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.07 147.57 21.05 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.247 1.965 . . . . 0.0 115.243 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 p -75.23 165.33 25.36 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-O 122.492 1.139 . . . . 0.0 113.933 176.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -52.03 -43.74 63.86 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 176.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.04 80.4 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 169.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.45 -49.5 77.32 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 120.294 1.406 . . . . 0.0 114.598 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.67 -44.7 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 171.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.02 -52.44 16.95 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.095 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -89.73 -37.32 14.63 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -167.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -64.24 -37.74 88.55 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.516 1.672 . . . . 0.0 115.516 172.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.97 -9.69 59.71 Favored 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 170.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.99 54.74 4.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 117.489 1.755 . . . . 0.0 117.489 178.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -96.65 135.83 38.03 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 121.78 0.8 . . . . 0.0 111.777 176.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -40.57 92.08 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 175.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.1 t -119.49 125.57 27.44 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.267 171.221 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.42 -36.7 49.25 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 N-CA-C 118.673 2.528 . . . . 0.0 118.673 165.237 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.22 -36.0 72.51 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 169.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.05 73.71 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 165.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.55 -48.86 71.52 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 172.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -33.05 72.56 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 165.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -60.78 -40.84 94.1 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 164.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.84 -49.44 73.29 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 164.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.1 -46.92 86.9 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 174.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.48 80.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 171.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.44 -46.87 53.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 169.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.82 76.73 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 172.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -55.56 -26.93 46.15 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 169.532 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -71.17 -50.95 27.82 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 170.307 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 165.0 -43.23 0.29 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 119.025 2.37 . . . . 0.0 119.025 -177.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.12 -35.1 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -168.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.5 155.81 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 C-N-CA 123.755 0.822 . . . . 0.0 110.688 172.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -112.06 145.6 39.44 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 112.221 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.96 151.1 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.187 0.994 . . . . 0.0 111.839 177.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.1 m -59.81 139.64 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -167.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 t -81.7 72.48 8.75 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 121.538 0.685 . . . . 0.0 112.759 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 -73.55 2.45 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -176.54 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.41 138.5 39.32 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 m -55.7 -34.39 65.04 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.573 3.175 . . . . 0.0 119.573 -174.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -89.2 69.06 8.24 Favored 'General case' 0 CA--C 1.581 2.166 0 CA-C-N 119.895 1.225 . . . . 0.0 112.369 172.001 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.59 43.13 0.85 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -179.05 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.4 mt -102.1 103.58 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -176.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.86 129.32 35.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -175.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -90.98 69.84 6.33 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.654 0.782 . . . . 0.0 112.428 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.33 1.8 pp -74.97 -23.87 58.36 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 120.186 3.402 . . . . 0.0 120.186 -167.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.49 -60.85 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.289 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -90.62 63.45 5.45 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.658 0.742 . . . . 0.0 112.491 178.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 123.881 1.801 . . . . 0.0 114.928 -165.476 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 mtp . . . . . 0 CA--C 1.567 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.411 32.6 mmtp 75.17 -106.78 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 124.446 1.099 . . . . 0.0 113.88 -178.646 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.64 103.18 6.94 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 118.919 0.781 . . . . 0.0 111.928 -174.156 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.26 121.23 40.59 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.001 0.52 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.6 p -64.04 154.32 34.66 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.85 46.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -63.41 -56.11 18.92 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 169.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.36 -33.73 76.17 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 174.115 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -58.06 -49.53 76.59 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 170.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.82 -27.13 66.45 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.65 -56.3 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 119.866 1.212 . . . . 0.0 112.764 160.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.43 -50.71 70.85 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 172.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.49 -44.4 96.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 tp -56.99 -37.83 72.18 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.058 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.4 -49.46 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.714 1.143 . . . . 0.0 113.119 169.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -56.88 -48.47 78.08 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.3 -53.02 62.65 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -74.18 -34.8 63.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -176.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -60.7 -42.95 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.575 0 CA-C-N 120.159 1.345 . . . . 0.0 112.637 163.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.61 -49.63 57.74 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -78.03 -15.7 58.71 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -143.21 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 112.469 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.93 -26.53 5.05 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 118.114 2.006 . . . . 0.0 118.114 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -97.54 152.04 37.96 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.66 121.31 6.62 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 C-N-CA 121.945 1.763 . . . . 0.0 114.6 -176.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.29 106.69 2.27 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.437 2.092 . . . . 0.0 112.325 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.305 7.3 t -84.96 -169.15 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -173.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -55.53 -39.37 70.46 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -168.063 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.57 86.37 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 168.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -60.03 -46.21 90.28 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 170.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.57 -58.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 123.909 0.884 . . . . 0.0 113.243 172.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.71 85.28 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -75.37 -32.85 60.95 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 171.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -53.22 18.53 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 171.776 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.72 -26.15 20.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -178.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.0 52.97 0.81 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -95.34 107.46 19.58 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 118.185 0.993 . . . . 0.0 110.053 170.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.48 53.53 2.69 Favored 'General case' 0 CA--C 1.584 2.262 0 O-C-N 121.29 -0.881 . . . . 0.0 113.078 169.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -178.32 111.32 0.22 Allowed Pre-proline 0 CA--C 1.577 2.015 0 C-N-CA 124.852 1.261 . . . . 0.0 109.158 -174.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.57 -38.7 75.87 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 N-CA-C 118.417 2.429 . . . . 0.0 118.417 169.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.88 -33.68 73.47 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 171.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -50.63 68.93 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.52 -48.83 76.4 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 170.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -43.48 92.73 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 171.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.86 -38.19 88.18 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 174.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -69.84 -35.65 74.92 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 168.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.45 -50.67 64.78 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.484 1.493 . . . . 0.0 114.659 160.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -51.6 -45.05 63.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 167.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.0 -39.09 65.75 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 169.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.98 -45.95 72.71 Favored 'General case' 0 CA--C 1.583 2.231 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 167.353 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.98 86.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 170.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -66.06 -37.75 86.6 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.42 -41.8 93.2 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 161.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 48.56 0.21 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 166.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.53 -35.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 pt -107.98 144.05 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 120.962 1.71 . . . . 0.0 113.412 -179.576 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.21 115.35 27.29 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 172.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.35 122.93 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.5 116.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 167.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -94.88 91.53 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.976 176.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.04 -63.14 0.49 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 114.818 0.687 . . . . 0.0 114.818 -174.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.14 164.9 25.24 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 174.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -76.52 -67.06 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 177.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -89.54 78.85 6.99 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 122.795 1.283 . . . . 0.0 113.544 -169.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.22 66.34 0.31 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.246 171.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.5 mm -130.7 96.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.64 137.19 26.48 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -164.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 mt -76.19 136.31 39.75 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.82 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -78.61 85.54 4.65 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 121.777 0.799 . . . . 0.0 110.057 174.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.299 4.2 tp60 75.48 124.83 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.059 -156.029 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -82.92 67.28 8.93 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-O 121.932 0.872 . . . . 0.0 113.334 -175.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 123.446 1.593 . . . . 0.0 110.267 -173.436 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 CA--C 1.568 1.664 0 CA-C-O 121.866 0.841 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -71.75 147.99 46.78 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.765 -0.585 . . . . 0.0 111.841 167.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.99 -39.77 56.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -66.97 -46.71 73.8 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -54.61 -45.96 73.75 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 164.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -58.99 -41.93 88.79 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.72 -40.0 95.67 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 165.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.93 -44.39 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 120.259 1.391 . . . . 0.0 113.7 167.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -54.2 -47.91 71.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.33 -39.28 86.51 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD21 ' HE ' ' A' ' 34' ' ' ARG . 36.5 mt -57.63 -29.84 64.87 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm -58.89 -50.8 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.267 0 CA-C-N 120.036 1.289 . . . . 0.0 113.027 164.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -65.05 -46.06 82.83 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.36 -42.25 96.29 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -36.03 81.73 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.187 1.812 . . . . 0.0 115.301 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.91 -53.45 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 164.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -72.68 -37.24 67.96 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -92.38 1.13 57.41 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.2 m -150.07 -57.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.024 1.284 . . . . 0.0 111.218 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.57 -29.83 2.55 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -105.19 145.3 30.5 Favored Pre-proline 0 CA--C 1.569 1.707 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.39 146.89 22.37 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-N 122.421 1.9 . . . . 0.0 114.26 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 146.64 13.95 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.211 1.825 . . . . 0.0 116.535 -161.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.8 p -73.7 161.81 29.86 Favored 'General case' 0 CA--C 1.577 2.014 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.321 165.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -34.41 67.79 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.17 83.13 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 163.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.68 -40.77 79.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 169.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.13 -47.2 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.309 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 162.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.6 -35.7 72.85 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.72 -42.89 81.24 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HE ' HD21 ' A' ' 14' ' ' LEU . 2.5 tmm_? -77.64 -55.34 5.43 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.275 1.398 . . . . 0.0 113.893 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.0 -20.67 60.26 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.24 58.97 2.49 Favored Glycine 0 N--CA 1.48 1.628 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -95.78 126.88 41.35 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -54.08 -28.24 37.83 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.071 2.989 . . . . 0.0 119.071 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.9 m -155.97 158.15 31.57 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 123.852 0.861 . . . . 0.0 111.335 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -46.36 -31.54 9.61 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 N-CA-C 120.375 3.183 . . . . 0.0 120.375 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -54.33 -34.42 61.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.732 2.864 . . . . 0.0 118.732 166.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.44 -40.79 42.13 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.44 84.61 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.87 -34.8 72.02 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.44 -43.58 88.81 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -70.34 -41.96 72.51 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 169.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.24 -50.67 58.72 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -67.73 -37.73 82.61 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.15 89.57 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -57.09 -44.22 82.94 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 163.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.91 96.24 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.64 -40.03 82.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.72 -22.34 65.28 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.71 17.69 37.67 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.34 -21.45 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.2 pt -139.48 143.94 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.165 0 CA-C-N 120.511 1.505 . . . . 0.0 111.9 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.82 111.01 21.87 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 124.811 1.245 . . . . 0.0 109.269 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.36 128.88 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.68 133.45 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -85.18 86.51 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.862 . . . . 0.0 112.146 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.23 -72.61 0.24 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.62 120.83 25.57 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.7 t -59.52 -35.7 74.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -97.89 84.28 3.3 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.163 0.892 . . . . 0.0 110.337 167.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.19 85.03 0.13 Allowed Glycine 0 N--CA 1.482 1.738 0 O-C-N 121.919 -0.488 . . . . 0.0 112.908 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.06 109.77 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -95.21 126.36 40.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.217 0.607 . . . . 0.0 109.751 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.46 125.49 29.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.808 -1.182 . . . . 0.0 113.565 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.574 1.886 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.3 2.1 pt? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.1 p -138.14 143.05 40.15 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 154.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 119.402 3.112 . . . . 0.0 119.402 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -78.31 -25.71 46.68 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.28 6.7 pt20 -70.07 -34.91 73.78 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 121.607 2.003 . . . . 0.0 115.807 160.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -57.4 -41.77 80.97 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 162.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -54.84 -45.96 74.57 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.58 -48.2 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.39 -48.4 81.79 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.58 -37.7 73.63 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.33 -42.28 96.36 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 164.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.2 mt -57.76 -46.03 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.938 1.699 . . . . 0.0 113.483 170.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -62.36 -49.24 76.35 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.64 -56.87 12.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -58.88 -40.29 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -44.07 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 167.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -70.67 -24.03 62.61 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 118.691 2.849 . . . . 0.0 118.691 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.53 -47.33 3.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.573 1.149 . . . . 0.0 113.481 -167.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -85.59 -43.52 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.95 -39.87 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -96.22 151.13 37.97 Favored Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.96 124.04 9.79 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 122.185 1.816 . . . . 0.0 113.427 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.9 114.48 3.84 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.182 1.921 . . . . 0.0 115.607 -167.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 t -83.59 -172.73 4.31 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -33.2 -58.19 0.39 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.76 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.52 -40.32 89.1 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 172.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.8 mm -60.59 -52.11 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 119.922 1.237 . . . . 0.0 113.349 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.42 -48.68 66.59 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -72.74 -44.33 61.79 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.1 mt -86.67 -9.64 55.55 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.541 2.422 . . . . 0.0 117.541 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.39 61.04 3.08 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.63 103.37 16.08 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.862 0.839 . . . . 0.0 111.435 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -9.75 57.55 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 161.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -107.25 109.5 62.85 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 117.496 -1.24 . . . . 0.0 110.725 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.73 -44.55 40.28 Favored 'Trans proline' 0 N--CA 1.509 2.422 0 N-CA-C 120.159 3.1 . . . . 0.0 120.159 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.01 -42.99 83.99 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.71 -47.45 73.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.5 -37.98 20.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.55 -35.54 80.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -60.13 -38.42 83.02 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 163.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.58 -45.81 92.57 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.06 -41.4 83.26 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.09 94.76 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 mt -57.68 -41.95 82.63 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 167.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.67 91.01 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 166.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -58.6 -40.97 84.72 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -71.89 -15.96 62.12 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.58 3.86 55.02 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.13 -17.8 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -130.79 129.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.052 1.297 . . . . 0.0 110.813 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -90.68 115.94 28.16 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.247 -0.908 . . . . 0.0 109.916 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.02 132.23 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.68 118.9 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.677 -0.639 . . . . 0.0 109.376 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.4 t -77.53 69.96 3.85 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.86 39.63 0.07 OUTLIER Glycine 0 CA--C 1.548 2.096 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.99 125.28 5.63 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.675 1.238 . . . . 0.0 110.231 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 m -59.53 -47.02 87.14 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -109.61 89.11 2.91 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.62 85.49 0.19 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 116.394 -0.366 . . . . 0.0 113.779 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.24 114.56 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.946 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -96.09 117.28 30.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.213 0.605 . . . . 0.0 110.757 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -74.99 105.17 5.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.571 1.753 0 CA-C-O 122.621 1.201 . . . . 0.0 109.135 171.763 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 98.5 mt . . . . . 0 CA--C 1.568 1.64 0 CA-C-O 121.418 0.628 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -68.45 159.68 31.2 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.05 -45.96 52.69 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -71.08 -39.91 71.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -67.44 -33.98 76.26 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -56.8 -42.92 80.35 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 165.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -53.19 -43.77 67.43 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 164.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.29 -48.5 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -56.64 -47.03 80.62 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.1 -43.24 66.7 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 168.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -39.06 79.89 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.61 -48.49 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 CA-C-N 120.216 1.371 . . . . 0.0 113.457 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.45 -49.44 77.8 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 166.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.37 -49.48 73.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -62.07 -35.68 79.37 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.449 1.931 . . . . 0.0 115.978 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.52 -43.3 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 119.51 1.05 . . . . 0.0 113.029 165.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -64.82 -33.82 76.89 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.55 -47.18 12.44 Favored 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -102.56 -23.97 13.83 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.31 -34.37 4.62 Favored Glycine 0 CA--C 1.552 2.36 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 -159.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.13 154.6 40.55 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.82 152.3 63.73 Favored 'Trans proline' 0 CA--C 1.567 2.129 0 C-N-CA 122.056 1.837 . . . . 0.0 114.929 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.49 144.65 10.29 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.294 1.855 . . . . 0.0 115.094 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 58.6 p -76.47 161.33 28.73 Favored 'General case' 0 CA--C 1.577 2.011 0 O-C-N 121.877 -0.514 . . . . 0.0 112.285 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -50.69 -28.54 9.21 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.84 -36.53 80.51 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 163.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -62.02 -45.84 91.81 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 120.586 1.539 . . . . 0.0 114.518 163.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.04 -53.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 CA-C-N 119.799 1.181 . . . . 0.0 112.603 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.5 99.01 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -78.01 -48.21 16.68 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -70.26 -41.87 72.91 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.12 -17.6 27.37 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.74 62.32 1.95 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -90.82 148.2 22.68 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.426 1.108 . . . . 0.0 113.136 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -35.48 73.75 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -144.94 149.76 43.64 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.843 167.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.36 -33.06 21.58 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 N-CA-C 119.393 2.805 . . . . 0.0 119.393 163.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -65.78 -37.1 85.39 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 167.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.6 96.01 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.49 63.88 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 164.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.98 -34.4 76.48 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 171.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.81 -46.62 84.4 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -63.48 -39.32 94.15 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -53.89 -47.34 71.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 166.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -59.45 -35.75 74.64 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.37 -18.79 65.28 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 169.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.71 -46.0 84.18 Favored 'General case' 0 CA--C 1.592 2.594 0 CA-C-N 119.913 1.233 . . . . 0.0 113.668 159.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.05 175.38 4.52 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.296 1.6 mpt_? 75.74 -54.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.245 -0.909 . . . . 0.0 113.157 -173.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -61.6 -56.58 18.33 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 156.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.22 52.28 0.18 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 117.982 1.953 . . . . 0.0 117.982 169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.298 10.2 p -116.04 -20.64 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 168.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.24 155.61 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 122.218 2.281 . . . . 0.0 113.287 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.21 128.08 34.18 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.914 -0.491 . . . . 0.0 111.577 161.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.83 134.23 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.11 116.79 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.738 0.78 . . . . 0.0 111.917 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -85.53 100.85 12.2 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.738 -0.601 . . . . 0.0 112.267 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.42 -64.74 0.58 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.81 30.85 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.8 m -75.84 -38.84 57.64 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -134.33 100.12 4.58 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.612 1.096 . . . . 0.0 112.306 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.98 64.79 0.45 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.809 167.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.7 96.21 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -86.89 133.24 33.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 122.928 0.491 . . . . 0.0 112.103 169.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.47 125.19 28.94 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-O 121.737 0.78 . . . . 0.0 112.56 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 CA--C 1.564 1.518 0 C-N-CA 123.957 0.903 . . . . 0.0 112.679 -171.199 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 CA--C 1.567 1.609 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -66.09 154.89 38.38 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.59 -47.96 28.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -71.11 -41.71 70.23 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.49 -37.19 86.09 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.06 -49.2 77.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 170.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.23 -36.3 79.58 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.47 -50.6 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.465 1.03 . . . . 0.0 113.333 165.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -50.21 -51.68 42.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.55 -39.16 92.74 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.76 -46.27 86.02 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 121.263 1.847 . . . . 0.0 115.043 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.282 36.6 pt -59.06 -46.18 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -54.78 -51.05 66.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 165.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.28 -38.2 90.22 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -72.16 -30.18 64.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.59 -42.3 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.746 1.157 . . . . 0.0 112.908 160.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -64.89 -31.05 72.09 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.3 -43.24 57.59 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 p -125.96 -18.18 5.15 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.29 -43.14 1.95 Allowed Glycine 0 CA--C 1.546 1.978 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 -165.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.05 147.0 32.89 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.15 146.3 88.88 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 N-CA-C 118.886 2.61 . . . . 0.0 118.886 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.45 120.32 3.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.528 2.152 . . . . 0.0 112.58 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -89.21 82.02 6.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 111.624 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.323 23.5 tpt180 66.66 -52.59 0.44 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.07 50.48 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 -167.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.6 -31.17 71.03 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.8 mt -61.21 -53.97 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 CA-C-N 118.941 0.791 . . . . 0.0 112.129 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.88 85.21 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -72.02 -52.11 18.55 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.54 -40.91 28.45 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.63 -24.73 26.98 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.53 81.2 1.33 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 119.411 1.005 . . . . 0.0 114.718 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.72 102.9 8.71 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 117.678 0.739 . . . . 0.0 109.658 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -25.97 61.19 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -98.2 127.13 37.53 Favored Pre-proline 0 CA--C 1.566 1.56 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.327 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.31 -49.27 14.67 Favored 'Trans proline' 0 N--CA 1.508 2.37 0 N-CA-C 119.332 2.782 . . . . 0.0 119.332 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -94.27 75.63 3.97 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.156 0.979 . . . . 0.0 111.444 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.77 -48.61 0.96 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.034 168.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.11 -35.57 80.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.22 -45.87 92.78 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -61.89 -29.21 70.05 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -62.47 -47.42 84.11 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 120.317 1.417 . . . . 0.0 114.301 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.46 -43.31 79.42 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -60.29 -46.14 90.89 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.84 88.73 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 167.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.78 -43.19 94.52 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.13 -46.39 71.01 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -59.72 -40.22 87.28 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -65.11 -30.34 71.27 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 166.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.7 17.21 7.6 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.49 -13.95 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.79 134.55 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 119.863 1.211 . . . . 0.0 111.885 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.19 108.72 19.42 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.164 0.585 . . . . 0.0 110.563 168.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.4 mt -93.38 119.35 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.3 t -83.25 98.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -68.84 98.49 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.92 -55.68 0.68 Allowed Glycine 0 N--CA 1.486 2.009 0 CA-C-N 115.454 -0.794 . . . . 0.0 114.34 -163.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 116.96 23.63 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.6 p -53.68 -41.26 66.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -104.49 41.73 1.29 Allowed 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.62 72.8 0.3 Allowed Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.467 -0.771 . . . . 0.0 112.746 165.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.26 93.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -121.58 133.02 55.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.798 -0.564 . . . . 0.0 111.81 -155.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.92 114.78 11.45 Favored 'General case' 0 CA--C 1.578 2.038 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -165.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 CA--C 1.572 1.798 0 CA-C-O 121.839 0.828 . . . . 0.0 109.171 173.352 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 CA--C 1.559 1.322 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 p -75.88 157.26 33.49 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.54 72.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -71.8 -31.39 66.53 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -69.89 -31.25 68.95 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 161.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -60.62 -43.47 97.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 165.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -55.06 -45.15 75.28 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 165.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.63 -50.23 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.13 -47.74 68.44 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.56 -44.22 89.62 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.48 -37.03 86.12 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.23 -48.62 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 118.05 -0.976 . . . . 0.0 113.208 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -51.23 -46.37 62.26 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -49.24 78.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -71.34 -27.68 63.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mm -51.48 -43.24 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.265 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 158.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -77.09 -35.44 56.52 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.32 -29.47 65.06 Favored 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -146.75 -49.7 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.129 0.971 . . . . 0.0 112.006 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.28 18.37 0.93 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 118.038 1.975 . . . . 0.0 118.038 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptp -155.96 159.18 31.73 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-N 119.652 1.726 . . . . 0.0 113.43 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.83 128.67 31.25 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 122.623 2.216 . . . . 0.0 115.015 160.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 175.18 11.71 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 123.831 2.404 . . . . 0.0 115.55 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.0 p -66.79 154.74 40.06 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -22.61 64.92 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.43 -46.64 69.31 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 160.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.6 -53.21 60.77 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.58 -43.11 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.17 -48.75 78.67 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -79.79 -35.06 39.09 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.68 -39.28 73.61 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 -20.19 21.75 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.95 49.16 2.52 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -105.27 111.36 24.07 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -83.05 56.91 3.66 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 m 171.59 114.17 0.05 OUTLIER Pre-proline 0 CA--C 1.582 2.197 0 C-N-CA 126.148 1.779 . . . . 0.0 107.685 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.7 -33.72 60.95 Favored 'Trans proline' 0 N--CA 1.511 2.523 0 N-CA-C 119.136 2.706 . . . . 0.0 119.136 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -65.95 -33.8 76.64 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.98 96.19 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -52.38 65.05 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 162.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.2 -44.84 68.3 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.73 -38.05 66.65 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -72.61 -31.54 65.24 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 167.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.91 -40.17 87.93 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 121.272 1.851 . . . . 0.0 114.747 159.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -60.32 -51.51 69.22 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-N 120.032 1.287 . . . . 0.0 114.248 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.88 73.26 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 169.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.61 -39.03 81.01 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.76 88.72 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 164.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -65.49 -32.78 74.58 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -60.31 -12.62 9.58 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 157.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.69 13.71 66.77 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.51 -3.1 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -164.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.02 137.73 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 119.861 1.21 . . . . 0.0 110.664 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.1 108.11 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 110.622 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.53 138.38 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.03 135.26 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.847 -0.533 . . . . 0.0 112.222 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.1 t -82.01 77.54 8.81 Favored 'General case' 0 CA--C 1.567 1.629 0 O-C-N 121.61 -0.682 . . . . 0.0 112.594 170.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.05 -72.37 0.1 OUTLIER Glycine 0 N--CA 1.484 1.849 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.567 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.69 135.14 39.08 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -65.24 -11.27 39.31 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -90.74 -87.37 0.19 Allowed 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 120.049 1.295 . . . . 0.0 111.591 173.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.4 36.43 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 121.755 -0.591 . . . . 0.0 114.07 -172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.77 -72.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.132 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -151.2 161.47 42.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -163.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -87.87 121.27 30.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.4 164.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 CA--C 1.573 1.847 0 C-N-CA 123.426 0.69 . . . . 0.0 109.957 -178.67 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.8 p -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.26 -36.04 72.66 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.18 -37.92 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 9.6 pt20 -66.18 -30.34 70.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -53.97 -47.01 71.78 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 162.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.88 -46.54 81.8 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 168.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.34 -48.26 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -54.41 -50.39 67.71 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.39 -34.32 73.74 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.66 -44.44 81.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.338 10.2 tt -61.06 -39.23 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 166.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -55.9 -49.43 73.45 Favored 'General case' 0 CA--C 1.584 2.279 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 163.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.05 -47.71 79.11 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -68.75 -32.83 72.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -55.91 -47.97 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-N 119.509 1.049 . . . . 0.0 113.027 160.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 t -65.88 -33.54 76.08 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.0 -39.52 69.17 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -127.18 -24.81 3.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -167.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -26.75 12.2 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -161.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -105.95 151.34 40.0 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-N 118.656 1.228 . . . . 0.0 114.166 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 66' ' ' ILE . 91.9 Cg_endo -80.55 161.05 22.22 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.471 2.114 . . . . 0.0 115.706 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.79 143.01 11.61 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.876 2.384 . . . . 0.0 115.21 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.0 p -79.32 161.23 26.39 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -52.0 -44.18 63.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.99 90.02 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -63.42 -46.44 86.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.2 mt -57.5 -48.82 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.412 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.19 95.1 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -65.31 -43.41 91.13 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -69.16 -47.79 64.01 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.14 -18.52 28.61 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.84 55.62 1.73 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 116.56 1.384 . . . . 0.0 116.56 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -102.3 106.81 17.67 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 117.696 0.748 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.32 -32.95 71.72 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -106.4 104.91 52.55 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.87 162.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -51.69 -29.23 32.53 Favored 'Trans proline' 0 N--CA 1.509 2.441 0 N-CA-C 120.131 3.089 . . . . 0.0 120.131 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -49.42 -40.03 35.04 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.87 72.28 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 169.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.64 90.66 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -65.31 -35.41 80.92 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 168.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.16 -39.38 94.5 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.372 1.897 . . . . 0.0 115.857 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -60.79 -42.22 97.15 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 163.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.16 -46.44 85.7 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 168.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -61.02 -41.96 97.55 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.82 91.29 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.75 -43.43 90.27 Favored 'General case' 0 CA--C 1.584 2.256 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 165.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.12 80.47 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -60.62 -40.45 91.94 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -64.49 -45.84 85.57 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 168.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.93 60.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.862 0 N-CA-C 116.897 1.519 . . . . 0.0 116.897 163.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.06 -38.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.12 134.25 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.921 1.691 . . . . 0.0 111.42 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.38 99.52 12.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.427 -0.796 . . . . 0.0 111.06 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.68 120.21 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 122.775 0.43 . . . . 0.0 110.444 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.15 128.47 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.8 p -85.78 79.34 9.32 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 121.293 -0.88 . . . . 0.0 112.591 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.09 -65.64 0.32 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 141.73 38.63 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -71.08 107.13 3.99 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.302 82.2 mtt-85 79.01 33.5 0.24 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.32 59.76 0.81 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 164.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' A' ' 25' ' ' PRO . 33.7 mt -117.7 89.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -103.06 135.24 45.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 111.957 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.25 143.63 26.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.677 0.751 . . . . 0.0 112.51 -172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.576 1.951 0 O-C-N 121.141 -0.974 . . . . 0.0 111.565 -179.568 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.523 0.4 OUTLIER . . . . . 0 CA--C 1.571 1.783 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -133.94 157.11 46.84 Favored 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 123.896 0.878 . . . . 0.0 110.449 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 -36.07 67.77 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -69.09 -47.17 65.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.2 -33.33 75.15 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -63.34 -39.18 93.83 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -57.25 -41.56 79.84 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 165.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.54 -47.32 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 163.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -58.12 -45.62 87.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -54.13 -40.97 67.85 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.45 -51.47 68.58 Favored 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 120.761 1.619 . . . . 0.0 115.362 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.15 -43.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -62.19 -44.69 96.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.34 -52.83 60.34 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 166.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -69.26 -36.21 76.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -54.92 -48.63 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 CA-C-N 119.524 1.056 . . . . 0.0 113.658 161.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -69.64 -34.15 73.62 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -98.6 -43.3 6.89 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 m -95.03 -44.65 7.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.48 -29.75 6.26 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 117.875 1.91 . . . . 0.0 117.875 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -100.12 155.4 36.47 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -74.34 123.08 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.381 2.054 . . . . 0.0 114.85 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.05 148.11 19.19 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 CA-C-N 123.017 2.113 . . . . 0.0 113.373 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -71.38 165.49 23.64 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 44' ' ' GLU . 8.9 ptm180 -52.41 -32.16 37.75 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 162.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.1 96.97 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.9 -37.84 86.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 168.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.3 -48.22 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.785 1.175 . . . . 0.0 113.524 166.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.46 96.77 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -62.99 -47.11 84.57 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -78.37 -46.49 19.84 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.1 -22.08 39.43 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.725 2.121 . . . . 0.0 116.725 168.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.57 48.0 4.66 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 117.003 1.561 . . . . 0.0 117.003 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.07 93.38 8.6 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.148 0.974 . . . . 0.0 109.388 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -58.85 -32.91 69.86 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -94.5 106.08 21.81 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.244 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.21 -12.07 34.58 Favored 'Trans proline' 0 N--CA 1.51 2.458 0 N-CA-C 118.712 2.543 . . . . 0.0 118.712 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -58.47 -32.56 68.86 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 159.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.38 93.61 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.2 73.07 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 19.0 tt0 -64.42 -48.24 76.12 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 171.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.72 -39.25 93.32 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -61.88 -42.44 99.07 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 164.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.82 -40.86 85.38 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.22 -51.54 65.84 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.21 -38.79 68.89 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 167.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.74 -43.15 99.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.03 -39.75 95.67 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.9 -34.15 75.52 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.2 -39.82 94.78 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 161.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.37 51.13 0.18 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 117.176 1.631 . . . . 0.0 117.176 164.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 -8.29 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.082 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.06 145.71 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 121.892 2.133 . . . . 0.0 112.703 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.05 112.46 21.89 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.569 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -83.61 105.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 109.605 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.15 123.31 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-O 121.319 0.58 . . . . 0.0 112.046 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.3 t -82.07 73.87 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.62 -83.77 0.13 Allowed Glycine 0 N--CA 1.482 1.745 0 O-C-N 122.068 -0.395 . . . . 0.0 113.53 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.84 89.89 6.37 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 27.5 t -59.12 -11.86 4.25 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -80.39 15.88 1.48 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 165.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.14 43.73 1.62 Allowed Glycine 0 CA--C 1.552 2.364 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 155.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.2 tp -93.03 75.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.158 0.98 . . . . 0.0 111.235 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -91.85 135.51 33.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 112.38 -166.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -93.29 142.67 27.06 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.564 1.494 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.571 1.772 0 CA-C-O 121.22 0.533 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 157.7 29.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.187 -0.946 . . . . 0.0 112.872 168.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.2 50.46 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.15 -38.57 85.72 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -56.57 -47.82 78.69 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -62.83 -41.74 99.45 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.33 -50.59 69.25 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.02 -49.25 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.1 -47.28 85.33 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.84 -33.4 70.39 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -38.72 71.51 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 167.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt -55.4 -56.68 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 123.995 0.918 . . . . 0.0 112.732 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -68.13 -32.2 72.32 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -55.56 -53.06 61.08 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -69.96 -37.63 75.85 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.34 -42.2 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-N 119.91 1.232 . . . . 0.0 113.421 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.84 -30.32 71.31 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 169.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.82 -50.08 7.41 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.3 m -107.01 -31.07 8.46 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.2 23.91 18.32 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -147.87 156.2 44.33 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-N 119.091 1.446 . . . . 0.0 112.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -57.48 137.43 81.42 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.65 143.2 14.84 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 122.448 1.91 . . . . 0.0 114.753 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -74.37 160.98 30.31 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -32.1 -55.19 0.31 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 166.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.96 75.53 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -56.19 -43.57 78.57 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.1 -56.39 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 118.927 0.785 . . . . 0.0 112.095 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.85 75.35 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -75.77 -25.86 56.84 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.0 -46.17 65.7 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.232 1.378 . . . . 0.0 114.547 166.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.55 -37.95 30.5 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.92 0.27 Allowed Glycine 0 CA--C 1.545 1.958 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -114.55 130.87 56.8 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 117.872 0.836 . . . . 0.0 109.647 165.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -70.79 -41.36 71.77 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -101.23 113.18 65.83 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.387 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -56.08 -19.67 27.62 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -58.0 -28.62 64.58 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.97 71.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.56 80.21 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.67 -40.98 94.11 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.24 -49.97 72.62 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.44 -39.23 77.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 tp -52.52 -44.6 65.86 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 166.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -57.93 -40.04 79.5 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 166.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.78 99.56 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 166.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.56 -45.16 81.43 Favored 'General case' 0 CA--C 1.59 2.503 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.28 92.45 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 174.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -56.2 -39.55 72.6 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 165.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -76.44 6.4 5.76 Favored 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 28.02 58.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.42 -37.77 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 118.55 1.175 . . . . 0.0 113.182 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.65 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-N 119.676 1.125 . . . . 0.0 111.409 169.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.36 127.04 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.166 163.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.6 103.88 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.65 81.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.988 0.899 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.3 t -88.37 72.46 8.94 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -166.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.39 -67.91 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 O-C-N 122.018 -0.427 . . . . 0.0 113.15 158.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.01 161.59 28.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 150.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.9 p -76.08 68.73 2.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.293 24.7 ptt180 -174.43 -110.49 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.744 1.617 . . . . 0.0 109.107 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.96 45.24 96.55 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mt -102.69 113.73 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 118.273 1.037 . . . . 0.0 110.37 -161.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -97.57 135.79 38.9 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 121.451 0.643 . . . . 0.0 111.94 162.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 109.91 17.86 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.275 0.63 . . . . 0.0 111.082 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 CA--C 1.572 1.819 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.57 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 121.997 0.903 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.0 p -80.76 145.55 31.45 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.028 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.3 66.12 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.73 -37.55 70.58 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -57.47 -46.32 83.8 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 121.02 1.736 . . . . 0.0 114.566 163.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -54.91 -47.29 74.54 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -53.37 -47.11 69.72 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 167.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.12 -47.77 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.24 -45.79 87.12 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -60.15 -37.2 79.4 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.22 -39.65 93.05 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 167.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -58.52 -45.62 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-N 119.405 1.002 . . . . 0.0 113.553 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -54.52 -51.34 65.46 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -60.9 -39.65 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -65.71 -47.71 74.45 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mm -57.51 -46.65 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 167.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -69.96 -12.63 61.75 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -70.74 -41.62 71.6 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 121.086 1.767 . . . . 0.0 115.022 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -149.11 -73.17 0.18 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.94 51.99 0.21 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 113.716 165.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -122.23 128.15 25.61 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.026 -164.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HB3' ' H ' ' A' ' 66' ' ' ILE . 36.8 Cg_exo -66.22 153.85 76.43 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 CA-C-N 123.092 2.14 . . . . 0.0 115.417 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.52 161.97 27.9 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 CA-C-N 122.55 1.947 . . . . 0.0 114.441 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -95.62 158.27 15.53 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.217 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -54.94 -37.58 66.6 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.05 99.86 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 166.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.26 -41.04 96.24 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 167.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.85 -51.04 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 119.647 1.112 . . . . 0.0 113.54 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.76 89.43 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -80.46 -39.23 28.52 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -78.88 -41.4 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.16 -36.86 34.49 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 61.91 0.69 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.21 101.88 10.35 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.67 62.32 6.8 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.365 1.078 . . . . 0.0 113.427 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m 175.9 126.98 0.15 Allowed Pre-proline 0 CA--C 1.58 2.115 0 C-N-CA 125.89 1.676 . . . . 0.0 107.995 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -61.22 -42.65 33.93 Favored 'Trans proline' 0 N--CA 1.51 2.442 0 CA-C-N 123.119 2.15 . . . . 0.0 116.503 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.34 -30.88 67.07 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.97 75.32 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.68 95.81 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 166.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.42 -53.25 60.48 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.47 -32.05 69.43 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -65.72 -37.9 87.71 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.333 1.879 . . . . 0.0 115.217 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.56 -51.3 70.48 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -57.45 -40.63 78.87 Favored 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 115.564 1.691 . . . . 0.0 115.564 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.45 95.64 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 167.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.68 -38.87 82.69 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.21 97.07 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 165.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -62.14 -36.22 81.14 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -58.63 -24.5 61.19 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 162.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.24 66.31 1.16 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 118.892 0.769 . . . . 0.0 114.99 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.269 10.5 p -149.33 -52.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.2 pt -96.01 131.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 120.864 1.666 . . . . 0.0 113.358 -171.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.76 110.01 20.64 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.297 0.639 . . . . 0.0 110.437 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.3 125.59 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.74 125.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 112.678 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -84.19 74.66 10.27 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.12 -67.52 0.23 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.27 142.04 34.95 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -66.45 -30.49 70.85 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 118.469 2.766 . . . . 0.0 118.469 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -108.73 88.88 2.83 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 119.971 1.26 . . . . 0.0 110.617 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.54 72.76 0.14 Allowed Glycine 0 N--CA 1.486 1.988 0 O-C-N 121.862 -0.524 . . . . 0.0 114.044 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.432 ' H ' ' HB3' ' A' ' 25' ' ' PRO . 66.4 mt -131.92 101.99 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -119.34 129.17 54.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.923 -0.485 . . . . 0.0 112.003 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 134.33 37.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.572 1.817 0 CA-C-O 122.218 1.009 . . . . 0.0 110.664 -175.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 CA--C 1.568 1.67 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 p -74.65 149.32 40.02 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.15 9.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.704 3.594 . . . . 0.0 120.704 -169.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.89 -45.82 40.27 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.48 -37.93 89.24 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 169.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -53.72 -40.97 66.53 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 164.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.11 -47.9 80.81 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 167.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.97 -49.04 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.645 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -55.48 -39.66 70.7 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.31 -45.64 90.76 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.495 HD23 ' HE ' ' A' ' 34' ' ' ARG . 2.9 tm? -60.39 -40.44 90.88 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 120.634 1.561 . . . . 0.0 114.909 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mt -60.58 -48.68 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -55.41 -48.22 74.71 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -59.27 -48.93 79.78 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -64.14 -41.12 97.31 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.4 mm -68.53 -50.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.494 1.043 . . . . 0.0 113.263 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -73.4 -38.02 65.75 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -88.56 -52.84 4.95 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 119.606 1.094 . . . . 0.0 113.448 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.46 -20.91 19.27 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 41.69 20.82 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 118.141 2.016 . . . . 0.0 118.141 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -149.23 142.67 16.19 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-N 118.893 1.346 . . . . 0.0 113.943 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.33 117.66 1.02 Allowed 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.121 1.881 . . . . 0.0 114.295 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.15 174.09 13.36 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 123.21 2.182 . . . . 0.0 117.644 -170.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -94.21 156.12 16.7 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.043 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -59.23 -28.19 66.45 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 166.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.94 96.58 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.68 -39.96 95.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 168.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.24 -51.08 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 123.734 0.814 . . . . 0.0 112.832 166.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.89 93.31 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -67.19 -45.89 75.55 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.495 ' HE ' HD23 ' A' ' 14' ' ' LEU . 2.8 tmm_? -74.73 -45.32 44.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.79 -14.49 34.39 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -171.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 63.61 1.21 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -117.44 120.83 39.32 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -55.95 -37.27 68.79 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -123.94 148.98 58.56 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.118 159.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -58.21 -12.63 13.55 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 164.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -58.06 -41.71 83.94 Favored 'General case' 0 CA--C 1.587 2.375 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 163.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.29 89.48 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.65 78.5 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 164.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -56.2 -36.95 68.98 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.34 -48.76 80.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -65.17 -38.19 89.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 168.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.59 -37.99 66.18 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -55.77 -57.03 13.74 Favored 'General case' 0 CA--C 1.574 1.897 0 CA-C-N 120.653 1.57 . . . . 0.0 114.811 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.98 75.64 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 168.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.79 -48.45 79.67 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.9 77.39 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -55.78 -41.98 74.86 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -71.83 -14.11 61.87 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.53 62.46 0.45 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 117.395 1.718 . . . . 0.0 117.395 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 m -141.74 -45.04 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.163 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 156.06 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 120.852 1.66 . . . . 0.0 114.548 -168.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.59 144.1 44.11 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 162.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.8 mt -114.11 120.09 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.65 106.59 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.677 0.751 . . . . 0.0 111.047 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.9 p -86.81 87.89 7.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 112.748 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.34 -65.86 0.42 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 169.55 18.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 170.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.1 p -91.66 -55.74 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -84.43 90.09 7.53 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.532 1.158 . . . . 0.0 112.225 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.3 44.83 0.16 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.6 mt -106.49 99.84 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -115.38 145.24 42.72 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.242 0.617 . . . . 0.0 112.006 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.13 123.1 18.98 Favored 'General case' 0 CA--C 1.579 2.093 0 O-C-N 122.05 -0.406 . . . . 0.0 111.853 166.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 122.608 1.194 . . . . 0.0 112.437 -177.804 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 CA--C 1.575 1.916 0 CA-C-O 121.419 0.628 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.5 p -71.16 159.45 34.65 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.92 75.22 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -70.19 -37.05 75.02 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -65.25 -38.52 90.58 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.721 1.6 . . . . 0.0 115.276 166.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -56.54 -40.91 75.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 164.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.59 -45.52 85.19 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -57.81 -50.33 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.07 -46.11 82.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -59.29 -30.17 68.13 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -64.8 -45.75 84.94 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.077 1.308 . . . . 0.0 114.345 165.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mm -55.68 -47.46 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 169.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -60.15 -46.51 89.43 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.31 -55.32 35.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.52 -34.42 75.83 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.78 -42.1 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.215 1.37 . . . . 0.0 112.716 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.1 t -63.21 -31.7 72.91 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 168.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -73.08 -44.31 60.7 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -120.43 -22.44 6.48 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -167.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.15 -30.74 6.85 Favored Glycine 0 CA--C 1.549 2.195 0 N-CA-C 117.886 1.915 . . . . 0.0 117.886 -163.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -104.69 138.88 19.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -60.93 135.86 62.09 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 N-CA-C 119.499 2.846 . . . . 0.0 119.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.5 123.43 6.5 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.46 2.107 . . . . 0.0 113.607 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -100.04 101.97 13.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -168.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.301 76.4 mtt85 70.85 -72.03 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 142.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.05 77.49 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 157.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -60.52 -40.54 91.82 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -62.72 -52.35 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 120.048 1.295 . . . . 0.0 112.664 166.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.74 81.96 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -71.39 -47.77 54.07 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.19 -43.12 87.7 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.27 -6.32 59.43 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.4 51.52 4.6 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.32 108.42 20.59 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 117.643 0.721 . . . . 0.0 109.641 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -80.46 50.3 1.27 Allowed 'General case' 0 CA--C 1.584 2.27 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 175.52 96.79 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 C-N-CA 126.673 1.989 . . . . 0.0 106.083 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -54.52 -30.54 65.16 Favored 'Trans proline' 0 N--CA 1.513 2.62 0 N-CA-C 120.048 3.057 . . . . 0.0 120.048 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -60.93 -35.53 76.95 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.35 79.64 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.76 -42.91 76.17 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 162.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.4 -34.89 78.97 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 173.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.33 -42.92 96.63 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -61.75 -45.03 95.65 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 165.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.54 -49.03 65.67 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -61.14 -46.71 89.43 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.88 74.43 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.64 -37.64 85.24 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.32 95.79 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 ttt-85 -54.39 -44.03 71.94 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.37 -7.24 23.35 Favored 'General case' 0 CA--C 1.592 2.569 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.42 53.23 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.929 2.332 . . . . 0.0 118.929 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.23 -25.28 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.66 128.99 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.868 1.213 . . . . 0.0 111.221 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.66 107.61 19.28 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.663 -0.648 . . . . 0.0 110.619 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -80.83 122.02 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.18 123.15 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.016 0.526 . . . . 0.0 110.032 -169.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 m -78.73 84.42 4.81 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 121.752 0.787 . . . . 0.0 112.417 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.58 -64.22 0.35 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.73 123.05 25.6 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 m -61.66 -57.04 13.55 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -81.66 79.49 8.22 Favored 'General case' 0 CA--C 1.577 1.988 0 CA-C-N 119.259 0.936 . . . . 0.0 110.375 159.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.38 0.49 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.215 -0.902 . . . . 0.0 114.016 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.34 86.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -109.3 157.14 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.469 1.128 . . . . 0.0 113.791 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.36 110.75 18.4 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -161.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.585 2.324 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 166.728 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 CA--C 1.575 1.931 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.1 p -75.69 147.78 39.16 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.833 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.34 44.01 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 119.004 2.965 . . . . 0.0 119.004 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -73.63 -39.42 64.53 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.78 -33.4 75.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.7 -45.3 85.88 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 163.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.96 -42.58 76.43 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 167.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.0 -45.06 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.203 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -55.91 -42.53 76.19 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -54.31 -46.17 72.77 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -55.89 -37.7 69.21 Favored 'General case' 0 CA--C 1.586 2.344 0 N-CA-C 116.901 2.185 . . . . 0.0 116.901 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.13 -53.59 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 119.826 1.194 . . . . 0.0 113.263 170.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -60.58 -46.61 89.58 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -64.11 -47.52 79.68 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -69.32 -37.62 77.83 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.7 mt -57.35 -47.64 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 120.526 1.512 . . . . 0.0 112.94 167.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -62.26 -25.89 68.09 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 168.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.27 -58.85 2.67 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.854 1.206 . . . . 0.0 113.388 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 m -151.03 68.83 0.94 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 119.899 1.227 . . . . 0.0 111.151 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.34 -49.51 3.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 121.084 3.194 . . . . 0.0 121.084 160.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.16 137.95 19.38 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -157.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.45 122.67 5.67 Favored 'Trans proline' 0 CA--C 1.572 2.403 0 C-N-CA 122.727 2.285 . . . . 0.0 114.822 172.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -55.99 157.07 17.75 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 N-CA-C 122.322 3.932 . . . . 0.0 122.322 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 p -115.92 -174.58 2.56 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.176 163.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -28.09 22.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -171.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.37 90.84 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -76.12 -50.44 14.64 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 119.554 1.07 . . . . 0.0 112.915 165.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.6 mt -57.98 -49.61 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.45 76.4 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.46 -44.68 18.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -70.06 -40.23 75.21 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.27 -18.67 48.67 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 64.78 1.46 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -100.22 152.6 20.1 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.354 1.073 . . . . 0.0 113.027 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -56.02 -32.91 64.41 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 166.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m -163.21 159.21 18.33 Favored Pre-proline 0 CA--C 1.577 1.987 0 C-N-CA 124.088 0.955 . . . . 0.0 112.045 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -57.87 -30.44 89.54 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.914 2.236 . . . . 0.0 117.914 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.34 -45.04 88.88 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 167.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.54 88.81 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.61 -49.53 70.72 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.88 -30.37 68.86 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.6 -40.19 86.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -66.05 -42.22 89.79 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.68 -51.76 62.17 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.16 -48.38 78.68 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -46.89 74.56 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.05 -37.58 87.94 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.88 65.48 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -68.42 -24.36 64.74 Favored 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -69.02 -27.77 65.97 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 160.57 -54.27 0.33 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 168.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.25 -20.25 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -158.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -117.42 145.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 121.192 1.814 . . . . 0.0 112.939 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.51 114.51 20.98 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.096 0.958 . . . . 0.0 113.549 -163.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.72 96.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.716 0.77 . . . . 0.0 111.155 -172.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.4 m -91.05 110.63 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 121.698 0.761 . . . . 0.0 112.311 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.8 p -83.22 81.51 8.67 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.009 -1.057 . . . . 0.0 112.831 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.07 -52.11 0.71 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.22 115.08 12.13 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 m -74.12 105.38 5.31 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.358 0.599 . . . . 0.0 111.32 170.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.332 75.5 mtt85 72.92 50.31 0.15 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -166.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.48 5.14 24.79 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 164.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.252 9.8 tt -77.55 80.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.56 1.68 . . . . 0.0 114.612 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -82.67 144.99 29.88 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.388 1.075 . . . . 0.0 113.222 -168.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.0 125.32 25.96 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.991 -1.068 . . . . 0.0 113.535 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.562 1.414 0 CA-C-O 121.874 0.845 . . . . 0.0 109.827 -173.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.568 1.642 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -81.23 160.04 24.39 Favored 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.169 -0.957 . . . . 0.0 113.092 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.17 -41.13 74.98 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -72.11 -29.61 64.26 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.67 -45.86 85.03 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.807 1.64 . . . . 0.0 114.714 159.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -44.23 87.62 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.14 -46.13 82.97 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.08 -46.95 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -56.56 -41.54 77.06 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.85 -40.14 79.42 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.29 -45.66 92.26 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.31 31.3 pt -63.23 -33.66 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -64.04 -50.44 68.41 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 120.652 1.569 . . . . 0.0 115.121 161.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -60.82 -47.54 85.87 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -67.69 -39.06 84.46 Favored 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.3 mm -57.37 -49.21 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.964 1.256 . . . . 0.0 113.122 165.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -62.89 -49.09 76.18 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -96.65 8.12 44.95 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -154.71 -54.91 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.561 -1.337 . . . . 0.0 111.489 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.04 38.91 1.1 Allowed Glycine 0 CA--C 1.545 1.913 0 N-CA-C 116.407 1.323 . . . . 0.0 116.407 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -144.21 135.56 12.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-N 118.782 1.291 . . . . 0.0 113.096 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 90.6 Cg_endo -91.14 107.18 0.29 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 CA-C-N 122.944 2.087 . . . . 0.0 113.908 175.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 36.2 Cg_endo -63.77 121.14 8.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.559 2.839 . . . . 0.0 115.582 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.48 ' H ' ' HE ' ' A' ' 64' ' ' ARG . 45.9 p -109.41 118.82 37.66 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.286 98.1 mtt180 72.17 -65.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 155.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.24 23.74 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.78 -36.21 80.41 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.8 mm -60.44 -52.87 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.41 95.29 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -67.17 -42.57 84.05 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -76.79 -47.13 22.53 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.08 -10.86 56.39 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 43.95 7.54 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 117.677 1.831 . . . . 0.0 117.677 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -89.69 85.32 6.42 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 118.615 1.208 . . . . 0.0 110.101 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.98 -24.13 66.72 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.5 m -91.37 112.49 54.41 Favored Pre-proline 0 CA--C 1.568 1.671 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.785 163.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.96 -18.52 62.43 Favored 'Trans proline' 0 N--CA 1.51 2.477 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -55.54 -44.45 76.77 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 166.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.09 -44.17 74.66 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.28 86.43 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 172.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -41.86 85.24 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 170.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.15 -50.02 50.28 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 166.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -64.93 -38.68 91.75 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.22 -49.53 77.25 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 21.9 pttm -63.89 -36.42 83.88 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 168.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.49 87.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 168.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.92 -43.8 86.48 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 164.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.12 84.31 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ttm105 -59.25 -36.88 76.29 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.94 -51.28 69.92 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.23 16.26 3.23 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.72 -10.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -136.84 138.14 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-N 120.02 1.282 . . . . 0.0 112.049 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.11 128.94 46.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.545 0.688 . . . . 0.0 110.149 166.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.6 mm -90.53 115.63 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 C-N-CA 123.141 0.576 . . . . 0.0 109.556 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.79 92.98 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -79.98 85.0 5.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.33 -84.71 0.05 OUTLIER Glycine 0 N--CA 1.481 1.633 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.725 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.95 52.89 2.52 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.297 63.2 m 64.65 -73.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.48 ' HE ' ' H ' ' A' ' 27' ' ' THR . 83.3 mtt180 -96.32 82.9 3.47 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 122.167 0.984 . . . . 0.0 111.589 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.77 95.5 0.28 Allowed Glycine 0 N--CA 1.48 1.629 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.293 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.0 120.03 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -93.96 128.32 40.22 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 121.696 -0.627 . . . . 0.0 110.993 173.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -84.57 111.74 19.79 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 123.023 0.529 . . . . 0.0 112.023 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 CA--C 1.573 1.829 0 CA-C-O 121.775 0.798 . . . . 0.0 110.4 -177.675 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 CA--C 1.566 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.7 p -80.54 94.98 6.36 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.294 . . 49.45 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 119.459 3.133 . . . . 0.0 119.459 168.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -74.79 -31.19 61.67 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.04 -32.13 73.12 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 161.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -57.85 -42.32 84.2 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 163.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.19 -44.69 68.12 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 163.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.33 -43.58 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.73 -40.23 87.36 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.41 -40.84 92.4 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 165.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.86 -47.23 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.446 0.1 OUTLIER -64.62 -39.22 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 121.106 1.775 . . . . 0.0 115.414 174.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtp85 -59.59 -39.67 84.92 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.37 -49.03 77.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -63.36 -39.92 95.86 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.75 -47.22 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 118.977 0.808 . . . . 0.0 113.16 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -61.05 -30.82 70.55 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -84.29 -41.69 16.58 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -116.96 -22.39 8.49 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.21 -47.9 1.45 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -161.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -90.1 159.74 41.78 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.89 162.5 37.24 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.403 2.069 . . . . 0.0 116.731 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 166.91 22.12 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.675 2.25 . . . . 0.0 116.862 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -67.0 147.2 53.53 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.792 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -57.5 -32.78 67.35 Favored 'General case' 0 CA--C 1.591 2.532 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.18 80.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 165.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.77 -33.37 66.55 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 170.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -60.69 -48.5 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-N 119.376 0.989 . . . . 0.0 112.629 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.56 61.16 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' HE ' ' A' ' 34' ' ' ARG . 27.8 tt0 -64.98 -54.09 35.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' HE ' HE21 ' A' ' 33' ' ' GLN . 25.9 mmt85 -75.97 -39.15 56.58 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.15 -18.67 59.01 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 56.34 1.37 Allowed Glycine 0 N--CA 1.481 1.695 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.88 116.69 32.37 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 117.583 0.691 . . . . 0.0 110.199 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -63.48 -33.43 75.55 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 157.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 t -94.97 103.01 10.39 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 123.791 0.837 . . . . 0.0 112.291 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.71 -23.55 56.04 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.406 2.041 . . . . 0.0 117.406 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -58.83 -40.73 85.05 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 161.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.16 96.42 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 167.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.11 71.34 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 173.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.55 -33.41 75.85 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.9 -46.98 84.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -65.81 -30.68 71.35 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 tp -60.39 -52.09 66.73 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 121.121 1.782 . . . . 0.0 114.929 166.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 61.7 pttt -62.79 -42.07 99.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.12 74.38 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 166.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.37 -38.79 81.74 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.05 87.6 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 163.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -61.82 -35.68 78.95 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -59.11 -32.93 70.27 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 163.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.11 34.74 1.1 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.565 2.186 . . . . 0.0 118.565 163.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.49 -4.63 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.13 153.34 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.191 0 CA-C-N 119.689 1.131 . . . . 0.0 111.82 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -112.66 122.69 48.42 Favored 'General case' 0 CA--C 1.571 1.763 0 O-C-N 121.745 -0.597 . . . . 0.0 109.545 163.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -88.68 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.63 92.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -85.66 100.23 11.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.632 0.729 . . . . 0.0 112.277 -157.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.83 -53.63 0.7 Allowed Glycine 0 N--CA 1.486 2.008 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.053 -160.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.53 113.09 12.55 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 117.481 0.64 . . . . 0.0 112.553 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.8 p -60.33 -46.19 90.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -91.26 84.95 5.7 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 159.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.12 71.61 0.22 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.05 111.34 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.824 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.84 135.21 37.9 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 111.995 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 tp -95.31 111.61 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.98 0.512 . . . . 0.0 111.346 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 121.746 0.784 . . . . 0.0 109.987 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 p -65.93 152.4 44.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -160.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.01 -40.37 58.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 120.406 3.484 . . . . 0.0 120.406 -165.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -39.38 34.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.96 -34.77 75.26 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 162.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.51 -41.28 96.5 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 167.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -57.42 -47.73 80.99 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 165.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.35 -49.34 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 165.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.0 -41.33 97.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.27 -40.87 95.72 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.93 -46.52 71.29 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.116 1.78 . . . . 0.0 114.983 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.262 3.6 tp -53.15 -46.98 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -62.81 -49.33 75.35 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 172.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.06 -44.17 97.78 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -72.85 -43.54 62.48 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.26 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 120.525 1.511 . . . . 0.0 114.776 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -59.94 -30.74 69.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 171.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -93.68 -47.63 6.71 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 p -93.33 -26.41 17.3 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.785 2.142 . . . . 0.0 116.785 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.91 3.76 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.25 141.58 24.18 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.7 132.63 8.88 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 122.187 1.817 . . . . 0.0 114.506 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -55.33 145.03 69.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 N-CA-C 118.272 2.374 . . . . 0.0 118.272 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 p -74.52 150.46 39.79 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.237 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.26 16.6 ptt180 -58.82 -26.98 64.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.2 -40.83 70.94 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -56.93 -49.74 74.71 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 166.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.05 -45.58 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.09 -55.0 36.01 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 170.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.21 -37.16 63.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.96 -36.5 72.59 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.25 -11.81 59.98 Favored 'General case' 0 CA--C 1.584 2.268 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 168.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.72 54.2 4.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -83.82 146.23 28.23 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.451 1.119 . . . . 0.0 113.888 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.02 88.45 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.0 m -152.8 143.97 16.05 Favored Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.718 164.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.45 -30.7 16.25 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -59.05 -31.68 69.07 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.06 99.24 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 165.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.25 96.48 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 165.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -55.74 -46.52 77.8 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 164.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.37 -42.32 95.55 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -66.21 -36.95 84.39 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -58.89 -41.37 87.0 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.5 -47.13 82.98 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 170.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.54 79.01 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.8 tp -63.31 -41.41 98.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.0 99.85 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -50.9 -38.02 47.29 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -77.37 6.21 7.29 Favored 'General case' 0 CA--C 1.592 2.558 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.58 40.97 16.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.42 -44.04 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.538 -169.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -127.51 137.65 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 119.709 1.14 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.67 115.86 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 110.684 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.46 123.92 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.07 105.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 164.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.0 m -77.59 95.74 4.63 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -161.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.13 -60.25 0.51 Allowed Glycine 0 N--CA 1.484 1.847 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.576 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.25 123.85 25.32 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.9 p -61.55 -41.31 97.18 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -99.68 28.57 4.6 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 163.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.58 69.81 3.26 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.309 -1.494 . . . . 0.0 114.305 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.03 98.94 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -168.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -98.61 108.58 21.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 110.281 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . 0.299 2.3 pp -82.09 93.1 6.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.1 pt? . . . . . 0 CA--C 1.576 1.972 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 165.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 CA--C 1.572 1.797 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -74.33 153.96 39.09 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.408 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -44.38 70.75 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -72.09 -33.29 67.77 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -56.55 -46.55 80.62 Favored 'General case' 0 CA--C 1.583 2.229 0 CA-C-N 120.502 1.501 . . . . 0.0 114.481 161.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -61.54 -40.05 93.28 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.93 -50.71 68.17 Favored 'General case' 0 CA--C 1.582 2.207 0 CA-C-N 121.004 1.729 . . . . 0.0 115.391 164.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.2 t -55.76 -50.01 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -59.62 -42.53 92.89 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.06 -38.14 75.74 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -44.01 97.69 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 120.597 1.544 . . . . 0.0 114.768 168.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -53.26 -53.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 166.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -62.87 -37.65 87.73 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.73 -47.79 83.39 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 170.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -66.04 -41.32 91.02 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 120.593 1.542 . . . . 0.0 115.031 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.2 mt -67.65 -44.93 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -65.09 -28.77 69.68 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -87.79 -45.93 9.9 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -105.56 -23.69 12.73 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.42 -47.43 1.34 Allowed Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -164.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -88.63 160.72 43.91 Favored Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 158.85 50.91 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.078 1.852 . . . . 0.0 116.059 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.07 164.87 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.263 1.976 . . . . 0.0 114.891 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.5 p -72.97 151.04 41.99 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.205 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -57.87 -25.15 60.37 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.15 94.45 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 160.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.18 -45.42 93.19 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.1 -50.46 78.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.302 0 CA-C-N 120.133 1.333 . . . . 0.0 112.359 170.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.41 81.89 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.43 -49.04 11.98 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -67.33 -40.14 85.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.2 -14.97 58.73 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.05 65.28 1.54 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.08 141.31 31.18 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 121.968 0.89 . . . . 0.0 112.91 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -35.34 79.78 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -136.42 142.29 38.92 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.307 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -61.55 -24.54 78.21 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 N-CA-C 118.006 2.272 . . . . 0.0 118.006 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -63.89 -28.31 69.75 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 167.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -45.47 92.37 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.17 73.77 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.43 -48.11 69.04 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 171.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.33 -30.78 68.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -62.36 -38.88 91.27 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 162.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.14 -43.22 99.22 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.5 -47.9 78.33 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 163.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.01 94.06 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.76 -38.02 77.53 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 164.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.5 -46.22 76.97 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 166.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -59.22 -34.98 72.83 Favored 'General case' 0 CA--C 1.582 2.186 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.88 -26.07 67.15 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 163.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.16 41.47 3.02 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -129.73 -41.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.216 0 CA-C-N 118.103 0.952 . . . . 0.0 113.315 -169.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -126.0 135.53 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.0 1.273 . . . . 0.0 110.914 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.12 118.05 31.94 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 110.015 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.44 125.39 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 121.045 0.45 . . . . 0.0 110.291 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.47 93.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -74.58 123.45 24.83 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -160.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.65 -47.03 1.09 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -161.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.87 119.63 22.33 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -58.19 -41.51 84.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 171.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -95.07 83.1 3.86 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.63 0.728 . . . . 0.0 109.821 161.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.39 67.01 0.33 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.7 mm -135.83 118.98 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -172.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -103.17 126.7 50.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.822 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.5 tp -91.71 121.28 33.21 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 CA--C 1.572 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 162.182 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 CA--C 1.569 1.692 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.6 p -67.15 155.94 37.48 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.06 61.18 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -74.25 -38.3 63.52 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 169.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -58.52 -44.96 89.7 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 120.823 1.647 . . . . 0.0 115.178 168.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -61.25 -41.28 96.63 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.46 -47.26 79.55 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 165.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.95 -44.68 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -61.58 -41.56 97.58 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 172.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.82 -46.59 89.93 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.75 -41.14 98.05 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.277 0.4 OUTLIER -58.17 -46.57 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 CA-C-N 120.548 1.522 . . . . 0.0 114.584 171.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -63.12 -49.5 74.15 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.54 -46.34 90.55 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -69.37 -36.3 76.7 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.26 -45.22 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 120.805 1.639 . . . . 0.0 112.899 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -64.43 -26.58 68.51 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.25 -54.07 4.67 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -102.45 -39.6 7.07 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.55 -46.53 1.12 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 115.839 1.096 . . . . 0.0 115.839 -170.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.2 ptp -87.61 156.67 53.13 Favored Pre-proline 0 CA--C 1.57 1.739 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.51 155.2 21.33 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 122.022 1.814 . . . . 0.0 116.4 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.99 94.39 0.98 Allowed 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.637 2.225 . . . . 0.0 112.932 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -84.4 81.87 8.64 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.299 2.3 tmt_? 66.73 -60.02 0.35 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.81 77.32 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.93 -31.99 70.04 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.69 -50.91 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.251 1.387 . . . . 0.0 113.156 165.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.01 94.76 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -69.61 -49.15 56.76 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -76.56 -40.09 50.84 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -91.41 -26.78 18.7 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 73.64 1.06 Allowed Glycine 0 N--CA 1.483 1.788 0 CA-C-N 119.532 1.06 . . . . 0.0 115.345 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -135.44 128.05 30.79 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 117.318 0.559 . . . . 0.0 111.418 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -73.96 -45.71 48.52 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 m -118.25 151.31 49.15 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -167.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.54 -20.31 53.91 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 N-CA-C 118.392 2.42 . . . . 0.0 118.392 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -57.65 -16.24 10.01 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 164.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.61 -62.56 1.24 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.407 1.003 . . . . 0.0 112.686 160.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.02 91.67 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -80.16 -45.18 18.56 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.18 -29.25 67.2 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -60.37 -40.45 90.83 Favored 'General case' 0 CA--C 1.581 2.148 0 CA-C-N 122.622 2.464 . . . . 0.0 114.787 165.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.31 -44.82 93.87 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.82 -47.48 86.15 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.9 84.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 169.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.57 -43.91 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.49 98.8 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 166.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -56.42 -35.14 67.48 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 168.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -59.07 -34.24 71.73 Favored 'General case' 0 CA--C 1.591 2.552 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 163.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.82 56.09 0.56 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.301 3.9 p -132.81 -53.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.28 143.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.028 0 CA-C-N 119.643 1.11 . . . . 0.0 112.699 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.79 143.61 56.8 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.252 155.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.48 114.34 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.62 105.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.685 0.755 . . . . 0.0 109.369 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 m -84.23 85.54 7.35 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.172 0.987 . . . . 0.0 112.281 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.26 -73.44 0.23 Allowed Glycine 0 N--CA 1.484 1.87 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.287 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 106.12 11.76 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 120.98 0.419 . . . . 0.0 111.454 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 m -60.34 -42.73 96.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 118.464 2.765 . . . . 0.0 118.464 -166.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -83.14 65.01 7.99 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 119.799 1.181 . . . . 0.0 113.361 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 76.42 0.27 Allowed Glycine 0 N--CA 1.48 1.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.869 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.29 106.34 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -124.64 141.28 52.21 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.021 0.528 . . . . 0.0 111.634 -167.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.28 106.64 6.91 Favored 'General case' 0 CA--C 1.574 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 112.795 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 173.279 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 5' ' ' THR 0.624 2.6 pt? . . . . . 0 CA--C 1.561 1.385 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HG ' ' A' ' 4' ' ' LEU . 20.0 p -143.83 138.17 28.49 Favored 'General case' 0 CA--C 1.57 1.75 0 C-N-CA 123.941 0.896 . . . . 0.0 109.304 170.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.66 53.08 1.28 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 -173.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -144.24 -54.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.03 1.332 . . . . 0.0 109.794 164.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -61.05 -34.78 75.41 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 163.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -57.18 -40.76 77.98 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 168.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.97 -42.42 80.13 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.43 -44.32 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 167.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -64.63 -41.87 95.87 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -55.94 -39.34 71.57 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 163.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.51 -34.23 77.46 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.0 mt -53.51 -57.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.515 1.507 . . . . 0.0 113.174 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.13 -32.21 73.53 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.3 -48.02 71.72 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.25 -38.31 89.94 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.173 1.806 . . . . 0.0 115.448 173.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.12 -38.64 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 166.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.1 m -66.31 -41.72 89.31 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 167.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.81 -26.91 62.59 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -148.33 -52.84 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 -174.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.98 18.45 0.96 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -148.11 148.79 30.65 Favored Pre-proline 0 CA--C 1.581 2.147 0 CA-C-N 118.853 1.326 . . . . 0.0 112.324 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 147.62 37.56 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 122.563 2.175 . . . . 0.0 115.796 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.38 160.63 35.46 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.779 2.319 . . . . 0.0 115.391 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -143.89 127.13 16.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.308 42.2 ttt85 62.91 -79.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 161.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.24 -44.5 59.4 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.08 -42.07 93.81 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.33 -51.92 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-N 119.27 0.941 . . . . 0.0 112.984 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.24 94.84 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -74.59 -40.99 61.26 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -64.34 -42.72 96.11 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.3 mt -106.36 -26.51 11.46 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.66 86.48 1.68 Allowed Glycine 0 N--CA 1.485 1.925 0 CA-C-N 120.243 1.383 . . . . 0.0 114.139 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -120.72 137.55 54.43 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.561 0.696 . . . . 0.0 111.771 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -28.71 67.56 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -148.52 149.02 30.26 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-N 119.249 0.931 . . . . 0.0 113.074 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -62.43 -27.95 77.7 Favored 'Trans proline' 0 N--CA 1.509 2.398 0 N-CA-C 117.872 2.22 . . . . 0.0 117.872 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -65.89 -40.34 91.46 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.06 93.38 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.98 -47.16 68.41 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.48 -36.73 76.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 171.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.28 -33.06 74.51 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.385 1.902 . . . . 0.0 116.01 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -66.9 -36.04 81.38 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 120.99 1.723 . . . . 0.0 115.346 164.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.99 -46.13 82.48 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 161.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.0 -49.7 76.62 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.02 -43.21 60.84 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.86 -45.75 84.73 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 168.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.09 93.59 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.72 -39.34 77.03 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -69.89 -40.1 75.86 Favored 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 165.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.49 38.77 0.32 Allowed Glycine 0 N--CA 1.484 1.855 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 165.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.18 -28.84 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.14 146.93 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-O 121.963 0.887 . . . . 0.0 112.571 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -85.99 115.17 23.43 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.859 -0.526 . . . . 0.0 110.832 168.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.72 124.41 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.536 0.684 . . . . 0.0 109.528 -174.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.48 123.01 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -72.84 105.16 4.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.591 0.71 . . . . 0.0 112.804 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.29 -65.36 0.4 Allowed Glycine 0 N--CA 1.485 1.965 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.778 -167.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.89 119.63 24.18 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 169.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.1 p -79.31 65.2 4.42 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 15.7 ptm180 -161.42 -65.15 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.14 1.376 . . . . 0.0 111.553 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.55 -166.85 14.99 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -132.92 -72.82 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.441 -172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.89 147.88 39.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -158.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.61 126.59 31.12 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 CA--C 1.569 1.697 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.683 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.562 1.409 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.0 p -66.67 153.52 42.95 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 121.387 -0.82 . . . . 0.0 112.592 167.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.89 56.32 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 118.769 2.877 . . . . 0.0 118.769 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -70.82 -37.0 73.18 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -59.47 -44.45 93.02 Favored 'General case' 0 CA--C 1.584 2.257 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 162.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -57.91 -39.29 77.59 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.62 -47.6 83.85 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 165.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.09 -49.43 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.16 -48.27 79.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.06 -38.85 68.56 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -48.57 69.86 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.258 26.0 pt -59.46 -42.57 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.126 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 167.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -63.77 -39.04 93.3 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.67 -47.53 83.28 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -58.85 -49.22 78.56 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.13 -40.61 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -61.97 -48.86 78.48 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -85.84 -37.49 19.15 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -116.33 -17.79 10.65 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.94 -28.98 10.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.651 2.22 . . . . 0.0 118.651 -173.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -88.59 129.82 47.62 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.99 115.97 4.37 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.391 2.06 . . . . 0.0 115.427 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 160.33 37.21 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 123.562 2.308 . . . . 0.0 116.401 -170.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.2 p -86.89 163.97 16.86 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -40.5 -57.7 1.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.62 89.65 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.79 -43.49 85.63 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.69 -57.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.011 0.823 . . . . 0.0 112.615 168.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.6 85.49 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 118.278 2.695 . . . . 0.0 118.278 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.63 -34.4 75.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -73.02 -48.06 39.55 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.68 -38.4 58.77 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.02 61.85 0.28 Allowed Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -117.61 128.52 55.01 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.984 168.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HE ' ' H ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -63.62 -42.24 98.21 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 169.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.472 ' H ' ' HE ' ' A' ' 38' ' ' ARG . 10.1 t -109.65 106.95 59.03 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.354 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -54.79 -19.55 19.34 Favored 'Trans proline' 0 N--CA 1.508 2.336 0 N-CA-C 121.832 3.743 . . . . 0.0 121.832 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -53.28 -31.82 45.67 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 170.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.34 55.44 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 165.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -51.5 69.58 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -70.18 -32.68 70.73 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.98 -44.2 97.24 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -63.25 -41.39 99.05 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tp -49.7 -44.33 48.08 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.97 -46.06 75.01 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.18 90.12 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 -41.68 92.84 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 166.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.75 94.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -56.8 -42.38 79.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 168.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.45 -8.59 52.13 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 167.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.14 -9.11 61.22 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 120.136 2.814 . . . . 0.0 120.136 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 p -85.12 -4.25 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.0 pt -142.78 143.75 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-N 119.973 1.261 . . . . 0.0 111.963 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.11 112.5 25.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 166.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -84.8 125.63 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.8 120.96 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.798 -0.564 . . . . 0.0 109.676 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -76.64 85.24 3.3 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.65 63.5 0.51 Allowed Glycine 0 N--CA 1.486 1.992 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.686 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.5 131.39 13.31 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 117.421 0.61 . . . . 0.0 111.925 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.1 t -78.85 103.62 8.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.784 -0.572 . . . . 0.0 110.938 167.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.262 79.3 mtt180 70.38 67.22 0.2 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.55 83.0 0.25 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 114.645 0.618 . . . . 0.0 114.645 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.97 117.93 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.44 118.73 23.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.702 . . . . 0.0 110.179 174.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.98 100.63 9.8 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 122.945 0.498 . . . . 0.0 110.99 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 CA--C 1.587 2.4 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 179.449 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 122.117 0.96 . . . . 0.0 113.268 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -67.8 157.75 34.06 Favored 'General case' 0 CA--C 1.577 2.012 0 O-C-N 121.643 -0.661 . . . . 0.0 112.155 168.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 -54.78 28.34 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.651 2.463 . . . . 0.0 117.651 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -65.12 -35.01 79.78 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.67 -49.81 76.3 Favored 'General case' 0 CA--C 1.592 2.561 0 CA-C-N 120.235 1.38 . . . . 0.0 114.611 166.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -57.37 -43.29 83.45 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.05 -47.61 77.57 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 166.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.87 -49.26 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -58.17 -46.92 84.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -65.52 -28.82 69.46 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.22 -47.16 77.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.726 1.603 . . . . 0.0 114.519 169.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.287 15.6 tt -57.47 -45.26 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 165.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.77 -44.04 73.31 Favored 'General case' 0 CA--C 1.581 2.147 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 169.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -59.71 -51.31 70.3 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -40.96 98.99 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.01 -48.61 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 C-N-CA 123.702 0.801 . . . . 0.0 112.767 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -70.9 -34.6 71.72 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.29 -21.83 49.13 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.2 m -148.08 -53.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.193 0.906 . . . . 0.0 111.86 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.55 40.79 0.65 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -142.96 132.48 11.86 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 118.426 1.113 . . . . 0.0 113.51 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.88 123.62 3.69 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 122.501 1.929 . . . . 0.0 115.183 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.1 127.39 8.41 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.761 2.308 . . . . 0.0 113.882 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 172.42 13.38 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -49.54 -35.71 21.24 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 119.174 3.027 . . . . 0.0 119.174 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.89 -46.19 75.69 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 165.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.97 -45.35 92.96 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.82 -49.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 167.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.75 84.45 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 170.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -65.54 -51.38 60.28 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -83.95 -37.59 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.6 -16.32 39.68 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.84 66.03 1.52 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 120.092 1.314 . . . . 0.0 115.998 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.89 125.66 53.04 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -59.2 -16.07 18.51 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -148.99 155.23 40.41 Favored Pre-proline 0 CA--C 1.573 1.844 0 O-C-N 121.293 -0.879 . . . . 0.0 111.379 165.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -56.03 -28.73 70.78 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.88 -33.75 74.78 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.01 -39.11 83.26 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.61 89.32 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 162.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.86 -36.56 65.22 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 167.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -67.74 -39.72 84.2 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 166.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.71 -46.84 77.63 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.265 63.6 pttt -64.83 -39.25 93.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.82 88.75 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 166.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.62 -40.47 83.42 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 163.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.57 74.16 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 168.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -64.86 -38.79 92.14 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -66.63 -33.92 76.74 Favored 'General case' 0 CA--C 1.586 2.365 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 158.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.99 60.31 1.6 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.12 -39.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.015 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.55 162.97 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 118.769 0.713 . . . . 0.0 110.546 152.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.74 132.6 47.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.874 -1.141 . . . . 0.0 111.051 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.3 mt -90.85 116.45 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 O-C-N 121.787 -0.571 . . . . 0.0 109.877 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.1 t -80.87 96.71 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.2 m -77.59 96.02 4.7 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.871 0.844 . . . . 0.0 112.47 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.24 -53.22 0.56 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.272 -163.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.32 133.7 41.2 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.8 t -60.79 -54.47 44.8 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -93.97 71.64 4.04 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.179 0.9 . . . . 0.0 111.17 161.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.95 63.55 0.27 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 115.361 0.904 . . . . 0.0 115.361 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.5 mm -126.44 97.72 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.876 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -93.45 122.04 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 112.038 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -84.02 123.53 30.11 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.582 2.189 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 CA--C 1.579 2.095 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 t -78.5 159.29 28.29 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -34.18 -55.89 0.5 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 121.017 3.71 . . . . 0.0 121.017 -164.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -77.69 -37.02 50.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -67.03 -34.37 77.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 163.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -42.78 88.78 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 163.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.58 -44.38 80.97 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 167.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.85 -41.31 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 167.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -62.47 -43.65 98.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 168.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.4 -41.47 69.31 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 167.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -42.25 91.78 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 175.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.319 6.2 tp -58.91 -46.51 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 163.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -59.32 -43.63 92.67 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.77 -51.05 71.0 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -63.37 -37.86 88.89 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 174.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.3 -47.74 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 CA-C-N 118.751 0.705 . . . . 0.0 112.861 169.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -65.23 -37.54 87.57 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 172.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.8 -12.84 55.09 Favored 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -149.31 -56.88 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.786 1.175 . . . . 0.0 111.509 -176.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.49 -44.52 0.98 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -81.98 161.52 60.3 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.02 159.52 52.9 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 122.202 1.822 . . . . 0.0 115.356 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 159.25 35.71 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.993 1.795 . . . . 0.0 114.621 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.6 p -71.09 147.92 48.0 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.665 -0.647 . . . . 0.0 111.548 165.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -62.36 -28.63 69.89 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 175.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.18 93.09 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 160.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.85 -39.98 95.48 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 166.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.5 mt -56.59 -46.14 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.271 0 CA-C-N 120.162 1.346 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.88 -54.18 42.76 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 170.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -76.94 -38.4 53.45 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -66.48 -41.89 88.31 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.09 -20.09 42.26 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 48.68 2.77 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 178.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -100.37 100.32 11.08 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 117.758 0.779 . . . . 0.0 109.872 177.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 62.09 7.27 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 122.449 1.119 . . . . 0.0 112.88 174.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -177.82 119.08 0.25 Allowed Pre-proline 0 CA--C 1.577 2.018 0 C-N-CA 125.381 1.472 . . . . 0.0 107.849 -175.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.78 -27.15 52.18 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 N-CA-C 118.631 2.512 . . . . 0.0 118.631 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.27 -47.71 72.8 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 167.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.87 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -169.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.72 70.86 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -20.55 62.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.07 2.619 . . . . 0.0 118.07 171.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -70.87 -41.42 71.4 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 173.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -61.34 -34.49 75.37 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 162.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.08 -45.68 86.74 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.12 78.85 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 166.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.4 -39.18 91.87 Favored 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.63 98.39 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 164.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -61.55 -34.89 76.34 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 169.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -30.13 65.95 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 162.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.2 29.34 8.01 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.029 1.972 . . . . 0.0 118.029 -177.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.252 6.5 p -108.52 -38.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.6 pt -123.03 138.63 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 123.788 0.835 . . . . 0.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.62 113.72 27.34 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.41 0.624 . . . . 0.0 109.796 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.88 127.21 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.215 0.606 . . . . 0.0 109.501 -172.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.7 115.77 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 O-C-N 121.726 -0.609 . . . . 0.0 109.75 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.8 p -76.28 86.18 3.08 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 -68.66 0.33 Allowed Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.69 -172.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.52 112.31 11.72 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.8 m -70.0 -21.55 63.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 178.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -91.79 83.67 5.3 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 119.802 1.183 . . . . 0.0 108.649 152.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.99 64.65 0.26 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -172.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.9 101.58 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -84.25 113.32 21.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.282 -0.886 . . . . 0.0 110.893 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.3 tp -80.68 83.2 6.51 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.674 0.75 . . . . 0.0 111.615 172.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 1.5 pp . . . . . 0 CA--C 1.567 1.618 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 159.9 24.14 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -174.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.26 76.55 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 118.288 2.699 . . . . 0.0 118.288 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -71.74 -39.7 69.88 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 172.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.47 -28.87 69.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 165.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.49 -40.34 96.37 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 162.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -59.19 -44.75 92.22 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 164.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.23 -48.47 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 164.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.19 -40.69 96.61 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 175.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.26 -42.81 78.03 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 167.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.16 -34.18 77.45 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 166.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.24 -55.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 120.725 1.602 . . . . 0.0 113.564 166.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.91 -41.88 88.29 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.5 -52.99 62.85 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 167.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -68.28 -35.36 77.73 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.04 1.291 . . . . 0.0 112.826 166.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -67.73 -32.98 73.98 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 170.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -75.83 -40.1 55.5 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 172.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -124.44 -49.28 1.79 Allowed 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -174.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.68 -44.62 1.12 Allowed Glycine 0 CA--C 1.545 1.916 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -175.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -90.84 142.06 27.3 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -168.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.17 117.51 4.37 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.981 2.454 . . . . 0.0 116.754 172.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.68 119.25 5.38 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 CA-C-N 122.683 1.994 . . . . 0.0 114.931 -176.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 p -115.8 98.56 6.74 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.555 0.693 . . . . 0.0 110.225 -177.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.391 0.5 OUTLIER 65.09 -50.7 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.32 -47.11 79.38 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -176.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.71 -38.29 23.56 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 165.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.01 -57.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.08 77.11 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -80.95 -49.83 10.48 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -78.57 -31.74 47.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.9 mt -84.47 -18.95 34.23 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 167.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.44 72.9 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.078 1.308 . . . . 0.0 115.617 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.13 134.6 40.25 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 121.985 0.898 . . . . 0.0 112.934 -176.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -14.39 45.58 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 119.732 3.234 . . . . 0.0 119.732 170.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.6 m -157.05 143.71 13.33 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 119.716 1.143 . . . . 0.0 112.185 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.05 -43.98 34.38 Favored 'Trans proline' 0 N--CA 1.512 2.598 0 C-N-CA 122.927 2.418 . . . . 0.0 117.724 165.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.36 -32.83 73.68 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 172.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.11 82.25 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 169.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.86 78.77 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 167.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -57.99 -48.38 80.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 172.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -53.45 -48.61 68.66 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -61.63 -39.93 93.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 170.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.37 -42.11 77.29 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 164.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -67.95 -47.56 68.33 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.21 87.73 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 167.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 tp -64.13 -48.25 76.81 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.79 -38.72 70.31 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 166.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -55.84 -32.38 63.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 166.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -66.36 -16.25 63.92 Favored 'General case' 0 CA--C 1.586 2.33 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 165.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.17 69.05 1.18 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.537 1.062 . . . . 0.0 114.921 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.84 -29.47 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -171.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 145.48 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 121.135 1.789 . . . . 0.0 112.641 -177.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.81 113.0 23.89 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 121.819 -0.551 . . . . 0.0 110.216 170.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.94 134.46 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.08 145.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.472 0.653 . . . . 0.0 112.113 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.4 p -75.11 89.48 2.48 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.8 -82.14 0.2 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 -173.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.55 95.6 1.84 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.785 0.802 . . . . 0.0 112.035 170.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -77.97 14.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.8 mtm-85 -82.12 -70.52 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 111.778 156.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.94 -147.05 18.17 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.25 -58.86 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.685 -0.758 . . . . 0.0 111.546 -176.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -154.55 169.41 23.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -163.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.31 122.74 27.82 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.082 0.553 . . . . 0.0 110.849 165.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.565 1.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.631 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 CA--C 1.58 2.122 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -74.49 163.38 27.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.807 -1.183 . . . . 0.0 113.054 170.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.76 67.8 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.735 2.865 . . . . 0.0 118.735 -177.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -71.27 -38.0 71.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 167.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.63 -47.77 84.28 Favored 'General case' 0 CA--C 1.587 2.386 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.93 -38.3 90.52 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.267 10.8 pt-20 -62.59 -37.17 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 163.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.55 -49.07 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 119.798 1.181 . . . . 0.0 113.364 163.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -57.99 -49.22 77.58 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 171.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.95 -34.8 66.0 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 171.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.15 -49.15 62.87 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 170.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.293 7.0 tt -59.71 -42.49 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 168.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -56.22 -51.71 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 166.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.92 -52.26 66.51 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -63.49 -42.13 98.55 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.76 -47.26 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.581 1.082 . . . . 0.0 112.78 170.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 t -63.81 -30.34 71.44 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -92.76 -40.21 10.8 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -114.86 -26.16 7.91 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.85 -27.58 11.82 Favored Glycine 0 CA--C 1.547 2.035 0 N-CA-C 118.714 2.246 . . . . 0.0 118.714 -174.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 51.6 mtm -106.48 119.6 51.23 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 119.309 1.554 . . . . 0.0 114.456 -156.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -58.87 116.97 3.63 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 N-CA-C 119.743 2.939 . . . . 0.0 119.743 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.61 127.55 16.56 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.56 2.173 . . . . 0.0 114.647 170.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -90.88 -74.15 0.51 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -142.07 -37.52 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.78 56.41 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -60.48 -41.91 95.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.86 -49.06 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 169.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.54 95.25 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 170.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.66 -44.12 87.27 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -74.11 -49.19 24.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 177.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.9 -12.25 36.71 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.46 54.15 2.61 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 178.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -100.92 110.17 22.19 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -53.71 -33.91 57.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 -177.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -112.51 135.94 21.49 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.415 163.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.94 -31.1 26.02 Favored 'Trans proline' 0 N--CA 1.509 2.409 0 N-CA-C 118.826 2.587 . . . . 0.0 118.826 165.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -55.99 -33.12 64.55 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 167.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -44.48 79.99 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -47.56 81.21 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 165.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.05 -44.37 74.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.56 -36.15 82.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 173.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -62.61 -44.44 96.29 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 tt -53.13 -46.12 68.66 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 120.903 1.683 . . . . 0.0 115.478 167.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.65 -47.88 81.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.36 83.64 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.96 -52.44 60.65 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 163.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.95 93.32 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 tpt85 -62.71 -38.49 90.66 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.936 2.198 . . . . 0.0 116.936 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.0 -46.27 82.12 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 166.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.27 39.29 0.45 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.41 -16.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.059 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -135.87 131.1 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 CA-C-N 119.267 0.939 . . . . 0.0 110.381 177.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.64 119.21 33.74 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.99 102.91 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.819 0 CA-C-O 121.527 0.68 . . . . 0.0 109.365 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.09 94.62 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.0 m -84.94 100.36 11.57 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.872 0.844 . . . . 0.0 112.969 -160.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.32 -62.59 0.17 Allowed Glycine 0 N--CA 1.484 1.854 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.632 -172.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 142.09 35.04 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 168.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.7 m -57.83 -43.66 85.93 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -99.62 78.88 2.2 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 163.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.64 87.14 0.37 Allowed Glycine 0 N--CA 1.486 2.02 0 CA-C-N 116.266 -0.425 . . . . 0.0 113.348 -174.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -146.86 129.5 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -175.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -114.01 156.41 24.12 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.984 0.897 . . . . 0.0 112.867 170.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.8 mt -101.49 123.87 46.24 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -162.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.575 1.93 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 163.276 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.571 1.754 0 CA-C-O 121.572 0.701 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -75.08 162.78 28.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.568 -0.708 . . . . 0.0 112.895 168.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.08 -55.22 10.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -169.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -67.96 -30.07 69.27 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -63.39 -42.29 98.79 Favored 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 164.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -58.91 -47.11 86.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 167.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -51.54 -50.61 59.69 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 165.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.85 -50.82 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.79 -51.68 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 170.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -59.73 -33.84 72.15 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.55 -51.0 69.11 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 164.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.1 mt -55.59 -52.27 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 172.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -48.44 -50.01 32.9 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 168.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.44 -44.92 93.15 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -62.75 -41.02 99.01 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.12 -43.15 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.405 1.002 . . . . 0.0 113.593 167.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 t -55.17 -45.92 75.74 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.55 -41.45 10.24 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -96.8 -33.58 11.62 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.98 -39.16 3.01 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.7 ptp -94.78 150.56 38.08 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -169.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.09 120.82 6.2 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.278 1.985 . . . . 0.0 113.626 169.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.16 156.31 42.29 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.607 1.967 . . . . 0.0 116.856 -172.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 t -89.59 176.94 6.68 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.723 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -47.95 -44.59 30.35 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.328 3.085 . . . . 0.0 119.328 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.24 83.83 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -61.0 -48.04 83.68 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.7 -45.19 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 170.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.64 75.74 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 173.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -41.38 67.14 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp85 -81.13 -26.71 35.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -178.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.08 -51.94 6.3 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-N 120.614 1.552 . . . . 0.0 114.877 165.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.76 75.14 0.4 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.479 0.581 . . . . 0.0 113.86 -170.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -118.31 133.53 55.81 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 123.608 0.763 . . . . 0.0 109.537 172.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -42.76 95.56 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 163.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.9 m -109.62 113.31 58.02 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.293 -175.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.91 -36.73 64.96 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 N-CA-C 118.568 2.488 . . . . 0.0 118.568 169.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -66.76 -25.85 66.69 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 171.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.49 85.2 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.76 -39.69 78.01 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 163.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -61.27 -53.23 59.5 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 168.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.66 -41.03 94.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 176.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -61.45 -44.64 96.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 165.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.8 tp -48.1 -51.39 24.76 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 121.22 1.827 . . . . 0.0 115.87 166.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -62.88 -52.12 64.32 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 172.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.61 81.15 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.27 -54.68 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 165.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.53 52.4 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 175.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.99 9.33 19.86 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -177.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.42 -47.36 82.25 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 120.742 -1.224 . . . . 0.0 113.464 144.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.14 60.7 0.04 OUTLIER Glycine 0 N--CA 1.48 1.576 0 C-N-CA 123.932 0.777 . . . . 0.0 114.068 174.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.77 -43.37 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.86 150.7 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.064 0.847 . . . . 0.0 110.989 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -96.77 117.91 32.07 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.211 0.605 . . . . 0.0 110.779 172.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.55 140.26 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.591 1.186 . . . . 0.0 110.047 176.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.93 134.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.415 172.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 m -72.59 97.03 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.477 -0.765 . . . . 0.0 112.58 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.24 -70.51 0.5 Allowed Glycine 0 N--CA 1.485 1.914 0 CA-C-N 115.547 -0.752 . . . . 0.0 113.004 -167.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 107.23 9.04 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.5 m -72.96 -14.23 61.41 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -82.47 102.82 11.58 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 145.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.45 -114.56 0.11 Allowed Glycine 0 N--CA 1.482 1.714 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -137.89 -65.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -134.48 136.26 43.04 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.099 1.318 . . . . 0.0 112.905 -161.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tt -89.83 119.41 30.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 156.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 1.6 pp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -167.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -72.95 157.74 36.83 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.83 -37.96 69.4 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 172.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -70.8 -33.37 70.65 Favored 'General case' 0 CA--C 1.579 2.077 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -58.33 -42.08 86.0 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 160.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -62.27 -40.78 97.34 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -51.27 -54.07 29.42 Favored 'General case' 0 CA--C 1.584 2.285 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 162.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.81 -49.39 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -55.36 -39.83 70.56 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 169.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.0 -45.88 76.21 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 171.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.72 -37.01 76.37 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 121.962 2.165 . . . . 0.0 116.569 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.291 0.2 OUTLIER -57.54 -48.83 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-N 120.376 1.444 . . . . 0.0 114.4 169.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.65 -47.98 83.82 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 166.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.49 -44.88 96.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -57.48 -39.61 76.8 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 171.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.37 -46.2 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 170.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 t -67.09 -27.37 67.3 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 168.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.11 -46.77 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -124.87 -39.41 2.27 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.02 -27.73 3.28 Favored Glycine 0 CA--C 1.548 2.101 0 N-CA-C 117.442 1.737 . . . . 0.0 117.442 -173.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.72 149.11 35.43 Favored Pre-proline 0 CA--C 1.579 2.078 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -164.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.39 113.91 1.76 Allowed 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 122.481 2.121 . . . . 0.0 114.241 172.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.05 160.43 23.8 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -168.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -105.99 -174.38 2.52 Favored 'General case' 0 CA--C 1.587 2.38 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.557 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -46.44 -30.33 2.12 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 120.16 3.393 . . . . 0.0 120.16 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.48 69.93 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 170.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.38 -46.87 8.1 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 163.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.29 -45.08 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 120.254 1.388 . . . . 0.0 114.311 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.65 69.58 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 171.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -74.11 -52.0 13.94 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -71.2 -37.4 72.11 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.0 mt -78.44 -8.95 59.07 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.84 51.99 4.04 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 117.46 1.744 . . . . 0.0 117.46 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.33 99.73 12.7 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 118.014 0.907 . . . . 0.0 111.265 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -60.01 -20.24 56.76 Favored 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 165.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.1 p -111.89 92.92 18.97 Favored Pre-proline 0 CA--C 1.572 1.792 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.597 162.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -55.94 -32.42 85.54 Favored 'Trans proline' 0 N--CA 1.512 2.562 0 N-CA-C 120.149 3.096 . . . . 0.0 120.149 -175.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -57.4 -34.64 69.1 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 170.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.32 63.18 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 172.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.96 -56.6 13.19 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.74 -18.68 37.03 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 -40.18 88.11 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.161 1.8 . . . . 0.0 115.005 165.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -61.67 -38.01 86.19 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 162.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.33 -41.48 80.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -61.44 -44.48 97.04 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 169.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.45 75.07 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 163.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.74 -41.01 97.09 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 167.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.97 -47.07 81.87 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 164.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -53.91 -45.79 71.27 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 170.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -66.7 -33.61 76.03 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 170.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.32 63.81 0.67 Allowed Glycine 0 N--CA 1.483 1.783 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -33.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.49 153.04 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-O 121.987 0.899 . . . . 0.0 111.338 169.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -105.28 104.23 13.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 110.514 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.93 110.77 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 O-C-N 121.483 -0.761 . . . . 0.0 109.018 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -94.39 138.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.474 0.71 . . . . 0.0 109.314 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.7 t -78.49 78.16 4.96 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 175.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.53 99.2 0.18 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.188 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 63.26 19.03 11.43 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 119.779 3.251 . . . . 0.0 119.779 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.371 51.9 p 71.97 -58.53 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -84.06 77.35 9.95 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 122.492 1.139 . . . . 0.0 111.914 172.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.42 77.39 0.26 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.261 174.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.48 115.61 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.61 ' HE ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.42 170.7 9.18 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.61 ' H ' ' HE ' ' A' ' 67' ' ' ARG . 10.1 mp -95.14 133.4 39.01 Favored 'General case' 0 CA--C 1.571 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 112.114 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.568 1.641 0 CA-C-O 121.809 0.814 . . . . 0.0 109.243 174.337 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.569 1.676 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.7 p -81.64 158.79 24.18 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.44 -40.13 71.17 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 174.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -64.52 -37.82 88.88 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -58.5 -45.56 88.5 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -64.85 -38.81 92.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 171.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -51.44 -48.4 62.74 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 161.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.3 t -59.77 -47.76 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.81 -44.41 86.34 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 170.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 170.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 -44.72 69.15 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.083 1.765 . . . . 0.0 114.994 175.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.316 0.2 OUTLIER -56.04 -47.78 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.634 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 167.234 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -54.15 -53.14 57.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 167.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.51 -46.28 90.66 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 178.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -70.06 -34.83 73.71 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.06 -49.96 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 120.0 1.273 . . . . 0.0 113.412 161.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 t -68.38 -32.34 72.34 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 176.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -90.59 -48.66 6.94 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 m -102.39 -38.52 7.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.19 32.3 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 118.156 2.023 . . . . 0.0 118.156 -169.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 mtm -97.03 144.14 27.34 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-N 119.548 1.674 . . . . 0.0 113.732 -174.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.03 114.4 2.87 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 C-N-CA 122.418 2.078 . . . . 0.0 113.68 174.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.54 124.57 7.09 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 CA-C-N 122.492 1.926 . . . . 0.0 115.035 -175.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 p -90.43 179.39 5.88 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -31.4 -45.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 121.596 3.924 . . . . 0.0 121.596 -178.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.53 -44.48 78.24 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 175.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -71.44 -44.16 65.36 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 172.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -50.91 -46.92 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.24 97.64 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 169.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -64.27 -46.88 81.77 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.01 -43.07 30.54 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.94 -21.2 26.4 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 51.43 2.05 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 178.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -101.82 102.25 12.83 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.103 0.951 . . . . 0.0 108.906 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -55.31 -37.8 67.85 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 179.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.8 m -104.17 116.01 62.14 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.393 164.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -53.07 -17.97 8.97 Favored 'Trans proline' 0 N--CA 1.51 2.463 0 N-CA-C 120.577 3.26 . . . . 0.0 120.577 173.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.85 -28.15 69.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 165.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -38.13 89.95 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.72 94.76 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 163.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -55.56 -46.68 77.15 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 165.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.63 -49.53 72.6 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 174.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -70.21 -32.87 70.96 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.5 -54.85 41.03 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.503 1.956 . . . . 0.0 114.448 165.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.82 -44.04 94.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.49 94.71 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.03 -38.47 88.82 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.01 82.22 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 165.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -68.08 -27.14 66.24 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 173.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.93 -34.88 73.82 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 160.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.94 -37.09 1.11 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 173.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.57 4.81 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -156.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.82 144.94 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 CA-C-N 120.246 1.385 . . . . 0.0 113.192 167.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -105.58 113.61 27.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.53 116.9 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.08 107.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 122.187 0.994 . . . . 0.0 112.667 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -84.46 94.78 8.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.011 0.91 . . . . 0.0 111.978 -170.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.51 -77.1 0.28 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.784 -167.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.6 -20.13 65.32 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 174.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.33 18.8 m 77.65 -70.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 171.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -84.75 72.65 10.71 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 123.114 1.435 . . . . 0.0 113.331 175.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.88 71.27 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.766 165.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.47 115.22 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -170.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -81.61 146.83 29.89 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.75 104.96 17.35 Favored 'General case' 0 CA--C 1.573 1.833 0 O-C-N 121.972 -0.455 . . . . 0.0 110.064 168.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.571 1.783 0 CA-C-O 121.732 0.777 . . . . 0.0 110.573 -179.837 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.9 p -75.07 159.1 32.11 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.17 -45.02 64.94 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.892 2.923 . . . . 0.0 118.892 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -69.07 -38.77 79.21 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 174.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 5.5 pt20 -70.31 -29.95 66.81 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 167.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -56.86 -47.76 79.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.99 -43.51 81.77 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.0 t -58.28 -48.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 168.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.51 -48.37 69.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 166.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.64 -37.42 73.3 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 170.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.43 -44.46 94.51 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 172.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.324 0.0 OUTLIER -61.98 -45.55 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 166.156 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -57.0 -46.89 81.97 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.85 -53.67 55.81 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 171.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -67.87 -36.55 80.48 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.32 -48.33 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-N 119.972 1.26 . . . . 0.0 112.563 167.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -63.23 -30.45 71.59 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 174.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -93.2 -42.92 9.1 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -107.98 -19.14 13.61 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.78 -48.39 1.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -173.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 149.86 43.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -62.14 148.05 93.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.412 2.075 . . . . 0.0 116.514 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.07 147.57 21.05 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.247 1.965 . . . . 0.0 115.243 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 p -75.23 165.33 25.36 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-O 122.492 1.139 . . . . 0.0 113.933 176.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -52.03 -43.74 63.86 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 176.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.04 80.4 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 169.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.45 -49.5 77.32 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 120.294 1.406 . . . . 0.0 114.598 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.67 -44.7 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 171.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.02 -52.44 16.95 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -89.73 -37.32 14.63 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -167.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -64.24 -37.74 88.55 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.516 1.672 . . . . 0.0 115.516 172.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.97 -9.69 59.71 Favored 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 170.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.99 54.74 4.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 117.489 1.755 . . . . 0.0 117.489 178.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -96.65 135.83 38.03 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 121.78 0.8 . . . . 0.0 111.777 176.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -40.57 92.08 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 175.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.1 t -119.49 125.57 27.44 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.267 171.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.42 -36.7 49.25 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 N-CA-C 118.673 2.528 . . . . 0.0 118.673 165.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.22 -36.0 72.51 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 169.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.05 73.71 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 165.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.55 -48.86 71.52 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 172.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -33.05 72.56 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 165.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -60.78 -40.84 94.1 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 164.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.84 -49.44 73.29 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 164.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.1 -46.92 86.9 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 174.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.48 80.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 171.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.44 -46.87 53.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 169.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.82 76.73 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 172.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -55.56 -26.93 46.15 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 169.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -71.17 -50.95 27.82 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 170.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 165.0 -43.23 0.29 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 119.025 2.37 . . . . 0.0 119.025 -177.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.12 -35.1 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -168.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.5 155.81 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 C-N-CA 123.755 0.822 . . . . 0.0 110.688 172.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -112.06 145.6 39.44 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 112.221 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.96 151.1 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.187 0.994 . . . . 0.0 111.839 177.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.1 m -59.81 139.64 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -167.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 t -81.7 72.48 8.75 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 121.538 0.685 . . . . 0.0 112.759 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 -73.55 2.45 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -176.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.41 138.5 39.32 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 m -55.7 -34.39 65.04 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.573 3.175 . . . . 0.0 119.573 -174.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -89.2 69.06 8.24 Favored 'General case' 0 CA--C 1.581 2.166 0 CA-C-N 119.895 1.225 . . . . 0.0 112.369 172.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.59 43.13 0.85 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -179.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.4 mt -102.1 103.58 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -176.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.86 129.32 35.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -175.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -90.98 69.84 6.33 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.654 0.782 . . . . 0.0 112.428 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.33 1.8 pp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 120.186 3.402 . . . . 0.0 120.186 -167.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 CA--C 1.572 1.805 0 CA-C-O 121.04 0.448 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.6 p -64.04 154.32 34.66 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.85 46.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -63.41 -56.11 18.92 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 169.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.36 -33.73 76.17 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 174.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -58.06 -49.53 76.59 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 170.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.82 -27.13 66.45 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.65 -56.3 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 119.866 1.212 . . . . 0.0 112.764 160.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.43 -50.71 70.85 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 172.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.49 -44.4 96.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 tp -56.99 -37.83 72.18 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.4 -49.46 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.714 1.143 . . . . 0.0 113.119 169.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -56.88 -48.47 78.08 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.3 -53.02 62.65 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -74.18 -34.8 63.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -176.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -60.7 -42.95 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.575 0 CA-C-N 120.159 1.345 . . . . 0.0 112.637 163.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.61 -49.63 57.74 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -78.03 -15.7 58.71 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -143.21 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 112.469 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.93 -26.53 5.05 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 118.114 2.006 . . . . 0.0 118.114 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -97.54 152.04 37.96 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.66 121.31 6.62 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 C-N-CA 121.945 1.763 . . . . 0.0 114.6 -176.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.29 106.69 2.27 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.437 2.092 . . . . 0.0 112.325 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.305 7.3 t -84.96 -169.15 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -173.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -55.53 -39.37 70.46 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -168.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.57 86.37 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 168.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -60.03 -46.21 90.28 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 170.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.57 -58.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 123.909 0.884 . . . . 0.0 113.243 172.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.71 85.28 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -75.37 -32.85 60.95 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 171.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -53.22 18.53 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 171.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.72 -26.15 20.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.0 52.97 0.81 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -95.34 107.46 19.58 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 118.185 0.993 . . . . 0.0 110.053 170.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.48 53.53 2.69 Favored 'General case' 0 CA--C 1.584 2.262 0 O-C-N 121.29 -0.881 . . . . 0.0 113.078 169.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -178.32 111.32 0.22 Allowed Pre-proline 0 CA--C 1.577 2.015 0 C-N-CA 124.852 1.261 . . . . 0.0 109.158 -174.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.57 -38.7 75.87 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 N-CA-C 118.417 2.429 . . . . 0.0 118.417 169.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.88 -33.68 73.47 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 171.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -50.63 68.93 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.52 -48.83 76.4 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 170.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -43.48 92.73 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 171.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.86 -38.19 88.18 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 174.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -69.84 -35.65 74.92 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 168.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.45 -50.67 64.78 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.484 1.493 . . . . 0.0 114.659 160.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -51.6 -45.05 63.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 167.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.0 -39.09 65.75 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 169.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.98 -45.95 72.71 Favored 'General case' 0 CA--C 1.583 2.231 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 167.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.98 86.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 170.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -66.06 -37.75 86.6 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.42 -41.8 93.2 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 161.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 48.56 0.21 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 166.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.53 -35.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 pt -107.98 144.05 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 120.962 1.71 . . . . 0.0 113.412 -179.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.21 115.35 27.29 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 172.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.35 122.93 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.5 116.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 167.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -94.88 91.53 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.976 176.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.04 -63.14 0.49 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 114.818 0.687 . . . . 0.0 114.818 -174.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.14 164.9 25.24 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 174.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -76.52 -67.06 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 177.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -89.54 78.85 6.99 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 122.795 1.283 . . . . 0.0 113.544 -169.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.22 66.34 0.31 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.246 171.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.5 mm -130.7 96.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.64 137.19 26.48 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -164.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 mt -76.19 136.31 39.75 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.82 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.574 1.891 0 CA-C-O 121.777 0.799 . . . . 0.0 110.057 174.893 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 121.412 0.625 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -105.45 65.39 0.72 Allowed 'General case' 0 CA--C 1.579 2.071 0 CA-C-O 121.651 0.738 . . . . 0.0 110.129 172.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.88 79.02 5.97 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.033 -1.042 . . . . 0.0 112.531 -176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.9 mt -128.93 148.16 50.9 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.866 0.841 . . . . 0.0 111.964 -168.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.7 p -71.75 147.99 46.78 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 121.765 -0.585 . . . . 0.0 111.841 167.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.99 -39.77 56.39 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.971 2.952 . . . . 0.0 118.971 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -66.97 -46.71 73.8 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 170.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -54.61 -45.96 73.75 Favored 'General case' 0 CA--C 1.592 2.568 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 164.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -58.99 -41.93 88.79 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -63.72 -40.0 95.67 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 165.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.93 -44.39 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 120.259 1.391 . . . . 0.0 113.7 167.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -54.2 -47.91 71.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 165.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -60.33 -39.28 86.51 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD21 ' HE ' ' A' ' 34' ' ' ARG . 36.5 mt -57.63 -29.84 64.87 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm -58.89 -50.8 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.267 0 CA-C-N 120.036 1.289 . . . . 0.0 113.027 164.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.2 mtp85 -65.05 -46.06 82.83 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.36 -42.25 96.29 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -36.03 81.73 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.187 1.812 . . . . 0.0 115.301 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.2 mm -59.91 -53.45 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.172 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 164.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -72.68 -37.24 67.96 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -92.38 1.13 57.41 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.2 m -150.07 -57.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 120.024 1.284 . . . . 0.0 111.218 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 138.57 -29.83 2.55 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -105.19 145.3 30.5 Favored Pre-proline 0 CA--C 1.569 1.707 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.39 146.89 22.37 Favored 'Trans proline' 0 CA--C 1.567 2.17 0 CA-C-N 122.421 1.9 . . . . 0.0 114.26 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.38 146.64 13.95 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.211 1.825 . . . . 0.0 116.535 -161.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.8 p -73.7 161.81 29.86 Favored 'General case' 0 CA--C 1.577 2.014 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.321 165.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -34.41 67.79 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.17 83.13 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 163.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -68.68 -40.77 79.95 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 169.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.13 -47.2 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.309 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 162.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.6 -35.7 72.85 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 170.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.72 -42.89 81.24 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' HE ' HD21 ' A' ' 14' ' ' LEU . 2.5 tmm_? -77.64 -55.34 5.43 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 120.275 1.398 . . . . 0.0 113.893 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.0 -20.67 60.26 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.24 58.97 2.49 Favored Glycine 0 N--CA 1.48 1.628 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -95.78 126.88 41.35 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.2 ppt_? -54.08 -28.24 37.83 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 119.071 2.989 . . . . 0.0 119.071 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.9 m -155.97 158.15 31.57 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 123.852 0.861 . . . . 0.0 111.335 170.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -46.36 -31.54 9.61 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 N-CA-C 120.375 3.183 . . . . 0.0 120.375 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -54.33 -34.42 61.0 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.732 2.864 . . . . 0.0 118.732 166.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.44 -40.79 42.13 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 167.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.44 84.61 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 117.223 2.305 . . . . 0.0 117.223 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.87 -34.8 72.02 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.44 -43.58 88.81 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -70.34 -41.96 72.51 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 169.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.24 -50.67 58.72 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -67.73 -37.73 82.61 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.15 89.57 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.7 mt -57.09 -44.22 82.94 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 163.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.91 96.24 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -58.64 -40.03 82.22 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.72 -22.34 65.28 Favored 'General case' 0 CA--C 1.58 2.116 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.71 17.69 37.67 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 118.925 2.33 . . . . 0.0 118.925 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.34 -21.45 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.009 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.2 pt -139.48 143.94 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.165 0 CA-C-N 120.511 1.505 . . . . 0.0 111.9 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -110.82 111.01 21.87 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 124.811 1.245 . . . . 0.0 109.269 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -95.36 128.88 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.68 133.45 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -85.18 86.51 7.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.322 -0.862 . . . . 0.0 112.146 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.23 -72.61 0.24 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.62 120.83 25.57 Favored 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.7 t -59.52 -35.7 74.69 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 118.45 2.759 . . . . 0.0 118.45 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -97.89 84.28 3.3 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.163 0.892 . . . . 0.0 110.337 167.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.19 85.03 0.13 Allowed Glycine 0 N--CA 1.482 1.738 0 O-C-N 121.919 -0.488 . . . . 0.0 112.908 175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.3 mt -130.06 109.77 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.792 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -95.21 126.36 40.48 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.217 0.607 . . . . 0.0 109.751 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.46 125.49 29.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.808 -1.182 . . . . 0.0 113.565 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt -85.55 -50.31 7.35 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.37 154.28 27.83 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-O 121.623 0.725 . . . . 0.0 111.919 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.297 5.8 tp10 75.48 -68.03 0.22 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.659 1.184 . . . . 0.0 113.742 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 123.884 1.802 . . . . 0.0 111.18 -177.123 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 CA--C 1.562 1.421 0 CA-C-O 121.848 0.832 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -75.01 120.3 20.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.819 -0.551 . . . . 0.0 111.289 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.1 103.95 3.45 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.3 2.1 pt? -61.81 -61.96 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.1 p -138.14 143.05 40.15 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 154.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 119.402 3.112 . . . . 0.0 119.402 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -78.31 -25.71 46.68 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.982 2.216 . . . . 0.0 116.982 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.28 6.7 pt20 -70.07 -34.91 73.78 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 121.607 2.003 . . . . 0.0 115.807 160.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -57.4 -41.77 80.97 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 162.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -54.84 -45.96 74.57 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 164.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.3 t -56.58 -48.2 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.39 -48.4 81.79 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.58 -37.7 73.63 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 169.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.6 tp -64.33 -42.28 96.36 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 164.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.2 mt -57.76 -46.03 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.938 1.699 . . . . 0.0 113.483 170.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -62.36 -49.24 76.35 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.64 -56.87 12.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -58.88 -40.29 83.95 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -44.07 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 167.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 t -70.67 -24.03 62.61 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 118.691 2.849 . . . . 0.0 118.691 170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -112.53 -47.33 3.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.573 1.149 . . . . 0.0 113.481 -167.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -85.59 -43.52 13.42 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 125.95 -39.87 1.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 117.031 1.573 . . . . 0.0 117.031 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -96.22 151.13 37.97 Favored Pre-proline 0 CA--C 1.568 1.653 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.96 124.04 9.79 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 CA-C-N 122.185 1.816 . . . . 0.0 113.427 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -76.9 114.48 3.84 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.182 1.921 . . . . 0.0 115.607 -167.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 t -83.59 -172.73 4.31 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -33.2 -58.19 0.39 Allowed 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 118.993 2.961 . . . . 0.0 118.993 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.93 92.76 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.52 -40.32 89.1 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 172.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.8 mm -60.59 -52.11 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 119.922 1.237 . . . . 0.0 113.349 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -67.42 -48.68 66.59 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -72.74 -44.33 61.79 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.1 mt -86.67 -9.64 55.55 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.541 2.422 . . . . 0.0 117.541 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.39 61.04 3.08 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -90.63 103.37 16.08 Favored 'General case' 0 CA--C 1.566 1.577 0 CA-C-O 121.862 0.839 . . . . 0.0 111.435 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -9.75 57.55 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 161.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -107.25 109.5 62.85 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-O 117.496 -1.24 . . . . 0.0 110.725 -169.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.73 -44.55 40.28 Favored 'Trans proline' 0 N--CA 1.509 2.422 0 N-CA-C 120.159 3.1 . . . . 0.0 120.159 -173.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -67.01 -42.99 83.99 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.71 -47.45 73.7 Favored 'General case' 0 CA--C 1.558 1.274 0 N-CA-C 119.315 3.08 . . . . 0.0 119.315 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.29 75.51 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.5 -37.98 20.64 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.55 -35.54 80.81 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -60.13 -38.42 83.02 Favored 'General case' 0 CA--C 1.583 2.235 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 163.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.58 -45.81 92.57 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 168.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.06 -41.4 83.26 Favored 'General case' 0 CA--C 1.582 2.207 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -44.09 94.76 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 mt -57.68 -41.95 82.63 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 167.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.67 91.01 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 166.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -58.6 -40.97 84.72 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 171.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -71.89 -15.96 62.12 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.58 3.86 55.02 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 119.733 2.653 . . . . 0.0 119.733 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.13 -17.8 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.8 pt -130.79 129.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 120.052 1.297 . . . . 0.0 110.813 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -90.68 115.94 28.16 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.247 -0.908 . . . . 0.0 109.916 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.02 132.23 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.971 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.68 118.9 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.677 -0.639 . . . . 0.0 109.376 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.4 t -77.53 69.96 3.85 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.86 39.63 0.07 OUTLIER Glycine 0 CA--C 1.548 2.096 0 N-CA-C 116.448 1.339 . . . . 0.0 116.448 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.99 125.28 5.63 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.675 1.238 . . . . 0.0 110.231 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 60.4 m -59.53 -47.02 87.14 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 mtm105 -109.61 89.11 2.91 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.62 85.49 0.19 Allowed Glycine 0 N--CA 1.484 1.853 0 CA-C-N 116.394 -0.366 . . . . 0.0 113.779 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.24 114.56 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.946 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -96.09 117.28 30.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.213 0.605 . . . . 0.0 110.757 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -74.99 105.17 5.87 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.22 81.61 7.29 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 122.621 1.201 . . . . 0.0 109.135 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -79.66 124.26 28.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -161.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.02 22.07 0.07 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 CA--C 1.559 1.305 0 CA-C-O 124.34 2.019 . . . . 0.0 108.449 -177.715 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -120.91 97.91 5.75 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.633 0.73 . . . . 0.0 110.677 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.62 89.2 7.89 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-O 121.538 0.685 . . . . 0.0 112.069 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 98.5 mt -120.81 118.79 30.9 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-O 121.418 0.628 . . . . 0.0 111.037 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -68.45 159.68 31.2 Favored 'General case' 0 CA--C 1.578 2.049 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.05 -45.96 52.69 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 119.153 3.02 . . . . 0.0 119.153 -172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -71.08 -39.91 71.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -67.44 -33.98 76.26 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 167.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -56.8 -42.92 80.35 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 115.791 1.775 . . . . 0.0 115.791 165.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -53.19 -43.77 67.43 Favored 'General case' 0 CA--C 1.581 2.165 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 164.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.29 -48.5 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -56.64 -47.03 80.62 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -53.1 -43.24 66.7 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 168.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.76 -39.06 79.89 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 mm -59.61 -48.49 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.259 0 CA-C-N 120.216 1.371 . . . . 0.0 113.457 173.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.9 mtp180 -59.45 -49.44 77.8 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 166.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.37 -49.48 73.7 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -62.07 -35.68 79.37 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 121.449 1.931 . . . . 0.0 115.978 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.52 -43.3 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 119.51 1.05 . . . . 0.0 113.029 165.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -64.82 -33.82 76.89 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -82.55 -47.18 12.44 Favored 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 p -102.56 -23.97 13.83 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.31 -34.37 4.62 Favored Glycine 0 CA--C 1.552 2.36 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 -159.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.13 154.6 40.55 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -170.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.82 152.3 63.73 Favored 'Trans proline' 0 CA--C 1.567 2.129 0 C-N-CA 122.056 1.837 . . . . 0.0 114.929 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -84.49 144.65 10.29 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 122.294 1.855 . . . . 0.0 115.094 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 58.6 p -76.47 161.33 28.73 Favored 'General case' 0 CA--C 1.577 2.011 0 O-C-N 121.877 -0.514 . . . . 0.0 112.285 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -50.69 -28.54 9.21 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.84 -36.53 80.51 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 163.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -62.02 -45.84 91.81 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 120.586 1.539 . . . . 0.0 114.518 163.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 mp -56.04 -53.07 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.136 0 CA-C-N 119.799 1.181 . . . . 0.0 112.603 170.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.5 99.01 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -78.01 -48.21 16.68 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -70.26 -41.87 72.91 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -90.12 -17.6 27.37 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.74 62.32 1.95 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 116.772 1.469 . . . . 0.0 116.772 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -90.82 148.2 22.68 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 122.426 1.108 . . . . 0.0 113.136 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -35.48 73.75 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -144.94 149.76 43.64 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.843 167.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.36 -33.06 21.58 Favored 'Trans proline' 0 N--CA 1.509 2.383 0 N-CA-C 119.393 2.805 . . . . 0.0 119.393 163.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -65.78 -37.1 85.39 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 167.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.4 -42.6 96.01 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 167.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.23 -49.49 63.88 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 164.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.98 -34.4 76.48 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.934 1.828 . . . . 0.0 115.934 171.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.81 -46.62 84.4 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -63.48 -39.32 94.15 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -53.89 -47.34 71.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 166.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -59.45 -35.75 74.64 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.37 -18.79 65.28 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 118.665 2.839 . . . . 0.0 118.665 169.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.71 -46.0 84.18 Favored 'General case' 0 CA--C 1.592 2.594 0 CA-C-N 119.913 1.233 . . . . 0.0 113.668 159.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.05 175.38 4.52 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 164.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.296 1.6 mpt_? 75.74 -54.71 0.62 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.245 -0.909 . . . . 0.0 113.157 -173.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -61.6 -56.58 18.33 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 156.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.22 52.28 0.18 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 117.982 1.953 . . . . 0.0 117.982 169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.298 10.2 p -116.04 -20.64 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 168.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.24 155.61 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 122.218 2.281 . . . . 0.0 113.287 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -83.21 128.08 34.18 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.914 -0.491 . . . . 0.0 111.577 161.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.1 mt -73.83 134.23 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.7 p -83.11 116.79 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.738 0.78 . . . . 0.0 111.917 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -85.53 100.85 12.2 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.738 -0.601 . . . . 0.0 112.267 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.42 -64.74 0.58 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.81 30.85 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.8 m -75.84 -38.84 57.64 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -173.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -134.33 100.12 4.58 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 119.612 1.096 . . . . 0.0 112.306 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.98 64.79 0.45 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.809 167.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.5 mm -115.7 96.21 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.719 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -86.89 133.24 33.63 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 122.928 0.491 . . . . 0.0 112.103 169.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.47 125.19 28.94 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-O 121.737 0.78 . . . . 0.0 112.56 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.3 mt -93.14 -61.61 1.54 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 123.957 0.903 . . . . 0.0 112.679 -171.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -82.33 87.83 6.57 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 122.054 0.93 . . . . 0.0 108.816 163.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.19 -58.53 7.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -146.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 123.024 1.392 . . . . 0.0 108.475 175.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -93.49 67.93 4.05 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.121 0.962 . . . . 0.0 113.27 -162.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.99 100.68 11.6 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.328 0.651 . . . . 0.0 111.939 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.7 mt -84.94 118.27 24.44 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -170.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.0 p -66.09 154.89 38.38 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.59 -47.96 28.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -71.11 -41.71 70.23 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.49 -37.19 86.09 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -58.06 -49.2 77.72 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.335 1.605 . . . . 0.0 115.335 170.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.23 -36.3 79.58 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 168.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.47 -50.6 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 CA-C-N 119.465 1.03 . . . . 0.0 113.333 165.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -50.21 -51.68 42.16 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 166.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.55 -39.16 92.74 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.76 -46.27 86.02 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 121.263 1.847 . . . . 0.0 115.043 171.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.282 36.6 pt -59.06 -46.18 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -54.78 -51.05 66.96 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 165.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.28 -38.2 90.22 Favored 'General case' 0 CA--C 1.564 1.51 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -72.16 -30.18 64.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 116.43 2.011 . . . . 0.0 116.43 168.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 72.0 mt -60.59 -42.3 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.746 1.157 . . . . 0.0 112.908 160.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.9 t -64.89 -31.05 72.09 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -74.3 -43.24 57.59 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.4 p -125.96 -18.18 5.15 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.29 -43.14 1.95 Allowed Glycine 0 CA--C 1.546 1.978 0 N-CA-C 116.803 1.481 . . . . 0.0 116.803 -165.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.05 147.0 32.89 Favored Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -58.15 146.3 88.88 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 N-CA-C 118.886 2.61 . . . . 0.0 118.886 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.45 120.32 3.97 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.528 2.152 . . . . 0.0 112.58 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -89.21 82.02 6.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.508 -0.745 . . . . 0.0 111.624 -169.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.323 23.5 tpt180 66.66 -52.59 0.44 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 116.79 2.145 . . . . 0.0 116.79 -170.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.73 -54.07 50.48 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 117.773 2.509 . . . . 0.0 117.773 -167.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.6 -31.17 71.03 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.8 mt -61.21 -53.97 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.108 0 CA-C-N 118.941 0.791 . . . . 0.0 112.129 172.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.88 85.21 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -72.02 -52.11 18.55 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.54 -40.91 28.45 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.63 -24.73 26.98 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.53 81.2 1.33 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 119.411 1.005 . . . . 0.0 114.718 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -120.72 102.9 8.71 Favored 'General case' 0 CA--C 1.566 1.582 0 CA-C-N 117.678 0.739 . . . . 0.0 109.658 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.98 -25.97 61.19 Favored 'General case' 0 CA--C 1.583 2.216 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.3 m -98.2 127.13 37.53 Favored Pre-proline 0 CA--C 1.566 1.56 0 CA-C-O 117.47 -1.252 . . . . 0.0 112.327 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.31 -49.27 14.67 Favored 'Trans proline' 0 N--CA 1.508 2.37 0 N-CA-C 119.332 2.782 . . . . 0.0 119.332 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -94.27 75.63 3.97 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.156 0.979 . . . . 0.0 111.444 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.77 -48.61 0.96 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 114.982 -1.008 . . . . 0.0 113.034 168.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.11 -35.57 80.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.22 -45.87 92.78 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -61.89 -29.21 70.05 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 168.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -62.47 -47.42 84.11 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 120.317 1.417 . . . . 0.0 114.301 161.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -56.46 -43.31 79.42 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 168.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -60.29 -46.14 90.89 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.3 -44.84 88.73 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 167.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.78 -43.19 94.52 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.13 -46.39 71.01 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -59.72 -40.22 87.28 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -65.11 -30.34 71.27 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 166.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.7 17.21 7.6 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.49 -13.95 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.102 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 pt -137.79 134.55 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 119.863 1.211 . . . . 0.0 111.885 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.19 108.72 19.42 Favored 'General case' 0 CA--C 1.561 1.399 0 C-N-CA 123.164 0.585 . . . . 0.0 110.563 168.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.4 mt -93.38 119.35 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.3 t -83.25 98.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.9 m -68.84 98.49 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 137.92 -55.68 0.68 Allowed Glycine 0 N--CA 1.486 2.009 0 CA-C-N 115.454 -0.794 . . . . 0.0 114.34 -163.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -84.9 116.96 23.63 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.6 p -53.68 -41.26 66.68 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -104.49 41.73 1.29 Allowed 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.62 72.8 0.3 Allowed Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.467 -0.771 . . . . 0.0 112.746 165.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.3 mt -131.26 93.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -121.58 133.02 55.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.798 -0.564 . . . . 0.0 111.81 -155.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.92 114.78 11.45 Favored 'General case' 0 CA--C 1.578 2.038 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -165.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.9 mt -90.42 86.73 6.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 121.839 0.828 . . . . 0.0 109.171 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.598 2.0 pp0? 58.78 -140.1 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.68 -70.94 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.933 0.788 . . . . 0.0 112.834 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 125.278 2.466 . . . . 0.0 109.436 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 CA--C 1.56 1.34 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -118.2 87.18 2.67 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.494 0.664 . . . . 0.0 110.955 -165.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.68 81.68 3.87 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.255 1.026 . . . . 0.0 113.06 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -111.56 146.01 38.11 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 p -75.88 157.26 33.49 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.54 72.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.01 2.967 . . . . 0.0 119.01 -172.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -71.8 -31.39 66.53 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -69.89 -31.25 68.95 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 161.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -60.62 -43.47 97.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 165.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -55.06 -45.15 75.28 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 165.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.9 t -56.63 -50.23 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -53.13 -47.74 68.44 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.56 -44.22 89.62 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.48 -37.03 86.12 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 168.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -60.23 -48.62 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 118.05 -0.976 . . . . 0.0 113.208 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -51.23 -46.37 62.26 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -49.24 78.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -71.34 -27.68 63.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.8 mm -51.48 -43.24 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.265 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 158.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.0 t -77.09 -35.44 56.52 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -71.32 -29.47 65.06 Favored 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -146.75 -49.7 0.2 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.129 0.971 . . . . 0.0 112.006 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.28 18.37 0.93 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 118.038 1.975 . . . . 0.0 118.038 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptp -155.96 159.18 31.73 Favored Pre-proline 0 CA--C 1.576 1.946 0 CA-C-N 119.652 1.726 . . . . 0.0 113.43 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -55.83 128.67 31.25 Favored 'Trans proline' 0 CA--C 1.568 2.204 0 C-N-CA 122.623 2.216 . . . . 0.0 115.015 160.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.91 175.18 11.71 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 123.831 2.404 . . . . 0.0 115.55 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.0 p -66.79 154.74 40.06 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -22.61 64.92 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.43 -46.64 69.31 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 160.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.6 -53.21 60.77 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 168.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.7 mt -60.58 -43.11 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.17 -48.75 78.67 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -79.79 -35.06 39.09 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -70.68 -39.28 73.61 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 -20.19 21.75 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.95 49.16 2.52 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 117.509 1.764 . . . . 0.0 117.509 -177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -105.27 111.36 24.07 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -83.05 56.91 3.66 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 m 171.59 114.17 0.05 OUTLIER Pre-proline 0 CA--C 1.582 2.197 0 C-N-CA 126.148 1.779 . . . . 0.0 107.685 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.7 -33.72 60.95 Favored 'Trans proline' 0 N--CA 1.511 2.523 0 N-CA-C 119.136 2.706 . . . . 0.0 119.136 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -65.95 -33.8 76.64 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.98 96.19 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -52.38 65.05 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 162.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.2 -44.84 68.3 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.73 -38.05 66.65 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -72.61 -31.54 65.24 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 167.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.91 -40.17 87.93 Favored 'General case' 0 CA--C 1.583 2.212 0 CA-C-N 121.272 1.851 . . . . 0.0 114.747 159.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -60.32 -51.51 69.22 Favored 'General case' 0 CA--C 1.577 1.983 0 CA-C-N 120.032 1.287 . . . . 0.0 114.248 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.88 73.26 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.436 2.384 . . . . 0.0 117.436 169.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.61 -39.03 81.01 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.76 88.72 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 164.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -65.49 -32.78 74.58 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -60.31 -12.62 9.58 Favored 'General case' 0 CA--C 1.588 2.433 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 157.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.69 13.71 66.77 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.51 -3.1 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -164.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 pt -140.02 137.73 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 119.861 1.21 . . . . 0.0 110.664 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.1 108.11 18.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 110.622 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.53 138.38 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.211 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.03 135.26 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.847 -0.533 . . . . 0.0 112.222 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.1 t -82.01 77.54 8.81 Favored 'General case' 0 CA--C 1.567 1.629 0 O-C-N 121.61 -0.682 . . . . 0.0 112.594 170.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.05 -72.37 0.1 OUTLIER Glycine 0 N--CA 1.484 1.849 0 CA-C-N 116.36 -0.382 . . . . 0.0 113.567 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.69 135.14 39.08 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -65.24 -11.27 39.31 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -90.74 -87.37 0.19 Allowed 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 120.049 1.295 . . . . 0.0 111.591 173.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.99 -165.4 36.43 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 121.755 -0.591 . . . . 0.0 114.07 -172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 42.8 mm -115.77 -72.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.132 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -151.2 161.47 42.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -163.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -87.87 121.27 30.08 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.4 164.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.73 114.98 27.66 Favored 'General case' 0 CA--C 1.573 1.847 0 C-N-CA 123.426 0.69 . . . . 0.0 109.957 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 68.87 91.11 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.209 1.003 . . . . 0.0 113.585 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.88 108.86 11.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 171.312 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ptm . . . . . 0 CA--C 1.561 1.369 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -79.89 101.73 8.74 Favored 'General case' 0 CA--C 1.565 1.534 0 O-C-N 121.388 -0.82 . . . . 0.0 112.007 170.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.88 121.7 36.75 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 pp -88.95 155.29 19.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.8 p -76.08 154.51 35.54 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.26 -36.04 72.66 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -74.18 -37.92 63.8 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 172.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 9.6 pt20 -66.18 -30.34 70.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -53.97 -47.01 71.78 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 162.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.88 -46.54 81.8 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 168.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.34 -48.26 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -54.41 -50.39 67.71 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.39 -34.32 73.74 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.66 -44.44 81.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.338 10.2 tt -61.06 -39.23 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 166.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -55.9 -49.43 73.45 Favored 'General case' 0 CA--C 1.584 2.279 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 163.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.05 -47.71 79.11 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -68.75 -32.83 72.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -55.91 -47.97 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-N 119.509 1.049 . . . . 0.0 113.027 160.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 t -65.88 -33.54 76.08 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.51 2.411 . . . . 0.0 117.51 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.0 -39.52 69.17 Favored 'General case' 0 CA--C 1.582 2.179 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -127.18 -24.81 3.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -167.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.29 -26.75 12.2 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 117.863 1.905 . . . . 0.0 117.863 -161.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -105.95 151.34 40.0 Favored Pre-proline 0 CA--C 1.573 1.852 0 CA-C-N 118.656 1.228 . . . . 0.0 114.166 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 66' ' ' ILE . 91.9 Cg_endo -80.55 161.05 22.22 Favored 'Trans proline' 0 CA--C 1.568 2.181 0 C-N-CA 122.471 2.114 . . . . 0.0 115.706 176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.79 143.01 11.61 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.876 2.384 . . . . 0.0 115.21 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.0 p -79.32 161.23 26.39 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -52.0 -44.18 63.98 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.99 90.02 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -63.42 -46.44 86.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 169.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.2 mt -57.5 -48.82 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.412 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.68 -45.19 95.1 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 118.155 2.65 . . . . 0.0 118.155 173.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -65.31 -43.41 91.13 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -69.16 -47.79 64.01 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.1 mt -88.14 -18.52 28.61 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.84 55.62 1.73 Allowed Glycine 0 N--CA 1.482 1.724 0 N-CA-C 116.56 1.384 . . . . 0.0 116.56 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -102.3 106.81 17.67 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 117.696 0.748 . . . . 0.0 109.319 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.32 -32.95 71.72 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.8 m -106.4 104.91 52.55 Favored Pre-proline 0 CA--C 1.57 1.739 0 CA-C-O 117.885 -1.055 . . . . 0.0 109.87 162.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -51.69 -29.23 32.53 Favored 'Trans proline' 0 N--CA 1.509 2.441 0 N-CA-C 120.131 3.089 . . . . 0.0 120.131 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -49.42 -40.03 35.04 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.87 72.28 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 169.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.64 90.66 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 167.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -65.31 -35.41 80.92 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 168.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.16 -39.38 94.5 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.372 1.897 . . . . 0.0 115.857 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -60.79 -42.22 97.15 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 163.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.16 -46.44 85.7 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 168.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -61.02 -41.96 97.55 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.82 91.29 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.75 -43.43 90.27 Favored 'General case' 0 CA--C 1.584 2.256 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 165.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.12 80.47 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.9 ttt85 -60.62 -40.45 91.94 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 168.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -64.49 -45.84 85.57 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 168.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.93 60.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.862 0 N-CA-C 116.897 1.519 . . . . 0.0 116.897 163.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.06 -38.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.12 134.25 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.921 1.691 . . . . 0.0 111.42 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.38 99.52 12.46 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.427 -0.796 . . . . 0.0 111.06 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.68 120.21 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 122.775 0.43 . . . . 0.0 110.444 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.15 128.47 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 169.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.8 p -85.78 79.34 9.32 Favored 'General case' 0 CA--C 1.564 1.495 0 O-C-N 121.293 -0.88 . . . . 0.0 112.591 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.09 -65.64 0.32 Allowed Glycine 0 N--CA 1.484 1.888 0 N-CA-C 116.345 1.298 . . . . 0.0 116.345 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 141.73 38.63 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.4 t -71.08 107.13 3.99 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.302 82.2 mtt-85 79.01 33.5 0.24 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.32 59.76 0.81 Allowed Glycine 0 N--CA 1.493 2.443 0 O-C-N 120.376 -1.452 . . . . 0.0 114.905 164.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' A' ' 25' ' ' PRO . 33.7 mt -117.7 89.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -103.06 135.24 45.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.278 -0.889 . . . . 0.0 111.957 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.25 143.63 26.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.677 0.751 . . . . 0.0 112.51 -172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.17 90.92 2.57 Favored 'General case' 0 CA--C 1.576 1.951 0 O-C-N 121.141 -0.974 . . . . 0.0 111.565 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.272 40.2 mt-30 84.16 76.43 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.454 -163.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.266 20.2 pt-20 -84.2 82.18 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -164.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 123.884 1.802 . . . . 0.0 110.143 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtm . . . . . 0 CA--C 1.565 1.542 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.329 56.0 mtmt 74.77 -61.56 0.48 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.44 81.17 3.92 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-O 121.801 0.81 . . . . 0.0 112.988 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.523 0.4 OUTLIER 57.58 -173.26 0.08 Allowed 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 -174.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -133.94 157.11 46.84 Favored 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 123.896 0.878 . . . . 0.0 110.449 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.11 -36.07 67.77 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -69.09 -47.17 65.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -67.2 -33.33 75.15 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 172.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -63.34 -39.18 93.83 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 163.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -57.25 -41.56 79.84 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 165.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.54 -47.32 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 163.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -58.12 -45.62 87.01 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -54.13 -40.97 67.85 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 170.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.45 -51.47 68.58 Favored 'General case' 0 CA--C 1.583 2.249 0 CA-C-N 120.761 1.619 . . . . 0.0 115.362 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 pt -64.15 -43.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -62.19 -44.69 96.04 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -54.34 -52.83 60.34 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 166.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -69.26 -36.21 76.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.5 mm -54.92 -48.63 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 CA-C-N 119.524 1.056 . . . . 0.0 113.658 161.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -69.64 -34.15 73.62 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -98.6 -43.3 6.89 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 m -95.03 -44.65 7.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 170.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.48 -29.75 6.26 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 117.875 1.91 . . . . 0.0 117.875 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -100.12 155.4 36.47 Favored Pre-proline 0 CA--C 1.57 1.721 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -74.34 123.08 7.95 Favored 'Trans proline' 0 CA--C 1.566 2.116 0 C-N-CA 122.381 2.054 . . . . 0.0 114.85 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.05 148.11 19.19 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 CA-C-N 123.017 2.113 . . . . 0.0 113.373 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -71.38 165.49 23.64 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 44' ' ' GLU . 8.9 ptm180 -52.41 -32.16 37.75 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 118.124 2.639 . . . . 0.0 118.124 162.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.1 96.97 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 163.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.9 -37.84 86.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 168.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.0 mt -55.3 -48.22 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.785 1.175 . . . . 0.0 113.524 166.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.46 96.77 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 167.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -62.99 -47.11 84.57 Favored 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -78.37 -46.49 19.84 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -170.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.1 -22.08 39.43 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.725 2.121 . . . . 0.0 116.725 168.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.57 48.0 4.66 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 117.003 1.561 . . . . 0.0 117.003 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -85.07 93.38 8.6 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-N 118.148 0.974 . . . . 0.0 109.388 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -58.85 -32.91 69.86 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -94.5 106.08 21.81 Favored Pre-proline 0 CA--C 1.57 1.715 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.244 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.21 -12.07 34.58 Favored 'Trans proline' 0 N--CA 1.51 2.458 0 N-CA-C 118.712 2.543 . . . . 0.0 118.712 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -58.47 -32.56 68.86 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 159.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.38 93.61 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.4 -46.2 73.07 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 19.0 tt0 -64.42 -48.24 76.12 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 171.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -64.72 -39.25 93.32 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -61.88 -42.44 99.07 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 164.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.82 -40.86 85.38 Favored 'General case' 0 CA--C 1.578 2.044 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.22 -51.54 65.84 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 170.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.21 -38.79 68.89 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 117.393 2.368 . . . . 0.0 117.393 167.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.74 -43.15 99.54 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.03 -39.75 95.67 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 167.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -61.9 -34.15 75.52 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -64.2 -39.82 94.78 Favored 'General case' 0 CA--C 1.581 2.159 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 161.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.37 51.13 0.18 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 117.176 1.631 . . . . 0.0 117.176 164.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.45 -8.29 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.082 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.06 145.71 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 CA-C-N 121.892 2.133 . . . . 0.0 112.703 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.05 112.46 21.89 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.569 166.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -83.61 105.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.321 -0.862 . . . . 0.0 109.605 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -75.15 123.31 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-O 121.319 0.58 . . . . 0.0 112.046 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.3 t -82.07 73.87 9.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 158.62 -83.77 0.13 Allowed Glycine 0 N--CA 1.482 1.745 0 O-C-N 122.068 -0.395 . . . . 0.0 113.53 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.84 89.89 6.37 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 27.5 t -59.12 -11.86 4.25 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 120.342 3.46 . . . . 0.0 120.342 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -80.39 15.88 1.48 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 165.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.14 43.73 1.62 Allowed Glycine 0 CA--C 1.552 2.364 0 N-CA-C 115.949 1.14 . . . . 0.0 115.949 155.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.2 tp -93.03 75.85 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 122.158 0.98 . . . . 0.0 111.235 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -91.85 135.51 33.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 112.38 -166.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 pp -93.29 142.67 27.06 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -170.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.55 99.68 6.6 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 171.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 85.82 3.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -161.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -80.0 87.48 5.4 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.561 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 124.491 2.091 . . . . 0.0 112.81 -171.181 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 CA--C 1.564 1.506 0 CA-C-O 121.209 0.528 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.92 114.64 6.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.686 -0.634 . . . . 0.0 110.196 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.63 -61.82 1.78 Allowed 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 165.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.42 144.66 51.53 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.731 1.212 . . . . 0.0 109.866 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -65.6 157.7 29.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.187 -0.946 . . . . 0.0 112.872 168.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.2 50.46 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 -176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -67.15 -38.57 85.72 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -56.57 -47.82 78.69 Favored 'General case' 0 CA--C 1.583 2.215 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 164.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -62.83 -41.74 99.45 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 173.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -55.33 -50.59 69.25 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 164.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.7 t -60.02 -49.25 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -62.1 -47.28 85.33 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -58.84 -33.4 70.39 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -38.72 71.51 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 167.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.3 mt -55.4 -56.68 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 123.995 0.918 . . . . 0.0 112.732 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.9 mtm105 -68.13 -32.2 72.32 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -55.56 -53.06 61.08 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -69.96 -37.63 75.85 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.34 -42.2 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 CA-C-N 119.91 1.232 . . . . 0.0 113.421 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.84 -30.32 71.31 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 169.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -85.82 -50.08 7.41 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.3 m -107.01 -31.07 8.46 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.2 23.91 18.32 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -147.87 156.2 44.33 Favored Pre-proline 0 CA--C 1.574 1.898 0 CA-C-N 119.091 1.446 . . . . 0.0 112.845 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -57.48 137.43 81.42 Favored 'Trans proline' 0 N--CA 1.503 2.039 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.65 143.2 14.84 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 122.448 1.91 . . . . 0.0 114.753 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -74.37 160.98 30.31 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -32.1 -55.19 0.31 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 166.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.96 75.53 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -56.19 -43.57 78.57 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 171.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.4 mt -62.1 -56.39 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 118.927 0.785 . . . . 0.0 112.095 172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.85 75.35 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -75.77 -25.86 56.84 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.0 -46.17 65.7 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.232 1.378 . . . . 0.0 114.547 166.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -80.55 -37.95 30.5 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.2 53.92 0.27 Allowed Glycine 0 CA--C 1.545 1.958 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -114.55 130.87 56.8 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 117.872 0.836 . . . . 0.0 109.647 165.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -70.79 -41.36 71.77 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 171.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -101.23 113.18 65.83 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 117.813 -1.089 . . . . 0.0 111.387 175.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -56.08 -19.67 27.62 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -58.0 -28.62 64.58 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -37.97 71.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.56 80.21 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 168.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -60.67 -40.98 94.11 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -56.24 -49.97 72.62 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 171.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.44 -39.23 77.94 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 tp -52.52 -44.6 65.86 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 166.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -57.93 -40.04 79.5 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 166.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.78 99.56 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 166.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -56.56 -45.16 81.43 Favored 'General case' 0 CA--C 1.59 2.503 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.28 92.45 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 174.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -56.2 -39.55 72.6 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 165.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -76.44 6.4 5.76 Favored 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 28.02 58.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -104.42 -37.77 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 118.55 1.175 . . . . 0.0 113.182 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.22 150.65 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-N 119.676 1.125 . . . . 0.0 111.409 169.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -95.36 127.04 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.29 -0.881 . . . . 0.0 110.166 163.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.6 103.88 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.005 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.65 81.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 121.988 0.899 . . . . 0.0 108.701 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.3 t -88.37 72.46 8.94 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -166.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.39 -67.91 1.5 Allowed Glycine 0 N--CA 1.491 2.353 0 O-C-N 122.018 -0.427 . . . . 0.0 113.15 158.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.01 161.59 28.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 150.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 82.9 p -76.08 68.73 2.58 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.293 24.7 ptt180 -174.43 -110.49 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.744 1.617 . . . . 0.0 109.107 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.96 45.24 96.55 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 118.501 2.16 . . . . 0.0 118.501 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 35.2 mt -102.69 113.73 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 118.273 1.037 . . . . 0.0 110.37 -161.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -97.57 135.79 38.9 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 121.451 0.643 . . . . 0.0 111.94 162.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 109.91 17.86 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.275 0.63 . . . . 0.0 111.082 -176.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt -85.48 -52.89 5.54 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -128.72 132.88 48.01 Favored 'General case' 0 CA--C 1.567 1.632 0 C-N-CA 123.907 0.883 . . . . 0.0 109.682 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -85.89 75.34 10.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.73 -1.231 . . . . 0.0 113.069 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 124.826 2.25 . . . . 0.0 111.811 179.584 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 CA--C 1.563 1.446 0 CA-C-O 120.677 0.275 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -83.89 122.53 28.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.465 -0.772 . . . . 0.0 111.826 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.0 74.05 10.29 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.415 1.578 . . . . 0.0 114.448 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.5 tp -77.06 139.38 40.01 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 113.558 -1.656 . . . . 0.0 110.904 157.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.0 p -80.76 145.55 31.45 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.028 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.3 66.12 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.73 -37.55 70.58 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -57.47 -46.32 83.8 Favored 'General case' 0 CA--C 1.584 2.268 0 CA-C-N 121.02 1.736 . . . . 0.0 114.566 163.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -54.91 -47.29 74.54 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -53.37 -47.11 69.72 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 167.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.12 -47.77 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.24 -45.79 87.12 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 171.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -60.15 -37.2 79.4 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 170.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.22 -39.65 93.05 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 167.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.9 mt -58.52 -45.62 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 CA-C-N 119.405 1.002 . . . . 0.0 113.553 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -54.52 -51.34 65.46 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 163.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -60.9 -39.65 90.11 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -65.71 -47.71 74.45 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.9 mm -57.51 -46.65 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 167.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -69.96 -12.63 61.75 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -70.74 -41.62 71.6 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 121.086 1.767 . . . . 0.0 115.022 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -149.11 -73.17 0.18 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 166.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.94 51.99 0.21 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 122.174 -0.329 . . . . 0.0 113.716 165.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -122.23 128.15 25.61 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.026 -164.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HB3' ' H ' ' A' ' 66' ' ' ILE . 36.8 Cg_exo -66.22 153.85 76.43 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 CA-C-N 123.092 2.14 . . . . 0.0 115.417 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.52 161.97 27.9 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 CA-C-N 122.55 1.947 . . . . 0.0 114.441 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -95.62 158.27 15.53 Favored 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.217 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.8 mtt85 -54.94 -37.58 66.6 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 116.809 2.152 . . . . 0.0 116.809 166.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.05 99.86 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 166.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.26 -41.04 96.24 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 167.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.85 -51.04 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 119.647 1.112 . . . . 0.0 113.54 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.76 89.43 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -80.46 -39.23 28.52 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -78.88 -41.4 29.88 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.16 -36.86 34.49 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.64 61.91 0.69 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 115.833 1.093 . . . . 0.0 115.833 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -111.21 101.88 10.35 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.67 62.32 6.8 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 122.365 1.078 . . . . 0.0 113.427 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m 175.9 126.98 0.15 Allowed Pre-proline 0 CA--C 1.58 2.115 0 C-N-CA 125.89 1.676 . . . . 0.0 107.995 -175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -61.22 -42.65 33.93 Favored 'Trans proline' 0 N--CA 1.51 2.442 0 CA-C-N 123.119 2.15 . . . . 0.0 116.503 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.34 -30.88 67.07 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.402 2.371 . . . . 0.0 117.402 173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.97 75.32 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.696 1.739 . . . . 0.0 115.696 168.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.68 95.81 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 166.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.42 -53.25 60.48 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.47 -32.05 69.43 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -65.72 -37.9 87.71 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.333 1.879 . . . . 0.0 115.217 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.1 mt -58.56 -51.3 70.48 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 163.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -57.45 -40.63 78.87 Favored 'General case' 0 CA--C 1.578 2.042 0 N-CA-C 115.564 1.691 . . . . 0.0 115.564 172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.0 -43.45 95.64 Favored 'General case' 0 CA--C 1.567 1.626 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 167.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.68 -38.87 82.69 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.25 -44.21 97.07 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 165.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -62.14 -36.22 81.14 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 170.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -58.63 -24.5 61.19 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 162.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.24 66.31 1.16 Allowed Glycine 0 N--CA 1.478 1.458 0 CA-C-N 118.892 0.769 . . . . 0.0 114.99 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.269 10.5 p -149.33 -52.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.2 pt -96.01 131.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 120.864 1.666 . . . . 0.0 113.358 -171.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.76 110.01 20.64 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.297 0.639 . . . . 0.0 110.437 171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.3 125.59 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.74 125.86 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.633 -0.667 . . . . 0.0 112.678 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.2 t -84.19 74.66 10.27 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 163.12 -67.52 0.23 Allowed Glycine 0 N--CA 1.484 1.876 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.27 142.04 34.95 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -66.45 -30.49 70.85 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 118.469 2.766 . . . . 0.0 118.469 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -108.73 88.88 2.83 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 119.971 1.26 . . . . 0.0 110.617 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.54 72.76 0.14 Allowed Glycine 0 N--CA 1.486 1.988 0 O-C-N 121.862 -0.524 . . . . 0.0 114.044 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.432 ' H ' ' HB3' ' A' ' 25' ' ' PRO . 66.4 mt -131.92 101.99 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.939 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -119.34 129.17 54.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.923 -0.485 . . . . 0.0 112.003 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 134.33 37.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.18 84.69 2.3 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-O 122.218 1.009 . . . . 0.0 110.664 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.313 16.8 tt0 74.72 -53.84 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 162.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -62.9 -63.78 1.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 117.039 2.236 . . . . 0.0 117.039 -161.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 124.078 1.895 . . . . 0.0 114.291 -163.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.563 1.462 0 CA-C-O 121.033 0.444 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -79.2 67.34 4.89 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -174.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.52 87.12 7.01 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 120.914 -1.117 . . . . 0.0 111.527 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.9 mt -78.57 106.54 10.61 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -160.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 p -74.65 149.32 40.02 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -45.27 -42.15 9.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 120.704 3.594 . . . . 0.0 120.704 -169.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.89 -45.82 40.27 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.48 -37.93 89.24 Favored 'General case' 0 CA--C 1.579 2.089 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 169.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -53.72 -40.97 66.53 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 164.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -63.11 -47.9 80.81 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 167.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.97 -49.04 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.645 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -55.48 -39.66 70.7 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 171.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.31 -45.64 90.76 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.495 HD23 ' HE ' ' A' ' 34' ' ' ARG . 2.9 tm? -60.39 -40.44 90.88 Favored 'General case' 0 N--CA 1.508 2.441 0 CA-C-N 120.634 1.561 . . . . 0.0 114.909 170.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.8 mt -60.58 -48.68 87.54 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.026 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 169.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -55.41 -48.22 74.71 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -59.27 -48.93 79.78 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -64.14 -41.12 97.31 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.4 mm -68.53 -50.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.494 1.043 . . . . 0.0 113.263 171.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -73.4 -38.02 65.75 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -88.56 -52.84 4.95 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 119.606 1.094 . . . . 0.0 113.448 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -94.46 -20.91 19.27 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 41.69 20.82 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 118.141 2.016 . . . . 0.0 118.141 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -149.23 142.67 16.19 Favored Pre-proline 0 CA--C 1.571 1.782 0 CA-C-N 118.893 1.346 . . . . 0.0 113.943 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.33 117.66 1.02 Allowed 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.121 1.881 . . . . 0.0 114.295 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.15 174.09 13.36 Favored 'Trans proline' 0 N--CA 1.502 1.981 0 CA-C-N 123.21 2.182 . . . . 0.0 117.644 -170.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -94.21 156.12 16.7 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.043 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -59.23 -28.19 66.45 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 166.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -43.94 96.58 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -62.68 -39.96 95.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 168.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.24 -51.08 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 123.734 0.814 . . . . 0.0 112.832 166.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -42.89 93.31 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 171.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -67.19 -45.89 75.55 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.495 ' HE ' HD23 ' A' ' 14' ' ' LEU . 2.8 tmm_? -74.73 -45.32 44.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.79 -14.49 34.39 Favored 'General case' 0 CA--C 1.576 1.969 0 N-CA-C 117.292 2.33 . . . . 0.0 117.292 -171.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.83 63.61 1.21 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 116.442 1.337 . . . . 0.0 116.442 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -117.44 120.83 39.32 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -55.95 -37.27 68.79 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -123.94 148.98 58.56 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 118.442 -0.79 . . . . 0.0 111.118 159.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -58.21 -12.63 13.55 Favored 'Trans proline' 0 N--CA 1.508 2.344 0 N-CA-C 118.74 2.554 . . . . 0.0 118.74 164.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -58.06 -41.71 83.94 Favored 'General case' 0 CA--C 1.587 2.375 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 163.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.41 -40.29 89.48 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.38 -48.65 78.5 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 164.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -56.2 -36.95 68.98 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.34 -48.76 80.38 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -65.17 -38.19 89.75 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 168.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.59 -37.99 66.18 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -55.77 -57.03 13.74 Favored 'General case' 0 CA--C 1.574 1.897 0 CA-C-N 120.653 1.57 . . . . 0.0 114.811 170.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.98 75.64 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 168.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -57.79 -48.45 79.67 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 171.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -46.9 77.39 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -55.78 -41.98 74.86 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -71.83 -14.11 61.87 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.53 62.46 0.45 Allowed Glycine 0 N--CA 1.485 1.942 0 N-CA-C 117.395 1.718 . . . . 0.0 117.395 160.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 m -141.74 -45.04 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.581 2.163 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.19 156.06 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 120.852 1.66 . . . . 0.0 114.548 -168.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.59 144.1 44.11 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 162.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.8 mt -114.11 120.09 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.65 106.59 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.677 0.751 . . . . 0.0 111.047 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.9 p -86.81 87.89 7.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 112.748 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.34 -65.86 0.42 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 114.02 0.368 . . . . 0.0 114.02 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.07 169.55 18.09 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 170.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.1 p -91.66 -55.74 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -84.43 90.09 7.53 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-O 122.532 1.158 . . . . 0.0 112.225 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.3 44.83 0.16 Allowed Glycine 0 N--CA 1.484 1.877 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.6 mt -106.49 99.84 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -115.38 145.24 42.72 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.242 0.617 . . . . 0.0 112.006 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.13 123.1 18.98 Favored 'General case' 0 CA--C 1.579 2.093 0 O-C-N 122.05 -0.406 . . . . 0.0 111.853 166.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.25 68.84 10.64 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.608 1.194 . . . . 0.0 112.437 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.37 29.6 tt0 55.78 -115.79 0.96 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.358 1.063 . . . . 0.0 113.298 -168.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.3 19.0 tt0 68.49 -62.38 0.38 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.558 1.262 0 CA-C-O 124.673 2.178 . . . . 0.0 111.6 -176.129 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.561 1.397 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -81.6 76.4 8.52 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.37 112.59 25.54 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 121.668 -0.645 . . . . 0.0 112.7 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.76 127.38 32.66 Favored 'General case' 0 CA--C 1.575 1.916 0 CA-C-O 121.419 0.628 . . . . 0.0 112.674 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.5 p -71.16 159.45 34.65 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 170.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.92 75.22 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -70.19 -37.05 75.02 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -65.25 -38.52 90.58 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 120.721 1.6 . . . . 0.0 115.276 166.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -56.54 -40.91 75.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 164.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.59 -45.52 85.19 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 165.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -57.81 -50.33 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 169.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -57.07 -46.11 82.75 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 170.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -59.29 -30.17 68.13 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -64.8 -45.75 84.94 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.077 1.308 . . . . 0.0 114.345 165.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 mm -55.68 -47.46 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 169.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -60.15 -46.51 89.43 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -60.31 -55.32 35.05 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -68.52 -34.42 75.83 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.78 -42.1 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.215 1.37 . . . . 0.0 112.716 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.1 t -63.21 -31.7 72.91 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 168.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -73.08 -44.31 60.7 Favored 'General case' 0 CA--C 1.582 2.182 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -120.43 -22.44 6.48 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -167.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.15 -30.74 6.85 Favored Glycine 0 CA--C 1.549 2.195 0 N-CA-C 117.886 1.915 . . . . 0.0 117.886 -163.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -104.69 138.88 19.64 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -169.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -60.93 135.86 62.09 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 N-CA-C 119.499 2.846 . . . . 0.0 119.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.5 123.43 6.5 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.46 2.107 . . . . 0.0 113.607 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -100.04 101.97 13.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -168.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.301 76.4 mtt85 70.85 -72.03 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 142.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.07 -35.05 77.49 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 157.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -60.52 -40.54 91.82 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 168.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mp -62.72 -52.35 60.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-N 120.048 1.295 . . . . 0.0 112.664 166.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.92 -47.74 81.96 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 117.73 2.493 . . . . 0.0 117.73 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -71.39 -47.77 54.07 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.19 -43.12 87.7 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.27 -6.32 59.43 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 174.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.4 51.52 4.6 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 117.242 1.657 . . . . 0.0 117.242 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.32 108.42 20.59 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-N 117.643 0.721 . . . . 0.0 109.641 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -80.46 50.3 1.27 Allowed 'General case' 0 CA--C 1.584 2.27 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 173.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 175.52 96.79 0.09 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 C-N-CA 126.673 1.989 . . . . 0.0 106.083 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -54.52 -30.54 65.16 Favored 'Trans proline' 0 N--CA 1.513 2.62 0 N-CA-C 120.048 3.057 . . . . 0.0 120.048 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -60.93 -35.53 76.95 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 167.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.29 -41.35 79.64 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.76 -42.91 76.17 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 162.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -66.4 -34.89 78.97 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 173.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.33 -42.92 96.63 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 168.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -61.75 -45.03 95.65 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 165.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.54 -49.03 65.67 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -61.14 -46.71 89.43 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 169.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.76 -37.88 74.43 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 169.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.64 -37.64 85.24 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.32 95.79 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.7 ttt-85 -54.39 -44.03 71.94 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -67.37 -7.24 23.35 Favored 'General case' 0 CA--C 1.592 2.569 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.58 30.42 53.23 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 118.929 2.332 . . . . 0.0 118.929 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.23 -25.28 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.66 128.99 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.868 1.213 . . . . 0.0 111.221 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -90.66 107.61 19.28 Favored 'General case' 0 CA--C 1.557 1.218 0 O-C-N 121.663 -0.648 . . . . 0.0 110.619 171.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -80.83 122.02 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.18 123.15 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.016 0.526 . . . . 0.0 110.032 -169.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 m -78.73 84.42 4.81 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 121.752 0.787 . . . . 0.0 112.417 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.58 -64.22 0.35 Allowed Glycine 0 N--CA 1.485 1.948 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.73 123.05 25.6 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.9 m -61.66 -57.04 13.55 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -81.66 79.49 8.22 Favored 'General case' 0 CA--C 1.577 1.988 0 CA-C-N 119.259 0.936 . . . . 0.0 110.375 159.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.57 68.38 0.49 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.215 -0.902 . . . . 0.0 114.016 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.34 86.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -109.3 157.14 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.469 1.128 . . . . 0.0 113.791 -166.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.36 110.75 18.4 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -161.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.6 mt -82.56 -26.46 32.38 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 166.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.307 14.2 mm100 74.03 -14.68 0.65 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 120.51 3.522 . . . . 0.0 120.51 169.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.81 93.06 6.17 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.511 1.05 . . . . 0.0 112.529 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 125.08 2.372 . . . . 0.0 114.425 -171.733 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.2 ttm . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.94 81.9 7.76 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.55 102.56 14.76 Favored 'General case' 0 CA--C 1.559 1.291 0 O-C-N 121.704 -0.622 . . . . 0.0 111.253 174.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.13 131.92 44.28 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -170.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.1 p -75.69 147.78 39.16 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.833 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.34 44.01 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 119.004 2.965 . . . . 0.0 119.004 -172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -73.63 -39.42 64.53 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.78 -33.4 75.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 165.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -57.7 -45.3 85.88 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 163.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -55.96 -42.58 76.43 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 167.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.0 -45.06 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.203 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -55.91 -42.53 76.19 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 165.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -54.31 -46.17 72.77 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -55.89 -37.7 69.21 Favored 'General case' 0 CA--C 1.586 2.344 0 N-CA-C 116.901 2.185 . . . . 0.0 116.901 169.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 65.1 mt -63.13 -53.59 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 CA-C-N 119.826 1.194 . . . . 0.0 113.263 170.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -60.58 -46.61 89.58 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -64.11 -47.52 79.68 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 172.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -69.32 -37.62 77.83 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.7 mt -57.35 -47.64 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 120.526 1.512 . . . . 0.0 112.94 167.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 t -62.26 -25.89 68.09 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 168.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.27 -58.85 2.67 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.854 1.206 . . . . 0.0 113.388 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 m -151.03 68.83 0.94 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 119.899 1.227 . . . . 0.0 111.151 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.34 -49.51 3.59 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 121.084 3.194 . . . . 0.0 121.084 160.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.16 137.95 19.38 Favored Pre-proline 0 CA--C 1.569 1.704 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -157.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.45 122.67 5.67 Favored 'Trans proline' 0 CA--C 1.572 2.403 0 C-N-CA 122.727 2.285 . . . . 0.0 114.822 172.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -55.99 157.07 17.75 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 N-CA-C 122.322 3.932 . . . . 0.0 122.322 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 p -115.92 -174.58 2.56 Favored 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.176 163.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.01 -28.09 22.53 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 119.279 3.066 . . . . 0.0 119.279 -171.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.37 90.84 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -76.12 -50.44 14.64 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 119.554 1.07 . . . . 0.0 112.915 165.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.6 mt -57.98 -49.61 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.45 76.4 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.46 -44.68 18.82 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -70.06 -40.23 75.21 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.7 mt -80.27 -18.67 48.67 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.01 64.78 1.46 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 116.176 1.23 . . . . 0.0 116.176 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -100.22 152.6 20.1 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-O 122.354 1.073 . . . . 0.0 113.027 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -56.02 -32.91 64.41 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 118.537 2.791 . . . . 0.0 118.537 166.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m -163.21 159.21 18.33 Favored Pre-proline 0 CA--C 1.577 1.987 0 C-N-CA 124.088 0.955 . . . . 0.0 112.045 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -57.87 -30.44 89.54 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.914 2.236 . . . . 0.0 117.914 168.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -58.34 -45.04 88.88 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 167.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.54 88.81 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.61 -49.53 70.72 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.88 -30.37 68.86 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -59.6 -40.19 86.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 116.793 2.146 . . . . 0.0 116.793 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -66.05 -42.22 89.79 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 168.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -53.68 -51.76 62.17 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -63.16 -48.38 78.68 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -46.89 74.56 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.05 -37.58 87.94 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.88 65.48 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 171.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -68.42 -24.36 64.74 Favored 'General case' 0 CA--C 1.584 2.262 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -69.02 -27.77 65.97 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 168.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 160.57 -54.27 0.33 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 118.857 2.303 . . . . 0.0 118.857 168.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.25 -20.25 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -158.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.6 pt -117.42 145.1 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-N 121.192 1.814 . . . . 0.0 112.939 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.51 114.51 20.98 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.096 0.958 . . . . 0.0 113.549 -163.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.2 mt -73.72 96.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-O 121.716 0.77 . . . . 0.0 111.155 -172.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.4 m -91.05 110.63 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 121.698 0.761 . . . . 0.0 112.311 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.8 p -83.22 81.51 8.67 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.009 -1.057 . . . . 0.0 112.831 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.07 -52.11 0.71 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 116.932 1.533 . . . . 0.0 116.932 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.22 115.08 12.13 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 m -74.12 105.38 5.31 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.358 0.599 . . . . 0.0 111.32 170.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.332 75.5 mtt85 72.92 50.31 0.15 Allowed 'General case' 0 CA--C 1.579 2.079 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -166.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.48 5.14 24.79 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 164.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.252 9.8 tt -77.55 80.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 119.56 1.68 . . . . 0.0 114.612 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -82.67 144.99 29.88 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.388 1.075 . . . . 0.0 113.222 -168.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.0 125.32 25.96 Favored 'General case' 0 CA--C 1.564 1.507 0 O-C-N 120.991 -1.068 . . . . 0.0 113.535 168.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.5 mt -81.3 96.99 7.47 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.874 0.845 . . . . 0.0 109.827 -173.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -48.83 111.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 117.293 2.331 . . . . 0.0 117.293 -168.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.27 128.17 11.79 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.228 -165.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 . . . . . 0 CA--C 1.564 1.508 0 CA-C-O 123.587 1.66 . . . . 0.0 110.054 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 CA--C 1.563 1.447 0 CA-C-O 121.585 0.707 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -88.62 97.13 10.94 Favored 'General case' 0 CA--C 1.567 1.608 0 O-C-N 121.594 -0.691 . . . . 0.0 110.678 -175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.84 83.27 4.19 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -170.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.15 163.11 16.35 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.2 p -81.23 160.04 24.39 Favored 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.169 -0.957 . . . . 0.0 113.092 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.17 -41.13 74.98 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -72.11 -29.61 64.26 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.67 -45.86 85.03 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.807 1.64 . . . . 0.0 114.714 159.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -44.23 87.62 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.14 -46.13 82.97 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.08 -46.95 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 170.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -56.56 -41.54 77.06 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.477 2.029 . . . . 0.0 116.477 167.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.85 -40.14 79.42 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 171.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.2 mt -62.29 -45.66 92.26 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.31 31.3 pt -63.23 -33.66 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 170.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 35.5 mtm105 -64.04 -50.44 68.41 Favored 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 120.652 1.569 . . . . 0.0 115.121 161.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -60.82 -47.54 85.87 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -67.69 -39.06 84.46 Favored 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.3 mm -57.37 -49.21 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.964 1.256 . . . . 0.0 113.122 165.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -62.89 -49.09 76.18 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -96.65 8.12 44.95 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -154.71 -54.91 0.1 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.561 -1.337 . . . . 0.0 111.489 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.04 38.91 1.1 Allowed Glycine 0 CA--C 1.545 1.913 0 N-CA-C 116.407 1.323 . . . . 0.0 116.407 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -144.21 135.56 12.64 Favored Pre-proline 0 CA--C 1.568 1.655 0 CA-C-N 118.782 1.291 . . . . 0.0 113.096 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 90.6 Cg_endo -91.14 107.18 0.29 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 CA-C-N 122.944 2.087 . . . . 0.0 113.908 175.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 36.2 Cg_endo -63.77 121.14 8.76 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.559 2.839 . . . . 0.0 115.582 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.48 ' H ' ' HE ' ' A' ' 64' ' ' ARG . 45.9 p -109.41 118.82 37.66 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.77 177.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.286 98.1 mtt180 72.17 -65.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 155.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.42 -52.24 23.74 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -61.78 -36.21 80.41 Favored 'General case' 0 CA--C 1.582 2.184 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.8 mm -60.44 -52.87 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.41 95.29 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 117.994 2.59 . . . . 0.0 117.994 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -67.17 -42.57 84.05 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -76.79 -47.13 22.53 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -85.08 -10.86 56.39 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.65 43.95 7.54 Favored Glycine 0 N--CA 1.481 1.651 0 N-CA-C 117.677 1.831 . . . . 0.0 117.677 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -89.69 85.32 6.42 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 118.615 1.208 . . . . 0.0 110.101 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.98 -24.13 66.72 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.5 m -91.37 112.49 54.41 Favored Pre-proline 0 CA--C 1.568 1.671 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.785 163.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.96 -18.52 62.43 Favored 'Trans proline' 0 N--CA 1.51 2.477 0 N-CA-C 118.971 2.643 . . . . 0.0 118.971 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -55.54 -44.45 76.77 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 166.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.09 -44.17 74.66 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.28 86.43 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 172.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -41.86 85.24 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 170.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.15 -50.02 50.28 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 166.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -64.93 -38.68 91.75 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.3 mt -60.22 -49.53 77.25 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 169.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 21.9 pttm -63.89 -36.42 83.88 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 168.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -37.49 87.57 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 168.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.7 mt -57.92 -43.8 86.48 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 164.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.12 84.31 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.9 ttm105 -59.25 -36.88 76.29 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.94 -51.28 69.92 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.23 16.26 3.23 Favored Glycine 0 CA--C 1.55 2.232 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.72 -10.51 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.7 pt -136.84 138.14 46.42 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 CA-C-N 120.02 1.282 . . . . 0.0 112.049 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.11 128.94 46.1 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.545 0.688 . . . . 0.0 110.149 166.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.6 mm -90.53 115.63 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 C-N-CA 123.141 0.576 . . . . 0.0 109.556 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.5 t -85.79 92.98 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.7 t -79.98 85.0 5.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -169.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.33 -84.71 0.05 OUTLIER Glycine 0 N--CA 1.481 1.633 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.725 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.95 52.89 2.52 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.297 63.2 m 64.65 -73.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.48 ' HE ' ' H ' ' A' ' 27' ' ' THR . 83.3 mtt180 -96.32 82.9 3.47 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-O 122.167 0.984 . . . . 0.0 111.589 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.77 95.5 0.28 Allowed Glycine 0 N--CA 1.48 1.629 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.293 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.0 120.03 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -93.96 128.32 40.22 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 121.696 -0.627 . . . . 0.0 110.993 173.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -84.57 111.74 19.79 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 123.023 0.529 . . . . 0.0 112.023 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.29 87.09 3.8 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 121.775 0.798 . . . . 0.0 110.4 -177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 74.31 144.59 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.508 1.123 . . . . 0.0 113.777 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.74 80.74 2.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.672 1.225 . . . . 0.0 113.901 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 123.628 1.68 . . . . 0.0 108.755 -170.562 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.968 0.413 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -134.38 89.45 2.56 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.359 0.6 . . . . 0.0 110.362 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.12 69.18 4.4 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.6 mt -114.78 124.1 50.91 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 110.079 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.7 p -80.54 94.98 6.36 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.294 . . 49.45 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 119.459 3.133 . . . . 0.0 119.459 168.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -74.79 -31.19 61.67 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.04 -32.13 73.12 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 116.62 2.081 . . . . 0.0 116.62 161.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -57.85 -42.32 84.2 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 163.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -53.19 -44.69 68.12 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 163.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.33 -43.58 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 170.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -59.73 -40.23 87.36 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 168.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.41 -40.84 92.4 Favored 'General case' 0 CA--C 1.583 2.213 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 165.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -64.86 -47.23 78.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.446 0.1 OUTLIER -64.62 -39.22 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 CA-C-N 121.106 1.775 . . . . 0.0 115.414 174.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.3 mtp85 -59.59 -39.67 84.92 Favored 'General case' 0 CA--C 1.573 1.843 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.37 -49.03 77.47 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -63.36 -39.92 95.86 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.1 mt -62.75 -47.22 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 118.977 0.808 . . . . 0.0 113.16 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -61.05 -30.82 70.55 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 170.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -84.29 -41.69 16.58 Favored 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.5 p -116.96 -22.39 8.49 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.21 -47.9 1.45 Allowed Glycine 0 CA--C 1.549 2.161 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -161.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -90.1 159.74 41.78 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -74.89 162.5 37.24 Favored 'Trans proline' 0 CA--C 1.567 2.142 0 C-N-CA 122.403 2.069 . . . . 0.0 116.731 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 166.91 22.12 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.675 2.25 . . . . 0.0 116.862 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -67.0 147.2 53.53 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.792 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.7 mmt-85 -57.5 -32.78 67.35 Favored 'General case' 0 CA--C 1.591 2.532 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.18 80.89 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 165.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -56.77 -33.37 66.55 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 170.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.3 mt -60.69 -48.5 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-N 119.376 0.989 . . . . 0.0 112.629 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.56 61.16 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' HE ' ' A' ' 34' ' ' ARG . 27.8 tt0 -64.98 -54.09 35.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' HE ' HE21 ' A' ' 33' ' ' GLN . 25.9 mmt85 -75.97 -39.15 56.58 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -172.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.15 -18.67 59.01 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.755 2.132 . . . . 0.0 116.755 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.44 56.34 1.37 Allowed Glycine 0 N--CA 1.481 1.695 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -105.88 116.69 32.37 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 117.583 0.691 . . . . 0.0 110.199 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -63.48 -33.43 75.55 Favored 'General case' 0 CA--C 1.582 2.202 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 157.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.6 t -94.97 103.01 10.39 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 123.791 0.837 . . . . 0.0 112.291 173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.71 -23.55 56.04 Favored 'Trans proline' 0 N--CA 1.511 2.513 0 N-CA-C 117.406 2.041 . . . . 0.0 117.406 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -58.83 -40.73 85.05 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 161.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.16 96.42 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 167.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.11 71.34 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 173.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.55 -33.41 75.85 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 168.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.9 -46.98 84.11 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -65.81 -30.68 71.35 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 tp -60.39 -52.09 66.73 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 121.121 1.782 . . . . 0.0 114.929 166.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 61.7 pttt -62.79 -42.07 99.54 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 171.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.0 -36.12 74.38 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 117.303 2.334 . . . . 0.0 117.303 166.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.37 -38.79 81.74 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.05 87.6 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 163.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -61.82 -35.68 78.95 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -59.11 -32.93 70.27 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 163.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.11 34.74 1.1 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.565 2.186 . . . . 0.0 118.565 163.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.49 -4.63 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 N-CA-C 116.904 2.187 . . . . 0.0 116.904 -176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.1 pt -143.13 153.34 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.191 0 CA-C-N 119.689 1.131 . . . . 0.0 111.82 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -112.66 122.69 48.42 Favored 'General case' 0 CA--C 1.571 1.763 0 O-C-N 121.745 -0.597 . . . . 0.0 109.545 163.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.9 mt -88.68 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.3 t -80.63 92.33 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -85.66 100.23 11.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.632 0.729 . . . . 0.0 112.277 -157.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.83 -53.63 0.7 Allowed Glycine 0 N--CA 1.486 2.008 0 CA-C-N 115.65 -0.705 . . . . 0.0 114.053 -160.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.53 113.09 12.55 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-N 117.481 0.64 . . . . 0.0 112.553 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.8 p -60.33 -46.19 90.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.421 2.378 . . . . 0.0 117.421 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -91.26 84.95 5.7 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 159.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.12 71.61 0.22 Allowed Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -169.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.05 111.34 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.824 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -77.84 135.21 37.9 Favored 'General case' 0 CA--C 1.57 1.731 0 O-C-N 121.376 -0.828 . . . . 0.0 111.995 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.9 tp -95.31 111.61 23.45 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.98 0.512 . . . . 0.0 111.346 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.91 88.41 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.746 0.784 . . . . 0.0 109.987 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -79.75 92.6 5.45 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -107.97 -46.87 3.68 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 125.126 2.393 . . . . 0.0 113.307 -178.024 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 CA--C 1.559 1.315 0 CA-C-O 121.253 0.549 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -88.41 108.55 19.43 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 121.647 0.737 . . . . 0.0 112.745 -172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.45 114.45 16.29 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.834 -0.541 . . . . 0.0 111.239 166.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp -127.12 156.6 41.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.4 p -65.93 152.4 44.6 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -160.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.01 -40.37 58.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 120.406 3.484 . . . . 0.0 120.406 -165.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -39.38 34.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -60.96 -34.77 75.26 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 162.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -64.51 -41.28 96.5 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 167.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -57.42 -47.73 80.99 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 165.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -52.35 -49.34 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 165.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.0 -41.33 97.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.27 -40.87 95.72 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 173.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.93 -46.52 71.29 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 121.116 1.78 . . . . 0.0 114.983 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.262 3.6 tp -53.15 -46.98 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.6 mtp85 -62.81 -49.33 75.35 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 172.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.06 -44.17 97.78 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -72.85 -43.54 62.48 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.26 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 120.525 1.511 . . . . 0.0 114.776 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 t -59.94 -30.74 69.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 118.295 2.702 . . . . 0.0 118.295 171.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -93.68 -47.63 6.71 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.7 p -93.33 -26.41 17.3 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.785 2.142 . . . . 0.0 116.785 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.3 -36.91 3.76 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 117.508 1.763 . . . . 0.0 117.508 -167.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -93.25 141.58 24.18 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.7 132.63 8.88 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 CA-C-N 122.187 1.817 . . . . 0.0 114.506 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -55.33 145.03 69.16 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 N-CA-C 118.272 2.374 . . . . 0.0 118.272 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 p -74.52 150.46 39.79 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.237 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.26 16.6 ptt180 -58.82 -26.98 64.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 118.348 2.722 . . . . 0.0 118.348 173.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.2 -40.83 70.94 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 161.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -56.93 -49.74 74.71 Favored 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 166.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.7 mt -55.05 -45.58 76.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.17 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.09 -55.0 36.01 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 170.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -74.21 -37.16 63.96 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.96 -36.5 72.59 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.25 -11.81 59.98 Favored 'General case' 0 CA--C 1.584 2.268 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 168.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 79.72 54.2 4.02 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 116.758 1.463 . . . . 0.0 116.758 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -83.82 146.23 28.23 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 122.451 1.119 . . . . 0.0 113.888 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.02 88.45 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 173.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.0 m -152.8 143.97 16.05 Favored Pre-proline 0 CA--C 1.576 1.978 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.718 164.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.45 -30.7 16.25 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 174.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -59.05 -31.68 69.07 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.86 -41.06 99.24 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 165.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.18 -41.25 96.48 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 165.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -55.74 -46.52 77.8 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 164.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -60.37 -42.32 95.55 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -66.21 -36.95 84.39 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.2 mt -58.89 -41.37 87.0 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 163.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.5 -47.13 82.98 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 170.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.1 -35.54 79.01 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.8 tp -63.31 -41.41 98.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.78 1.771 . . . . 0.0 115.78 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.0 99.85 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 165.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -50.9 -38.02 47.29 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 171.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -77.37 6.21 7.29 Favored 'General case' 0 CA--C 1.592 2.558 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.58 40.97 16.94 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 117.975 1.95 . . . . 0.0 117.975 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.42 -44.04 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.538 -169.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -127.51 137.65 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 119.709 1.14 . . . . 0.0 111.28 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.67 115.86 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 110.684 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.46 123.92 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.07 105.14 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 164.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.0 m -77.59 95.74 4.63 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -161.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.13 -60.25 0.51 Allowed Glycine 0 N--CA 1.484 1.847 0 CA-C-N 114.876 -1.056 . . . . 0.0 113.576 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.25 123.85 25.32 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.9 p -61.55 -41.31 97.18 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.363 2.727 . . . . 0.0 118.363 -175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -99.68 28.57 4.6 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 163.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.58 69.81 3.26 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.309 -1.494 . . . . 0.0 114.305 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.0 mt -130.03 98.94 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -168.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -98.61 108.58 21.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 110.281 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . 0.299 2.3 pp -82.09 93.1 6.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.1 pt? -64.4 -23.21 67.21 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 165.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.425 22.6 pt20 62.49 69.44 0.61 Allowed 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.23 88.99 6.92 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 121.042 -1.036 . . . . 0.0 108.361 156.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . 0.298 4.3 tm-20 . . . . . 0 N--CA 1.506 2.334 0 CA-C-O 124.485 2.088 . . . . 0.0 111.263 -151.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 mtt . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.321 22.4 ttpp 75.98 -52.05 0.62 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 119.215 3.043 . . . . 0.0 119.215 165.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.17 84.55 7.01 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -168.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.9 mt -82.02 154.18 25.8 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -74.33 153.96 39.09 Favored 'General case' 0 CA--C 1.574 1.881 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.408 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.98 -44.38 70.75 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 117.902 2.556 . . . . 0.0 117.902 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -72.09 -33.29 67.77 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -56.55 -46.55 80.62 Favored 'General case' 0 CA--C 1.583 2.229 0 CA-C-N 120.502 1.501 . . . . 0.0 114.481 161.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -61.54 -40.05 93.28 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -54.93 -50.71 68.17 Favored 'General case' 0 CA--C 1.582 2.207 0 CA-C-N 121.004 1.729 . . . . 0.0 115.391 164.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 79.2 t -55.76 -50.01 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -59.62 -42.53 92.89 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 172.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.06 -38.14 75.74 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.89 -44.01 97.69 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 120.597 1.544 . . . . 0.0 114.768 168.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.7 mm -53.26 -53.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 166.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -62.87 -37.65 87.73 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.73 -47.79 83.39 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 170.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -66.04 -41.32 91.02 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 120.593 1.542 . . . . 0.0 115.031 173.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.2 mt -67.65 -44.93 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -65.09 -28.77 69.68 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -87.79 -45.93 9.9 Favored 'General case' 0 CA--C 1.577 2.005 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p -105.56 -23.69 12.73 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.42 -47.43 1.34 Allowed Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.393 1.317 . . . . 0.0 116.393 -164.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -88.63 160.72 43.91 Favored Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.29 158.85 50.91 Favored 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 122.078 1.852 . . . . 0.0 116.059 172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.07 164.87 13.29 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 122.263 1.976 . . . . 0.0 114.891 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.5 p -72.97 151.04 41.99 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.205 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -57.87 -25.15 60.37 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 167.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.15 94.45 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 160.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.18 -45.42 93.19 Favored 'General case' 0 CA--C 1.574 1.892 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.1 -50.46 78.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.302 0 CA-C-N 120.133 1.333 . . . . 0.0 112.359 170.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.56 -48.41 81.89 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -80.43 -49.04 11.98 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -175.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -67.33 -40.14 85.89 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.2 -14.97 58.73 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 116.87 2.174 . . . . 0.0 116.87 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.05 65.28 1.54 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 116.019 1.168 . . . . 0.0 116.019 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -98.08 141.31 31.18 Favored 'General case' 0 CA--C 1.562 1.423 0 CA-C-O 121.968 0.89 . . . . 0.0 112.91 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.91 -35.34 79.78 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.0 t -136.42 142.29 38.92 Favored Pre-proline 0 CA--C 1.57 1.737 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.307 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -61.55 -24.54 78.21 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 N-CA-C 118.006 2.272 . . . . 0.0 118.006 171.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -63.89 -28.31 69.75 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 167.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.91 -45.47 92.37 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.002 1.852 . . . . 0.0 116.002 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.17 73.77 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -53.43 -48.11 69.04 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 171.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.33 -30.78 68.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.133 2.271 . . . . 0.0 117.133 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -62.36 -38.88 91.27 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 162.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.14 -43.22 99.22 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.5 -47.9 78.33 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 163.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.01 94.06 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.76 -38.02 77.53 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 164.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.5 -46.22 76.97 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 166.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -59.22 -34.98 72.83 Favored 'General case' 0 CA--C 1.582 2.186 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 170.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 tptt -60.88 -26.07 67.15 Favored 'General case' 0 CA--C 1.583 2.228 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 163.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.16 41.47 3.02 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -129.73 -41.91 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.583 2.216 0 CA-C-N 118.103 0.952 . . . . 0.0 113.315 -169.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.0 pt -126.0 135.53 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.0 1.273 . . . . 0.0 110.914 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.12 118.05 31.94 Favored 'General case' 0 CA--C 1.566 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 110.015 178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.44 125.39 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.743 0 CA-C-O 121.045 0.45 . . . . 0.0 110.291 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.47 93.42 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -74.58 123.45 24.83 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -160.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.65 -47.03 1.09 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 -161.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.87 119.63 22.33 Favored 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.1 t -58.19 -41.51 84.11 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 171.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.8 ttp85 -95.07 83.1 3.86 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-O 121.63 0.728 . . . . 0.0 109.821 161.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.39 67.01 0.33 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -172.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.7 mm -135.83 118.98 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -172.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -103.17 126.7 50.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.311 -0.868 . . . . 0.0 110.822 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.5 tp -91.71 121.28 33.21 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -111.07 92.73 4.16 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 162.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -73.35 87.82 1.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 -162.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.47 111.35 12.21 Favored 'General case' 0 CA--C 1.567 1.61 0 C-N-CA 123.567 0.747 . . . . 0.0 109.123 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 124.761 2.219 . . . . 0.0 113.939 174.468 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 CA--C 1.56 1.348 0 CA-C-O 121.288 0.566 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -86.49 144.84 27.06 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 121.862 -0.524 . . . . 0.0 112.131 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.25 99.11 2.79 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.82 149.74 22.55 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.6 p -67.15 155.94 37.48 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 172.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.16 -43.06 61.18 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -74.25 -38.3 63.52 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 169.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -58.52 -44.96 89.7 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 120.823 1.647 . . . . 0.0 115.178 168.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -61.25 -41.28 96.63 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -56.46 -47.26 79.55 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 165.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.95 -44.68 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 168.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -61.58 -41.56 97.58 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 172.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.82 -46.59 89.93 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.75 -41.14 98.05 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.277 0.4 OUTLIER -58.17 -46.57 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 CA-C-N 120.548 1.522 . . . . 0.0 114.584 171.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -63.12 -49.5 74.15 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.54 -46.34 90.55 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -69.37 -36.3 76.7 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.26 -45.22 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 CA-C-N 120.805 1.639 . . . . 0.0 112.899 165.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -64.43 -26.58 68.51 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.25 -54.07 4.67 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 m -102.45 -39.6 7.07 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.55 -46.53 1.12 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 115.839 1.096 . . . . 0.0 115.839 -170.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.2 ptp -87.61 156.67 53.13 Favored Pre-proline 0 CA--C 1.57 1.739 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.51 155.2 21.33 Favored 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 122.022 1.814 . . . . 0.0 116.4 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.99 94.39 0.98 Allowed 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.637 2.225 . . . . 0.0 112.932 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -84.4 81.87 8.64 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.299 2.3 tmt_? 66.73 -60.02 0.35 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.81 77.32 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -171.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -69.93 -31.99 70.04 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.69 -50.91 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.251 1.387 . . . . 0.0 113.156 165.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.82 -43.01 94.76 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 170.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -69.61 -49.15 56.76 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -76.56 -40.09 50.84 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 78.9 mt -91.41 -26.78 18.7 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 73.64 1.06 Allowed Glycine 0 N--CA 1.483 1.788 0 CA-C-N 119.532 1.06 . . . . 0.0 115.345 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -135.44 128.05 30.79 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 117.318 0.559 . . . . 0.0 111.418 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -73.96 -45.71 48.52 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 117.015 2.228 . . . . 0.0 117.015 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 m -118.25 151.31 49.15 Favored Pre-proline 0 CA--C 1.57 1.749 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -167.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -66.54 -20.31 53.91 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 N-CA-C 118.392 2.42 . . . . 0.0 118.392 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -57.65 -16.24 10.01 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 164.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.61 -62.56 1.24 Allowed 'General case' 0 CA--C 1.564 1.518 0 CA-C-N 119.407 1.003 . . . . 0.0 112.686 160.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -46.02 91.67 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -80.16 -45.18 18.56 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -69.18 -29.25 67.2 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -60.37 -40.45 90.83 Favored 'General case' 0 CA--C 1.581 2.148 0 CA-C-N 122.622 2.464 . . . . 0.0 114.787 165.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.31 -44.82 93.87 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -60.82 -47.48 86.15 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.9 84.17 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 169.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.57 -43.91 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.49 98.8 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 166.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -56.42 -35.14 67.48 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 168.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -59.07 -34.24 71.73 Favored 'General case' 0 CA--C 1.591 2.552 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 163.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.82 56.09 0.56 Allowed Glycine 0 N--CA 1.481 1.664 0 N-CA-C 115.937 1.135 . . . . 0.0 115.937 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.301 3.9 p -132.81 -53.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.28 143.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.028 0 CA-C-N 119.643 1.11 . . . . 0.0 112.699 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.79 143.61 56.8 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.252 155.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.48 114.34 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 163.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.62 105.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.685 0.755 . . . . 0.0 109.369 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 m -84.23 85.54 7.35 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 122.172 0.987 . . . . 0.0 112.281 -175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.26 -73.44 0.23 Allowed Glycine 0 N--CA 1.484 1.87 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.287 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.98 106.12 11.76 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 120.98 0.419 . . . . 0.0 111.454 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 m -60.34 -42.73 96.29 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 118.464 2.765 . . . . 0.0 118.464 -166.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -83.14 65.01 7.99 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 119.799 1.181 . . . . 0.0 113.361 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.36 76.42 0.27 Allowed Glycine 0 N--CA 1.48 1.618 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.869 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.4 mp -128.29 106.34 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -124.64 141.28 52.21 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.021 0.528 . . . . 0.0 111.634 -167.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.28 106.64 6.91 Favored 'General case' 0 CA--C 1.574 1.867 0 O-C-N 121.121 -0.987 . . . . 0.0 112.795 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.69 -48.0 56.98 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.51 -14.34 62.08 Favored 'General case' 0 CA--C 1.584 2.273 0 N-CA-C 117.771 2.508 . . . . 0.0 117.771 172.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.285 44.6 mt-10 74.0 -49.2 0.67 Allowed 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 CA--C 1.564 1.502 0 CA-C-O 124.369 2.033 . . . . 0.0 115.656 178.319 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.562 1.426 0 CA-C-O 121.24 0.543 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.35 101.49 13.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 111.754 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.25 79.8 9.28 Favored 'General case' 0 CA--C 1.566 1.573 0 CA-C-O 122.03 0.919 . . . . 0.0 112.604 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 5' ' ' THR 0.624 2.6 pt? 43.49 -92.95 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 118.748 2.87 . . . . 0.0 118.748 -169.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HG ' ' A' ' 4' ' ' LEU . 20.0 p -143.83 138.17 28.49 Favored 'General case' 0 CA--C 1.57 1.75 0 C-N-CA 123.941 0.896 . . . . 0.0 109.304 170.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.66 53.08 1.28 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 117.689 2.478 . . . . 0.0 117.689 -173.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -144.24 -54.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.03 1.332 . . . . 0.0 109.794 164.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -61.05 -34.78 75.41 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 163.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -57.18 -40.76 77.98 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 168.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.97 -42.42 80.13 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.43 -44.32 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 167.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -64.63 -41.87 95.87 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -55.94 -39.34 71.57 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 115.213 1.561 . . . . 0.0 115.213 163.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 tp -66.51 -34.23 77.46 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.0 mt -53.51 -57.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 CA-C-N 120.515 1.507 . . . . 0.0 113.174 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -66.13 -32.21 73.53 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.3 -48.02 71.72 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 166.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.25 -38.31 89.94 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.173 1.806 . . . . 0.0 115.448 173.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.12 -38.64 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 166.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.1 m -66.31 -41.72 89.31 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 116.653 2.094 . . . . 0.0 116.653 167.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.81 -26.91 62.59 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.1 m -148.33 -52.84 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.323 0.965 . . . . 0.0 112.308 -174.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 133.98 18.45 0.96 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -148.11 148.79 30.65 Favored Pre-proline 0 CA--C 1.581 2.147 0 CA-C-N 118.853 1.326 . . . . 0.0 112.324 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 147.62 37.56 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 122.563 2.175 . . . . 0.0 115.796 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.38 160.63 35.46 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.779 2.319 . . . . 0.0 115.391 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -143.89 127.13 16.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.308 42.2 ttt85 62.91 -79.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 161.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.24 -44.5 59.4 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.08 -42.07 93.81 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 170.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.33 -51.92 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-N 119.27 0.941 . . . . 0.0 112.984 171.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.24 94.84 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -74.59 -40.99 61.26 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -64.34 -42.72 96.11 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.3 mt -106.36 -26.51 11.46 Favored 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.66 86.48 1.68 Allowed Glycine 0 N--CA 1.485 1.925 0 CA-C-N 120.243 1.383 . . . . 0.0 114.139 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -120.72 137.55 54.43 Favored 'General case' 0 CA--C 1.565 1.551 0 CA-C-O 121.561 0.696 . . . . 0.0 111.771 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.71 -28.71 67.56 Favored 'General case' 0 CA--C 1.565 1.527 0 N-CA-C 119.008 2.966 . . . . 0.0 119.008 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 94.6 p -148.52 149.02 30.26 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-N 119.249 0.931 . . . . 0.0 113.074 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -62.43 -27.95 77.7 Favored 'Trans proline' 0 N--CA 1.509 2.398 0 N-CA-C 117.872 2.22 . . . . 0.0 117.872 170.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -65.89 -40.34 91.46 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.06 93.38 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.98 -47.16 68.41 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 167.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.48 -36.73 76.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 171.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.28 -33.06 74.51 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.385 1.902 . . . . 0.0 116.01 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -66.9 -36.04 81.38 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 120.99 1.723 . . . . 0.0 115.346 164.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.5 tp -56.99 -46.13 82.48 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 161.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -60.0 -49.7 76.62 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.02 -43.21 60.84 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 117.403 2.372 . . . . 0.0 117.403 170.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.86 -45.75 84.73 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 168.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.09 93.59 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 172.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -57.72 -39.34 77.03 Favored 'General case' 0 CA--C 1.582 2.208 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -69.89 -40.1 75.86 Favored 'General case' 0 CA--C 1.585 2.315 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 165.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.49 38.77 0.32 Allowed Glycine 0 N--CA 1.484 1.855 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 165.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.18 -28.84 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.112 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.14 146.93 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-O 121.963 0.887 . . . . 0.0 112.571 -171.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -85.99 115.17 23.43 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.859 -0.526 . . . . 0.0 110.832 168.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -104.72 124.41 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 121.536 0.684 . . . . 0.0 109.528 -174.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.48 123.01 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -72.84 105.16 4.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.591 0.71 . . . . 0.0 112.804 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.29 -65.36 0.4 Allowed Glycine 0 N--CA 1.485 1.965 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.778 -167.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.89 119.63 24.18 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 169.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.1 p -79.31 65.2 4.42 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.269 15.7 ptm180 -161.42 -65.15 0.06 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.14 1.376 . . . . 0.0 111.553 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.55 -166.85 14.99 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 115.381 0.912 . . . . 0.0 115.381 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 41.4 mm -132.92 -72.82 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.333 -0.841 . . . . 0.0 110.441 -172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.89 147.88 39.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -158.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.61 126.59 31.12 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.4 mt -124.03 92.56 3.7 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.254 15.2 pt20 -70.62 90.77 0.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 -163.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.5 109.15 12.42 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.929 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 123.411 1.577 . . . . 0.0 110.845 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 tpt . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 71.5 107.88 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.747 1.219 . . . . 0.0 112.304 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.58 89.34 4.5 Favored 'General case' 0 CA--C 1.563 1.466 0 O-C-N 121.161 -0.962 . . . . 0.0 113.053 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.7 mp 68.87 109.21 0.05 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.0 p -66.67 153.52 42.95 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 121.387 -0.82 . . . . 0.0 112.592 167.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.52 -38.89 56.32 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 118.769 2.877 . . . . 0.0 118.769 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -70.82 -37.0 73.18 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 170.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -59.47 -44.45 93.02 Favored 'General case' 0 CA--C 1.584 2.257 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 162.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -57.91 -39.29 77.59 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -58.62 -47.6 83.85 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 165.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.09 -49.43 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 170.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.16 -48.27 79.13 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.06 -38.85 68.56 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 168.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -48.57 69.86 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.258 26.0 pt -59.46 -42.57 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.126 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 167.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -63.77 -39.04 93.3 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.67 -47.53 83.28 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -58.85 -49.22 78.56 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 169.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 91.8 mt -64.13 -40.61 89.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -61.97 -48.86 78.48 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -85.84 -37.49 19.15 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -116.33 -17.79 10.65 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.94 -28.98 10.67 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 118.651 2.22 . . . . 0.0 118.651 -173.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -88.59 129.82 47.62 Favored Pre-proline 0 CA--C 1.564 1.511 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -69.99 115.97 4.37 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.391 2.06 . . . . 0.0 115.427 172.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 160.33 37.21 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 123.562 2.308 . . . . 0.0 116.401 -170.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.2 p -86.89 163.97 16.86 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -40.5 -57.7 1.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.62 89.65 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.79 -43.49 85.63 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.69 -57.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.011 0.823 . . . . 0.0 112.615 168.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.6 85.49 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 118.278 2.695 . . . . 0.0 118.278 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -68.63 -34.4 75.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mtm180 -73.02 -48.06 39.55 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.68 -38.4 58.77 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.02 61.85 0.28 Allowed Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -117.61 128.52 55.01 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 121.58 0.705 . . . . 0.0 109.984 168.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' HE ' ' H ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -63.62 -42.24 98.21 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 117.074 2.25 . . . . 0.0 117.074 169.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.472 ' H ' ' HE ' ' A' ' 38' ' ' ARG . 10.1 t -109.65 106.95 59.03 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.354 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -54.79 -19.55 19.34 Favored 'Trans proline' 0 N--CA 1.508 2.336 0 N-CA-C 121.832 3.743 . . . . 0.0 121.832 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -53.28 -31.82 45.67 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.74 2.496 . . . . 0.0 117.74 170.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.83 -38.34 55.44 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 165.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -51.5 69.58 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -70.18 -32.68 70.73 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -61.98 -44.2 97.24 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -63.25 -41.39 99.05 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 164.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tp -49.7 -44.33 48.08 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 169.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -54.97 -46.06 75.01 Favored 'General case' 0 CA--C 1.581 2.169 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 164.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.18 90.12 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 -41.68 92.84 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 166.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -42.75 94.72 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 168.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -56.8 -42.38 79.43 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 168.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -70.45 -8.59 52.13 Favored 'General case' 0 CA--C 1.585 2.306 0 N-CA-C 117.686 2.476 . . . . 0.0 117.686 167.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.14 -9.11 61.22 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 120.136 2.814 . . . . 0.0 120.136 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 p -85.12 -4.25 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.0 pt -142.78 143.75 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.788 0 CA-C-N 119.973 1.261 . . . . 0.0 111.963 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.11 112.5 25.66 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 166.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -84.8 125.63 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.6 t -78.8 120.96 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.798 -0.564 . . . . 0.0 109.676 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -76.64 85.24 3.3 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.65 63.5 0.51 Allowed Glycine 0 N--CA 1.486 1.992 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.686 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.5 131.39 13.31 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 117.421 0.61 . . . . 0.0 111.925 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.1 t -78.85 103.62 8.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.784 -0.572 . . . . 0.0 110.938 167.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . 0.262 79.3 mtt180 70.38 67.22 0.2 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.55 83.0 0.25 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 114.645 0.618 . . . . 0.0 114.645 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.0 mt -133.97 117.93 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.0 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.44 118.73 23.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.702 . . . . 0.0 110.179 174.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.98 100.63 9.8 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 122.945 0.498 . . . . 0.0 110.99 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 mt -77.28 -10.67 59.57 Favored 'General case' 0 CA--C 1.587 2.4 0 N-CA-C 117.563 2.431 . . . . 0.0 117.563 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.311 5.0 tp-100 82.97 124.68 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.004 1.722 . . . . 0.0 115.355 167.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -84.77 -45.92 11.9 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 168.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 124.659 2.171 . . . . 0.0 110.355 -169.203 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 121.387 0.613 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -88.78 65.42 7.67 Favored 'General case' 0 CA--C 1.581 2.156 0 CA-C-O 121.981 0.896 . . . . 0.0 111.336 168.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.22 162.19 40.98 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.836 0.827 . . . . 0.0 112.481 -173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 93.5 mt -112.4 155.98 23.27 Favored 'General case' 0 CA--C 1.571 1.776 0 CA-C-O 122.117 0.96 . . . . 0.0 113.268 -177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -67.8 157.75 34.06 Favored 'General case' 0 CA--C 1.577 2.012 0 O-C-N 121.643 -0.661 . . . . 0.0 112.155 168.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.59 -54.78 28.34 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.651 2.463 . . . . 0.0 117.651 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -65.12 -35.01 79.78 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -59.67 -49.81 76.3 Favored 'General case' 0 CA--C 1.592 2.561 0 CA-C-N 120.235 1.38 . . . . 0.0 114.611 166.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -57.37 -43.29 83.45 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.05 -47.61 77.57 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 166.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.87 -49.26 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -58.17 -46.92 84.88 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -65.52 -28.82 69.46 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 tt -65.22 -47.16 77.81 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 120.726 1.603 . . . . 0.0 114.519 169.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.287 15.6 tt -57.47 -45.26 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 165.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.77 -44.04 73.31 Favored 'General case' 0 CA--C 1.581 2.147 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 169.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -59.71 -51.31 70.3 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 167.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -40.96 98.99 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.01 -48.61 85.25 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.181 0 C-N-CA 123.702 0.801 . . . . 0.0 112.767 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -70.9 -34.6 71.72 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.888 2.551 . . . . 0.0 117.888 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -78.29 -21.83 49.13 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.2 m -148.08 -53.24 0.19 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 119.193 0.906 . . . . 0.0 111.86 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 118.55 40.79 0.65 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 115.983 1.153 . . . . 0.0 115.983 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -142.96 132.48 11.86 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 118.426 1.113 . . . . 0.0 113.51 -170.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.88 123.62 3.69 Favored 'Trans proline' 0 CA--C 1.566 2.077 0 CA-C-N 122.501 1.929 . . . . 0.0 115.183 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.1 127.39 8.41 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.761 2.308 . . . . 0.0 113.882 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.6 t -77.53 172.42 13.38 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -49.54 -35.71 21.24 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 119.174 3.027 . . . . 0.0 119.174 174.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.89 -46.19 75.69 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 165.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.97 -45.35 92.96 Favored 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.3 mm -54.82 -49.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.127 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 167.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.75 84.45 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 170.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -65.54 -51.38 60.28 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -83.95 -37.59 22.08 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.6 -16.32 39.68 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.84 66.03 1.52 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 120.092 1.314 . . . . 0.0 115.998 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -109.89 125.66 53.04 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -59.2 -16.07 18.51 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 118.648 2.833 . . . . 0.0 118.648 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 m -148.99 155.23 40.41 Favored Pre-proline 0 CA--C 1.573 1.844 0 O-C-N 121.293 -0.879 . . . . 0.0 111.379 165.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -56.03 -28.73 70.78 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 N-CA-C 118.05 2.289 . . . . 0.0 118.05 173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -61.88 -33.75 74.78 Favored 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.01 -39.11 83.26 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 168.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.35 -46.61 89.32 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 162.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -54.86 -36.56 65.22 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 167.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -55.45 -46.05 76.8 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -67.74 -39.72 84.2 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 166.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.71 -46.84 77.63 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.265 63.6 pttt -64.83 -39.25 93.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.82 88.75 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 166.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.1 mt -58.62 -40.47 83.42 Favored 'General case' 0 CA--C 1.586 2.336 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 163.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.85 -32.57 74.16 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 168.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -64.86 -38.79 92.14 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -66.63 -33.92 76.74 Favored 'General case' 0 CA--C 1.586 2.365 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 158.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.99 60.31 1.6 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 115.353 0.901 . . . . 0.0 115.353 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.12 -39.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.015 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.55 162.97 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 118.769 0.713 . . . . 0.0 110.546 152.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -128.74 132.6 47.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.874 -1.141 . . . . 0.0 111.051 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.3 mt -90.85 116.45 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 O-C-N 121.787 -0.571 . . . . 0.0 109.877 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.1 t -80.87 96.71 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.2 m -77.59 96.02 4.7 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.871 0.844 . . . . 0.0 112.47 -172.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 146.24 -53.22 0.56 Allowed Glycine 0 N--CA 1.486 2.021 0 CA-C-N 115.319 -0.855 . . . . 0.0 114.272 -163.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.32 133.7 41.2 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 173.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.8 t -60.79 -54.47 44.8 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -93.97 71.64 4.04 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 119.179 0.9 . . . . 0.0 111.17 161.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.95 63.55 0.27 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 115.361 0.904 . . . . 0.0 115.361 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.5 mm -126.44 97.72 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.876 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -93.45 122.04 35.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.047 -1.033 . . . . 0.0 112.038 -172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -84.02 123.53 30.11 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.65 -3.51 9.28 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.389 15.4 mm100 76.1 -63.83 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 117.792 2.515 . . . . 0.0 117.792 171.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -146.03 144.18 29.9 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 122.149 0.976 . . . . 0.0 108.966 174.596 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.293 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.59 106.51 18.54 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.137 0.575 . . . . 0.0 112.003 175.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.52 125.52 29.19 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.899 -1.126 . . . . 0.0 111.419 162.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.9 mt -67.03 116.68 8.12 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -167.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 t -78.5 159.29 28.29 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -34.18 -55.89 0.5 Allowed 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 121.017 3.71 . . . . 0.0 121.017 -164.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -77.69 -37.02 50.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -67.03 -34.37 77.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 163.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.57 -42.78 88.78 Favored 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 163.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -56.58 -44.38 80.97 Favored 'General case' 0 CA--C 1.577 2.008 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 167.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.85 -41.31 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 167.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -62.47 -43.65 98.29 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 168.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.4 -41.47 69.31 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 167.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -42.25 91.78 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 175.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.319 6.2 tp -58.91 -46.51 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 163.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -59.32 -43.63 92.67 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 168.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.77 -51.05 71.0 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -179.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -63.37 -37.86 88.89 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 174.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.3 -47.74 88.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 CA-C-N 118.751 0.705 . . . . 0.0 112.861 169.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -65.23 -37.54 87.57 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 172.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -83.8 -12.84 55.09 Favored 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 175.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.3 m -149.31 -56.88 0.2 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.786 1.175 . . . . 0.0 111.509 -176.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.49 -44.52 0.98 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -81.98 161.52 60.3 Favored Pre-proline 0 CA--C 1.57 1.738 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.02 159.52 52.9 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 CA-C-N 122.202 1.822 . . . . 0.0 115.356 169.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 159.25 35.71 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.993 1.795 . . . . 0.0 114.621 178.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.6 p -71.09 147.92 48.0 Favored 'General case' 0 CA--C 1.573 1.839 0 O-C-N 121.665 -0.647 . . . . 0.0 111.548 165.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -62.36 -28.63 69.89 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 175.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.18 93.09 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 160.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.85 -39.98 95.48 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 166.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.5 mt -56.59 -46.14 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.271 0 CA-C-N 120.162 1.346 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.88 -54.18 42.76 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 170.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -76.94 -38.4 53.45 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -66.48 -41.89 88.31 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.09 -20.09 42.26 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 173.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 48.68 2.77 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 117.403 1.721 . . . . 0.0 117.403 178.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -100.37 100.32 11.08 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-N 117.758 0.779 . . . . 0.0 109.872 177.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.36 62.09 7.27 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 122.449 1.119 . . . . 0.0 112.88 174.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -177.82 119.08 0.25 Allowed Pre-proline 0 CA--C 1.577 2.018 0 C-N-CA 125.381 1.472 . . . . 0.0 107.849 -175.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.78 -27.15 52.18 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 N-CA-C 118.631 2.512 . . . . 0.0 118.631 -175.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.27 -47.71 72.8 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.927 1.455 . . . . 0.0 114.927 167.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.97 -44.15 63.87 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 -169.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.05 -50.72 70.86 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -20.55 62.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 118.07 2.619 . . . . 0.0 118.07 171.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -70.87 -41.42 71.4 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 173.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -61.34 -34.49 75.37 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 115.667 1.728 . . . . 0.0 115.667 162.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.08 -45.68 86.74 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -63.82 -30.48 71.57 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.868 2.544 . . . . 0.0 117.868 172.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.12 78.85 Favored 'General case' 0 CA--C 1.575 1.915 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 166.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.4 -39.18 91.87 Favored 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.63 98.39 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 164.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -61.55 -34.89 76.34 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 169.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.06 -30.13 65.95 Favored 'General case' 0 CA--C 1.58 2.132 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 162.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.2 29.34 8.01 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.029 1.972 . . . . 0.0 118.029 -177.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . 0.252 6.5 p -108.52 -38.51 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.6 pt -123.03 138.63 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 C-N-CA 123.788 0.835 . . . . 0.0 112.231 -178.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.62 113.72 27.34 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.41 0.624 . . . . 0.0 109.796 172.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -93.88 127.21 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 123.215 0.606 . . . . 0.0 109.501 -172.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.7 115.77 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 O-C-N 121.726 -0.609 . . . . 0.0 109.75 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.8 p -76.28 86.18 3.08 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 -68.66 0.33 Allowed Glycine 0 N--CA 1.484 1.862 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.69 -172.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.52 112.31 11.72 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 177.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.8 m -70.0 -21.55 63.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 178.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -91.79 83.67 5.3 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 119.802 1.183 . . . . 0.0 108.649 152.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.99 64.65 0.26 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -172.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.9 101.58 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -84.25 113.32 21.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.282 -0.886 . . . . 0.0 110.893 -179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.3 tp -80.68 83.2 6.51 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.674 0.75 . . . . 0.0 111.615 172.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 1.5 pp -80.31 -21.18 42.83 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -115.91 121.64 42.92 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 168.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -87.61 82.02 7.55 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-O 121.916 0.865 . . . . 0.0 110.983 -176.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 124.852 2.263 . . . . 0.0 111.857 -167.8 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.639 0.733 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.363 55.4 tttm 69.98 -77.84 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -171.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.35 90.98 8.62 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.273 1.035 . . . . 0.0 111.084 165.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.21 143.58 26.96 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -169.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 159.9 24.14 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -174.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.26 76.55 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 118.288 2.699 . . . . 0.0 118.288 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -71.74 -39.7 69.88 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 172.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.47 -28.87 69.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 165.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.49 -40.34 96.37 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 162.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -59.19 -44.75 92.22 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 164.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 73.6 t -52.23 -48.47 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 164.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.19 -40.69 96.61 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 175.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.26 -42.81 78.03 Favored 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 167.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.16 -34.18 77.45 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 166.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.24 -55.11 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 120.725 1.602 . . . . 0.0 113.564 166.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -58.91 -41.88 88.29 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.5 -52.99 62.85 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 167.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -68.28 -35.36 77.73 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.04 1.291 . . . . 0.0 112.826 166.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 t -67.73 -32.98 73.98 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 170.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -75.83 -40.1 55.5 Favored 'General case' 0 CA--C 1.581 2.166 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 172.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.2 p -124.44 -49.28 1.79 Allowed 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -174.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.68 -44.62 1.12 Allowed Glycine 0 CA--C 1.545 1.916 0 N-CA-C 116.59 1.396 . . . . 0.0 116.59 -175.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -90.84 142.06 27.3 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 -168.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -62.17 117.51 4.37 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.981 2.454 . . . . 0.0 116.754 172.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.68 119.25 5.38 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 CA-C-N 122.683 1.994 . . . . 0.0 114.931 -176.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 p -115.8 98.56 6.74 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.555 0.693 . . . . 0.0 110.225 -177.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.391 0.5 OUTLIER 65.09 -50.7 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 -174.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.32 -47.11 79.38 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -176.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.71 -38.29 23.56 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 165.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mm -61.01 -57.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.08 77.11 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 118.012 2.597 . . . . 0.0 118.012 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -80.95 -49.83 10.48 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -78.57 -31.74 47.43 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.9 mt -84.47 -18.95 34.23 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 167.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.44 72.9 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.078 1.308 . . . . 0.0 115.617 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -97.13 134.6 40.25 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 121.985 0.898 . . . . 0.0 112.934 -176.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -14.39 45.58 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 119.732 3.234 . . . . 0.0 119.732 170.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.6 m -157.05 143.71 13.33 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-N 119.716 1.143 . . . . 0.0 112.185 173.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.05 -43.98 34.38 Favored 'Trans proline' 0 N--CA 1.512 2.598 0 C-N-CA 122.927 2.418 . . . . 0.0 117.724 165.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.36 -32.83 73.68 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 172.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.11 82.25 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 169.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.86 78.77 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 167.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -57.99 -48.38 80.18 Favored 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 172.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -53.45 -48.61 68.66 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -61.63 -39.93 93.04 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 170.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -56.37 -42.11 77.29 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 164.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -67.95 -47.56 68.33 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.21 87.73 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 167.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 tp -64.13 -48.25 76.81 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 171.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.79 -38.72 70.31 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 166.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -55.84 -32.38 63.56 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 166.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -66.36 -16.25 63.92 Favored 'General case' 0 CA--C 1.586 2.33 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 165.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.17 69.05 1.18 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.537 1.062 . . . . 0.0 114.921 176.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.84 -29.47 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.922 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -171.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.19 145.48 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.829 0 CA-C-N 121.135 1.789 . . . . 0.0 112.641 -177.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -88.81 113.0 23.89 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 121.819 -0.551 . . . . 0.0 110.216 170.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.94 134.46 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 172.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.08 145.54 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.472 0.653 . . . . 0.0 112.113 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.4 p -75.11 89.48 2.48 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.8 -82.14 0.2 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.829 -173.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.55 95.6 1.84 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.785 0.802 . . . . 0.0 112.035 170.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -77.97 14.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -164.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.8 mtm-85 -82.12 -70.52 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 111.778 156.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.94 -147.05 18.17 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.25 -58.86 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 114.685 -0.758 . . . . 0.0 111.546 -176.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.7 ptt-85 -154.55 169.41 23.88 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -163.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.31 122.74 27.82 Favored 'General case' 0 CA--C 1.573 1.831 0 C-N-CA 123.082 0.553 . . . . 0.0 110.849 165.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.4 mt -101.25 113.28 26.2 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 175.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.429 16.2 pt20 63.25 -15.32 0.07 Allowed 'General case' 0 N--CA 1.502 2.147 1 N-CA-C 122.261 4.171 . . . . 0.0 122.261 171.632 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.335 17.1 tt0 73.64 -38.48 0.41 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 -177.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 124.375 2.036 . . . . 0.0 110.045 173.571 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.56 1.35 0 CA-C-O 121.396 0.617 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -81.6 135.25 35.56 Favored 'General case' 0 CA--C 1.566 1.592 0 O-C-N 121.74 -0.6 . . . . 0.0 111.845 172.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.17 77.33 2.99 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 172.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.9 mt 65.87 145.96 0.03 OUTLIER 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -172.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -74.49 163.38 27.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.807 -1.183 . . . . 0.0 113.054 170.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.76 67.8 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.735 2.865 . . . . 0.0 118.735 -177.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -71.27 -38.0 71.87 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 167.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -59.63 -47.77 84.28 Favored 'General case' 0 CA--C 1.587 2.386 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.93 -38.3 90.52 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . 0.267 10.8 pt-20 -62.59 -37.17 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 163.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.55 -49.07 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 CA-C-N 119.798 1.181 . . . . 0.0 113.364 163.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -57.99 -49.22 77.58 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 171.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.95 -34.8 66.0 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 171.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 tp -68.15 -49.15 62.87 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 170.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.293 7.0 tt -59.71 -42.49 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.55 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 168.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -56.22 -51.71 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 166.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.92 -52.26 66.51 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 171.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -63.49 -42.13 98.55 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.76 -47.26 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.581 1.082 . . . . 0.0 112.78 170.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 t -63.81 -30.34 71.44 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 174.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -92.76 -40.21 10.8 Favored 'General case' 0 CA--C 1.575 1.904 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.9 p -114.86 -26.16 7.91 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.85 -27.58 11.82 Favored Glycine 0 CA--C 1.547 2.035 0 N-CA-C 118.714 2.246 . . . . 0.0 118.714 -174.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 51.6 mtm -106.48 119.6 51.23 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 119.309 1.554 . . . . 0.0 114.456 -156.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -58.87 116.97 3.63 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 N-CA-C 119.743 2.939 . . . . 0.0 119.743 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.61 127.55 16.56 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 122.56 2.173 . . . . 0.0 114.647 170.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.8 p -90.88 -74.15 0.51 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -142.07 -37.52 0.4 Allowed 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.78 56.41 Favored 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -60.48 -41.91 95.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.86 -49.06 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 169.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.54 95.25 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 170.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.66 -44.12 87.27 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 173.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -74.11 -49.19 24.97 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 177.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.9 -12.25 36.71 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -177.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.46 54.15 2.61 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 178.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -100.92 110.17 22.19 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -53.71 -33.91 57.09 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 118.977 2.954 . . . . 0.0 118.977 -177.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.4 p -112.51 135.94 21.49 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.415 163.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.94 -31.1 26.02 Favored 'Trans proline' 0 N--CA 1.509 2.409 0 N-CA-C 118.826 2.587 . . . . 0.0 118.826 165.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -55.99 -33.12 64.55 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.999 2.222 . . . . 0.0 116.999 167.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -44.48 79.99 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 168.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -47.56 81.21 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 165.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.05 -44.37 74.64 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 167.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.56 -36.15 82.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 173.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -62.61 -44.44 96.29 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 163.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 tt -53.13 -46.12 68.66 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 120.903 1.683 . . . . 0.0 115.478 167.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -57.65 -47.88 81.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.36 83.64 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 171.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.96 -52.44 60.65 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 163.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.95 93.32 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.4 tpt85 -62.71 -38.49 90.66 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.936 2.198 . . . . 0.0 116.936 171.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -65.0 -46.27 82.12 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 166.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.27 39.29 0.45 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 175.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.41 -16.83 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.059 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -176.174 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.5 pt -135.87 131.1 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 CA-C-N 119.267 0.939 . . . . 0.0 110.381 177.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.64 119.21 33.74 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 174.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.7 mm -83.99 102.91 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.819 0 CA-C-O 121.527 0.68 . . . . 0.0 109.365 -176.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.09 94.62 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.0 m -84.94 100.36 11.57 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.872 0.844 . . . . 0.0 112.969 -160.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.32 -62.59 0.17 Allowed Glycine 0 N--CA 1.484 1.854 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.632 -172.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.18 142.09 35.04 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 168.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.7 m -57.83 -43.66 85.93 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -99.62 78.88 2.2 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 121.595 0.712 . . . . 0.0 109.735 163.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.64 87.14 0.37 Allowed Glycine 0 N--CA 1.486 2.02 0 CA-C-N 116.266 -0.425 . . . . 0.0 113.348 -174.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.2 mt -146.86 129.5 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -175.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -114.01 156.41 24.12 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.984 0.897 . . . . 0.0 112.867 170.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.8 mt -101.49 123.87 46.24 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -162.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -99.43 105.88 17.87 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 163.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -71.7 96.71 1.63 Allowed 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -158.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -84.12 80.4 9.2 Favored 'General case' 0 CA--C 1.571 1.784 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.851 167.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 124.871 2.272 . . . . 0.0 112.039 -171.426 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.564 1.497 0 CA-C-O 121.404 0.621 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -93.75 170.74 9.34 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.26 96.15 9.41 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 120.842 -1.161 . . . . 0.0 113.728 178.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.71 123.7 47.5 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 121.572 0.701 . . . . 0.0 111.673 -174.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.4 p -75.08 162.78 28.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.568 -0.708 . . . . 0.0 112.895 168.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -48.08 -55.22 10.73 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -169.248 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -67.96 -30.07 69.27 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 171.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -63.39 -42.29 98.79 Favored 'General case' 0 CA--C 1.583 2.24 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 164.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -58.91 -47.11 86.17 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 167.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -51.54 -50.61 59.69 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 165.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 76.0 t -58.85 -50.82 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.79 -51.68 66.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 170.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -59.73 -33.84 72.15 Favored 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.55 -51.0 69.11 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 164.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.1 mt -55.59 -52.27 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 172.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 57.2 ttp85 -48.44 -50.01 32.9 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 168.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -63.44 -44.92 93.15 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -62.75 -41.02 99.01 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 172.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 88.8 mt -63.12 -43.15 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.405 1.002 . . . . 0.0 113.593 167.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.1 t -55.17 -45.92 75.74 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.245 2.313 . . . . 0.0 117.245 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -92.55 -41.45 10.24 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 179.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -96.8 -33.58 11.62 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 108.98 -39.16 3.01 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.517 1.767 . . . . 0.0 117.517 -169.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.7 ptp -94.78 150.56 38.08 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -169.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.09 120.82 6.2 Favored 'Trans proline' 0 CA--C 1.569 2.253 0 C-N-CA 122.278 1.985 . . . . 0.0 113.626 169.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.16 156.31 42.29 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 CA-C-N 122.607 1.967 . . . . 0.0 116.856 -172.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 t -89.59 176.94 6.68 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.723 178.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -47.95 -44.59 30.35 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 119.328 3.085 . . . . 0.0 119.328 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.24 83.83 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 173.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -61.0 -48.04 83.68 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.7 -45.19 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 170.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.64 75.74 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 173.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -41.38 67.14 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 ttp85 -81.13 -26.71 35.91 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -178.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 mt -85.08 -51.94 6.3 Favored 'General case' 0 CA--C 1.576 1.974 0 CA-C-N 120.614 1.552 . . . . 0.0 114.877 165.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.76 75.14 0.4 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.479 0.581 . . . . 0.0 113.86 -170.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -118.31 133.53 55.81 Favored 'General case' 0 CA--C 1.57 1.746 0 C-N-CA 123.608 0.763 . . . . 0.0 109.537 172.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -42.76 95.56 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 163.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.9 m -109.62 113.31 58.02 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.226 -0.893 . . . . 0.0 111.293 -175.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -51.91 -36.73 64.96 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 N-CA-C 118.568 2.488 . . . . 0.0 118.568 169.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -66.76 -25.85 66.69 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 171.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.87 -44.49 85.2 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 164.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.76 -39.69 78.01 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 163.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -61.27 -53.23 59.5 Favored 'General case' 0 CA--C 1.571 1.775 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 168.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -60.66 -41.03 94.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 176.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -61.45 -44.64 96.75 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 165.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.8 tp -48.1 -51.39 24.76 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 121.22 1.827 . . . . 0.0 115.87 166.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -62.88 -52.12 64.32 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 172.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.61 81.15 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.696 2.48 . . . . 0.0 117.696 177.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.27 -54.68 37.25 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 165.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.48 -50.53 52.4 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 175.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.99 9.33 19.86 Favored 'General case' 0 CA--C 1.577 2.0 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -177.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.42 -47.36 82.25 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 120.742 -1.224 . . . . 0.0 113.464 144.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.14 60.7 0.04 OUTLIER Glycine 0 N--CA 1.48 1.576 0 C-N-CA 123.932 0.777 . . . . 0.0 114.068 174.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.77 -43.37 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.924 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.86 150.7 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.064 0.847 . . . . 0.0 110.989 172.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -96.77 117.91 32.07 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.211 0.605 . . . . 0.0 110.779 172.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 93.1 mt -96.55 140.26 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 122.591 1.186 . . . . 0.0 110.047 176.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.93 134.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.415 172.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.1 m -72.59 97.03 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.477 -0.765 . . . . 0.0 112.58 177.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.24 -70.51 0.5 Allowed Glycine 0 N--CA 1.485 1.914 0 CA-C-N 115.547 -0.752 . . . . 0.0 113.004 -167.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.86 107.23 9.04 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.5 m -72.96 -14.23 61.41 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.8 mtt85 -82.47 102.82 11.58 Favored 'General case' 0 CA--C 1.582 2.198 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 145.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.45 -114.56 0.11 Allowed Glycine 0 N--CA 1.482 1.714 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.347 0.1 OUTLIER -137.89 -65.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -134.48 136.26 43.04 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.099 1.318 . . . . 0.0 112.905 -161.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tt -89.83 119.41 30.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 156.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 1.6 pp -82.36 63.22 6.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -167.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.287 50.3 mm-40 67.21 7.58 5.57 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.3 -23.13 60.23 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 177.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 123.26 1.505 . . . . 0.0 114.991 173.66 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 CA--C 1.564 1.499 0 CA-C-O 121.372 0.606 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 78.06 9.57 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.12 111.61 6.9 Favored 'General case' 0 CA--C 1.561 1.372 0 C-N-CA 123.357 0.663 . . . . 0.0 110.9 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.92 155.89 20.73 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -72.95 157.74 36.83 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.83 -37.96 69.4 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 172.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -70.8 -33.37 70.65 Favored 'General case' 0 CA--C 1.579 2.077 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -58.33 -42.08 86.0 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 160.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -62.27 -40.78 97.34 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -51.27 -54.07 29.42 Favored 'General case' 0 CA--C 1.584 2.285 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 162.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.81 -49.39 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 175.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -55.36 -39.83 70.56 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 169.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.0 -45.88 76.21 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 171.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.72 -37.01 76.37 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 121.962 2.165 . . . . 0.0 116.569 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.291 0.2 OUTLIER -57.54 -48.83 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-N 120.376 1.444 . . . . 0.0 114.4 169.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.65 -47.98 83.82 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 166.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.49 -44.88 96.3 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 177.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -57.48 -39.61 76.8 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 171.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.37 -46.2 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 170.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 t -67.09 -27.37 67.3 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 118.047 2.61 . . . . 0.0 118.047 168.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.11 -46.77 14.45 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 177.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -124.87 -39.41 2.27 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.02 -27.73 3.28 Favored Glycine 0 CA--C 1.548 2.101 0 N-CA-C 117.442 1.737 . . . . 0.0 117.442 -173.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.72 149.11 35.43 Favored Pre-proline 0 CA--C 1.579 2.078 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -164.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.39 113.91 1.76 Allowed 'Trans proline' 0 CA--C 1.572 2.419 0 C-N-CA 122.481 2.121 . . . . 0.0 114.241 172.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -80.05 160.43 23.8 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 N-CA-C 118.475 2.452 . . . . 0.0 118.475 -168.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -105.99 -174.38 2.52 Favored 'General case' 0 CA--C 1.587 2.38 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.557 170.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -46.44 -30.33 2.12 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 120.16 3.393 . . . . 0.0 120.16 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.29 -39.48 69.93 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 170.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -90.38 -46.87 8.1 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 163.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.29 -45.08 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-N 120.254 1.388 . . . . 0.0 114.311 -173.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.41 -43.65 69.58 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 171.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -74.11 -52.0 13.94 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -71.2 -37.4 72.11 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -177.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.0 mt -78.44 -8.95 59.07 Favored 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 173.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.84 51.99 4.04 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 117.46 1.744 . . . . 0.0 117.46 177.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -90.33 99.73 12.7 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 118.014 0.907 . . . . 0.0 111.265 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -60.01 -20.24 56.76 Favored 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 165.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 98.1 p -111.89 92.92 18.97 Favored Pre-proline 0 CA--C 1.572 1.792 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.597 162.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -55.94 -32.42 85.54 Favored 'Trans proline' 0 N--CA 1.512 2.562 0 N-CA-C 120.149 3.096 . . . . 0.0 120.149 -175.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -57.4 -34.64 69.1 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 170.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.32 63.18 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 172.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.96 -56.6 13.19 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.74 -18.68 37.03 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 170.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.77 -40.18 88.11 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.161 1.8 . . . . 0.0 115.005 165.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -61.67 -38.01 86.19 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 162.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 tp -57.33 -41.48 80.08 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 165.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -61.44 -44.48 97.04 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 169.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.45 75.07 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 163.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.74 -41.01 97.09 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 167.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.97 -47.07 81.87 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 164.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -53.91 -45.79 71.27 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 170.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -66.7 -33.61 76.03 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 170.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.32 63.81 0.67 Allowed Glycine 0 N--CA 1.483 1.783 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.49 -33.94 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.49 153.04 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-O 121.987 0.899 . . . . 0.0 111.338 169.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -105.28 104.23 13.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.103 -0.998 . . . . 0.0 110.514 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.6 mt -80.93 110.77 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.954 0 O-C-N 121.483 -0.761 . . . . 0.0 109.018 176.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -94.39 138.98 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.474 0.71 . . . . 0.0 109.314 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.7 t -78.49 78.16 4.96 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 175.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.53 99.2 0.18 Allowed Glycine 0 N--CA 1.479 1.508 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.188 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 63.26 19.03 11.43 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 119.779 3.251 . . . . 0.0 119.779 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.371 51.9 p 71.97 -58.53 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 -175.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -84.06 77.35 9.95 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 122.492 1.139 . . . . 0.0 111.914 172.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.42 77.39 0.26 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.261 174.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.48 115.61 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.61 ' HE ' ' H ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -95.42 170.7 9.18 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.61 ' H ' ' HE ' ' A' ' 67' ' ' ARG . 10.1 mp -95.14 133.4 39.01 Favored 'General case' 0 CA--C 1.571 1.771 0 O-C-N 121.259 -0.901 . . . . 0.0 112.114 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.43 104.35 10.26 Favored 'General case' 0 CA--C 1.568 1.641 0 CA-C-O 121.809 0.814 . . . . 0.0 109.243 174.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -75.94 84.37 2.86 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.851 0.834 . . . . 0.0 113.154 173.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -137.14 -72.06 0.44 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.039 -176.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 125.38 2.514 . . . . 0.0 111.946 177.698 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 CA--C 1.566 1.576 0 CA-C-O 121.306 0.574 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -146.76 84.15 1.6 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . 0.356 . . 70.44 -65.2 0.34 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -165.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -68.99 164.83 21.44 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 160.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.7 p -81.64 158.79 24.18 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 176.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.44 -40.13 71.17 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 174.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -64.52 -37.82 88.88 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 169.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -58.5 -45.56 88.5 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 166.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -64.85 -38.81 92.21 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 171.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -51.44 -48.4 62.74 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 161.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.3 t -59.77 -47.76 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -57.81 -44.41 86.34 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 170.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.32 -40.68 91.48 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 170.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 -44.72 69.15 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.083 1.765 . . . . 0.0 114.994 175.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.316 0.2 OUTLIER -56.04 -47.78 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.634 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 167.234 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -54.15 -53.14 57.44 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 167.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -61.51 -46.28 90.66 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 178.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -70.06 -34.83 73.71 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 174.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.5 mm -56.06 -49.96 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 CA-C-N 120.0 1.273 . . . . 0.0 113.412 161.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 t -68.38 -32.34 72.34 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 176.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -90.59 -48.66 6.94 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 m -102.39 -38.52 7.57 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 109.56 -15.19 32.3 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 118.156 2.023 . . . . 0.0 118.156 -169.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 64.8 mtm -97.03 144.14 27.34 Favored Pre-proline 0 CA--C 1.576 1.961 0 CA-C-N 119.548 1.674 . . . . 0.0 113.732 -174.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -81.03 114.4 2.87 Favored 'Trans proline' 0 CA--C 1.566 2.089 0 C-N-CA 122.418 2.078 . . . . 0.0 113.68 174.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.54 124.57 7.09 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 CA-C-N 122.492 1.926 . . . . 0.0 115.035 -175.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.8 p -90.43 179.39 5.88 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 175.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -31.4 -45.84 0.09 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 121.596 3.924 . . . . 0.0 121.596 -178.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.53 -44.48 78.24 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 175.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -71.44 -44.16 65.36 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 172.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.9 mm -50.91 -46.92 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.381 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.24 97.64 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 169.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -64.27 -46.88 81.77 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.318 1.969 . . . . 0.0 116.318 178.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -78.01 -43.07 30.54 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 179.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 70.3 mt -86.94 -21.2 26.4 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 51.43 2.05 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 178.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -101.82 102.25 12.83 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 118.103 0.951 . . . . 0.0 108.906 171.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.9 ttt85 -55.31 -37.8 67.85 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 179.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.8 m -104.17 116.01 62.14 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.393 164.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -53.07 -17.97 8.97 Favored 'Trans proline' 0 N--CA 1.51 2.463 0 N-CA-C 120.577 3.26 . . . . 0.0 120.577 173.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.85 -28.15 69.66 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 165.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.28 -38.13 89.95 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.72 94.76 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 163.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -55.56 -46.68 77.15 Favored 'General case' 0 CA--C 1.583 2.237 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 165.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.63 -49.53 72.6 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 174.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -70.21 -32.87 70.96 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.3 mt -56.5 -54.85 41.03 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-N 121.503 1.956 . . . . 0.0 114.448 165.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -63.82 -44.04 94.45 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 174.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.49 94.71 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 169.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.03 -38.47 88.82 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 167.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.01 82.22 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 116.419 2.007 . . . . 0.0 116.419 165.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -68.08 -27.14 66.24 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 173.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.93 -34.88 73.82 Favored 'General case' 0 CA--C 1.585 2.324 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 160.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.94 -37.09 1.11 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 173.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -93.57 4.81 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -156.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.82 144.94 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 CA-C-N 120.246 1.385 . . . . 0.0 113.192 167.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -105.58 113.61 27.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.53 116.9 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.08 107.23 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 122.187 0.994 . . . . 0.0 112.667 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.7 m -84.46 94.78 8.61 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.011 0.91 . . . . 0.0 111.978 -170.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.51 -77.1 0.28 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.784 -167.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.6 -20.13 65.32 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 174.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . 0.33 18.8 m 77.65 -70.68 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 171.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -84.75 72.65 10.71 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-O 123.114 1.435 . . . . 0.0 113.331 175.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.88 71.27 0.29 Allowed Glycine 0 CA--C 1.539 1.561 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.766 165.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 46.2 mt -105.47 115.22 46.83 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -170.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -81.61 146.83 29.89 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.8 mt -91.75 104.96 17.35 Favored 'General case' 0 CA--C 1.573 1.833 0 O-C-N 121.972 -0.455 . . . . 0.0 110.064 168.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -93.39 88.85 6.11 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 121.732 0.777 . . . . 0.0 110.573 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.255 2.9 mp0 78.73 125.86 0.04 OUTLIER 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 124.537 1.135 . . . . 0.0 113.109 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -95.61 169.45 10.02 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 122.251 1.024 . . . . 0.0 113.074 -177.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.574 1.867 0 CA-C-O 124.345 2.021 . . . . 0.0 114.122 -168.669 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 tpt . . . . . 0 CA--C 1.561 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -143.29 83.76 1.79 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 121.811 0.815 . . . . 0.0 112.357 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.0 4.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.073 -1.017 . . . . 0.0 109.58 164.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.87 139.27 51.21 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -153.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.9 p -75.07 159.1 32.11 Favored 'General case' 0 CA--C 1.576 1.949 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.17 -45.02 64.94 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.892 2.923 . . . . 0.0 118.892 -177.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -69.07 -38.77 79.21 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 174.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.27 5.5 pt20 -70.31 -29.95 66.81 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 167.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -56.86 -47.76 79.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 161.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.99 -43.51 81.77 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 70.0 t -58.28 -48.98 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 168.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -53.51 -48.37 69.05 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 166.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.64 -37.42 73.3 Favored 'General case' 0 CA--C 1.576 1.952 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 170.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.43 -44.46 94.51 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 172.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.324 0.0 OUTLIER -61.98 -45.55 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 166.156 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -57.0 -46.89 81.97 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 168.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -58.85 -53.67 55.81 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 171.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -67.87 -36.55 80.48 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 66.2 mt -67.32 -48.33 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-N 119.972 1.26 . . . . 0.0 112.563 167.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -63.23 -30.45 71.59 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 118.021 2.6 . . . . 0.0 118.021 174.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -93.2 -42.92 9.1 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.7 p -107.98 -19.14 13.61 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -179.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.78 -48.39 1.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 116.852 1.501 . . . . 0.0 116.852 -173.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 149.86 43.63 Favored Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -175.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -62.14 148.05 93.91 Favored 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 122.412 2.075 . . . . 0.0 116.514 170.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.07 147.57 21.05 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.247 1.965 . . . . 0.0 115.243 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 p -75.23 165.33 25.36 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-O 122.492 1.139 . . . . 0.0 113.933 176.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -52.03 -43.74 63.86 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 176.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.04 80.4 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 117.176 2.287 . . . . 0.0 117.176 169.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.45 -49.5 77.32 Favored 'General case' 0 CA--C 1.578 2.05 0 CA-C-N 120.294 1.406 . . . . 0.0 114.598 167.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.9 mt -56.67 -44.7 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 171.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.02 -52.44 16.95 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -89.73 -37.32 14.63 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -167.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -64.24 -37.74 88.55 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.516 1.672 . . . . 0.0 115.516 172.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.97 -9.69 59.71 Favored 'General case' 0 CA--C 1.585 2.29 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 170.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.99 54.74 4.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 117.489 1.755 . . . . 0.0 117.489 178.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -96.65 135.83 38.03 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-O 121.78 0.8 . . . . 0.0 111.777 176.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -40.57 92.08 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 175.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.1 t -119.49 125.57 27.44 Favored Pre-proline 0 CA--C 1.567 1.622 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.267 171.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.42 -36.7 49.25 Favored 'Trans proline' 0 N--CA 1.506 2.257 0 N-CA-C 118.673 2.528 . . . . 0.0 118.673 165.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -58.22 -36.0 72.51 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 169.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 -49.05 73.71 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 165.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.55 -48.86 71.52 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.243 2.312 . . . . 0.0 117.243 172.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.32 -33.05 72.56 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 171.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.79 -36.0 82.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 165.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -60.78 -40.84 94.1 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 164.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 tp -55.84 -49.44 73.29 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 164.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.1 -46.92 86.9 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 174.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.32 -37.48 80.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 171.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.44 -46.87 53.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 169.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.48 -36.82 76.73 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 172.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -55.56 -26.93 46.15 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 169.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -71.17 -50.95 27.82 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 170.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 165.0 -43.23 0.29 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 119.025 2.37 . . . . 0.0 119.025 -177.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.12 -35.1 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 N-CA-C 119.268 3.062 . . . . 0.0 119.268 -168.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.5 155.81 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 C-N-CA 123.755 0.822 . . . . 0.0 110.688 172.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -112.06 145.6 39.44 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 112.221 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.96 151.1 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 122.187 0.994 . . . . 0.0 111.839 177.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.1 m -59.81 139.64 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -167.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.2 t -81.7 72.48 8.75 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 121.538 0.685 . . . . 0.0 112.759 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.93 -73.55 2.45 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 116.25 1.26 . . . . 0.0 116.25 -176.54 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.41 138.5 39.32 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 m -55.7 -34.39 65.04 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.573 3.175 . . . . 0.0 119.573 -174.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -89.2 69.06 8.24 Favored 'General case' 0 CA--C 1.581 2.166 0 CA-C-N 119.895 1.225 . . . . 0.0 112.369 172.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.59 43.13 0.85 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 117.013 1.565 . . . . 0.0 117.013 -179.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.4 mt -102.1 103.58 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -176.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -88.86 129.32 35.61 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -175.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.1 tp -90.98 69.84 6.33 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.654 0.782 . . . . 0.0 112.428 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.33 1.8 pp -74.97 -23.87 58.36 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 120.186 3.402 . . . . 0.0 120.186 -167.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -98.49 -60.85 1.46 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -90.62 63.45 5.45 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 121.658 0.742 . . . . 0.0 112.491 178.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 123.881 1.801 . . . . 0.0 114.928 -165.476 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.1 mtp . . . . . 0 CA--C 1.567 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.411 32.6 mmtp 75.17 -106.78 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 124.446 1.099 . . . . 0.0 113.88 -178.646 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.64 103.18 6.94 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 118.919 0.781 . . . . 0.0 111.928 -174.156 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.26 121.23 40.59 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 123.001 0.52 . . . . 0.0 110.008 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.6 p -64.04 154.32 34.66 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 167.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.85 46.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -63.41 -56.11 18.92 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 169.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -63.36 -33.73 76.17 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 174.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -58.06 -49.53 76.59 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 170.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -67.82 -27.13 66.45 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.65 -56.3 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.357 0 CA-C-N 119.866 1.212 . . . . 0.0 112.764 160.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.43 -50.71 70.85 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 172.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.49 -44.4 96.48 Favored 'General case' 0 CA--C 1.563 1.46 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 179.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 tp -56.99 -37.83 72.18 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 171.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.4 -49.46 83.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 119.714 1.143 . . . . 0.0 113.119 169.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -56.88 -48.47 78.08 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 169.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.3 -53.02 62.65 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -74.18 -34.8 63.9 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -176.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.4 mm -60.7 -42.95 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.575 0 CA-C-N 120.159 1.345 . . . . 0.0 112.637 163.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.9 m -68.61 -49.63 57.74 Favored 'General case' 0 CA--C 1.575 1.916 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 175.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -78.03 -15.7 58.71 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -143.21 -50.62 0.34 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 112.469 -177.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.93 -26.53 5.05 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 118.114 2.006 . . . . 0.0 118.114 -179.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -97.54 152.04 37.96 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.66 121.31 6.62 Favored 'Trans proline' 0 CA--C 1.56 1.789 0 C-N-CA 121.945 1.763 . . . . 0.0 114.6 -176.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -77.29 106.69 2.27 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 122.437 2.092 . . . . 0.0 112.325 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . 0.305 7.3 t -84.96 -169.15 2.51 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -173.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -55.53 -39.37 70.46 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -168.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.57 86.37 Favored 'General case' 0 CA--C 1.567 1.622 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 168.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.5 mp0 -60.03 -46.21 90.28 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 170.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 60.2 mt -57.57 -58.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 123.909 0.884 . . . . 0.0 113.243 172.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.71 85.28 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 118.188 2.662 . . . . 0.0 118.188 -179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -75.37 -32.85 60.95 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 171.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -53.22 18.53 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 171.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.72 -26.15 20.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 -178.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.0 52.97 0.81 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -95.34 107.46 19.58 Favored 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 118.185 0.993 . . . . 0.0 110.053 170.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -84.48 53.53 2.69 Favored 'General case' 0 CA--C 1.584 2.262 0 O-C-N 121.29 -0.881 . . . . 0.0 113.078 169.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -178.32 111.32 0.22 Allowed Pre-proline 0 CA--C 1.577 2.015 0 C-N-CA 124.852 1.261 . . . . 0.0 109.158 -174.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.57 -38.7 75.87 Favored 'Trans proline' 0 N--CA 1.51 2.486 0 N-CA-C 118.417 2.429 . . . . 0.0 118.417 169.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.88 -33.68 73.47 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 171.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -50.63 68.93 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 169.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.52 -48.83 76.4 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 170.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.33 -43.48 92.73 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 171.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.86 -38.19 88.18 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 174.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -69.84 -35.65 74.92 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 168.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 71.6 mt -53.45 -50.67 64.78 Favored 'General case' 0 CA--C 1.582 2.192 0 CA-C-N 120.484 1.493 . . . . 0.0 114.659 160.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -51.6 -45.05 63.04 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 167.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.0 -39.09 65.75 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 169.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.98 -45.95 72.71 Favored 'General case' 0 CA--C 1.583 2.231 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 167.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.98 86.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 170.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -66.06 -37.75 86.6 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -65.42 -41.8 93.2 Favored 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 161.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 48.56 0.21 Allowed Glycine 0 N--CA 1.485 1.947 0 N-CA-C 116.651 1.42 . . . . 0.0 116.651 166.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.53 -35.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 -170.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.6 pt -107.98 144.05 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 120.962 1.71 . . . . 0.0 113.412 -179.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -96.21 115.35 27.29 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 172.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.35 122.93 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -81.5 116.38 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 167.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.4 m -94.88 91.53 6.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 110.976 176.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.04 -63.14 0.49 Allowed Glycine 0 N--CA 1.488 2.115 0 N-CA-C 114.818 0.687 . . . . 0.0 114.818 -174.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.14 164.9 25.24 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 174.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -76.52 -67.06 0.73 Allowed 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 177.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -89.54 78.85 6.99 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 122.795 1.283 . . . . 0.0 113.544 -169.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.22 66.34 0.31 Allowed Glycine 0 N--CA 1.483 1.773 0 CA-C-N 114.355 -1.293 . . . . 0.0 114.246 171.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.5 mm -130.7 96.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.64 137.19 26.48 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -164.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 mt -76.19 136.31 39.75 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.82 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -78.61 85.54 4.65 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-O 121.777 0.799 . . . . 0.0 110.057 174.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . 0.299 4.2 tp60 75.48 124.83 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.059 -156.029 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -82.92 67.28 8.93 Favored 'General case' 0 CA--C 1.579 2.063 0 CA-C-O 121.932 0.872 . . . . 0.0 113.334 -175.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 123.446 1.593 . . . . 0.0 110.267 -173.436 . . . . . . . . 0 0 . 1 stop_ save_